Fungicidal compositions

Abstract

A fungicidal composition comprising a mixture of components (A) and (B), wherein components (A) and (B) are as defined in claim 1, and use of the compositions in agriculture or horticulture for controlling or preventing infestation of plants by phytopathogenic microorganisms, preferably fungi.

Claims

1. A fungicidal composition comprising a mixture of components (A) and (B) as active ingredients, wherein component (A) is a compound of formula (I): ##STR00066## Y is CF or CH; X is N; R.sup.1 is C.sub.1-C.sub.4alkyl, C.sub.1-C.sub.4alkoxy, C.sub.1-C.sub.4haloalkyl or HC(O)NH; R.sup.2 is C.sub.1-C.sub.8alkyl, C.sub.3-C.sub.8cycloalkyl, C.sub.3-CacycloalkylC.sub.1-C.sub.2alkyl (wherein the cycloalkyl groups are optionally substituted with 1 to 3 groups represented by R.sup.3), phenyl, phenylC.sub.1-C.sub.2alkyl (wherein the phenyl rings are optionally substituted with 1 to 3 groups represented by R.sup.3), or a 5- to 12-membered non-aromatic spirocyclic carbobi- or carbotri-cyclyl ring system; R.sup.3 is C.sub.1-C.sub.3alkyl, C.sub.1-C.sub.3haloalkyl, or C.sub.3-C.sub.6cycloalkylC.sub.1-C.sub.2alkyl; or a salt or an N-oxide thereof; and component (B) is a compound selected from the group consisting of: azoxystrobin, trifloxystrobin, pyraclostrobin, picoxystrobin, coumoxystrobin, metyltetraprole, cyproconazole, tebuconazole, difenoconazole, hexaconazole, propiconazole, fenhexamid, prothioconazole, mefentrifluconazole, prochloraz, fenpropidin, fenpropimorph, fluxapyroxad, fluopyram, isopyrazam, sedaxane, benzovindiflupyr, pydiflumetofen, isoflucypram, bixafen, penthiopyrad, inpyrfluxam, isofetamid, pyrapropoyne, fluindapyr, fenpicoxamid, florylpicoxamid, acibenzolar-S-methyl, trinexepac-ethyl, fosetyl-aluminium, chlorothalonil, mancozeb, mandipropamid, oxathiapiprolin, fluazinam, fludioxonil, cyprodinil, metalaxyl-M, aminopyrifen, folpet, ipflufenoquin, quinofumelin, tebufloquin, tolprocarb, tricyclazole, pyroquilon, cyflufenamid, metrafenone, N-[2-chloro-4-(2-fluorophenoxy)-5-methyl-phenyl]-N-ethyl-N-methyl-formamidine, N-[4-(2-bromophenoxy)-5-chloro-2-methyl-phenyl]-N-ethyl-N-methyl-formamidine, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4, 5-trifluoro-3,3-dimethyl-isoquinoline, 4,4-difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4, 6-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, 6-chloro-4,4-difluoro-3,3-dimethyl-1-(4-methylbenzimidazol-1-yl)isoquinoline, N-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidine, N-[5-chloro-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidine, N-[5-bromo-2-methyl-6- (1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-isopropyl-N-methyl-formamidine, N-isopropyl-N-[5-methoxy-2-methyl-4-(2,2,2-trifluoro-1-hydroxy-1-phenyl-ethyl)phenyl]-N-methyl-formamidine, N-methoxy-N-[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]cyclopropanecarboxamide, N,2-dimethoxy-N-[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propanamide, N-ethyl-2-methyl-N-[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propanamide, 1-methoxy-3-methyl-1-[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1,3-dimethoxy-1-[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 3-ethyl-1-methoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, ethyl 1-[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxylate, N,N-dimethyl-1-[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-1,2,4-triazol-3-amine, methyl (Z)-3-methoxy-2-[2-methyl-5-[3-(trifluoromethyl)pyrazol-1-yl]phenoxy]prop-2-enoate, methyl (Z)-3-methoxy-2-[2-methyl-5-(3-propylpyrazol-1-yl)phenoxy]prop-2-enoate, methyl (Z)-2-[5-(3-isopropylpyrazol-1-yl)-2-methyl-phenoxy]-3-methoxy-prop-2-enoate, methyl (Z)-3-methoxy-2-[2-methyl-5-(4-propyltriazol-2-yl)phenoxy]prop-2-enoate, methyl (Z)-3-methoxy-2-[2-methyl-5-[4-(trifluoromethyl)triazol-2-yl]phenoxy]prop-2-enoate, methyl (Z)-2-(5-cyclohexyl-2-methyl-phenoxy)-3-methoxy-prop-2-enoate, methyl (Z)-2-(5-cyclopentyl-2-methyl-phenoxy)-3-methoxy-prop-2-enoate, methyl (Z)-2-[5-(4-cyclohexylthiazol-2-yl)-2-methyl-phenoxy]-3-methoxy-prop-2-enoate, methyl (Z)-2-[5-[4-(ethoxymethyl)thiazol-2-yl]-2-methyl-phenoxy]-3-methoxy-prop-2-enoate, methyl (Z)-2-[5-(4-bromothiazol-2-yl)-2-methyl-phenoxy]-3-methoxy-prop-2-enoate, methyl (Z)-3-methoxy-2-[2-methyl-5-[5-(trifluoromethyl) thiazol-2-yl]phenoxy]prop-2-enoate, Bacillus amyloliquefaciens strain FZB24, plant extract comprising tea tree oil, and metarylpicoxamid.

2. The fungicidal composition according claim 1, wherein component (A) is a compound selected from: 2-[cyano-(5-fluoro-3-pyridyl)amino]-N-cyclobutyl-5-methyl-thiazole-4-carboxamide (compound X.01); 2-[cyano-(2,6-difluoro-4-pyridyl)amino]-N-cyclobutyl-5-methyl-thiazole-4-carboxamide (compound X.02); 2-(N-cyano-3,5-difluoro-anilino)-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazole-4-carboxamide (compound X.03); 2-[cyano-(5-fluoro-3-pyridyl)amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazole-4-carboxamide (compound X.04); 2-[cyano-(2,6-difluoro-4-pyridyl)amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazole-4-carboxamide (compound X.05); 2-[cyano-(2,6-difluoro-4-pyridyl)amino]-N-(2,2-dimethylcyclobutyl)-5-formamido-thiazole-4-carboxamide (compound X.06); 2-[cyano-(2,6-difluoro-4-pyridyl)amino]-5-methyl-N-spiro [3.4] octan-3-yl-thiazole-4-carboxamide (compound X.07); 2-[cyano-(2,6-difluoro-4-pyridyl)amino]-5-methyl-N-spiro [cyclobutane-2,2-indane]-1-yl-thiazole-4-carboxamide (compound X.08); 2-[cyano-(2,6-difluoro-4-pyridyl)amino]-5-methyl-N-spiro [3.3] heptan-3-yl-thiazole-4-carboxamide (compound X.09); 2-[cyano-(2,6-difluoro-4-pyridyl)amino]-N-[1-(cyclopropylmethyl) cyclopropyl] methyl]-5-methyl-thiazole-4-carboxamide (compound X.10); 2-(N-cyano-3,5-difluoro-anilino)-5-methyl-N-(1-methylcyclopentyl) thiazole-4-carboxamide (compound X.11); 2-[cyano-(2,6-difluoro-4-pyridyl)amino]-5-methyl-N-(1-methylcyclopentyl) thiazole-4-carboxamide (compound X.12); 2-[cyano-(5-fluoro-3-pyridyl)amino]-N-hexyl-5-methyl-thiazole-4-carboxamide (compound X.13); 2-[cyano-(2,6-difluoro-4-pyridyl)amino]-N-hexyl-5-methyl-thiazole-4-carboxamide (compound X.14); 2-[cyano-(2,6-difluoro-4-pyridyl)amino]-N-isobutyl-5-methyl-thiazole-4-carboxamide (compound X.15); 2-[cyano-(2,6-difluoro-4-pyridyl)amino]-5-methyl-N-(1-phenylethyl) thiazole-4-carboxamide (compound X.16); 2-[cyano-(5-fluoro-3-pyridyl)amino]-N-(2,2-dimethylpropyl)-5-methyl-thiazole-4-carboxamide (compound X.17); 2-[cyano-(2,6-difluoro-4-pyridyl)amino]-N-(2,2-dimethylpropyl)-5-methyl-thiazole-4-carboxamide (compound X.18); 2-[cyano-(5-fluoro-3-pyridyl)amino]-5-methyl-N-pentyl-thiazole-4-carboxamide (compound X.19); 2-[cyano-(2,6-difluoro-4-pyridyl)amino]-5-methyl-N-pentyl-thiazole-4-carboxamide (compound X.20); 2-[cyano-(5-fluoro-3-pyridyl)amino]-N-isopentyl-5-methyl-thiazole-4-carboxamide (compound X.21); N-[[3,5-bis (trifluoromethyl)phenyl]methyl]-2-[cyano-(2,6-difluoro-4-pyridyl)amino]-5-methyl-thiazole-4-carboxamide (compound X.22); N-benzyl-2-[cyano-(2,6-difluoro-4-pyridyl)amino]-5-methyl-thiazole-4-carboxamide (compound X.23); and N-butyl-2-[cyano-(2,6-difluoro-4-pyridyl)amino]-5-methyl-thiazole-4-carboxamide (compound X.24).

3. The fungicidal composition according to claim 1, wherein component (A) is a compound selected from: 2-[cyano-(5-fluoro-3-pyridyl)amino]-N-cyclobutyl-5-methyl-thiazole-4-carboxamide (compound X.01); 2-[cyano-(2,6-difluoro-4-pyridyl)amino]-N-cyclobutyl-5-methyl-thiazole-4-carboxamide (compound X.02); 2-(N-cyano-3,5-difluoro-anilino)-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazole-4-carboxamide (compound X.03); 2-[cyano-(5-fluoro-3-pyridyl)amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazole-4-carboxamide (compound X.04); 2-[cyano-(2,6-difluoro-4-pyridyl)amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazole-4-carboxamide (compound X.05); 2-[cyano-(2,6-difluoro-4-pyridyl)amino]-5-methyl-N-spiro [3.4] octan-3-yl-thiazole-4-carboxamide (compound X.07); 2-[cyano-(2,6-difluoro-4-pyridyl)amino]-5-methyl-N-spiro [3.3] heptan-3-yl-thiazole-4-carboxamide (compound X.09); 2-(N-cyano-3,5-difluoro-anilino)-5-methyl-N-(1-methylcyclopentyl) thiazole-4-carboxamide (compound X.11); 2-[cyano-(2,6-difluoro-4-pyridyl)amino]-5-methyl-N-(1-methylcyclopentyl) thiazole-4-carboxamide (compound X.12); X.14, X.15, X.16, X.17, X.18, 2-[cyano-(2,6-difluoro-4-pyridyl)amino]-N-hexyl-5-methyl-thiazole-4-carboxamide (compound X.14); 2-[cyano-(2,6-difluoro-4-pyridyl)amino]-N-isobutyl-5-methyl-thiazole-4-carboxamide (compound X.15); 2-[cyano-(2,6-difluoro-4-pyridyl)amino]-5-methyl-N-(1-phenylethyl) thiazole-4-carboxamide (compound X.16); 2-[cyano-(5-fluoro-3-pyridyl)amino]-N-(2,2-dimethylpropyl)-5-methyl-thiazole-4-carboxamide (compound X.17); 2-[cyano-(2,6-difluoro-4-pyridyl)amino]-N-(2,2-dimethylpropyl)-5-methyl-thiazole-4-carboxamide (compound X.18); and N-butyl-2-[cyano-(2,6-difluoro-4-pyridyl)amino]-5-methyl-thiazole-4-carboxamide (compound X.24).

4. The fungicidal composition according to claim 1, wherein component (A) is a compound selected from: 2-[cyano-(5-fluoro-3-pyridyl)amino]-N-cyclobutyl-5-methyl-thiazole-4-carboxamide (compound X.01); 2-[cyano-(2,6-difluoro-4-pyridyl)amino]-N-cyclobutyl-5-methyl-thiazole-4-carboxamide (compound X.02); 2-(N-cyano-3,5-difluoro-anilino)-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazole-4-carboxamide (compound X.03); 2-[cyano-(5-fluoro-3-pyridyl)amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazole-4-carboxamide (compound X.04); 2-[cyano-(2,6-difluoro-4-pyridyl)amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazole-4-carboxamide (compound X.05); 2-[cyano-(2,6-difluoro-4-pyridyl)amino]-5-methyl-N-spiro [3.4] octan-3-yl-thiazole-4-carboxamide (compound X.07); 2-[cyano-(2,6-difluoro-4-pyridyl)amino]-5-methyl-N-spiro [3.3] heptan-3-yl-thiazole-4-carboxamide (compound X.09); 2-(N-cyano-3,5-difluoro-anilino)-5-methyl-N-(1-methylcyclopentyl) thiazole-4-carboxamide (compound X.11); 2-[cyano-(2,6-difluoro-4-pyridyl)amino]-5-methyl-N-(1-methylcyclopentyl) thiazole-4-carboxamide (compound X.12); X.14, X.15, X.16, X.17, X.18, 2-[cyano-(2,6-difluoro-4-pyridyl)amino]-N-hexyl-5-methyl-thiazole-4-carboxamide (compound X.14); and 2-[cyano-(2,6-difluoro-4-pyridyl)amino]-N-(2,2-dimethylpropyl)-5-methyl-thiazole-4-carboxamide (compound X.18).

5. The fungicidal composition according to claim 1, wherein component (B) is a compound selected from the group consisting of azoxystrobin, trifloxystrobin, metyltetraprole, difenoconazole, hexaconazole, propiconazole, prothioconazole, mefentrifluconazole, fenpropidin, fenpropimorph, fluxapyroxad, fluopyram, isopyrazam, sedaxane, benzovindiflupyr, pydiflumetofen, isoflucypram, isofetamid, pyrapropoyne, fluindapyr, fenpicoxamid, florylpicoxamid, acibenzolar-S-methyl, chlorothalonil, mancozeb, mandipropamid, oxathiapiprolin, fluazinam, fludioxonil, cyprodinil, metalaxyl-M, aminopyrifen, folpet, ipflufenoquin, quinofumelin, tricyclazole, pyroquilon, cyflufenamid, metrafenone, N-[2-chloro-4-(2-fluorophenoxy)-5-methyl-phenyl]-N-ethyl-N-methyl-formamidine N-[4-(2-bromophenoxy)-5-chloro-2-methyl-phenyl]-N-ethyl-N-methyl-formamidine, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 4,4-difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,6-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, 6-chloro-4,4-difluoro-3,3-dimethyl-1-(4-methylbenzimidazol-1-yl)isoquinoline, N-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidine, N-[5-chloro-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidine, N-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-isopropyl-N-methyl-formamidine, N-isopropyl-N-[5-methoxy-2-methyl-4-(2,2,2-trifluoro-1-hydroxy-1-phenyl-ethyl)phenyl]-N-methyl-formamidine, N-methoxy-N-[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]cyclopropanecarboxamide, N,2-dimethoxy-N-[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propanamide, N-ethyl-2-methyl-N-[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propanamide, 1-methoxy-3-methyl-1-[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1,3-dimethoxy-1-[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 3-ethyl-1-methoxy-1-[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, ethyl 1-[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxylate, N,N-dimethyl-1-[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-1,2,4-triazol-3-amine, methyl (Z)-3-methoxy-2-[2-methyl-5-[3-(trifluoromethyl)pyrazol-1-yl]phenoxy]prop-2-enoate, methyl (Z)-3-methoxy-2-[2-methyl-5-(3-propylpyrazol-1-yl)phenoxy]prop-2-enoate, methyl (Z)-2-[5-(3-isopropylpyrazol-1-yl)-2-methyl-phenoxy]-3-methoxy-prop-2-enoate, methyl (Z)-3-methoxy-2-[2-methyl-5-(4-propyltriazol-2-yl)phenoxy]prop-2-enoate, methyl (Z)-3-methoxy-2-[2-methyl-5-[4-(trifluoromethyl)triazol-2-yl]phenoxy]prop-2-enoate, methyl (Z)-2-(5-cyclohexyl-2-methyl-phenoxy)-3-methoxy-prop-2-enoate, methyl (Z)-2-(5-cyclopentyl-2-methyl-phenoxy)-3-methoxy-prop-2-enoate, methyl (Z)-2-[5-(4-cyclohexylthiazol-2-yl)-2-methyl-phenoxy]-3-methoxy-prop-2-enoate, methyl (Z)-2-[5-[4-(ethoxymethyl)thiazol-2-yl]-2-methyl-phenoxy]-3-methoxy-prop-2-enoate, methyl (Z)-2-[5-(4-bromothiazol-2-yl)-2-methyl-phenoxy]-3-methoxy-prop-2-enoate, methyl (Z)-3-methoxy-2-[2-methyl-5-[5-(trifluoromethyl) thiazol-2-yl]phenoxy]prop-2-enoate, bixafen, fosetyl-aluminium, Bacillus amyloliquefaciens strain FZB24, plant extract comprising tea tree oil, and metarylpicoxamid.

6. The fungicidal composition according to claim 1, wherein component (B) is a compound selected from the group consisting of azoxystrobin, trifloxystrobin, metyltetraprole, difenoconazole, hexaconazole, propiconazole, prothioconazole, mefentrifluconazole, fenpropidin, fenpropimorph, fluxapyroxad, fluopyram, isopyrazam, sedaxane, benzovindiflupyr, pydiflumetofen, isoflucypram, isofetamid, pyrapropoyne, fluindapyr, fenpicoxamid, florylpicoxamid, chlorothalonil, mancozeb, mandipropamid, oxathiapiprolin, fluazinam, fludioxonil, cyprodinil, metalaxyl-M, aminopyrifen, folpet, ipflufenoquin, quinofumelin, tricyclazole, pyroquilon, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4, 5-trifluoro-3,3-dimethyl-isoquinoline, 4,4-difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, and 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline.

7. The fungicidal composition according to claim 1, wherein the weight ratio of component (A) to component (B) is from 100:1 to 1:100.

8. The fungicidal composition according to claim 1, wherein the weight ratio of component (A) to component (B) is from 20:1 to 1:40.

9. The fungicidal composition according to claim 1, wherein the weight ratio of component (A) to component (B) is from 12:1 to 1:25.

10. The fungicidal composition according to claim 1, wherein the weight ratio of component (A) to component (B) is from 5:1 and 1:15.

11. The fungicidal composition according to claim 1, wherein the weight ratio of component (A) to component (B) is from 2:1 to 1:5.

12. The fungicidal composition according to claim 1, wherein the composition comprises one or more further pesticides selected from the group consisting of: a fungicide, selected from etridiazole, fluazinam, benzovindiflupyr, pydiflumetofen, benalaxyl, benalaxyl-M (kiralaxyl), furalaxyl, metalaxyl, metalaxyl-M (mefenoxam), dodicin, N-(2,5-Dimethyl-4-phenoxy-phenyl)-N-ethyl-N-methyl-formamidine, N-[4-(4,5-Dichloro-thiazol-2-yloxy)-2,5-dimethyl-phenyl]-N-ethyl-N-methyl-formamidine, N-[4-[3-[(4-chlorophenyl) methyl]-1,2,4-thiadiazol-5-yl] oxy]-2,5-dimethyl-phenyl]-N-ethyl-N-methyl-formamidine, ethirimol, 3-chloro-2-methoxy-N-[(3RS)-tetrahydro-2-oxofuran-3-yl]acet-2,6-xylidide (clozylacon), cyprodinil, mepanipyrim, pyrimethanil, dithianon, aureofungin, blasticidin-S, biphenyl, chloroneb, dicloran, hexachlorobenzene, quintozene, tecnazene, (TCNB), tolclofos-methyl, metrafenone, 2,6-dichloro-N-(4-trifluoromethylbenzyl)-benzamide, fluopicolide (flupicolide), tioxymid, flusulfamide, benomyl, carbendazim, carbendazim chlorhydrate, chlorfenazole, fuberidazole, thiabendazole, thiophanate-methyl, benthiavalicarb, chlobenthiazone, probenazole, acibenzolar, bethoxazin, pyriofenone (IKF-309), acibenzolar-S-methyl, pyribencarb (KIF-7767), butylamine, 3-iodo-2-propinyl n-butylcarbamate (IPBC), iodocarb (isopropanyl butylcarbamate), isopropanyl butylcarbamate (iodocarb), picarbutrazox, polycarbamate, propamocarb, tolprocarb, 3-(difluoromethyl)-N-(7-fluoro-1, 1,3,3-tetramethyl-indan-4-yl)-1-methyl-pyrazole-4-carboxamide diclocymet, N-[(5-chloro-2-isopropyl-phenyl) methyl]-N-cyclopropyl-3-(difluoromethyl)-5-fluoro-1-methyl-pyrazole-4-carboxamide N-cyclopropyl-3-(difluoromethyl)-5-fluoro-N-[(2-isopropylphenyl) methyl]-1-methyl-pyrazole-4-carboxamide carpropamid, chlorothalonil, flumorph, oxine-copper, cymoxanil, phenamacril, cyazofamid, flutianil, thicyofen, chlozolinate, iprodione, procymidone, vinclozolin, bupirimate, dinocton, dinopenton, dinobuton, dinocap, meptyldinocap, diphenylamine, phosdiphen, 2,6-dimethyl-[1,4]dithiino[2,3-c:5,6-c]dipyrrole-1,3,5,7 (2H,6H)-tetraone, azithiram, etem, ferbam, mancozeb, maneb, metam, metiram (polyram), metiram-zinc, nabam, propineb, thiram, vapam (metam sodium), zineb, ziram, dithioether, isoprothiolane, ethaboxam, fosetyl, fosetyl-aluminium (fosetyl-al), methyl bromide, methyl iodide, methyl isothiocyanate, cyclafuramid, fenfuram, validamycin, streptomycin, (2RS)-2-bromo-2-(bromomethyl) glutaronitrile (bromothalonil), dodine, doguadine, guazatine, iminoctadine, iminoctadine triacetate, 2,4-D, 2,4-DB, kasugamycin, dimethirimol, fenhexamid, hymexazole, hydroxyisoxazole imazalil, imazalil sulphate, oxpoconazole, pefurazoate, prochloraz, triflumizole, fenamidone, Bordeaux mixture, calcium polysulfide, copper acetate, copper carbonate, copper hydroxide, copper naphthenate, copper oleate, copper oxychloride, copper oxyquinolate, copper silicate, copper sulphate, copper tallate, cuprous oxide, sulphur, carbaryl, phthalide (fthalide), dingjunezuo (Jun Si Qi), oxathiapiprolin, fluoroimide, mandipropamid, KSF-1002, benzamorf, dimethomorph, fenpropimorph, tridemorph, dodemorph, diethofencarb, fentin acetate, fentin hydroxide, carboxin, oxycarboxin, drazoxolon, famoxadone, m-phenylphenol, p-phenylphenol, tribromophenol (TBP), 2-[2-[(7,8-difluoro-2-methyl-3-quinolyl)oxy]-6-fluoro-phenyl]propan-2-ol 2-[2-fluoro-6-[(8-fluoro-2-methyl-3-quinolyl)oxy]phenyl]propan-2-ol, cyflufenamid, ofurace, oxadixyl, flutolanil, mepronil, isofetamid, fenpiclonil, fludioxonil, pencycuron, edifenphos, iprobenfos, pyrazophos, phosphorus acids, tecloftalam, captafol, captan, ditalimfos, triforine, fenpropidin, piperalin, osthol, 1-methylcyclopropene, 4-CPA, chlormequat, clofencet, dichlorprop, dimethipin, endothal, ethephon, flumetralin, forchlorfenuron, gibberellic acid, gibberellins, hymexazol, maleic hydrazide, mepiquat, naphthalene acetamide, paclobutrazol, prohexadione, prohexadione-calcium, thidiazuron, tribufos (tributyl phosphorotrithioate), trinexapac, uniconazole, -naphthalene acetic acid, polyoxin D (polyoxrim), BLAD, chitosan, fenoxanil, folpet, 3-(difluoromethyl)-N-methoxy-1-methyl-N-[1-methyl-2-(2,4,6-trichlorophenyl) ethyl] pyrazole-4-carboxamide, bixafen, fluxapyroxad, furametpyr, isopyrazam, penflufen, penthiopyrad, sedaxane, fenpyrazamine, diclomezine, pyrifenox, boscalid, fluopyram, diflumetorim, fenarimol, 5-fluoro-2-(p-tolylmethoxy) pyrimidin-4-amine ferimzone, dimetachlone (dimethaclone), pyroquilon, proquinazid, ethoxyquin, quinoxyfen, 4,4,5-trifluoro-3,3-dimethyl-1-(3-quinolyl)isoquinoline 4,4-difluoro-3,3-dimethyl-1-(3-quinolyl)isoquinoline 5-fluoro-3,3,4,4-tetramethyl-1-(3-quinolyl)isoquinoline 9-fluoro-2,2-dimethyl-5-(3-quinolyl)-3H-1,4-benzoxazepine, tebufloquin, oxolinic acid, chinomethionate (oxythioquinox, quinoxymethionate), spiroxamine, (E)-N-methyl-2-[2-(2, 5-dimethylphenoxymethyl) phenyl]-2-methoxy-iminoacetamide, (mandestrobin), azoxystrobin, coumoxystrobin, dimoxystrobin, enestroburin, pyriotrobin, fenamistrobin, flufenoxystrobin, fluoxastrobin, kresoxim-methyl, mandestrobin, metaminostrobin, metominostrobin, orysastrobin, picoxystrobin, pyraclostrobin, pyrametostrobin, pyraoxystrobin, triclopyricarb, trifloxystrobin, amisulbrom, dichlofluanid, tolylfluanid, but-3-ynyl N-[6-[(Z)-[(1-methyltetrazol-5-yl)-phenyl-methylene] amino] oxymethyl]-2-pyridyl] carbamate, dazomet, isotianil, tiadinil, thifluzamide, benthiazole (TCMTB), silthiofam, zoxamide, anilazine, tricyclazole, (.+.)-cis-1-(4-chlorophenyl)-2-(1H-1,2,4-triazol-1-yl)-cycloheptanol (huanjunzuo), 1-(5-bromo-2-pyridyl)-2-(2,4-difluorophenyl)-1,1-difluoro-3-(1,2,4-triazol-1-yl) propan-2-ol 2-(1-tert-butyl)-1-(2-chlorophenyl)-3-(1,2,4-triazol-1-yl)-propan-2-ol (TCDP), (N-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidine), azaconazole, bitertanol (biloxazol), bromuconazole, climbazole, cyproconazole, difenoconazole, dimetconazole, diniconazole, diniconazole-M, epoxiconazole, etaconazole, fenbuconazole, fluquinconazole, flusilazole, flutriafol, hexaconazole, imibenconazole, ipconazole, metconazole, myclobutanil, penconazole, propiconazole, prothioconazole, mefentrifluconazole, simeconazole, tebuconazole, tetraconazole, triadimefon, triadimenol, triazoxide, triticonazole, 2-[[(1R,5S)-5-[(4-fluorophenyl)methyl]-1-hydroxy-2,2-dimethyl-cyclopentyl]methyl]-4H-1,2,4-triazole-3-thione 2-[3-(2-chlorophenyl)-2-(2,4-difluorophenyl) oxiran-2-yl] methyl]-4H-1,2,4-triazole-3-thione, ametoctradin (imidium), iprovalicarb, valifenalate, 2-benzyl-4-chlorophenol (Chlorophene), allyl alcohol, azafenidin, benzalkonium chloride, chloropicrin, cresol, daracide, dichlorophen (dichlorophene), difenzoquat, dipyrithione, N-(2-p-chlorobenzoylethyl)-hexaminium chloride, NNF-0721, octhilinone, oxasulfuron, plant extract comprising tea tree oil, propamidine and propionic acid; or an insecticide selected from abamectin, acephate, acetamiprid, amidoflumet (S-1955), avermectin, azadirachtin, azinphos-methyl, bifenthrin, bifenazate, buprofezin, carbofuran, cartap, chlorantraniliprole (DPX-E2Y45), chlorfenapyr, chlorfluazuron, chlorpyrifos, chlorpyrifos-methyl, chromafenozide, clothianidin, cyflumetofen, cyfluthrin, beta-cyfluthrin, cyhalothrin, lambda-cyhalothrin, cypermethrin, cyromazine, deltamethrin, diafenthiuron, diazinon, dieldrin, diflubenzuron, dimefluthrin, dimethoate, dinotefuran, diofenolan, emamectin, endosulfan, esfenvalerate, ethiprole, fenothiocarb, fenoxycarb, fenpropathrin, fenvalerate, fipronil, flonicamid, flubendiamide, flucythrinate, tau-fluvalinate, flufenerim (UR-50701), flufenoxuron, fonophos, halofenozide, hexaflumuron, hydramethylnon, imidacloprid, indoxacarb, isofenphos, lufenuron, malathion, metaflumizone, metaldehyde, methamidophos, methidathion, methomyl, methoprene, methoxychlor, metofluthrin, monocrotophos, methoxyfenozide, nitenpyram, nithiazine, novaluron, noviflumuron (XDE-007), oxamyl, parathion, parathion-methyl, permethrin, phorate, phosalone, phosmet, phosphamidon, pirimicarb, profenofos, profluthrin, pymetrozine, pyrafluprole, pyrethrin, pyridalyl, pyrifluquinazon, pyriprole, pyriproxyfen, rotenone, ryanodine, spinetoram, spinosad, spirodiclofen, spiromesifen (BSN 2060), spirotetramat, sulprofos, tebufenozide, teflubenzuron, tefluthrin, terbufos, tetrachlorvinphos, thiacloprid, thiamethoxam, thiodicarb, thiosultap-sodium, tralomethrin, triazamate, trichlorfon and triflumuron; or a bactericide selected from streptomycin; or an acaricide selected from amitraz, chinomethionat, chlorobenzilate, cyenopyrafen, cyhexatin, dicofol, dienochlor, etoxazole, fenazaquin, fenbutatin oxide, fenpropathrin, fenpyroximate, hexythiazox, propargite, pyridaben and tebufenpyrad; or a biological agent selected from Bacillus thuringiensis, Bacillus thuringiensis delta endotoxin, baculovirus, and entomopathogenic bacteria, virus and fungi.

13. The fungicidal composition according to claim 1, wherein the composition further comprises an agriculturally acceptable carrier and, optionally, a surfactant and/or formulation adjuvants.

14. A method of controlling phytopathogenic diseases on useful plants or on propagation material thereof comprising applying to the useful plants, the locus thereof or propagation material thereof a fungicidal composition as defined in claim 1.

15. A method according to claim 14, wherein the composition components (A) and (B) are applied in a sequential manner.

16. The fungicidal composition according to claim 1, wherein component (A) is 2-[cyano-(2,6-difluoro-4-pyridyl)amino]-5-methyl-N-spiro [3.4] octan-3-yl-thiazole-4-carboxamide (compound X.07).

17. The fungicidal composition according to claim 1, wherein component (A) is 2-[cyano-(2,6-difluoro-4-pyridyl)amino]-N-cyclobutyl-5-methyl-thiazole-4-carboxamide (compound X.02).

18. The fungicidal composition according to claim 1, wherein component (A) is 2-(N-cyano-3,5-difluoro-anilino)-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazole-4-carboxamide (compound X.03).

19. The fungicidal composition according to claim 1, wherein component (A) is 2-[cyano-(5-fluoro-3-pyridyl)amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazole-4-carboxamide (compound X.04).

20. The fungicidal composition according to claim 1, wherein component (A) is 2-[cyano-(2,6-difluoro-4-pyridyl)amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazole-4-carboxamide (compound X.05).

Description

EXAMPLES

(1) The Examples which follow serve to illustrate the invention. The compounds (and compositions) of the invention may be distinguished from known compounds (and compositions) by virtue of greater efficacy at low application rates, which can be verified by the person skilled in the art using the experimental procedures outlined in the Examples, using lower application rates if necessary, for example 50 ppm, 12.5 ppm, 6 ppm, 3 ppm, 1.5 ppm or 0.2 ppm of active ingredient(s). Throughout this description, temperatures are given in degrees Celsius ( C.) and mp. means melting point. LC/MS means Liquid Chromatography Mass Spectrometry and the description of the apparatus and the methods are as follows: Method A: ACQUITY UPLC from Waters, Waters UPLC HSS T3, 1.8 m particle size, 302.1 mm column, 0.85 mL/min., 60 C., H.sub.2O/MeOH 95:5+0.05% HOOCH (90%)/CH.sub.3CN+0.05% HCOOH (10%)1.2 min.CH.sub.3CN+0.05% HCOOH (100%)0.30 min., ACQUITY SQD Mass Spectrometer from Waters, ionization method: electrospray (ESI), Polarity: positive ions, Capillary (kV) 3.00, Cone V) 30.00, Extractor (V) 2.00, Source Temperature ( C.) 150, Desolvation Temperature ( C.) 350, Cone Gas Flow (L/Hr) 0, Desolvation Gas Flow (L/Hr) 650).

(2) Method B: ACQUITY UPLC from Waters, Waters UPLC HSS T3, 1.8 m particle size, 302.1 mm column, 0.85 mL/min., 60 C., H.sub.2O/MeOH 95:5+0.05% HCOOH (90%)/CH.sub.3CN+0.05% HCOOH (10%)2.7 min.CH.sub.3CN+0.05% HCOOH (100%)030 min., ACQUITY SQD Mass Spectrometer from Waters, ionization method: electrospray (ESI), Polarity: positive ions, Capillary (kV) 3.00, Cone (V) 30.00, Extractor (V) 2.00, Source Temperature ( C.) 150, Desolvation Temperature ( C.) 350, Cone Gas Flow (L/Hr) 0, Desolvation Gas Flow (L/Hr) 650)). Method C: MS: ZQ Mass Spectrometer from Waters (Single quadrupole mass spectrometer)

(3) Instrument Parameter: Ionisation method: Electrospray Polarity: positive (negative) ions Capillary (kV) 3.00, Cone (V) 30.00, Extractor (V) 2.00, Gas Temperature ( C.) 350, Drying Gas Flow (mL/min) 9.8, Neb press 45 psig, Mass range: 90 to 1000 Da. HPLC: HP 1100 HPLC from Agilent: solvent degasser, quaternary pump (ZCQ)/binary pump (ZDQ), heated column compartment and diode-array detector. Column: porpshell 120 C18, 2.7 m particle size, 120 Angstrm, 4.650 mm, Temp: 30 C. DAD Wavelength range (nm): 190 to 400 Solvent Gradient: A=water+0.1% HCOOH. B=Acetonitril+0.08% HCOOH

(4) TABLE-US-00002 Time (min) A % B % Flow (ml/min) 0.00 85.0 15.0 0.6 4.00 5.00 95.00 0.6 10.00 5.00 95.00 0.6

FORMULATION EXAMPLES

(5) TABLE-US-00003 Wettable powders a) b) c) active ingredients [components (A) and (B)] 25% 50% 75% sodium lignosulfonate 5% 5% sodium lauryl sulfate 3% 5% sodium diisobutylnaphthalenesulfonate 6% 10% phenol polyethylene glycol ether 2% (7-8 mol of ethylene oxide) highly dispersed silicic acid 5% 10% 10% Kaolin 62% 27%

(6) The active ingredient is thoroughly mixed with the adjuvants and the mixture is thoroughly ground in a suitable mill, affording wettable powders that can be diluted with water to give suspensions of the desired concentration,

(7) TABLE-US-00004 Powders for dry seed treatment a) b) c) active ingredients [components (A) and (B)] 25% 50% 75% light mineral oil 5% 5% 5% highly dispersed silicic acid 5% 5% Kaolin 65% 40% Talcum 20%

(8) The active ingredient is thoroughly mixed with the adjuvants and the mixture is thoroughly ground in a suitable mill, affording powders that can be used directly for seed treatment.

(9) TABLE-US-00005 Emulsifiable concentrate active ingredients [components (A) and (B)] 10% octylphenol polyethylene glycol ether 3% (4-5 mol of ethylene oxide) calcium dodecylbenzenesulfonate 3% castor oil polyglycol ether 4% (35 mol of ethylene oxide) Cyclohexanone 30% xylene mixture 50%

(10) Emulsions of any required dilution, which can be used in plant protection, can be obtained from this concentrate by dilution with water.

(11) TABLE-US-00006 Dusts a) b) c) active ingredients [components (A) and (B)] 5% 6% 4% talcum 95% Kaolin 94% mineral filler 96%

(12) Ready-for-use dusts are obtained by mixing the active ingredient with the carrier and grinding the mixture in a suitable mill. Such powders can also be used for dry dressings for seed.

(13) TABLE-US-00007 Extruder granules active ingredients [components (A) and (B)] 15% sodium lignosulfonate 2% carboxymethylcellulose 1% Kaolin 82%

(14) The active ingredient is mixed and ground with the adjuvants, and the mixture is moistened with water. The mixture is extruded and then dried in a stream of air.

(15) TABLE-US-00008 Coated granules active ingredients [components (A) and (B)] 8% polyethylene glycol (mol. wt. 200) 3% Kaolin 89%

(16) The finely ground active ingredient is uniformly applied, in a mixer, to the kaolin moistened with polyethylene glycol. Non-dusty coated granules are obtained in this manner.

(17) TABLE-US-00009 Suspension concentrate active ingredients [components (A) and (B)] 40% propylene glycol 10% nonylphenol polyethylene glycol ether (15 mol of ethylene oxide) 6% Sodium lignosulfonate 10% carboxymethylcellulose 1% silicone oil (in the form of a 75% emulsion in water) 1% Water 32%

(18) The finely ground active ingredient is intimately mixed with the adjuvants, giving a suspension concentrate from which suspensions of any desired dilution can be obtained by dilution with water. Using such dilutions, living plants as well as plant propagation material can be treated and protected against infestation by microorganisms, by spraying, pouring or immersion.

(19) TABLE-US-00010 Flowable concentrate for seed treatment active ingredients [components (A) and (B)] 40% propylene glycol 5% copolymer butanol PO/EO 2% tristyrenephenole with 10-20 moles EO 2% 1,2-benzisothiazolin-3-one (in the form of a 20% 0.5%.sup. solution in water) monoazo-pigment calcium salt 5% Silicone oil (in the form of a 75% emulsion in water) 0.2%.sup. Water 45.3%

(20) The finely ground active ingredient is intimately mixed with the adjuvants, giving a suspension concentrate from which suspensions of any desired dilution can be obtained by dilution with water. Using such dilutions, living plants as well as plant propagation material can be treated and protected against infestation by microorganisms, by spraying, pouring or immersion.

(21) Slow Release Capsule Suspension

(22) 28 pails of a combination of the active ingredients [components (A) and (B)] is mixed with 2 parts of an aromatic solvent and 7 parts of toluene diisocyanate/polymethylene-polyphenylisocyanate-mixture (8:1). This mixture is emulsified in a mixture of 1.2 parts of polyvinylalcohol, 0.05 parts of a defoamer and 51.6 parts of water until the desired particle size is achieved. To this emulsion a mixture of 2.8 parts 1,6-diaminohexane in 5.3 parts of water is added. The mixture is agitated until the polymerization reaction is completed. The obtained capsule suspension is stabilized by adding 0.25 parts of a thickener and 3 parts of a dispersing agent. The capsule suspension formulation contains 28% of the active ingredients. The medium capsule diameter is 8-15 microns. The resulting formulation is applied to seeds as an aqueous suspension in an apparatus suitable for that purpose.

(23) List of Abbreviations: bs=broad singlet, C.=degrees Celsius, CDCl.sub.3=chloroform-d, d=doublet, Pd.sub.2(dba).sub.3=Tris(dibenzylideneacetone)dipalladium(0), DIPEA=N,N-diisopropyiethylamine, DMF=dimethylformamide, h=hours, HATU=1-[Bis(dimethylamino)methylene]-1H-1,2,3-triazolo[4,5-b]pyridinium 3-oxid hexafluorophosphate, m=multiplet, MHz=mega hertz, mp=melting point, N=normal, ppm=parts per million, s=singlet, THF=tetrahydrofuran, Xantphos=4,5-Bis(diphenylphosphino)-9,9-dimethylxanthene

PREPARATION EXAMPLES

(24) Using the synthetic techniques described both above and below, compounds of formula (I) may be prepared accordingly.

Example 1

(25) This example illustrates the preparation of 2-[cyano-(2,6-difluoro-4-pyridyl)amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazole-4-carboxamide (Compound X.05):

(26) ##STR00037##

a) Preparation of methyl 2-[(2,6-difluoro-4-pyridyl)amino]-5-methyl-thiazole-4-carboxylate

(27) ##STR00038##

(28) Under Argon atmosphere, Xantphos (0.2 equiv.), Pd.sub.2(dba).sub.3 (0.1 equiv.) and cesium carbonate (2 equiv.) were added to a degassed, stirred mixture of methyl 2-bromo-5-methyl-thiazole-4-carboxylate (4.6 g, 18.5 mmol, 1 equiv.) and 2,6-difluoropyridin-4-amine (1 equiv.) in 1,4-dioxane (660 mL). The reaction was heated to reflux and stirred for 4 h before allowing the temperature to cool to room temperature. The mixture was diluted with ethyl acetate and filtered over Celite, and the resulting filtrate was concentrated using a rotatory evaporator. Purification by column chromatography on silica gel (eluent mixtures cyclohexane/ethyl acetate) afforded the desired methyl 2-[(2,6-difluoro-4-pyridyl)amino]-5-methyl-thiazole-4-carboxylate (1.8 g, 6.31 mmol). .sup.1H-NMR (400 MHz, CDCl.sub.3): =2.73 (s, 3H), 3.94 (s, 3H), 6.75 (s, 1H).

b) Preparation of 2-[(2,6-difluoro-4-pyridyl)amino]-5-methyl-thiazole-4-carboxylic acid

(29) ##STR00039##

(30) Lithium hydroxide monohydrate (4 equiv.) was added to a solution of 2-[(2,6-difluoro-4-pyridyl)amino]-5-methyl-thiazole-4-carboxylic acid (1.8 g, 6.31 mmol) in a mixture of tetrahydrofuran (35 mL) and water (12 mL). The reaction mixture was stirred 16 h at room temperature, then the solvents were removed in vacuo. The residue was diluted with ethyl acetate and water, then 2 N hydrochloric acid was slowly added until a pH of 3-4 was reached. The formed precipitate was isolated by filtration and washed twice with water, giving the desired product 2-[(2,6-difluoro-4-pyridyl)amino]-5-methyl-thiazole-4-carboxylic acid (1.55 g, 5.71 mmol). .sup.1H-NMR (400 MHz, (CD.sub.3).sub.2SO): =2.69 (s, 3H), 7.30 (s, 2H), 11.35 (bs, 1H), 12.90 (bs, 1H).

c) Preparation of 2-[(2,6-difluoro-4-pyridyl)amino]-N-(2,2-dimethycyclobutyl)-5-methy-thiazole-4-carboxamide

(31) ##STR00040##

(32) (2,2-dimethylcyclobutyl) ammonium chloride (1.1 equiv.), HATU (1.1. equiv.), and DIPEA (2.6 equiv.) were added in sequence to a DMF solution (9.2 mL) of 2-[(2,6-difluoro-4-pyridyl)amino]-5-methyl-thiazole-4-carboxylic acid (250 mg, 092 mmol, 1 equiv.). The resulting solution was stirred at room temperature for 1 h until consumption of starting material (LCMS control). Then a saturated NaHCO.sub.3 solution was added to the mixture and the solution extracted three times with ethyl acetate. The organic phases were combined, dried over sodium sulphate and the volatiles removed by rotatory evaporator. Purification by column chromatography on silica gel (eluent: mixtures of cyclohexane/ethyl acetate) gave the desired product 2-[(2,6-difluoro-4-pyridyl)amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazole-4-carboxamide (280 mg, 86% yield). .sup.1H-NMR (400 MHz, CDCl.sub.3): =1.17 (s, 3H), 1.20 (s, 3H), 1.50-1.75 (m, 2H), 1.86-1.92 (m, 1H), 2.29-2.36 (in 1H), 2.79 (s, 3H), 4.25-4.31 (in 1H), 6.87 (s, 2H), 7.32 (d, 1H), 7.67 (s, 1H).

d) 2-[cyano-(2,6-difluoro-4-pyridyl)amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazole-4-carboxamide (Compound X.05)

(33) ##STR00041##

(34) Buthyllithium (2.5 M solution in hexane, 1.25 equiv.) was added at 78 C. to a stirred solution of 2-[(2,6-difluoro-4-pyridyl)amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazole-4-carboxamide (300 mg, 0.85 mmol, 1 equiv.) in THF (4.3 mL). After 30 min, cyanogen bromide was added to the solution, the reaction was allowed to reach room temperature and stirred for 2 h. Then the reaction was quenched with a NaHCO.sub.3 saturated aqueous solution and the aqueous phase was extracted three times with ethyl acetate. The combined organic phases were dried over sodium sulphate and the volatiles removed using a rotatory evaporator. Purification by column chromatography on silica gel (eluent: mixtures of cyclohexane/ethyl acetate) gave the desired product 2-[cyano-(2,6-difluoro-4-pyridyl)amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazole-4-carboxamide (190 mg, 050 mmol, 59% yield). .sup.1H-NMR (400 MHz, CDCl.sub.3): =1.10 (s, 3H), 1.21 (s, 3H), 1.55-1.69 (m, 2H), 1.80-1.93 (m, 1H), 2.25-2-35 (m, 1H), 2.90 (s, 3H), 4.25-4.31 (in, 1H), 6.92 (s, 2H), 7.12 (d, 1H).

(35) methyl (Z)-2-(5-cyclopentyl-2-methyl-phenoxy)-3-methoxy-prop-2-enoate may be prepared as follows: Under an argon atmosphere, a zinc chloride 1 M THF solution (2.54 mmol) was added to a cyclopentyl magnesium bromide 2M THF solution (2.54 mmol) and the pale-yellow suspension was stirred at RT for 10 min during time which a small exotherm was observed. After, a solution of methyl (Z)-2-(5-bromo-2-methyl-phenoxy)-3-methoxy-prop-2-enoate (0.153 g, 0.51 mmol) in tetrahydrofuran (2.5 mL) and PdCl.sub.2(dppf) (0.19 g, 0.025 mmol) were added and the pale yellow suspension was heated at 50 C. for 3 hours. The reaction mixture was then allowed to reach RT, quenched with an aqueous saturated NH.sub.4Cl solution, and extracted with tert-butyl methylether. The total combined organic fraction was then washed with water and brine, dried over sodium sulfate, filtered, and concentrated under reduced pressure. The resultant crude residue was purified by flash chromatography (cyclohexane:EtOAc gradient) to give 0.106 mg the title compound as a white solid (mp 80-830C).

(36) .sup.1H NMR (400 MHz, CDC) 6 ppm: 7.35 (s, 1H), 7.09 (d, 1H), 6.82 (d, 1H), 6.60 (s, 1H), 3.90 (s, 3H), 3.72 (s, 3H), 2.91 (m, 1H), 2.32 (s, 3H), 2.10-1.97 (m, 2H), 1.85-1.75 (m, 2H), 1.74-1.65 (m, 2H), 1.60-1.45 (n, 2H).

(37) The skilled person will recognize that methyl (Z)-2-(5-cyclohexyl-2-methyl-phenoxy)-3-methoxy-prop-2-enoate can be synthesized using an equivalent method, by replacing cyclopentyl magnesium bromide with cyclohexyl magnesium bromide.

(38) methyl (Z)-2-[5-(4-bromothiazol-2-yl)-2-methyl-phenoxy]-3-methoxy-prop-2-enoate may be prepared as follows: To a solution of [3-[(Z)-2-methoxy-1-methoxycarbonyl-vinyloxy]-4-methyl-phenyl]boronic acid (1 g, 3.76 mmol, 1.00 equiv.) and 2,4-dibromothiazole (1.37 g, 5.64 mmol, 1.50 equiv.) in 1,4-dioxane (15 mL) and water (3 mL) under argon was added sodium carbonate (1.19 g, 11.28 mmol, 3 equiv.) and Pd(dppf)Cl.sub.2.Math.DCM (0.157 g, 0.188 mmol, 0.05 equiv.). The reaction was warmed to 90 C. and stirred at this temperature for 2h. The resulting dark brown solution was cooled to RT, diluted with EtOAc, and washed with aq. saturated NaHCO.sub.3 solution. The organic layer was washed with brine, dried over Na.sub.2SO.sub.4, filtered, and concentrated in vacuo. The residue was purified by flash chromatography (cyclohexane:EtOAc) to give methyl (Z)-2-[5-(4-bromothiazol-2-yl)-2-methyl-phenoxy]-3-methoxy-prop-2-enoate as an orange solid.

(39) .sup.1H NMR (400 MHz, CCl.sub.3) ppm=7.43-7.47 (dd, 1H), 7.32-7.34 (d, 1H), 7.28-7.30 (s, 1H), 7.21-7.25 (m, 1H), 7.18 (s, 1H), 3.93 (s, 3H), 3.74 (s, 3H), 2.41 (s, 3H).

(40) methyl (Z)-3-methoxy-2-[2-methyl-5-[5-(trifluoromethyl)thiazol-2-yl]phenoxy]prop-2-enoate may be prepared as follows: To a solution of methyl (Z)-3-methoxy-2-[2-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy]prop-2-enoate (5.00 g, 14.4 mmol) in tetrahydrofuran: water mixture (4:1 V/V, 72 mL) was added sodium periodate (9.31 g, 43.1 mmol, 3.00 equiv.) followed by an aqueous solution of HCl (2.0 M, 1.79 mL, 3.59 mmol, 0.25 equiv.). The obtained white suspension was stirred at room temperature for 4h, then EtOAc and water were added. The layers were separated, and the aqueous phase was extracted with EtOAc. The total combined organic layer was washed with brine, dried with Na.sub.2SO.sub.4, filtered, and concentrated in vacuo to give [3-[(Z)-2-methoxy-1-methoxycarbonyl-vinyloxy]-4-methyl-phenyl]boronic acid as a white solid.

(41) .sup.1H NMR (400 MHz, DMSO) ppm 7.96 (brs, 2H), 7.54 (s, 1H), 7.33 (d, 1H), 7.12 (m, 2H), 3.85 (s, 3H), 3.64 (s, 3H), 2.23 (s, 3H).

(42) Then: To a solution of [3-[(Z)-2-methoxy-1-methoxycarbonyl-vinyloxy]-4-methyl-phenyl]boronic acid (5.0 g, 19 mmol) and 2-bromo-5-(trifluoromethyl)thiazole (1.2 equiv.) in 1,4-dioxane (38 mL) and water (3.8 mL), degassed with argon, X-Phos Pd G2 (0.032 equiv.) was added then cesium carbonate (2.0 equiv.). Reaction mixture was stirred at 90 C. for 2h. The dark brown solution was allowed to come back at RT, diluted with EtOAc and washed with aq. NaHCO.sub.3 solution and brine. The organic layer was dried with MgSO.sub.4, filtered, and concentrated in vacuo. The residue was purified by flash chromatography (cyclohexane:EtOAc) to give methyl (Z)-3-methoxy-2-[2-methyl-5-[5-(trifluoromethyl)thiazol-2-yl]phenoxy]prop-2-enoate.

(43) The skilled person will recognize that methyl (Z)-2-[5-(4-cyclohexylthiazol-2-yl)-2-methyl-phenoxy]-3-methoxy-prop-2-enoate and methyl (Z)-2-[5-[4-(ethoxymethyl)thiazol-2-yl]-2-methyl-phenoxy]-3-methoxy-prop-2-enoate can be synthesized using an equivalent method, by replacing 2-bromo-5-(trifluoromethyl)thiazole with the suitable thiazole group.

(44) TABLE-US-00011 TABLE T1 Melting point (mp) data and/or retention times (R.sub.t) for compounds X.01 to X.24 according to Formula (I): Compound Mp No. Name Structure ( C.) LC/MS X.01 2-[cyano-(5-fluoro-3- pyridyl)amino]-N- cyclobutyl-5-methyl- thiazole-4- carboxamide 126-127 R.sub.t = 4.08 min (C); MS: m/z = 332 (M + 1) X.02 2-[cyano-(2,6- difluoro-4- pyridyl)amino]-N- cyclobutyl-5-methyl- thiazole-4- carboxamide 136-137 R.sub.t = 4.53 min (C); MS: m/z = 350 (M + 1) X.03 2-(N-cyano-3,5- difluoro-anilino)-N- (2,2- dimethylcyclobutyl)- 5-methyl-thiazole-4- carboxamide 165-166 R.sub.t = 5.22 min (C); MS: m/z = 377 (M + 1) X.04 2-[cyano-(5-fluoro-3- pyridyl)amino]-N- (2,2- dimethylcyclobutyl)- 5-methyl-thiazole-4- carboxamide 150-152 R.sub.t = 4.82 min (C); MS: m/z = 360 (M + 1) X.05 2-[cyano-(2,6- difluoro-4- pyridyl)amino]-N- (2,2- dimethylcyclobutyl)- 5-methyl-thiazole-4- carboxamide 117-120 R.sub.t = 1.13 min (A); MS: m/z = 378 (M + 1) X.06 2-[cyano-(2,6- difluoro-4- pyridyl)amino]-N- (2,2- dimethylcyclobutyl)- 5-formamido- thiazole-4- carboxamide 183-185 R.sub.t = 1.09 min (A); MS: m/z = 453 (M + 1) X.07 2-(cyano-(2,6- difluoro-4- pyridyl)amino]-5- methyl-N- spiro[3.4]octan-3-yl- thiazole-4- carboxamide 122-124 R.sub.t = 1.20 min (A); MS: m/z = 404 (M + 1) X.08 2-[cyano-(2,6- difluoro-4- pyridyl)amino]-5- methyl-N- spiro[cyclobutane- 2,2-indane]-1-yl- thiazole-4- carboxamide 67-69 R.sub.t = 1.20 min (A); MS: m/z = 452 (M + 1) X.09 2-[cyano-(2,6- difluoro-4- pyridyl)amino]-5- methyl-N- spiro[3.3]heptan-3-yl- thiazole-4- carboxamide 0 100-102 R.sub.t = 1.16 min (A); MS: m/z = 390 (M + 1) X.10 2-[cyano-(2,6- difluoro-4- pyridyl)amino]-N-[[1- (cyclopropylmethyl) cyclopropyl]methyl]-5- methyl-thiazole-4- carboxamide 95-95 R.sub.t = 1.16 min (A); MS: m/z = 404 (M + 1) X.11 2-(N-cyano-3,5- difluoro-anilino)-5- methyl-N-(1- methylcyclopentyl) thiazole-4-carboxamide 137-139 R.sub.t = 1.20 min (A); MS: m/z = 295 (M + 1) X.12 2-[cyano-(2,6- difluoro-4- pyridyl)amino]-5- methyl-N-(1- methylcyclopentyl) thiazole-4-carboxamide 126-128 R.sub.t = 1.16 min (A); MS: m/z = 296 (M + 1) X.13 2-[cyano-(5-fluoro-3- pyridyl)amino]-N- hexyl-5-methyl- thiazole-4- carboxamide R.sub.t = 4.81 min (C); MS: m/z = 362 (M + 1) X.14 2-[cyano-(2,6- difluoro-4- pyridyl)amino]-N- hexyl-5-methyl- thiazole-4- carboxamide R.sub.t = 5.18 min (C); MS: m/z = 380 (M + 1) X.15 2-[cyano-(2,6- difluoro-4- pyridyl)amino]-N- isobutyl-5-methyl- thiazole-4- carboxamide 107-109 R.sub.t = 4.68 min (C); MS: m/z = 352 (M + 1) X.16 2-[cyano-(2,6- difluoro-4- pyridyl)amino]-5- methyl-N-(1- phenylethyl)thiazole- 4-carboxamide 141-143 R.sub.t = 4.88 min (C); MS: m/z = 400 (M + 1) X.17 2-[cyano-(5-fluoro-3- pyridyl)amino]-N- (2,2-dimethylpropyl)- 5-methyl-thiazole-4- carboxamide 110-111 R.sub.t = 4.50 min (C); MS: m/z = 348 (M + 1) X.18 2-[cyano-(2,6- difluoro-4- pyridyl)amino]-N- (2,2-dimethylpropyl)- 5-methyl-thiazole-4- carboxamide R.sub.t = 4.89 min (C); MS: m/z = 366 (M + 1) X.19 2-[cyano-(5-fluoro-3- pyridyl)amino]-5- methyl-N-pentyl- thiazole-4- carboxamide 0 128-130 R.sub.t = 4.56 min (C); MS: m/z = 348 (M + 1) X.20 2-[cyano-(2,6- difluoro-4- pyridyl)amino]-5- methyl-N-pentyl- thiazole-4- carboxamide R.sub.t = 4.96 min (C); MS: m/z = 366 (M + 1) X.21 2-[cyano-(5-fluoro-3- pyridyl)amino]-N- isopentyl-5-methyl- thiazole-4- carboxamide 132-133 R.sub.t = 4.51 min (C); MS: m/z = 348 (M + 1) X.22 N-[[3,5- bis(trifluoromethyl) phenyl]methyl]-2- [cyano-(2,6-difluoro- 4-pyridyl)amino]-5- methyl-thiazole-4- carboxamide R.sub.t = 5.28 min (C); MS: m/z = 522 (M + 1) X.23 N-benzyl-2-[cyano- (2,6-difluoro-4- pyridyl)amino]-5- methyl-thiazole-4- carboxamide R.sub.t = 4.71 min (C); MS: m/z = 386 (M + 1) X.24 N-butyl-2-[cyano- (2,6-difluoro-4- pyridyl)amino]-5- methyl-thiazole-4- carboxamide 89-90 R.sub.t = 4.71 min (C); MS: m/z = 352 (M + 1)

BIOLOGICAL EXAMPLES

Example A1: Alternaria solani/Tomato/Leaf Disc (Early Blight)

(45) Tomato leaf disks cv. Baby are placed on agar in multiwell plates (24-well format) and sprayed with the formulated test compound diluted in water. The leaf disks are inoculated with a spore suspension of the fungus 2 days after application. The inoculated leaf disks are incubated at 23 C./21 C. (day/night) and 80% rh under a light regime of 12/12 h (light/dark) in a climate cabinet and the activity of a compound is assessed as percent disease control compared to untreated when an appropriate level of disease damage appears on untreated check disk leaf disks (5-7 days after application). The following compounds gave at least 80% control of Alternaria solani at 200 ppm when compared to untreated control under the same conditions, which showed extensive disease development: X.02, X.03, X.05, X.07, X.12, X.15, X.17, X.21.

Example A2: Botryotinia fuckeliana (Botrytis cinerea)/Liquid Culture (Gray Mould)

(46) Conidia of the fungus from cryogenic storage are directly mixed into nutrient broth (Vogels broth) containing 200 M SHAM. After placing a (DMSO) solution of test compound into a microtiter plate (96-well format), the nutrient broth containing the fungal spores is added. The test plates are incubated at 24 C. and the inhibition of growth is determined photometrically 3-4 days after application. The following compounds gave at least 80% control of Botryotinia fuckeliana at 20 ppm when compared to untreated control under the same conditions, which showed extensive disease development: X.05, X.07, X.14, X.18, X.23.

Example A3: Glomerella lagenarium (Colletotrichum lagenarium)/Liquid Culture (Anthracnose)

(47) Conidia of the fungus from cryogenic storage are directly mixed into nutrient broth (PDB potato dextrose broth). After placing a (DMSO) solution of test compound into a microtiter plate (96-well format), the nutrient broth containing the fungal spores is added. The test plates are incubated at 24 C. and the inhibition of growth is measured photometrically 3-4 days after application. The following compounds gave at least 80% control of Glomerella lagenarium at 20 ppm when compared to untreated control under the same conditions, which showed extensive disease development: X.01, X.03, X.04, X.05, X.06, X.07, X.08, X.09, X.10, X.11, X.12. X.13, X.14, X.15, X.16, X.17. X.18, X.19, X.20, X.21, X.23, X.24.

Example A4: Blumeria graminis f. sp, tritici (Erysiphe graminis f. sp. tritici)/Wheat/Leaf Disc Preventative (Powdery Mildew on Wheat)

(48) Wheat leaf segments cv. Kanzler are placed on agar in a multiwell plate (24-well format) and sprayed with the formulated test compound diluted in water. The leaf disks are inoculated by shaking powdery mildew infected plants above the test plates 1 day after application. The inoculated leaf disks are incubated at 20 C. and 60% rh under a light regime of 24 h darkness followed by 12 h light/12 h darkness in a climate chamber and the activity of a compound is assessed as percent disease control compared to untreated when an appropriate level of disease damage appears on untreated check leaf segments (6-8 days after application). The following compounds gave at least 80% control of Blumeria graminis f. sp. tritici at 200 ppm when compared to untreated control under the same conditions, which showed extensive disease development: X.02, X.03, X.04, X.05, X.07, X.08, X.09, X.10, X.11, X.12, X.14, X.15, X.16, X.17, X.18, X.20, X.21, X.23, X.24.

Example A5: Phaeosphaeria nodorum (Septoria nodorum)/Wheat/Leaf Disc Preventative (Glume Blotch)

(49) Wheat leaf segments cv. Kanzler are placed on agar in a multiwell plate (24-well format) and sprayed with the formulated test compound diluted in water. The leaf disks are inoculated with a spore suspension of the fungus 2 days after application. The inoculated test leaf disks are incubated at 20 C. and 75% rh under a light regime of 12 h light/12 h darkness in a climate cabinet and the activity of a compound is assessed as percent disease control compared to untreated when an appropriate level of disease damage appears in untreated check leaf disks (5-7 days after application). The following compounds gave at least 80% control of Phaeosphaeria nodorum at 200 ppm when compared to untreated control under the same conditions, which showed extensive disease development: X.02, X.05, X.08, X.10, X.12, X.15, X.17, X.18.

Example A6: Monographella nivalis (Microdochium nivale)/Liquid Culture (Foot Rot Cereals)

(50) Conidia of the fungus from cryogenic storage are directly mixed into nutrient broth (PDB potato dextrose broth). After placing a (DMSO) solution of test compound into a microtiter plate (96-well format), the nutrient broth containing the fungal spores is added. The test plates are incubated at 24 C. and the inhibition of growth is determined photometrically 4-5 days after application. The following compounds gave at least 80% control of Monographella nivalis at 20 ppm when compared to untreated control under the same conditions, which showed extensive disease development: X.01, X.02, X.03, X.04, X.05, X.06, X.07, X.08, X.09, X.10, X.11, X.12, X.13, X.14, X.15, X.16, X.17, X.18, X.19, X.20, X.21, X.23, X.24.

Example A7: Mycosphaerella arachidis (Cercospora arachidicola)/Liquid Culture (Early Leaf Spot)

(51) Conidia of the fungus from cryogenic storage are directly mixed into nutrient broth (PDB potato dextrose broth). After placing a (DMSO) solution of test compound into a microtiter plate (96-well format), the nutrient broth containing the fungal spores is added. The test plates are incubated at 24 C. and the inhibition of growth is determined photometrically 4-5 days after application. The following compounds gave at least 80% control of Mycosphaerella arachidis at 20 ppm when compared to untreated control under the same conditions, which showed extensive disease development: X.01, X.03, X.04, X.05, X.07, X.08, X.09, X.10, X.11, X.12, X.13, X.14, X.15, X.17, X.18, X.19, X.20, X.21, X.23, X.24.

Example A8: Phakopsora pachyrhizi/Soybean/Preventative (Soybean Rust)

(52) Soybean leaf disks are placed on water agar in multiwell plates (24-well format) and sprayed with the formulated test compound diluted in water. One day after application leaf discs are inoculated by spraying a spore suspension on the lower leaf surface. After an incubation period in a climate cabinet of 24-36 hours in darkness at 20 C. and 75% rh leaf disc are kept at 20 C. with 12 h light/day and 75% rh. The activity of a compound is assessed as percent disease control compared to untreated when an appropriate level of disease damage appears in untreated check leaf disks (12-14 days after application). The following compounds gave at least 80% control of Phakopsora pachyrhizi at 200 ppm when compared to untreated control under the same conditions, which showed extensive disease development: X.05, X.10, X.12, X.14, X.15, X.20, X.24.

Example A9: Puccinia recondita f. sp. tritici/Wheat/Leaf Disc Curative (Brown Rust)

(53) Wheat leaf segments cv. Kanzler are placed on agar in multiwell plates (24-well format). The leaf segments are inoculated with a spore suspension of the fungus. Plates are stored in darkness at 19 C. and 75% rh. The formulated test compound diluted in water is applied 1 day after inoculation. The leaf segments are incubated at 19 C. and 75% rh under a light regime of 12 h light/12 h darkness in a climate cabinet and the activity of a compound is assessed as percent disease control compared to untreated when an appropriate level of disease damage appears in untreated check leaf segments (6-8 days after application). The following compounds gave at least 80% control of Puccinia recondita f. sp. tritici at 200 ppm when compared to untreated control under the same conditions, which showed extensive disease development: X.05, X.07, X.14, X.15, X.18, X.20, X.24.

Example A10: Puccinia recondita f. sp. tritici/Wheat/Leaf Disc Preventative (Brown Rust)

(54) Wheat leaf segments cv. Kanzler are placed on agar in multiwell plates (24-well format) and sprayed with the formulated test compound diluted in water. The leaf disks are inoculated with a spore suspension of the fungus 1 day after application. The inoculated leaf segments are incubated at 19 C. and 75% rh under a light regime of 12 h light/12 h darkness in a climate cabinet and the activity of a compound is assessed as percent disease control compared to untreated when an appropriate level of disease damage appears in untreated check leaf segments (7-9 days after application). The following compounds gave at least 80% control of Puccinia recondita f, sp. tritici at 200 ppm when compared to untreated control under the same conditions, which showed extensive disease development: X.01, X.02, X.03, X.04, X.05, X.07, X.08, X.09, X.10, X.11, X.12, X.13, X.14, X.15, X.16, X.18, X.19, X.20, X.21, X.23. X.24.

Example A11: Magnaporthe grisea (Pyricularia oryzae)/Rice/Leaf Disc Preventative (Rice Blast)

(55) Rice leaf segments cv. Ballila are placed on agar in a multiwell plate (24-well format) and sprayed with the formulated test compound diluted in water. The leaf segments are inoculated with a spore suspension of the fungus 2 days after application. The inoculated leaf segments are incubated at 22 C. and 80% rh under a light regime of 24 h darkness followed by 12 h light/12 h darkness in a climate cabinet and the activity of a compound is assessed as percent disease control compared to untreated when an appropriate level of disease damage appears in untreated check leaf segments (5-7 days after application). The following compounds gave at least 80% control of Magnaporthe grisea at 200 ppm when compared to untreated control under the same conditions, which showed extensive disease development: X.01, X.02, X.03, X.04, X.05, X.07, X.08, X.09, X.10, X.11, X.12, X.14, X.15, X.16, X.17. X.18, X.19, X.20, X.21, X.23, X.24.

Example A12: Pyrenophora teres/Barley/Leaf Disc Preventative (Net Blotch)

(56) Barley leaf segments cv. Hasso are placed on agar in a multiwell plate (24-well format) and sprayed with the formulated test compound diluted in water. The leaf segmens are inoculated with a spore suspension of the fungus 2 days after application. The inoculated leaf segments are incubated at 20 C. and 65% rh under a light regime of 12 h light/12 h darkness in a climate cabinet and the activity of a compound is assessed as disease control compared to untreated when an appropriate level of disease damage appears in untreated check leaf segments (5-7 days after application). The following compounds gave at least 80% control of Pyrenophora teres at 200 ppm when compared to untreated control under the same conditions, which showed extensive disease development: X.02, X.04, X.05, X.07, X.08, X.12, X.15, X.18, X.24.

Example A13: Sclerotinia sclerotiorum/Liquid Culture (Cottony Rot)

(57) Mycelia fragments of a newly grown liquid culture of the fungus are directly mixed into nutrient broth (PDB potato dextrose broth). After placing a (DMO) solution of test compound into a microtiter plate (96-well format) the nutrient broth containing the fungal material is added. The test plates are incubated at 24 C. and the inhibition of growth is determined photometrically 3-4 days after application. The following compounds gave at least 80% control of Sclerotinia sclerotiorum at 20 ppm when compared to untreated control under the same conditions, which showed extensive disease development: X.04, X.05, X.07, X.10, X.12, X.14, X.15.

Example A14: Mycosphaerella graminicola (Septoria tritici)/Liquid Culture (Septoria blotch)

(58) Conidia of the fungus from cryogenic storage are directly mixed into nutrient broth (PDB potato dextrose broth). After placing a (DMSO) solution of test compound into a microtiter plate (96-well format), the nutrient broth containing the fungal spores is added. The test plates are incubated at 24 C. and the inhibition of growth is determined photometrically 4-5 days after application. The following compounds gave at least 80% control of Mycosphaerella graminicola at 20 ppm when compared to untreated control under the same conditions, which showed extensive disease development: X.02, X.03, X.04, X.05, X.06, X.07, X.08, X.09, X.10, X.12, X.13, X.14, X.15, X.16, X.17, X.18, X.19, X.20, X.21, X.23, X.24.

(59) Further biological test examples relating to fungicidal compositions comprising a mixture of components (A) and (B) as active ingredients:

Example B1: Activity Against Zymoseptoria tritici (Leaf Blotch)

(60) Conidia of the fungus from cryogenic storage were directly mixed into nutrient broth (PDB potato dextrose broth) A DMSO solution of the test compounds was placed into a microtiter plate (96-well format) and the nutrient broth containing the fungal spores was added to it. The test plates were incubated at 24 C. and the inhibition of growth was determined photometrically after 72 hrs. The following mixture compositions (A:6) at the reported concentration (in ppm) gave at least 80% disease control in this test.

(61) TABLE-US-00012 Component A Ratio Conc. (ppm) (Compound) Component B A:B (A:B) X.05 Azoxystrobin 3:1 6:2 X.05 Azoxystrobin 30:1 .sup.6:0.2 X.05 Azoxystrobin .sup.1:3.3 0.6:2.sup. X.05 Azoxystrobin 3:1 0.6:0.2 X.05 Trifloxystrobin 3:1 6:2 X.05 Trifloxystrobin 30:1 .sup.6:0.2 X.05 Trifloxystrobin .sup.1:3.3 0.6:2.sup. X.05 Trifloxystrobin 3:1 0.6:0.2 X.05 Metyltetraprole 3:1 6:2 X.05 Metyltetraprole 30:1 .sup.6:0.2 X.05 Metyltetraprole .sup.1:3.3 0.6:2.sup. X.05 Metyltetraprole 3:1 0.6:0.2 X.05 Difenoconazole 1:1 6:6 X.05 Difenoconazole 10:1 .sup.6:0.6 X.05 Difenoconazole 1:10 0.6:6.sup. X.05 Difenoconazole 1:1 0.6:0.6 X.05 Hexaconazole 1:1 6:6 X.05 Hexaconazole 10:1 .sup.6:0.6 X.05 Hexaconazole 1:10 0.6:6.sup. X.05 Hexaconazole 1:1 0.6:0.6 X.05 Propiconazole 1:1 6:6 X.05 Propiconazole 10:1 .sup.6:0.6 X.05 Propiconazole 1:10 0.6:6.sup. X.05 Propiconazole 1:1 0.6:0.6 X.05 Prothioconazole 1:1 6:6 X.05 Prothioconazole 10:1 .sup.6:0.6 X.05 Prothioconazole 1:10 0.6:6.sup. X.05 Prothioconazole 1:1 0.6:0.6 X.05 Mefentrifluconazole 1:1 6:6 X.05 Mefentrifluconazole 10:1 .sup.6:0.6 X.05 Mefentrifluconazole 1:10 0.6:6.sup. X.05 Mefentrifluconazole 1:1 0.6:0.6 X.05 Fenpropidin .sup.1:3.3 6:20 X.05 Fenpropidin 3:1 6:2 X.05 Fenpropidin 1:33.3 0.6:20 X.05 Fenpropidin .sup.1:3.3 0.6:2.sup. X.05 Fenpropimorph .sup.1:3.3 6:20 X.05 Fenpropimorph 3:1 6:2 X.05 Fenpropimorph 1:33.3 0.6:20 X.05 Fenpropimorph .sup.1:3.3 0.6:2.sup. X.05 Fluxapyroxad 3:1 6:2 X.05 Fluxapyroxad 30:1 .sup.6:0.2 X.05 Fluxapyroxad .sup.1:3.3 0.6:2.sup. X.05 Fluxapyroxad 3:1 0.6:0.2 X.05 Fluopyram 3:1 6:2 X.05 Fluopyram 30:1 .sup.6:0.2 X.05 Fluopyram .sup.1:3.3 0.6:2.sup. X.05 Fluopyram 3:1 0.6:0.2 X.05 Isopyrazam 3:1 6:2 X.05 Isopyrazam 30:1 .sup.6:0.2 X.05 Isopyrazam .sup.1:3.3 0.6:2.sup. X.05 Isopyrazam 3:1 0.6:0.2 X.05 Sedaxane 3:1 6:2 X.05 Sedaxane 30:1 .sup.6:0.2 X.05 Sedaxane .sup.1:3.3 0.6:2.sup. X.05 Sedaxane 3:1 0.6:0.2 X.05 Benzovindiflupyr 3:1 6:2 X.05 Benzovindiflupyr 30:1 .sup.6:0.2 X.05 Benzovindiflupyr .sup.1:3.3 0.6:2.sup. X.05 Benzovindiflupyr 3:1 0.6:0.2 X.05 Pydiflumetofen 3:1 6:2 X.05 Pydiflumetofen 30:1 .sup.6:0.2 X.05 Pydiflumetofen .sup.1:3.3 0.6:2.sup. X.05 Pydiflumetofen 3:1 0.6:0.2 X.05 Isoflucypram 3:1 6:2 X.05 Isoflucypram 30:1 .sup.6:0.2 X.05 Isoflucypram .sup.1:3.3 0.6:2.sup. X.05 Isoflucypram 3:1 0.6:0.2 X.05 Isofetamid 3:1 6:2 X.05 Isofetamid 30:1 .sup.6:0.2 X.05 Isofetamid .sup.1:3.3 0.6:2.sup. X.05 Isofetamid 3:1 0.6:0.2 X.05 Pyrapropoyne 3:1 6:2 X.05 Pyrapropoyne 30:1 .sup.6:0.2 X.05 Pyrapropoyne .sup.1:3.3 0.6:2.sup. X.05 Pyrapropoyne 3:1 0.6:0.2 X.05 Fluindapyr 3:1 6:2 X.05 Fluindapyr 30:1 .sup.6:0.2 X.05 Fluindapyr .sup.1:3.3 0.6:2.sup. X.05 Fluindapyr 3:1 0.6:0.2 X.05 Fenpicoxamid 1:1 6:6 X.05 Fenpicoxamid 10:1 .sup.6:0.6 X.05 Fenpicoxamid 1:10 0.6:6.sup. X.05 Fenpicoxamid 1:1 0.6:0.6 X.05 Florylpicoxamid 3:1 6:2 X.05 Florylpicoxamid 30:1 .sup.6:0.2 X.05 Florylpicoxamid .sup.1:3.3 0.6:2.sup. X.05 Florylpicoxamid 3:1 0.6:0.2 X.05 Chlorothalonil 1:1 6:6 X.05 Chlorothalonil 10:1 .sup.6:0.6 X.05 Chlorothalonil 1:10 0.6:6.sup. X.05 Chlorothalonil 1:1 0.6:0.6 X.05 Mancozeb .sup.1:3.3 6:20 X.05 Mancozeb 1:1 6:6 X.05 Mancozeb 1:33.3 0.6:20 X.05 Mancozeb 1:10 0.6:6.sup. X.05 Mandipropamid .sup.1:3.3 6:20 X.05 Mandipropamid 1:1 6:6 X.05 Mandipropamid 1:33.3 0.6:20 X.05 Mandipropamid 1:10 0.6:6.sup. X.05 Oxathiapiprolin .sup.1:3.3 6:20 X.05 Oxathiapiprolin 1:1 6:6 X.05 Oxathiapiprolin 1:33.3 0.6:20 X.05 Oxathiapiprolin 1:10 0.6:6.sup. X.05 Fluazinam 3:1 6:2 X.05 Fluazinam 30:1 .sup.6:0.2 X.05 Fluazinam .sup.1:3.3 0.6:2.sup. X.05 Fluazinam 3:1 0.6:0.2 X.05 Fludioxonil 1:1 6:6 X.05 Fludioxonil 10:1 .sup.6:0.6 X.05 Fludioxonil 1:10 0.6:6.sup. X.05 Fludioxonil 1:1 0.6:0.6 X.05 Cyprodinil 1:1 6:6 X.05 Cyprodinil 10:1 .sup.6:0.6 X.05 Cyprodinil 1:10 0.6:6.sup. X.05 Cyprodinil 1:1 0.6:0.6 X.05 Metalaxyl-M .sup.1:3.3 6:20 X.05 Metalaxyl-M 1:1 6:6 X.05 Metalaxyl-M 1:33.3 0.6:20 X.05 Metalaxyl-M 1:10 0.6:6.sup. X.05 Aminopyrifen 3:1 6:2 X.05 Aminopyrifen 30:1 .sup.6:0.2 X.05 Aminopyrifen .sup.1:3.3 0.6:2.sup. X.05 Aminopyrifen 3:1 0.6:0.2 X.05 Folpet 1:1 6:6 X.05 Folpet 3:1 6:2 X.05 Folpet 1:10 0.6:6.sup. X.05 Folpet .sup.1:3.3 0.6:2.sup. X.05 Ipflufenoquin 3:1 6:2 X.05 Ipflufenoquin 30:1 .sup.6:0.2 X.05 Ipflufenoquin .sup.1:3.3 0.6:2.sup. X.05 Ipflufenoquin 3:1 0.6:0.2 X.05 Quinofumelin 3:1 6:2 X.05 Quinofumelin 30:1 .sup.6:0.2 X.05 Quinofumelin .sup.1:3.3 0.6:2.sup. X.05 Quinofumelin 3:1 0.6:0.2 X.05 Tricyclazole .sup.1:3.3 6:20 X.05 Tricyclazole 1:1 6:6 X.05 Tricyclazole 1:33.3 0.6:20 X.05 Tricyclazole 1:10 0.6:6.sup. X.05 Pyroquilon .sup.1:3.3 6:20 X.05 Pyroquilon 1:1 6:6 X.05 Pyroquilon 1:33.3 0.6:20 X.05 Pyroquilon 1:10 0.6:6.sup. X.05 N-(1-benzyl-1,3-dimethyl-butyl)- 3:1 6:2 8-fluoro-quinoline-3- carboxamide X.05 N-(1-benzyl-1,3-dimethyl-butyl)- 30:1 .sup.6:0.2 8-fluoro-quinoline-3- carboxamide X.05 N-(1-benzyl-1,3-dimethyl-butyl)- .sup.1:3.3 0.6:2.sup. 8-fluoro-quinoline-3- carboxamide X.05 N-(1-benzyl-1,3-dimethyl-butyl)- 3:1 0.6:0.2 8-fluoro-quinoline-3- carboxamide X.05 N-(1-benzyl-3,3,3-trifluoro-1- 3:1 6:2 methyl-propyl)-8-fluoro- quinoline-3-carboxamide X.05 N-(1-benzyl-3,3,3-trifluoro-1- 30:1 .sup.6:0.2 methyl-propyl)-8-fluoro- quinoline-3-carboxamide X.05 N-(1-benzyl-3,3,3-trifluoro-1- .sup.1:3.3 0.6:2.sup. methyl-propyl)-8-fluoro- quinoline-3-carboxamide X.05 N-(1-benzyl-3,3,3-trifluoro-1- 3:1 0.6:0.2 methyl-propyl)-8-fluoro- quinoline-3-carboxamide X.05 1-(6,7-dimethylpyrazolo[1,5- 3:1 6:2 a]pyridin-3-yl)-4,4,5-trifluoro-3,3- dimethyl-isoquinoline X.05 1-(6,7-dimethylpyrazolo[1,5- 30:1 .sup.6:0.2 a]pyridin-3-yl)-4,4,5-trifluoro-3,3- dimethyl-isoquinoline X.05 1-(6,7-dimethylpyrazolo[1,5- .sup.1:3.3 0.6:2.sup. a]pyridin-3-yl)-4,4,5-trifluoro-3,3- dimethyl-isoquinoline X.05 1-(6,7-dimethylpyrazolo[1,5- 3:1 0.6:0.2 a]pyridin-3-yl)-4,4,5-trifluoro-3,3- dimethyl-isoquinoline X.05 4,4-difluoro-3,3-dimethyl-1-(7- 3:1 6:2 methylpyrazolo[1,5-a]pyridin-3- yl)isoquinoline X.05 4,4-difluoro-3,3-dimethyl-1-(7- 30:1 .sup.6:0.2 methylpyrazolo[1,5-a]pyridin-3- yl)isoquinoline X.05 4,4-difluoro-3,3-dimethyl-1-(7- .sup.1:3.3 0.6:2.sup. methylpyrazolo[1,5-a]pyridin-3- yl)isoquinoline X.05 4,4-difluoro-3,3-dimethyl-1-(7- 3:1 0.6:0.2 methylpyrazolo[1,5-a]pyridin-3- yl)isoquinoline X.05 1-(4,5-dimethylbenzimidazol-1- 3:1 6:2 yl)-4,4,5-trifluoro-3,3-dimethyl- isoquinoline X.05 1-(4,5-dimethylbenzimidazol-1- 30:1 .sup.6:0.2 yl)-4,4,5-trifluoro-3,3-dimethyl- isoquinoline X.05 1-(4,5-dimethylbenzimidazol-1- .sup.1:3.3 0.6:2.sup. yl)-4,4,5-trifluoro-3,3-dimethyl- isoquinoline X.05 1-(4,5-dimethylbenzimidazol-1- 3:1 0.6:0.2 yl)-4,4,5-trifluoro-3,3-dimethyl- isoquinoline X.05 1-(4,5-dimethylbenzimidazol-1- 3:1 6:2 yl)-4,4-difluoro-3,3-dimethyl- isoquinoline X.05 1-(4,5-dimethylbenzimidazol-1- 30:1 .sup.6:0.2 yl)-4,4-difluoro-3,3-dimethyl- isoquinoline X.05 1-(4,5-dimethylbenzimidazol-1- .sup.1:3.3 0.6:2.sup. yl)-4,4-difluoro-3,3-dimethyl- isoquinoline X.05 1-(4,5-dimethylbenzimidazol-1- 3:1 0.6:0.2 yl)-4,4-difluoro-3,3-dimethyl- isoquinoline

(62) TABLE-US-00013 Component A Ratio Conc. (ppm) (Compound) Component B A:B (A:B) X.07 Azoxystrobin 3:1 6:2 X.07 Azoxystrobin 30:1 .sup.6:0.2 X.07 Azoxystrobin .sup.1:3.3 0.6:2.sup. X.07 Azoxystrobin 3:1 0.6:0.2 X.07 Trifloxystrobin 3:1 6:2 X.07 Trifloxystrobin 30:1 .sup.6:0.2 X.07 Trifloxystrobin .sup.1:3.3 0.6:2.sup. X.07 Trifloxystrobin 3:1 0.6:0.2 X.07 Metyltetraprole 3:1 6:2 X.07 Metyltetraprole 30:1 .sup.6:0.2 X.07 Metyltetraprole .sup.1:3.3 0.6:2.sup. X.07 Metyltetraprole 3:1 0.6:0.2 X.07 Difenoconazole 1:1 6:6 X.07 Difenoconazole 10:1 .sup.6:0.6 X.07 Difenoconazole 1:10 0.6:6.sup. X.07 Difenoconazole 1:1 0.6:0.6 X.07 Hexaconazole 1:1 6:6 X.07 Hexaconazole 10:1 .sup.6:0.6 X.07 Hexaconazole 1:10 0.6:6.sup. X.07 Hexaconazole 1:1 0.6:0.6 X.07 Propiconazole 1:1 6:6 X.07 Propiconazole 10:1 .sup.6:0.6 X.07 Propiconazole 1:10 0.6:6.sup. X.07 Propiconazole 1:1 0.6:0.6 X.07 Prothioconazole 1:1 6:6 X.07 Prothioconazole 10:1 .sup.6:0.6 X.07 Prothioconazole 1:10 0.6:6.sup. X.07 Prothioconazole 1:1 0.6:0.6 X.07 Mefentrifluconazole 1:1 6:6 X.07 Mefentrifluconazole 10:1 .sup.6:0.6 X.07 Mefentrifluconazole 1:10 0.6:6.sup. X.07 Mefentrifluconazole 1:1 0.6:0.6 X.07 Fenpropidin .sup.1:3.3 6:20 X.07 Fenpropidin 3:1 6:2 X.07 Fenpropidin 1:33.3 0.6:20 X.07 Fenpropidin .sup.1:3.3 0.6:2.sup. X.07 Fenpropimorph .sup.1:3.3 6:20 X.07 Fenpropimorph 3:1 6:2 X.07 Fenpropimorph 1:33.3 0.6:20 X.07 Fenpropimorph .sup.1:3.3 0.6:2.sup. X.07 Fluxapyroxad 3:1 6:2 X.07 Fluxapyroxad 30:1 .sup.6:0.2 X.07 Fluxapyroxad .sup.1:3.3 0.6:2.sup. X.07 Fluxapyroxad 3:1 0.6:0.2 X.07 Fluopyram 3:1 6:2 X.07 Fluopyram 30:1 .sup.6:0.2 X.07 Fluopyram .sup.1:3.3 0.6:2.sup. X.07 Fluopyram 3:1 0.6:0.2 X.07 Isopyrazam 3:1 6:2 X.07 Isopyrazam 30:1 .sup.6:0.2 X.07 Isopyrazam .sup.1:3.3 0.6:2.sup. X.07 Isopyrazam 3:1 0.6:0.2 X.07 Sedaxane 3:1 6:2 X.07 Sedaxane 30:1 .sup.6:0.2 X.07 Sedaxane .sup.1:3.3 0.6:2.sup. X.07 Sedaxane 3:1 0.6:0.2 X.07 Benzovindiflupyr 3:1 6:2 X.07 Benzovindiflupyr 30:1 .sup.6:0.2 X.07 Benzovindiflupyr .sup.1:3.3 0.6:2.sup. X.07 Benzovindiflupyr 3 0.6:0.2 X.07 Pydiflumetofen 3:1 6:2 X.07 Pydiflumetofen 30:1 .sup.6:0.2 X.07 Pydiflumetofen .sup.1:3.3 0.6:2.sup. X.07 Pydiflumetofen 3:1 0.6:0.2 X.07 Isoflucypram 3:1 6:2 X.07 Isoflucypram 30:1 .sup.6:0.2 X.07 Isoflucypram .sup.1:3.3 0.6:2.sup. X.07 Isoflucypram 3:1 0.6:0.2 X.07 Isofetamid 3:1 6:2 X.07 Isofetamid 30:1 .sup.6:0.2 X.07 Isofetamid .sup.1:3.3 0.6:2.sup. X.07 Isofetamid 3:1 0.6:0.2 X.07 Pyrapropoyne 3:1 6:2 X.07 Pyrapropoyne 30:1 .sup.6:0.2 X.07 Pyrapropoyne .sup.1:3.3 0.6:2.sup. X.07 Pyrapropoyne 3:1 0.6:0.2 X.07 Fluindapyr 3:1 6:2 X.07 Fluindapyr 30:1 .sup.6:0.2 X.07 Fluindapyr .sup.1:3.3 0.6:2.sup. X.07 Fluindapyr 3:1 0.6:0.2 X.07 Fenpicoxamid 1:1 6:6 X.07 Fenpicoxamid 10:1 .sup.6:0.6 X.07 Fenpicoxamid 1:10 0.6:6.sup. X.07 Fenpicoxamid 1:1 0.6:0.6 X.07 Florylpicoxamid 3:1 6:2 X.07 Florylpicoxamid 30:1 .sup.6:0.2 X.07 Florylpicoxamid .sup.1:3.3 0.6:2.sup. X.07 Florylpicoxamid 3:1 0.6:0.2 X.07 Chlorothalonil 1:1 6:6 X.07 Chlorothalonil 10:1 .sup.6:0.6 X.07 Chlorothalonil 1:10 0.6:6.sup. X.07 Chlorothalonil 1:1 0.6:0.6 X.07 Mancozeb .sup.1:3.3 6:20 X.07 Mancozeb 1:1 6:6 X.07 Mancozeb 1:33.3 0.6:20 X.07 Mancozeb 1:10 0.6:6.sup. X.07 Mandipropamid .sup.1:3.3 6:20 X.07 Mandipropamid 1:1 6:6 X.07 Mandipropamid 1:33.3 0.6:20 X.07 Mandipropamid 1:10 0.6:6.sup. X.07 Oxathiapiprolin .sup.1:3.3 6:20 X.07 Oxathiapiprolin 1:1 6:6 X.07 Oxathiapiprolin 1:33.3 0.6:20 X.07 Oxathiapiprolin 1:10 0.6:6.sup. X.07 Fluazinam 3:1 6:2 X.07 Fluazinam 30:1 .sup.6:0.2 X.07 Fluazinam .sup.1:3.3 0.6:2.sup. X.07 Fluazinam 3:1 0.6:0.2 X.07 Fludioxonil 1:1 6:6 X.07 Fludioxonil 10:1 .sup.6:0.6 X.07 Fludioxonil 1:10 0.6:6.sup. X.07 Fludioxonil 1:1 0.6:0.6 X.07 Cyprodinil 1:1 6:6 X.07 Cyprodinil 10:1 .sup.6:0.6 X.07 Cyprodinil 1:10 0.6:6.sup. X.07 Cyprodinil 1:1 0.6:0.6 X.07 Metalaxyl-M .sup.1:3.3 6:20 X.07 Metalaxyl-M 1:1 6:6 X.07 Metalaxyl-M 1:33.3 0.6:20 X.07 Metalaxyl-M 1:10 0.6:6.sup. X.07 Aminopyrifen 3:1 6:2 X.07 Aminopyrifen 30:1 .sup.6:0.2 X.07 Aminopyrifen .sup.1:3.3 0.6:2.sup. X.07 Aminopyrifen 3:1 0.6:0.2 X.07 Folpet 1:1 6:6 X.07 Folpet 3:1 6:2 X.07 Folpet 1:10 0.6:6.sup. X.07 Folpet .sup.1:3.3 0.6:2.sup. X.07 Ipflufenoquin 3:1 6:2 X.07 Ipflufenoquin 30:1 .sup.6:0.2 X.07 Ipflufenoquin .sup.1:3.3 0.6:2.sup. X.07 Ipflufenoquin 3:1 0.6:0.2 X.07 Quinofumelin 3:1 6:2 X.07 Quinofumelin 30:1 .sup.6:0.2 X.07 Quinofumelin .sup.1:3.3 0.6:2.sup. X.07 Quinofumelin 3:1 0.6:0.2 X.07 Tricyclazole .sup.1:3.3 6:20 X.07 Tricyclazole 1:1 6:6 X.07 Tricyclazole 1:33.3 0.6:20 X.07 Tricyclazole 1:10 0.6:6.sup. X.07 Pyroquilon .sup.1:3.3 6:20 X.07 Pyroquilon 1:1 6:6 X.07 Pyroquilon 1:33.3 0.6:20 X.07 Pyroquilon 1:10 0.6:6.sup. X.07 N-(1-benzyl-1,3-dimethyl-butyl)- 3:1 6:2 8-fluoro-quinoline-3- carboxamide X.07 N-(1-benzyl-1,3-dimethyl-butyl)- 30:1 .sup.6:0.2 8-fluoro-quinoline-3- carboxamide X.07 N-(1-benzyl-1,3-dimethyl-butyl)- .sup.1:3.3 0.6:2.sup. 8-fluoro-quinoline-3- carboxamide X.07 N-(1-benzyl-1,3-dimethyl-butyl)- 3:1 0.6:0.2 8-fluoro-quinoline-3- carboxamide X.07 N-(1-benzyl-3,3,3-trifluoro-1- 3:1 6:2 methyl-propyl)-8-fluoro- quinoline-3-carboxamide X.07 N-(1-benzyl-3,3,3-trifluoro-1- 30:1 .sup.6:0.2 methyl-propyl)-8-fluoro- quinoline-3-carboxamide X.07 N-(1-benzyl-3,3,3-trifluoro-1- .sup.1:3.3 0.6:2.sup. methyl-propyl)-8-fluoro- quinoline-3-carboxamide X.07 N-(1-benzyl-3,3,3-trifluoro-1- 3:1 0.6:0.2 methyl-propyl)-8-fluoro- quinoline-3-carboxamide X.07 1-(6,7-dimethylpyrazolo[1,5- 3:1 6:2 a]pyridin-3-yl)-4,4,5-trifluoro-3,3- dimethyl-isoquinoline X.07 1-(6,7-dimethylpyrazolo[1,5- 30:1 .sup.6:0.2 a]pyridin-3-yl)-4,4,5-trifluoro-3,3- dimethyl-isoquinoline X.07 1-(6,7-dimethylpyrazolo[1,5- .sup.1:3.3 0.6:2.sup. a]pyridin-3-yl)-4,4,5-trifluoro-3,3- dimethyl-isoquinoline X.07 1-(6,7-dimethylpyrazolo[1,5- 3:1 0.6:0.2 a]pyridin-3-yl)-4,4,5-trifluoro-3,3- dimethyl-isoquinoline X.07 4,4-difluoro-3,3-dimethyl-1-(7- 3:1 6:2 methylpyrazolo[1,5-a]pyridin-3- yl)isoquinoline X.07 4,4-difluoro-3,3-dimethyl-1-(7- 30:1 .sup.6:0.2 methylpyrazolo[1,5-a]pyridin-3- yl)isoquinoline X.07 4,4-difluoro-3,3-dimethyl-1-(7- .sup.1:3.3 0.6:2.sup. methylpyrazolo[1,5-a]pyridin-3- yl)isoquinoline X.07 4,4-difluoro-3,3-dimethyl-1-(7- 3:1 0.6:0.2 methylpyrazolo[1,5-a]pyridin-3- yl)isoquinoline X.07 1-(4,5-dimethylbenzimidazol-1- 3:1 6:2 yl)-4,4,5-trifluoro-3,3-dimethyl- isoquinoline X.07 1-(4,5-dimethylbenzimidazol-1- 30:1 .sup.6:0.2 yl)-4,4,5-trifluoro-3,3-dimethyl- isoquinoline X.07 1-(4,5-dimethylbenzimidazol-1- .sup.1:3.3 0.6:2.sup. yl)-4,4,5-trifluoro-3,3-dimethyl- isoquinoline X.07 1-(4,5-dimethylbenzimidazol-1- 3:1 0.6:0.2 yl)-4,4,5-trifluoro-3,3-dimethyl- isoquinoline X.07 1-(4,5-dimethylbenzimidazol-1- 3:1 6:2 yl)-4,4-difluoro-3,3-dimethyl- isoquinoline X.07 1-(4,5-dimethylbenzimidazol-1- 30:1 .sup.6:0.2 yl)-4,4-difluoro-3,3-dimethyl- isoquinoline X.07 1-(4,5-dimethylbenzimidazol-1- .sup.1:3.3 0.6:2.sup. yl)-4,4-difluoro-3,3-dimethyl- isoquinoline X.07 1-(4,5-dimethylbenzimidazol-1- 3:1 0.6:0.2 yl)-4,4-difluoro-3,3-dimethyl- isoquinoline

(63) TABLE-US-00014 Component A Ratio Conc. (ppm) (Compound) Component B A:B (A:B) X.14 Azoxystrobin 3:1 6:2 X.14 Azoxystrobin 30:1 .sup.6:0.2 X.14 Azoxystrobin .sup.1:3.3 0.6:2.sup. X.14 Azoxystrobin 3:1 0.6:0.2 X.14 Trifloxystrobin 3:1 6:2 X.14 Trifloxystrobin 30:1 .sup.6:0.2 X.14 Trifloxystrobin .sup.1:3.3 0.6:2.sup. X.14 Trifloxystrobin 3:1 0.6:0.2 X.14 Metyltetraprole 3:1 6:2 X.14 Metyltetraprole 30:1 .sup.6:0.2 X.14 Metyltetraprole .sup.1:3.3 0.6:2.sup. X.14 Metyltetraprole 3:1 0.6:0.2 X.14 Difenoconazole 1:1 6:6 X.14 Difenoconazole 10:1 .sup.6:0.6 X.14 Difenoconazole 1:10 0.6:6.sup. X.14 Difenoconazole 1:1 0.6:0.6 X.14 Hexaconazole 1:1 6:6 X.14 Hexaconazole 10:1 .sup.6:0.6 X.14 Hexaconazole 1:10 0.6:6.sup. X.14 Hexaconazole 1:1 0.6:0.6 X.14 Propiconazole 1:1 6:6 X.14 Propiconazole 10:1 .sup.6:0.6 X.14 Propiconazole 1:10 0.6:6.sup. X.14 Propiconazole 1:1 0.6:0.6 X.14 Prothioconazole 1:1 6:6 X.14 Prothioconazole 10:1 .sup.6:0.6 X.14 Prothioconazole 1:10 0.6:6.sup. X.14 Prothioconazole 1:1 0.6:0.6 X.14 Mefentrifluconazole 1:1 6:6 X.14 Mefentrifluconazole 10:1 .sup.6:0.6 X.14 Mefentrifluconazole 1:10 0.6:6.sup. X.14 Mefentrifluconazole 1:1 0.6:0.6 X.14 Fenpropidin .sup.1:3.3 6:20 X.14 Fenpropidin 3:1 6:2 X.14 Fenpropidin 1:33.3 0.6:20 X.14 Fenpropidin .sup.1:3.3 0.6:2.sup. X.14 Fenpropimorph .sup.1:3.3 6:20 X.14 Fenpropimorph 3:1 6:2 X.14 Fenpropimorph 1:33.3 0.6:20 X.14 Fenpropimorph .sup.1:3.3 0.6:2.sup. X.14 Fluxapyroxad 3:1 6:2 X.14 Fluxapyroxad 30:1 .sup.6:0.2 X.14 Fluxapyroxad .sup.1:3.3 0.6:2.sup. X.14 Fluxapyroxad 3:1 0.6:0.2 X.14 Fluopyram 3:1 6:2 X.14 Fluopyram 30:1 .sup.6:0.2 X.14 Fluopyram .sup.1:3.3 0.6:2.sup. X.14 Fluopyram 3:1 0.6:0.2 X.14 Isopyrazam 3:1 6:2 X.14 Isopyrazam 30:1 .sup.6:0.2 X.14 Isopyrazam .sup.1:3.3 0.6:2.sup. X.14 Isopyrazam 3:1 0.6:0.2 X.14 Sedaxane 3:1 6:2 X.14 Sedaxane 30:1 .sup.6:0.2 X.14 Sedaxane .sup.1:3.3 0.6:2.sup. X.14 Sedaxane 3:1 0.6:0.2 X.14 Benzovindiflupyr 3:1 6:2 X.14 Benzovindiflupyr 30:1 .sup.6:0.2 X.14 Benzovindiflupyr .sup.1:3.3 0.6:2.sup. X.14 Benzovindiflupyr 3:1 0.6:0.2 X.14 Pydiflumetofen 3:1 6:2 X.14 Pydiflumetofen 30:1 .sup.6:0.2 X.14 Pydiflumetofen .sup.1:3.3 0.6:2.sup. X.14 Pydiflumetofen 3:1 0.6:0.2 X.14 Isoflucypram 3:1 6:2 X.14 Isoflucypram 30:1 .sup.6:0.2 X.14 Isoflucypram .sup.1:3.3 0.6:2.sup. X.14 Isoflucypram 3:1 0.6:0.2 X.14 Isofetamid 3:1 6:2 X.14 Isofetamid 30:1 .sup.6:0.2 X.14 Isofetamid .sup.1:3.3 0.6:2.sup. X.14 Isofetamid 3:1 0.6:0.2 X.14 Pyrapropoyne 3:1 6:2 X.14 Pyrapropoyne 30:1 .sup.6:0.2 X.14 Pyrapropoyne .sup.1:3.3 0.6:2.sup. X.14 Pyrapropoyne 3:1 0.6:0.2 X.14 Fluindapyr 3:1 6:2 X.14 Fluindapyr 30:1 .sup.6:0.2 X.14 Fluindapyr .sup.1:3.3 0.6:2.sup. X.14 Fluindapyr 3:1 0.6:0.2 X.14 Fenpicoxamid 1:1 6:6 X.14 Fenpicoxamid 10:1 .sup.6:0.6 X.14 Fenpicoxamid 1:10 0.6:6.sup. X.14 Fenpicoxamid 1:1 0.6:0.6 X.14 Florylpicoxamid 3:1 6:2 X.14 Florylpicoxamid 30:1 .sup.6:0.2 X.14 Florylpicoxamid .sup.1:3.3 0.6:2.sup. X.14 Florylpicoxamid 3:1 0.6:0.2 X.14 Chlorothalonil 1:1 6:6 X.14 Chlorothalonil 10:1 .sup.6:0.6 X.14 Chlorothalonil 1:10 0.6:6.sup. X.14 Chlorothalonil 1:1 0.6:0.6 X.14 Mancozeb .sup.1:3.3 6:20 X.14 Mancozeb 1:1 6:6 X.14 Mancozeb 1:33.3 0.6:20 X.14 Mancozeb 1:10 0.6:6.sup. X.14 Mandipropamid .sup.1:3.3 6:20 X.14 Mandipropamid 1:1 6:6 X.14 Mandipropamid 1:33.3 0.6:20 X.14 Mandipropamid 1:10 0.6:6.sup. X.14 Oxathiapiprolin .sup.1:3.3 6:20 X.14 Oxathiapiprolin 1:1 6:6 X.14 Oxathiapiprolin 1:33.3 0.6:20 X.14 Oxathiapiprolin 1:10 0.6:6.sup. X.14 Fluazinam 3:1 6:2 X.14 Fluazinam 30:1 .sup.6:0.2 X.14 Fluazinam .sup.1:3.3 0.6:2.sup. X.14 Fluazinam 3:1 0.6:0.2 X.14 Fludioxonil 1:1 6:6 X.14 Fludioxonil 10:1 .sup.6:0.6 X.14 Fludioxonil 1:10 0.6:6.sup. X.14 Fludioxonil 1:1 0.6:0.6 X.14 Cyprodinil 1:1 6:6 X.14 Cyprodinil 10:1 .sup.6:0.6 X.14 Cyprodinil 1:10 0.6:6.sup. X.14 Cyprodinil 1:1 0.6:0.6 X.14 Metalaxyl-M .sup.1:3.3 6:20 X.14 Metalaxyl-M 1:1 6:6 X.14 Metalaxyl-M 1:33.3 0.6:20 X.14 Metalaxyl-M 1:10 0.6:6.sup. X.14 Aminopyrifen 3:1 6:2 X.14 Aminopyrifen 30:1 .sup.6:0.2 X.14 Aminopyrifen .sup.1:3.3 0.6:2.sup. X.14 Aminopyrifen 3:1 0.6:0.2 X.14 Folpet 1:1 6:6 X.14 Folpet 3:1 6:2 X.14 Folpet 1:10 0.6:6.sup. X.14 Folpet .sup.1:3.3 0.6:2.sup. X.14 Ipflufenoquin 3:1 6:2 X.14 Ipflufenoquin 30:1 .sup.6:0.2 X.14 Ipflufenoquin .sup.1:3.3 0.6:2.sup. X.14 Ipflufenoquin 3:1 0.6:0.2 X.14 Quinofumelin 3:1 6:2 X.14 Quinofumelin 30:1 .sup.6:0.2 X.14 Quinofumelin .sup.1:3.3 0.6:2.sup. X.14 Quinofumelin 3:1 0.6:0.2 X.14 Tricyclazole .sup.1:3.3 6:20 X.14 Tricyclazole 1:1 6:6 X.14 Tricyclazole 1:33.3 0.6:20 X.14 Tricyclazole 1:10 0.6:6.sup. X.14 Pyroquilon .sup.1:3.3 6:20 X.14 Pyroquilon 1:1 6:6 X.14 Pyroquilon 1:33.3 0.6:20 X.14 Pyroquilon 1:10 0.6:6.sup. X.14 N-(1-benzyl-1,3-dimethyl-butyl)- 3:1 6:2 8-fluoro-quinoline-3- carboxamide X.14 N-(1-benzyl-1,3-dimethyl-butyl)- 30:1 .sup.6:0.2 8-fluoro-quinoline-3- carboxamide X.14 N-(1-benzyl-1,3-dimethyl-butyl)- .sup.1:3.3 0.6:2.sup. 8-fluoro-quinoline-3- carboxamide X.14 N-(1-benzyl-1,3-dimethyl-butyl)- 3:1 0.6:0.2 8-fluoro-quinoline-3- carboxamide X.14 N-(1-benzyl-3,3,3-trifluoro-1- 3:1 6:2 methyl-propyl)-8-fluoro- quinoline-3-carboxamide X.14 N-(1-benzyl-3,3,3-trifluoro-1- 30:1 .sup.6:0.2 methyl-propyl)-8-fluoro- quinoline-3-carboxamide X.14 N-(1-benzyl-3,3,3-trifluoro-1- .sup.1:3.3 0.6:2.sup. methyl-propyl)-8-fluoro- quinoline-3-carboxamide X.14 N-(1-benzyl-3,3,3-trifluoro-1- 3:1 0.6:0.2 methyl-propyl)-8-fluoro- quinoline-3-carboxamide X.14 1-(6,7-dimethylpyrazolo[1,5- 3:1 6:2 a]pyridin-3-yl)-4,4,5-trifluoro-3,3- dimethyl-isoquinoline X.14 1-(6,7-dimethylpyrazolo[1,5- 30:1 .sup.6:0.2 a]pyridin-3-yl)-4,4,5-trifluoro-3,3- dimethyl-isoquinoline X.14 1-(6,7-dimethylpyrazolo[1,5- .sup.1:3.3 0.6:2.sup. a]pyridin-3-yl)-4,4,5-trifluoro-3,3- dimethyl-isoquinoline X.14 1-(6,7-dimethylpyrazolo[1,5- 3:1 0.6:0.2 a]pyridin-3-yl)-4,4,5-trifluoro-3,3- dimethyl-isoquinoline X.14 4,4-difluoro-3,3-dimethyl-1-(7- 3:1 6:2 methylpyrazolo[1,5-a]pyridin-3- yl)isoquinoline X.14 4,4-difluoro-3,3-dimethyl-1-(7- 30:1 .sup.6:0.2 methylpyrazolo[1,5-a]pyridin-3- yl)isoquinoline X.14 4,4-difluoro-3,3-dimethyl-1-(7- .sup.1:3.3 0.6:2.sup. methylpyrazolo[1,5-a]pyridin-3- yl)isoquinoline X.14 4,4-difluoro-3,3-dimethyl-1-(7- 3:1 0.6:0.2 methylpyrazolo[1,5-a]pyridin-3- yl)isoquinoline X.14 1-(4,5-dimethylbenzimidazol-1- 3:1 6:2 yl)-4,4,5-trifluoro-3,3-dimethyl- isoquinoline X.14 1-(4,5-dimethylbenzimidazol-1- 30:1 .sup.6:0.2 yl)-4,4,5-trifluoro-3,3-dimethyl- isoquinoline X.14 1-(4,5-dimethylbenzimidazol-1- .sup.1:3.3 0.6:2.sup. yl)-4,4,5-trifluoro-3,3-dimethyl- isoquinoline X.14 1-(4,5-dimethylbenzimidazol-1- 3:1 0.6:0.2 yl)-4,4,5-trifluoro-3,3-dimethyl- isoquinoline X.14 1-(4,5-dimethylbenzimidazol-1- 3:1 6:2 yl)-4,4-difluoro-3,3-dimethyl- isoquinoline X.14 1-(4,5-dimethylbenzimidazol-1- 30:1 .sup.6:0.2 yl)-4,4-difluoro-3,3-dimethyl- isoquinoline X.14 1-(4,5-dimethylbenzimidazol-1- .sup.1:3.3 0.6:2.sup. yl)-4,4-difluoro-3,3-dimethyl- isoquinoline X.14 1-(4,5-dimethylbenzimidazol-1- 3:1 0.6:0.2 yl)-4,4-difluoro-3,3-dimethyl- isoquinoline

Example B32: Activity Against Botrytis cinerea (Gray Mold)

(64) Conidia of the fungus from cryogenic storage were directly mixed into nutrient broth (Vogel's minimal media) containing 200 Mol SHAM. A D MSO solution of the test compounds was placed into a microtiter plate (96-well formant) and the nutrient broth containing the fungal spores was added to it. The test plates were incubated at 24 C. and the inhibition of growth was determined photometrically after 72 hrs. The following mixture compositions (A:B) at the reported concentration (in ppm) gave at least 80% disease control in this test.

(65) TABLE-US-00015 Component A Ratio Conc. (ppm) (Compound) Component B A:B (A:B) X.05 Azoxystrobin 3:1 6:2 X.05 Azoxystrobin 30:1 .sup.6:0.2 X.05 Azoxystrobin .sup.1:3.3 0.6:2.sup. X.05 Azoxystrobin 3:1 0.6:0.2 X.05 Trifloxystrobin 3:1 6:2 X.05 Trifloxystrobin 30:1 .sup.6:0.2 X.05 Trifloxystrobin .sup.1:3.3 0.6:2.sup. X.05 Trifloxystrobin 3:1 0.6:0.2 X.05 Metyltetraprole 3:1 6:2 X.05 Metyltetraprole 30:1 .sup.6:0.2 X.05 Metyltetraprole .sup.1:3.3 0.6:2.sup. X.05 Metyltetraprole 3:1 0.6:0.2 X.05 Difenoconazole 1:1 6:6 X.05 Difenoconazole 10:1 .sup.6:0.6 X.05 Difenoconazole 1:10 0.6:6.sup. X.05 Difenoconazole 1:1 0.6:0.6 X.05 Hexaconazole 1:1 6:6 X.05 Hexaconazole 10:1 .sup.6:0.6 X.05 Hexaconazole 1:10 0.6:6.sup. X.05 Hexaconazole 1:1 0.6:0.6 X.05 Propiconazole 1:1 6:6 X.05 Propiconazole 10:1 .sup.6:0.6 X.05 Propiconazole 1:10 0.6:6.sup. X.05 Propiconazole 1:1 0.6:0.6 X.05 Prothioconazole 1:1 6:6 X.05 Prothioconazole 10:1 .sup.6:0.6 X.05 Prothioconazole 1:10 0.6:6.sup. X.05 Prothioconazole 1:1 0.6:0.6 X.05 Mefentrifluconazole 1:1 6:6 X.05 Mefentrifluconazole 10:1 .sup.6:0.6 X.05 Mefentrifluconazole 1:10 0.6:6.sup. X.05 Mefentrifluconazole 1:1 0.6:0.6 X.05 Fenpropidin .sup.1:3.3 6:20 X.05 Fenpropidin 3:1 6:2 X.05 Fenpropidin 1:33.3 0.6:20 X.05 Fenpropidin .sup.1:3.3 0.6:2.sup. X.05 Fenpropimorph .sup.1:3.3 6:20 X.05 Fenpropimorph 3:1 6:2 X.05 Fenpropimorph 1:33.3 0.6:20 X.05 Fenpropimorph .sup.1:3.3 0.6:2.sup. X.05 Fluxapyroxad 3:1 6:2 X.05 Fluxapyroxad 30:1 .sup.6:0.2 X.05 Fluxapyroxad .sup.1:3.3 0.6:2.sup. X.05 Fluxapyroxad 3:1 0.6:0.2 X.05 Fluopyram 3:1 6:2 X.05 Fluopyram 30:1 .sup.6:0.2 X.05 Fluopyram .sup.1:3.3 0.6:2.sup. X.05 Fluopyram 3:1 0.6:0.2 X.05 Isopyrazam 3:1 6:2 X.05 Isopyrazam 30:1 .sup.6:0.2 X.05 Isopyrazam .sup.1:3.3 0.6:2.sup. X.05 Isopyrazam 3:1 0.6:0.2 X.05 Sedaxane 3:1 6:2 X.05 Sedaxane 30:1 .sup.6:0.2 X.05 Sedaxane .sup.1:3.3 0.6:2.sup. X.05 Sedaxane 3:1 0.6:0.2 X.05 Benzovindiflupyr 3:1 6:2 X.05 Benzovindiflupyr 30:1 .sup.6:0.2 X.05 Benzovindiflupyr .sup.1:3.3 0.6:2.sup. X.05 Benzovindiflupyr 3:1 0.6:0.2 X.05 Pydiflumetofen 3:1 6:2 X.05 Pydiflumetofen 30:1 .sup.6:0.2 X.05 Pydiflumetofen .sup.1:3.3 0.6:2.sup. X.05 Pydiflumetofen 3:1 0.6:0.2 X.05 Isoflucypram 3:1 6:2 X.05 Isoflucypram 30:1 .sup.6:0.2 X.05 Isoflucypram .sup.1:3.3 0.6:2.sup. X.05 Isoflucypram 3:1 0.6:0.2 X.05 Isofetamid 3:1 6:2 X.05 Isofetamid 30:1 .sup.6:0.2 X.05 Isofetamid .sup.1:3.3 0.6:2.sup. X.05 Isofetamid 3:1 0.6:0.2 X.05 Pyrapropoyne 3:1 6:2 X.05 Pyrapropoyne 30:1 .sup.6:0.2 X.05 Pyrapropoyne .sup.1:3.3 0.6:2.sup. X.05 Pyrapropoyne 3:1 0.6:0.2 X.05 Fluindapyr 3:1 6:2 X.05 Fluindapyr 30:1 .sup.6:0.2 X.05 Fluindapyr .sup.1:3.3 0.6:2.sup. X.05 Fluindapyr 3:1 0.6:0.2 X.05 Fenpicoxamid 1:1 6:6 X.05 Fenpicoxamid 10:1 .sup.6:0.6 X.05 Fenpicoxamid 1:10 0.6:6.sup. X.05 Fenpicoxamid 1:1 0.6:0.6 X.05 Florylpicoxamid 3:1 6:2 X.05 Florylpicoxamid 30:1 .sup.6:0.2 X.05 Florylpicoxamid .sup.1:3.3 0.6:2.sup. X.05 Florylpicoxamid 3:1 0.6:0.2 X.05 Chlorothalonil 1:1 6:6 X.05 Chlorothalonil 10:1 .sup.6:0.6 X.05 Chlorothalonil 1:10 0.6:6.sup. X.05 Chlorothalonil 1:1 0.6:0.6 X.05 Mancozeb .sup.1:3.3 6:20 X.05 Mancozeb 1:1 6:6 X.05 Mancozeb 1:33.3 0.6:20 X.05 Mancozeb 1:10 0.6:6.sup. X.05 Mandipropamid .sup.1:3.3 6:20 X.05 Mandipropamid 1:1 6:6 X.05 Mandipropamid 1:33.3 0.6:20 X.05 Mandipropamid 1:10 0.6:6.sup. X.05 Oxathiapiprolin .sup.1:3.3 6:20 X.05 Oxathiapiprolin 1:1 6:6 X.05 Oxathiapiprolin 1:33.3 0.6:20 X.05 Oxathiapiprolin 1:10 0.6:6.sup. X.05 Fluazinam 3:1 6:2 X.05 Fluazinam 30:1 .sup.6:0.2 X.05 Fluazinam .sup.1:3.3 0.6:2.sup. X.05 Fluazinam 3:1 0.6:0.2 X.05 Fludioxonil 1:1 6:6 X.05 Fludioxonil 10:1 .sup.6:0.6 X.05 Fludioxonil 1:10 0.6:6.sup. X.05 Fludioxonil 1:1 0.6:0.6 X.05 Cyprodinil 1:1 6:6 X.05 Cyprodinil 10:1 .sup.6:0.6 X.05 Cyprodinil 1:10 0.6:6.sup. X.05 Cyprodinil 1:1 0.6:0.6 X.05 Metalaxyl-M .sup.1:3.3 6:20 X.05 Metalaxyl-M 1:1 6:6 X.05 Metalaxyl-M 1:33.3 0.6:20 X.05 Metalaxyl-M 1:10 0.6:6.sup. X.05 Aminopyrifen 3:1 6:2 X.05 Aminopyrifen 30:1 .sup.6:0.2 X.05 Aminopyrifen .sup.1:3.3 0.6:2.sup. X.05 Aminopyrifen 3:1 0.6:0.2 X.05 Folpet 1:1 6:6 X.05 Folpet 3:1 6:2 X.05 Folpet 1:10 0.6:6.sup. X.05 Folpet .sup.1:3.3 0.6:2.sup. X.05 Ipflufenoquin 3:1 6:2 X.05 Ipflufenoquin 30:1 .sup.6:0.2 X.05 Ipflufenoquin .sup.1:3.3 0.6:2.sup. X.05 Ipflufenoquin 3:1 0.6:0.2 X.05 Quinofumelin 3:1 6:2 X.05 Quinofumelin 30:1 .sup.6:0.2 X.05 Quinofumelin .sup.1:3.3 0.6:2.sup. X.05 Quinofumelin 3:1 0.6:0.2 X.05 Tricyclazole .sup.1:3.3 6:20 X.05 Tricyclazole 1:1 6:6 X.05 Tricyclazole 1:33.3 0.6:20 X.05 Tricyclazole 1:10 0.6:6.sup. X.05 Pyroquilon .sup.1:3.3 6:20 X.05 Pyroquilon 1:1 6:6 X.05 Pyroquilon 1:33.3 0.6:20 X.05 Pyroquilon 1:10 0.6:6.sup. X.05 N-(1-benzyl-1,3-dimethyl-butyl)- 3:1 6:2 8-fluoro-quinoline-3- carboxamide X.05 N-(1-benzyl-1,3-dimethyl-butyl)- 30:1 .sup.6:0.2 8-fluoro-quinoline-3- carboxamide X.05 N-(1-benzyl-1,3-dimethyl-butyl)- .sup.1:3.3 0.6:2.sup. 8-fluoro-quinoline-3- carboxamide X.05 N-(1-benzyl-1,3-dimethyl-butyl)- 3:1 0.6:0.2 8-fluoro-quinoline-3- carboxamide X.05 N-(1-benzyl-3,3,3-trifluoro-1- 3:1 6:2 methyl-propyl)-8-fluoro- quinoline-3-carboxamide X.05 N-(1-benzyl-3,3,3-trifluoro-1- 30:1 .sup.6:0.2 methyl-propyl)-8-fluoro- quinoline-3-carboxamide X.05 N-(1-benzyl-3,3,3-trifluoro-1- .sup.1:3.3 0.6:2.sup. methyl-propyl)-8-fluoro- quinoline-3-carboxamide X.05 N-(1-benzyl-3,3,3-trifluoro-1- 3:1 0.6:0.2 methyl-propyl)-8-fluoro- quinoline-3-carboxamide X.05 1-(6,7-dimethylpyrazolo[1,5- 3:1 6:2 a]pyridin-3-yl)-4,4,5-trifluoro-3,3- dimethyl-isoquinoline X.05 1-(6,7-dimethylpyrazolo[1,5- 30:1 .sup.6:0.2 a]pyridin-3-yl)-4,4,5-trifluoro-3,3- dimethyl-isoquinoline X.05 1-(6,7-dimethylpyrazolo[1,5- .sup.1:3.3 0.6:2.sup. a]pyridin-3-yl)-4,4,5-trifluoro-3,3- dimethyl-isoquinoline X.05 1-(6,7-dimethylpyrazolo[1,5- 3:1 0.6:0.2 a]pyridin-3-yl)-4,4,5-trifluoro-3,3- dimethyl-isoquinoline X.05 4,4-difluoro-3,3-dimethyl-1-(7- 3:1 6:2 methylpyrazolo[1,5-a]pyridin-3- yl)isoquinoline X.05 4,4-difluoro-3,3-dimethyl-1-(7- 30:1 .sup.6:0.2 methylpyrazolo[1,5-a]pyridin-3- yl)isoquinoline X.05 4,4-difluoro-3,3-dimethyl-1-(7- .sup.1:3.3 0.6:2.sup. methylpyrazolo[1,5-a]pyridin-3- yl)isoquinoline X.05 4,4-difluoro-3,3-dimethyl-1-(7- 3:1 0.6:0.2 methylpyrazolo[1,5-a]pyridin-3- yl)isoquinoline X.05 1-(4,5-dimethylbenzimidazol-1- 3:1 6:2 yl)-4,4,5-trifluoro-3,3-dimethyl- isoquinoline X.05 1-(4,5-dimethylbenzimidazol-1- 30:1 .sup.6:0.2 yl)-4,4,5-trifluoro-3,3-dimethyl- isoquinoline X.05 1-(4,5-dimethylbenzimidazol-1- .sup.1:3.3 0.6:2.sup. yl)-4,4,5-trifluoro-3,3-dimethyl- isoquinoline X.05 1-(4,5-dimethylbenzimidazol-1- 3:1 0.6:0.2 yl)-4,4,5-trifluoro-3,3-dimethyl- isoquinoline X.05 1-(4,5-dimethylbenzimidazol-1- 3:1 6:2 yl)-4,4-difluoro-3,3-dimethyl- isoquinoline X.05 1-(4,5-dimethylbenzimidazol-1- 30:1 .sup.6:0.2 yl)-4,4-difluoro-3,3-dimethyl- isoquinoline X.05 1-(4,5-dimethylbenzimidazol-1- .sup.1:3.3 0.6:2.sup. yl)-4,4-difluoro-3,3-dimethyl- isoquinoline X.05 1-(4,5-dimethylbenzimidazol-1- 3:1 0.6:0.2 yl)-4,4-difluoro-3,3-dimethyl- isoquinoline

(66) TABLE-US-00016 Component A Ratio Conc. (ppm) (Compound) Component B A:B (A:B) X.07 Azoxystrobin 3:1 6:2 X.07 Azoxystrobin 30:1 .sup.6:0.2 X.07 Azoxystrobin .sup.1:3.3 0.6:2.sup. X.07 Azoxystrobin 3:1 0.6:0.2 X.07 Trifloxystrobin 3:1 6:2 X.07 Trifloxystrobin 30:1 .sup.6:0.2 X.07 Trifloxystrobin .sup.1:3.3 0.6:2.sup. X.07 Trifloxystrobin 3:1 0.6:0.2 X.07 Metyltetraprole 3:1 6:2 X.07 Metyltetraprole 30:1 .sup.6:0.2 X.07 Metyltetraprole .sup.1:3.3 0.6:2.sup. X.07 Metyltetraprole 3:1 0.6:0.2 X.07 Difenoconazole 1:1 6:6 X.07 Difenoconazole 10:1 .sup.6:0.6 X.07 Difenoconazole 1:10 0.6:6.sup. X.07 Difenoconazole 1:1 0.6:0.6 X.07 Hexaconazole 1:1 6:6 X.07 Hexaconazole 10:1 .sup.6:0.6 X.07 Hexaconazole 1:10 0.6:6.sup. X.07 Hexaconazole 1:1 0.6:0.6 X.07 Propiconazole 1:1 6:6 X.07 Propiconazole 10:1 .sup.6:0.6 X.07 Propiconazole 1:10 0.6:6.sup. X.07 Propiconazole 1:1 0.6:0.6 X.07 Prothioconazole 1:1 6:6 X.07 Prothioconazole 10:1 .sup.6:0.6 X.07 Prothioconazole 1:10 0.6:6.sup. X.07 Prothioconazole 1:1 0.6:0.6 X.07 Mefentrifluconazole 1:1 6:6 X.07 Mefentrifluconazole 10:1 .sup.6:0.6 X.07 Mefentrifluconazole 1:10 0.6:6.sup. X.07 Mefentrifluconazole 1:1 0.6:0.6 X.07 Fenpropidin .sup.1:3.3 6:20 X.07 Fenpropidin 3:1 6:2 X.07 Fenpropidin 1:33.3 0.6:20 X.07 Fenpropidin .sup.1:3.3 0.6:2.sup. X.07 Fenpropimorph .sup.1:3.3 6:20 X.07 Fenpropimorph 3:1 6:2 X.07 Fenpropimorph 1:33.3 0.6:20 X.07 Fenpropimorph .sup.1:3.3 0.6:2.sup. X.07 Fluxapyroxad 3:1 6:2 X.07 Fluxapyroxad 30:1 .sup.6:0.2 X.07 Fluxapyroxad .sup.1:3.3 0.6:2.sup. X.07 Fluxapyroxad 3:1 0.6:0.2 X.07 Fluopyram 3:1 6:2 X.07 Fluopyram 30:1 .sup.6:0.2 X.07 Fluopyram .sup.1:3.3 0.6:2.sup. X.07 Fluopyram 3:1 0.6:0.2 X.07 Isopyrazam 3:1 6:2 X.07 Isopyrazam 30:1 .sup.6:0.2 X.07 Isopyrazam .sup.1:3.3 0.6:2.sup. X.07 Isopyrazam 3:1 0.6:0.2 X.07 Sedaxane 3:1 6:2 X.07 Sedaxane 30:1 .sup.6:0.2 X.07 Sedaxane .sup.1:3.3 0.6:2.sup. X.07 Sedaxane 3:1 0.6:0.2 X.07 Benzovindiflupyr 3:1 6:2 X.07 Benzovindiflupyr 30:1 .sup.6:0.2 X.07 Benzovindiflupyr .sup.1:3.3 0.6:2.sup. X.07 Benzovindiflupyr 3:1 0.6:0.2 X.07 Pydiflumetofen 3:1 6:2 X.07 Pydiflumetofen 30:1 .sup.6:0.2 X.07 Pydiflumetofen .sup.1:3.3 0.6:2.sup. X.07 Pydiflumetofen 3:1 0.6:0.2 X.07 Isoflucypram 3:1 6:2 X.07 Isoflucypram 30:1 .sup.6:0.2 X.07 Isoflucypram .sup.1:3.3 0.6:2.sup. X.07 Isoflucypram 3:1 0.6:0.2 X.07 Isofetamid 3:1 6:2 X.07 Isofetamid 30:1 .sup.6:0.2 X.07 Isofetamid .sup.1:3.3 0.6:2.sup. X.07 Isofetamid 3:1 0.6:0.2 X.07 Pyrapropoyne 3:1 6:2 X.07 Pyrapropoyne 30:1 .sup.6:0.2 X.07 Pyrapropoyne .sup.1:3.3 0.6:2.sup. X.07 Pyrapropoyne 3:1 0.6:0.2 X.07 Fluindapyr 3:1 6:2 X.07 Fluindapyr 30:1 .sup.6:0.2 X.07 Fluindapyr .sup.1:3.3 0.6:2.sup. X.07 Fluindapyr 3:1 0.6:0.2 X.07 Fenpicoxamid 1:1 6:6 X.07 Fenpicoxamid 10:1 .sup.6:0.6 X.07 Fenpicoxamid 1:10 0.6:6.sup. X.07 Fenpicoxamid 1:1 0.6:0.6 X.07 Florylpicoxamid 3:1 6:2 X.07 Florylpicoxamid 30:1 .sup.6:0.2 X.07 Florylpicoxamid .sup.1:3.3 0.6:2.sup. X.07 Florylpicoxamid 3:1 0.6:0.2 X.07 Chlorothalonil 1:1 6:6 X.07 Chlorothalonil 10:1 .sup.6:0.6 X.07 Chlorothalonil 1:10 0.6:6.sup. X.07 Chlorothalonil 1:1 0.6:0.6 X.07 Mancozeb .sup.1:3.3 6:20 X.07 Mancozeb 1:1 6:6 X.07 Mancozeb 1:33.3 0.6:20 X.07 Mancozeb 1:10 0.6:6.sup. X.07 Mandipropamid .sup.1:3.3 6:20 X.07 Mandipropamid 1:1 6:6 X.07 Mandipropamid 1:33.3 0.6:20 X.07 Mandipropamid 1:10 0.6:6.sup. X.07 Oxathiapiprolin .sup.1:3.3 6:20 X.07 Oxathiapiprolin 1:1 6:6 X.07 Oxathiapiprolin 1:33.3 0.6:20 X.07 Oxathiapiprolin 1:10 0.6:6.sup. X.07 Fluazinam 3:1 6:2 X.07 Fluazinam 30:1 .sup.6:0.2 X.07 Fluazinam .sup.1:3.3 0.6:2.sup. X.07 Fluazinam 3:1 0.6:0.2 X.07 Fludioxonil 1:1 6:6 X.07 Fludioxonil 10:1 .sup.6:0.6 X.07 Fludioxonil 1:10 0.6:6.sup. X.07 Fludioxonil 1:1 0.6:0.6 X.07 Cyprodinil 1:1 6:6 X.07 Cyprodinil 10:1 .sup.6:0.6 X.07 Cyprodinil 1:10 0.6:6.sup. X.07 Cyprodinil 1:1 0.6:0.6 X.07 Metalaxyl-M .sup.1:3.3 6:20 X.07 Metalaxyl-M 1:1 6:6 X.07 Metalaxyl-M 1:33.3 0.6:20 X.07 Metalaxyl-M 1:10 0.6:6.sup. X.07 Aminopyrifen 3:1 6:2 X.07 Aminopyrifen 30:1 .sup.6:0.2 X.07 Aminopyrifen .sup.1:3.3 0.6:2.sup. X.07 Aminopyrifen 3:1 0.6:0.2 X.07 Folpet 1:1 6:6 X.07 Folpet 3:1 6:2 X.07 Folpet 1:10 0.6:6.sup. X.07 Folpet .sup.1:3.3 0.6:2.sup. X.07 Ipflufenoquin 3:1 6:2 X.07 Ipflufenoquin 30:1 .sup.6:0.2 X.07 Ipflufenoquin .sup.1:3.3 0.6:2.sup. X.07 Ipflufenoquin 3:1 0.6:0.2 X.07 Quinofumelin 3:1 6:2 X.07 Quinofumelin 30:1 .sup.6:0.2 X.07 Quinofumelin .sup.1:3.3 0.6:2.sup. X.07 Quinofumelin 3:1 0.6:0.2 X.07 Tricyclazole .sup.1:3.3 6:20 X.07 Tricyclazole 1:1 6:6 X.07 Tricyclazole 1:33.3 0.6:20 X.07 Tricyclazole 1:10 0.6:6.sup. X.07 Pyroquilon .sup.1:3.3 6:20 X.07 Pyroquilon 1:1 6:6 X.07 Pyroquilon 1:33.3 0.6:20 X.07 Pyroquilon 1:10 0.6:6.sup. X.07 N-(1-benzyl-1,3-dimethyl-butyl)- 3:1 6:2 8-fluoro-quinoline-3- carboxamide X.07 N-(1-benzyl-1,3-dimethyl-butyl)- 30:1 .sup.6:0.2 8-fluoro-quinoline-3- carboxamide X.07 N-(1-benzyl-1,3-dimethyl-butyl)- .sup.1:3.3 0.6:2.sup. 8-fluoro-quinoline-3- carboxamide X.07 N-(1-benzyl-1,3-dimethyl-butyl)- 3:1 0.6:0.2 8-fluoro-quinoline-3- carboxamide X.07 N-(1-benzyl-3,3,3-trifluoro-1- 3:1 6:2 methyl-propyl)-8-fluoro- quinoline-3-carboxamide X.07 N-(1-benzyl-3,3,3-trifluoro-1- 30:1 .sup.6:0.2 methyl-propyl)-8-fluoro- quinoline-3-carboxamide X.07 N-(1-benzyl-3,3,3-trifluoro-1- .sup.1:3.3 0.6:2.sup. methyl-propyl)-8-fluoro- quinoline-3-carboxamide X.07 N-(1-benzyl-3,3,3-trifluoro-1- 3:1 0.6:0.2 methyl-propyl)-8-fluoro- quinoline-3-carboxamide X.07 1-(6,7-dimethylpyrazolo[1,5- 3:1 6:2 a]pyridin-3-yl)-4,4,5-trifluoro-3,3- dimethyl-isoquinoline X.07 1-(6,7-dimethylpyrazolo[1,5- 30:1 .sup.6:0.2 a]pyridin-3-yl)-4,4,5-trifluoro-3,3- dimethyl-isoquinoline X.07 1-(6,7-dimethylpyrazolo[1,5- .sup.1:3.3 0.6:2.sup. a]pyridin-3-yl)-4,4,5-trifluoro-3,3- dimethyl-isoquinoline X.07 1-(6,7-dimethylpyrazolo[1,5- 3:1 0.6:0.2 a]pyridin-3-yl)-4,4,5-trifluoro-3,3- dimethyl-isoquinoline X.07 4,4-difluoro-3,3-dimethyl-1-(7- 3:1 6:2 methylpyrazolo[1,5-a]pyridin-3- yl)isoquinoline X.07 4,4-difluoro-3,3-dimethyl-1-(7- 30:1 .sup.6:0.2 methylpyrazolo[1,5-a]pyridin-3- yl)isoquinoline X.07 4,4-difluoro-3,3-dimethyl-1-(7- .sup.1:3.3 0.6:2.sup. methylpyrazolo[1,5-a]pyridin-3- yl)isoquinoline X.07 4,4-difluoro-3,3-dimethyl-1-(7- 3:1 0.6:0.2 methylpyrazolo[1,5-a]pyridin-3- yl)isoquinoline X.07 1-(4,5-dimethylbenzimidazol-1- 3:1 6:2 yl)-4,4,5-trifluoro-3,3-dimethyl- isoquinoline X.07 1-(4,5-dimethylbenzimidazol-1- 30:1 .sup.6:0.2 yl)-4,4,5-trifluoro-3,3-dimethyl- isoquinoline X.07 1-(4,5-dimethylbenzimidazol-1- .sup.1:3.3 0.6:2.sup. yl)-4,4,5-trifluoro-3,3-dimethyl- isoquinoline X.07 1-(4,5-dimethylbenzimidazol-1- 3:1 0.6:0.2 yl)-4,4,5-trifluoro-3,3-dimethyl- isoquinoline X.07 1-(4,5-dimethylbenzimidazol-1- 3:1 6:2 yl)-4,4-difluoro-3,3-dimethyl- isoquinoline X.07 1-(4,5-dimethylbenzimidazol-1- 30:1 .sup.6:0.2 yl)-4,4-difluoro-3,3-dimethyl- isoquinoline X.07 1-(4,5-dimethylbenzimidazol-1- .sup.1:3.3 0.6:2.sup. yl)-4,4-difluoro-3,3-dimethyl- isoquinoline X.07 1-(4,5-dimethylbenzimidazol-1- 3:1 0.6:0.2 yl)-4,4-difluoro-3,3-dimethyl- isoquinoline

(67) TABLE-US-00017 Component A Ratio Conc. (ppm) (Compound) Component B A:B (A:B) X.14 Azoxystrobin 3:1 6:2 X.14 Azoxystrobin 30:1 6:02 X.14 Azoxystrobin .sup.1:3.3 0.6:2.sup. X.14 Azoxystrobin 3:1 0.6:0.2 X.14 Trifloxystrobin 3:1 6:2 X.14 Trifloxystrobin 30:1 .sup.6:0.2 X.14 Trifloxystrobin .sup.1:3.3 0.6:2.sup. X.14 Trifloxystrobin 3:1 0.6:0.2 X.14 Metyltetraprole 3:1 6:2 X.14 Metyltetraprole 30:1 .sup.6:0.2 X.14 Metyltetraprole .sup.1:3.3 0.6:2.sup. X.14 Metyltetraprole 3:1 0.6:0.2 X.14 Difenoconazole 1:1 6:6 X.14 Difenoconazole 10:1 .sup.6:0.6 X.14 Hexaconazole 1:1 6:6 X.14 Hexaconazole 10:1 .sup.6:0.6 X.14 Hexaconazole 1:10 0.6:6.sup. X.14 Propiconazole 1:1 6:6 X.14 Propiconazole 10:1 .sup.6:0.6 X.14 Propiconazole 1:10 0.6:6.sup. X.14 Prothioconazole 1:1 6:6 X.14 Prothioconazole 10:1 .sup.6:0.6 X.14 Prothioconazole 1:10 0.6:6.sup. X.14 Prothioconazole 1:1 0.6:0.6 X.14 Mefentrifluconazole 1:1 6:6 X.14 Mefentrifluconazole 10:1 .sup.6:0.6 X.14 Mefentrifluconazole 1:10 0.6:6.sup. X.14 Fenpropidin .sup.1:3.3 6:20 X.14 Fenpropidin 3:1 6:2 X.14 Fenpropimorph .sup.1:3.3 6:20 X.14 Fenpropimorph 3:1 6:2 X.14 Fenpropimorph 1:33.3 0.6:20 X.14 Fluxapyroxad 3:1 6:2 X.14 Fluxapyroxad 30:1 .sup.6:0.2 X.14 Fluopyram 3:1 6:2 X.14 Fluopyram 30:1 .sup.6:0.2 X.14 Isopyrazam 3:1 6:2 X.14 Isopyrazam 30:1 .sup.6:0.2 X.14 Isopyrazam .sup.1:3.3 0.6:2.sup. X.14 Sedaxane 3:1 6:2 X.14 Sedaxane 30:1 .sup.6:0.2 X.14 Benzovindiflupyr 3:1 6:2 X.14 Benzovindiflupyr 30:1 .sup.6:0.2 X.14 Benzovindiflupyr .sup.1:3.3 0.6:2.sup. X.14 Pydiflumetofen 3:1 6:2 X.14 Pydiflumetofen 30:1 .sup.6:0.2 X.14 Pydiflumetofen .sup.1:3.3 0.6:2.sup. X.14 Pydiflumetofen 3:1 0.6:0.2 X.14 Isoflucypram 3:1 6:2 X.14 Isoflucypram 30:1 .sup.6:0.2 X.14 Isoflucypram .sup.1:3.3 0.6:2.sup. X.14 Isofetamid 3:1 6:2 X.14 Isofetamid 30:1 .sup.6:0.2 X.14 Pyrapropoyne 3:1 6:2 X.14 Pyrapropoyne 30:1 .sup.6:0.2 X.14 Pyrapropoyne .sup.1:3.3 0.6:2.sup. X.14 Pyrapropoyne 3:1 0.6:0.2 X.14 Fluindapyr 3:1 6:2 X.14 Fluindapyr 30:1 .sup.6:0.2 X.14 Fenpicoxamid 1:1 6:6 X.14 Fenpicoxamid 10:1 .sup.6:0.6 X.14 Fenpicoxamid 1:10 0.6:6.sup. X.14 Fenpicoxamid 1:1 0.6:0.6 X.14 Florylpicoxamid 3:1 6:2 X.14 Florylpicoxamid 30:1 .sup.6:0.2 X.14 Florylpicoxamid .sup.1:3.3 0.6:2.sup. X.14 Florylpicoxamid 3:1 0.6:0.2 X.14 Chlorothalonil 1:1 6:6 X.14 Chlorothalonil 10:1 .sup.6:0.6 X.14 Chlorothalonil 1:10 0.6:6.sup. X.14 Chlorothalonil 1:1 0.6:0.6 X.14 Mancozeb .sup.1:3.3 6:20 X.14 Mancozeb 1:1 6:6 X.14 Mancozeb 1:33.3 0.6:20 X.14 Mancozeb 1:10 0.6:6.sup. X.14 Mandipropamid .sup.1:3.3 6:20 X.14 Mandipropamid 1:1 6:6 X.14 Oxathiapiprolin .sup.1:3.3 6:20 X.14 Oxathiapiprolin 1:1 6:6 X.14 Fluazinam 3:1 6:2 X.14 Fluazinam 30:1 .sup.6:0.2 X.14 Fluazinam .sup.1:3.3 0.6:2.sup. X.14 Fluazinam 3:1 0.6:0.2 X.14 Fludioxonil 1:1 6:6 X.14 Fludioxonil 10:1 .sup.6:0.6 X.14 Fludioxonil 1:10 0.6:6.sup. X.14 Cyprodinil 1:1 6:6 X.14 Cyprodinil 10:1 .sup.6:0.6 X.14 Cyprodinil 1:10 0.6:6.sup. X.14 Cyprodinil 1:1 0.6:0.6 X.14 Metalaxyl-M .sup.1:3.3 6:20 X.14 Metalaxyl-M 1:1 6:6 X.14 Metalaxyl-M 1:33.3 0.6:20 X.14 Metalaxyl-M 1:10 0.6:6.sup. X.14 X.14 Aminopyrifen 3:1 6:2 X.14 Aminopyrifen 30:1 .sup.6:0.2 X.14 Aminopyrifen .sup.1:3.3 0.6:2.sup. X.14 Folpet 1:1 6:6 X.14 Folpet 3:1 6:2 X.14 Folpet 1:10 0.6:6.sup. X.14 Folpet .sup.1:3.3 0.6:2.sup. X.14 Ipflufenoquin 3:1 6:2 X.14 Ipflufenoquin 30:1 .sup.6:0.2 X.14 Ipflufenoquin .sup.1:3.3 0.6:2.sup. X.14 Ipflufenoquin 3:1 0.6:0.2 X.14 Quinofumelin 3:1 6:2 X.14 Quinofumelin 30:1 .sup.6:0.2 X.14 Quinofumelin .sup.1:3.3 0.6:2.sup. X.14 Quinofumelin 3:1 0.6:0.2 X.14 Tricyclazole .sup.1:3.3 6:20 X.14 Tricyclazole 1:1 6:6 X.14 Pyroquilon .sup.1:3.3 6:20 X.14 Pyroquilon 1:1 6:6 X.14 N-(1-benzyl-1,3-dimethyl-butyl)- 3:1 6:2 8-fluoro-quinoline-3- carboxamide X.14 N-(1-benzyl-1,3-dimethyl-butyl)- 30:1 .sup.6:0.2 8-fluoro-quinoline-3- carboxamide X.14 N-(1-benzyl-1,3-dimethyl-butyl)- .sup.1:3.3 0.6:2.sup. 8-fluoro-quinoline-3- carboxamide X.14 N-(1-benzyl-1,3-dimethyl-butyl)- 3:1 0.6:0.2 8-fluoro-quinoline-3- carboxamide X.14 N-(1-benzyl-3,3,3-trifluoro-1- 3:1 6:2 methyl-propyl)-8-fluoro- quinoline-3-carboxamide X.14 N-(1-benzyl-3,3,3-trifluoro-1- 30:1 .sup.6:0.2 methyl-propyl)-8-fluoro- quinoline-3-carboxamide X.14 N-(1-benzyl-3,3,3-trifluoro-1- .sup.1:3.3 0.6:2.sup. methyl-propyl)-8-fluoro- quinoline-3-carboxamide X.14 N-(1-benzyl-3,3,3-trifluoro-1- 3:1 0.6:0.2 methyl-propyl)-8-fluoro- quinoline-3-carboxamide X.14 1-(6,7-dimethylpyrazolo[1,5- 3:1 6:2 a]pyridin-3-yl)-4,4,5-trifluoro-3,3- dimethyl-isoquinoline X.14 1-(6,7-dimethylpyrazolo[1,5- 30:1 .sup.6:0.2 a]pyridin-3-yl)-4,4,5-trifluoro-3,3- dimethyl-isoquinoline X.14 1-(6,7-dimethylpyrazolo[1,5- .sup.1:3.3 0.6:2.sup. a]pyridin-3-yl)-4,4,5-trifluoro-3,3- dimethyl-isoquinoline X.14 1-(6,7-dimethylpyrazolo[1,5- 3:1 0.6:0.2 a]pyridin-3-yl)-4,4,5-trifluoro-3,3- dimethyl-isoquinoline X.14 4,4-difluoro-3,3-dimethyl-1-(7- 3:1 6:2 methylpyrazolo[1,5-a]pyridin-3- yl)isoquinoline X.14 4,4-difluoro-3,3-dimethyl-1-(7- 30:1 .sup.6:0.2 methylpyrazolo[1,5-a]pyridin-3- yl)isoquinoline X.14 4,4-difluoro-3,3-dimethyl-1-(7- .sup.1:3.3 0.6:2.sup. methylpyrazolo[1,5-a]pyridin-3- yl)isoquinoline X.14 4,4-difluoro-3,3-dimethyl-1-(7- 3:1 0.6:0.2 methylpyrazolo[1,5-a]pyridin-3- yl)isoquinoline X.14 1-(4,5-dimethylbenzimidazol-1- 3:1 6:2 yl)-4,4,5-trifluoro-3,3-dimethyl- isoquinoline X.14 1-(4,5-dimethylbenzimidazol-1- 30:1 .sup.6:0.2 yl)-4,4,5-trifluoro-3,3-dimethyl- isoquinoline X.14 1-(4,5-dimethylbenzimidazol-1- .sup.1:3.3 0.6:2.sup. yl)-4,4,5-trifluoro-3,3-dimethyl- isoquinoline X.14 1-(4,5-dimethylbenzimidazol-1- 3:1 0.6:0.2 yl)-4,4,5-trifluoro-3,3-dimethyl- isoquinoline X.14 1-(4,5-dimethylbenzimidazol-1- 3:1 6:2 yl)-4,4-difluoro-3,3-dimethyl- isoquinoline X.14 1-(4,5-dimethylbenzimidazol-1- 30:1 .sup.6:0.2 yl)-4,4-difluoro-3,3-dimethyl- isoquinoline X.14 1-(4,5-dimethylbenzimidazol-1- .sup.1:3.3 0.6:2.sup. yl)-4,4-difluoro-3,3-dimethyl- isoquinoline X.14 1-(4,5-dimethylbenzimidazol-1- 3:1 0.6:0.2 yl)-4,4-difluoro-3,3-dimethyl- isoquinoline

Example B3: Activity Against Glomerella lagenarium Syn. Colletotrichum lagenarium (Anthracnose of Cucurbits)

(68) Conidia of the fungus from cryogenic storage were directly mixed into nutrient broth (PDB potato dextrose broth). A DSO solution of the test compounds was placed into a microtiter plate (96-well format) and the nutrient broth containing the fungal spores was added to it. The test plates were incubated at 24 C. and the inhibition of growth was determined photometrically after 72 hrs at 620 nm. The following mixture compositions (A:B) at the reported concentration (in ppm) gave at least 70% disease control in this test.

(69) TABLE-US-00018 Component A Ratio Conc. (ppm) (Compound) Component B A:B (A:B) X.05 Azoxystrobin 3:1 6:2 X.05 Azoxystrobin 30:1 .sup.6:0.2 X.05 Azoxystrobin .sup.1:3.3 0.6:2.sup. X.05 Azoxystrobin 3:1 0.6:0.2 X.05 Trifloxystrobin 3:1 6:2 X.05 Trifloxystrobin 30:1 .sup.6:0.2 X.05 Trifloxystrobin .sup.1:3.3 0.6:2.sup. X.05 Trifloxystrobin 3:1 0.6:0.2 X.05 Metyltetraprole 3:1 6:2 X.05 Metyltetraprole 30:1 .sup.6:0.2 X.05 Metyltetraprole .sup.1:3.3 0.6:2.sup. X.05 Metyltetraprole 3:1 0.6:0.2 X.05 Difenoconazole 1:1 6:6 X.05 Difenoconazole 10:1 .sup.6:0.6 X.05 Difenoconazole 1:10 0.6:6.sup. X.05 Difenoconazole 1:1 0.6:0.6 X.05 Hexaconazole 1:1 6:6 X.05 Hexaconazole 10:1 .sup.6:0.6 X.05 Hexaconazole 1:10 0.6:6.sup. X.05 Hexaconazole 1:1 0.6:0.6 X.05 Propiconazole 1:1 6:6 X.05 Propiconazole 10:1 .sup.6:0.6 X.05 Propiconazole 1:10 0.6:6.sup. X.05 Propiconazole 1:1 0.6:0.6 X.05 Prothioconazole 1:1 6:6 X.05 Prothioconazole 10:1 .sup.6:0.6 X.05 Prothioconazole 1:10 0.6:6.sup. X.05 Prothioconazole 1:1 0.6:0.6 X.05 Mefentrifluconazole 1:1 6:6 X.05 Mefentrifluconazole 10:1 .sup.6:0.6 X.05 Mefentrifluconazole 1:10 0.6:6.sup. X.05 Mefentrifluconazole 1:1 0.6:0.6 X.05 Fenpropidin .sup.1:3.3 6:20 X.05 Fenpropidin 3:1 6:2 X.05 Fenpropidin 1:33.3 0.6:20 X.05 Fenpropidin .sup.1:3.3 0.6:2.sup. X.05 Fenpropimorph .sup.1:3.3 6:20 X.05 Fenpropimorph 3:1 6:2 X.05 Fenpropimorph 1:33.3 0.6:20 X.05 Fenpropimorph .sup.1:3.3 0.6:2.sup. X.05 Fluxapyroxad 3:1 6:2 X.05 Fluxapyroxad 30:1 .sup.6:0.2 X.05 Fluxapyroxad .sup.1:3.3 0.6:2.sup. X.05 Fluxapyroxad 3:1 0.6:0.2 X.05 Fluopyram 3:1 6:2 X.05 Fluopyram 30:1 .sup.6:0.2 X.05 Fluopyram .sup.1:3.3 0.6:2.sup. X.05 Fluopyram 3:1 0.6:0.2 X.05 Isopyrazam 3:1 6:2 X.05 Isopyrazam 30:1 .sup.6:0.2 X.05 Isopyrazam .sup.1:3.3 0.6:2.sup. X.05 Isopyrazam 3:1 0.6:0.2 X.05 Sedaxane 3:1 6:2 X.05 Sedaxane 30:1 .sup.6:0.2 X.05 Sedaxane .sup.1:3.3 0.6:2.sup. X.05 Sedaxane 3:1 0.6:0.2 X.05 Benzovindiflupyr 3:1 6:2 X.05 Benzovindiflupyr 30:1 .sup.6:0.2 X.05 Benzovindiflupyr .sup.1:3.3 0.6:2.sup. X.05 Benzovindiflupyr 3:1 0.6:0.2 X.05 Pydiflumetofen 3:1 6:2 X.05 Pydiflumetofen 30:1 .sup.6:0.2 X.05 Pydiflumetofen .sup.1:3.3 0.6:2.sup. X.05 Pydiflumetofen 3:1 0.6:0.2 X.05 Isoflucypram 3:1 6:2 X.05 Isoflucypram 30:1 .sup.6:0.2 X.05 Isoflucypram .sup.1:3.3 0.6:2.sup. X.05 Isoflucypram 3:1 0.6:0.2 X.05 Isofetamid 3:1 6:2 X.05 Isofetamid 30:1 .sup.6:0.2 X.05 Isofetamid .sup.1:3.3 0.6:2.sup. X.05 Isofetamid 3:1 0.6:0.2 X.05 Pyrapropoyne 3:1 6:2 X.05 Pyrapropoyne 30:1 .sup.6:0.2 X.05 Pyrapropoyne .sup.1:3.3 0.6:2.sup. X.05 Pyrapropoyne 3:1 0.6:0.2 X.05 Fluindapyr 3:1 6:2 X.05 Fluindapyr 30:1 .sup.6:0.2 X.05 Fluindapyr .sup.1:3.3 0.6:2.sup. X.05 Fluindapyr 3:1 0.6:0.2 X.05 Fenpicoxamid 1:1 6:6 X.05 Fenpicoxamid 10:1 .sup.6:0.6 X.05 Fenpicoxamid 1:10 0.6:6.sup. X.05 Fenpicoxamid 1:1 0.6:0.6 X.05 Florylpicoxamid 3:1 6:2 X.05 Florylpicoxamid 30:1 .sup.6:0.2 X.05 Florylpicoxamid .sup.1:3.3 0.6:2.sup. X.05 Florylpicoxamid 3:1 0.6:0.2 X.05 Chlorothalonil 1:1 6:6 X.05 Chlorothalonil 10:1 .sup.6:0.6 X.05 Chlorothalonil 1:10 0.6:6.sup. X.05 Chlorothalonil 1:1 0.6:0.6 X.05 Mancozeb .sup.1:3.3 6:20 X.05 Mancozeb 1:1 6:6 X.05 Mancozeb 1:33.3 0.6:20 X.05 Mancozeb 1:10 0.6:6.sup. X.05 Mandipropamid .sup.1:3.3 6:20 X.05 Mandipropamid 1:1 6:6 X.05 Mandipropamid 1:33.3 0.6:20 X.05 Mandipropamid 1:10 0.6:6.sup. X.05 Oxathiapiprolin .sup.1:3.3 6:20 X.05 Oxathiapiprolin 1:1 6:6 X.05 Oxathiapiprolin 1:33.3 0.6:20 X.05 Oxathiapiprolin 1:10 0.6:6.sup. X.05 Fluazinam 3:1 6:2 X.05 Fluazinam 30:1 .sup.6:0.2 X.05 Fluazinam .sup.1:3.3 0.6:2.sup. X.05 Fluazinam 3:1 0.6:0.2 X.05 Fludioxonil 1:1 6:6 X.05 Fludioxonil 10:1 .sup.6:0.6 X.05 Fludioxonil 1:10 0.6:6.sup. X.05 Fludioxonil 1:1 0.6:0.6 X.05 Cyprodinil 1:1 6:6 X.05 Cyprodinil 10:1 .sup.6:0.6 X.05 Cyprodinil 1:10 0.6:6.sup. X.05 Cyprodinil 1:1 0.6:0.6 X.05 Metalaxyl-M .sup.1:3.3 6:20 X.05 Metalaxyl-M 1:1 6:6 X.05 Metalaxyl-M 1:33.3 0.6:20 X.05 Metalaxyl-M 1:10 0.6:6.sup. X.05 Aminopyrifen 3:1 6:2 X.05 Aminopyrifen 30:1 .sup.6:0.2 X.05 Aminopyrifen .sup.1:3.3 0.6:2.sup. X.05 Aminopyrifen 3:1 0.6:0.2 X.05 Folpet 1:1 6:6 X.05 Folpet 3:1 6:2 X.05 Folpet 1:10 0.6:6.sup. X.05 Folpet .sup.1:3.3 0.6:2.sup. X.05 Ipflufenoquin 3:1 6:2 X.05 Ipflufenoquin 30:1 .sup.6:0.2 X.05 Ipflufenoquin .sup.1:3.3 0.6:2.sup. X.05 Ipflufenoquin 3:1 0.6:0.2 X.05 Quinofumelin 3:1 6:2 X.05 Quinofumelin 30:1 .sup.6:0.2 X.05 Quinofumelin .sup.1:3.3 0.6:2.sup. X.05 Quinofumelin 3:1 0.6:0.2 X.05 Tricyclazole .sup.1:3.3 6:20 X.05 Tricyclazole 1:1 6:6 X.05 Tricyclazole 1:33.3 0.6:20 X.05 Tricyclazole 1:10 0.6:6.sup. X.05 Pyroquilon .sup.1:3.3 6:20 X.05 Pyroquilon 1:1 6:6 X.05 Pyroquilon 1:33.3 0.6:20 X.05 Pyroquilon 1:10 0.6:6.sup. X.05 N-(1-benzyl-1,3-dimethyl-butyl)- 3:1 6:2 8-fluoro-quinoline-3- carboxamide X.05 N-(1-benzyl-1,3-dimethyl-butyl)- 30:1 .sup.6:0.2 8-fluoro-quinoline-3- carboxamide X.05 N-(1-benzyl-1,3-dimethyl-butyl)- .sup.1:3.3 0.6:2.sup. 8-fluoro-quinoline-3- carboxamide X.05 N-(1-benzyl-1,3-dimethyl-butyl)- 3:1 0.6:0.2 8-fluoro-quinoline-3- carboxamide X.05 N-(1-benzyl-3,3,3-trifluoro-1- 3:1 6:2 methyl-propyl)-8-fluoro- quinoline-3-carboxamide X.05 N-(1-benzyl-3,3,3-trifluoro-1- 30:1 .sup.6:0.2 methyl-propyl)-8-fluoro- quinoline-3-carboxamide X.05 N-(1-benzyl-3,3,3-trifluoro-1- .sup.1:3.3 0.6:2.sup. methyl-propyl)-8-fluoro- quinoline-3-carboxamide X.05 N-(1-benzyl-3,3,3-trifluoro-1- 3:1 0.6:0.2 methyl-propyl)-8-fluoro- quinoline-3-carboxamide X.05 1-(6,7-dimethylpyrazolo[1,5- 3:1 6:2 a]pyridin-3-yl)-4,4,5-trifluoro-3,3- dimethyl-isoquinoline X.05 1-(6,7-dimethylpyrazolo[1,5- 30:1 .sup.6:0.2 a]pyridin-3-yl)-4,4,5-trifluoro-3,3- dimethyl-isoquinoline X.05 1-(6,7-dimethylpyrazolo[1,5- .sup.1:3.3 0.6:2.sup. a]pyridin-3-yl)-4,4,5-trifluoro-3,3- dimethyl-isoquinoline X.05 1-(6,7-dimethylpyrazolo[1,5- 3:1 0.6:0.2 a]pyridin-3-yl)-4,4,5-trifluoro-3,3- dimethyl-isoquinoline X.05 4,4-difluoro-3,3-dimethyl-1-(7- 3:1 6:2 methylpyrazolo[1,5-a]pyridin-3- yl)isoquinoline X.05 4,4-difluoro-3,3-dimethyl-1-(7- 30:1 .sup.6:0.2 methylpyrazolo[1,5-a]pyridin-3- yl)isoquinoline X.05 4,4-difluoro-3,3-dimethyl-1-(7- .sup.1:3.3 0.6:2.sup. methylpyrazolo[1,5-a]pyridin-3- yl)isoquinoline X.05 4,4-difluoro-3,3-dimethyl-1-(7- 3:1 0.6:0.2 methylpyrazolo[1,5-a]pyridin-3- yl)isoquinoline X.05 1-(4,5-dimethylbenzimidazol-1- 3:1 6:2 yl)-4,4,5-trifluoro-3,3-dimethyl- isoquinoline X.05 1-(4,5-dimethylbenzimidazol-1- 30:1 .sup.6:0.2 yl)-4,4,5-trifluoro-3,3-dimethyl- isoquinoline X.05 1-(4,5-dimethylbenzimidazol-1- .sup.1:3.3 0.6:2.sup. yl)-4,4,5-trifluoro-3,3-dimethyl- isoquinoline X.05 1-(4,5-dimethylbenzimidazol-1- 3:1 0.6:0.2 yl)-4,4,5-trifluoro-3,3-dimethyl- isoquinoline X.05 1-(4,5-dimethylbenzimidazol-1- 3:1 6:2 yl)-4,4-difluoro-3,3-dimethyl- isoquinoline X.05 1-(4,5-dimethylbenzimidazol-1- 30:1 .sup.6:0.2 yl)-4,4-difluoro-3,3-dimethyl- isoquinoline X.05 1-(4,5-dimethylbenzimidazol-1- .sup.1:3.3 0.6:2.sup. yl)-4,4-difluoro-3,3-dimethyl- isoquinoline X.05 1-(4,5-dimethylbenzimidazol-1- 3:1 0.6:0.2 yl)-4,4-difluoro-3,3-dimethyl- isoquinoline

(70) TABLE-US-00019 Component A Ratio Conc. (ppm) (Compound) Component B A:B (A:B) X.07 Azoxystrobin 3:1 6:2 X.07 Azoxystrobin 30:1 .sup.6:0.2 X.07 Azoxystrobin .sup.1:3.3 0.6:2.sup. X.07 Azoxystrobin 3:1 0.6:0.2 X.07 Trifloxystrobin 3:1 6:2 X.07 Trifloxystrobin 30:1 .sup.6:0.2 X.07 Trifloxystrobin .sup.1:3.3 0.6:2.sup. X.07 Trifloxystrobin 3:1 0.6:0.2 X.07 Metyltetraprole 3:1 6:2 X.07 Metyltetraprole 30:1 .sup.6:0.2 X.07 Metyltetraprole .sup.1:3.3 0.6:2.sup. X.07 Metyltetraprole 3:1 0.6:0.2 X.07 Difenoconazole 1:1 6:6 X.07 Difenoconazole 10:1 .sup.6:0.6 X.07 Difenoconazole 1:10 0.6:6.sup. X.07 Difenoconazole 1:1 0.6:0.6 X.07 Hexaconazole 1:1 6:6 X.07 Hexaconazole 10:1 .sup.6:0.6 X.07 Hexaconazole 1:10 0.6:6.sup. X.07 Hexaconazole 1:1 0.6:0.6 X.07 Propiconazole 1:1 6:6 X.07 Propiconazole 10:1 .sup.6:0.6 X.07 Propiconazole 1:10 0.6:6.sup. X.07 Propiconazole 1:1 0.6:0.6 X.07 Prothioconazole 1:1 6:6 X.07 Prothioconazole 10:1 .sup.6:0.6 X.07 Prothioconazole 1:10 0.6:6.sup. X.07 Prothioconazole 1:1 0.6:0.6 X.07 Mefentrifluconazole 1:1 6:6 X.07 Mefentrifluconazole 10:1 .sup.6:0.6 X.07 Mefentrifluconazole 1:10 0.6:6.sup. X.07 Mefentrifluconazole 1:1 0.6:0.6 X.07 Fenpropidin .sup.1:3.3 6:20 X.07 Fenpropidin 3:1 6:2 X.07 Fenpropidin 1:33.3 0.6:20 X.07 Fenpropidin .sup.1:3.3 0.6:2.sup. X.07 Fenpropimorph .sup.1:3.3 6:20 X.07 Fenpropimorph 3:1 6:2 X.07 Fenpropimorph 1:33.3 0.6:20 X.07 Fenpropimorph .sup.1:3.3 0.6:2.sup. X.07 Fluxapyroxad 3:1 6:2 X.07 Fluxapyroxad 30:1 .sup.6:0.2 X.07 Fluxapyroxad .sup.1:3.3 0.6:2.sup. X.07 Fluxapyroxad 3:1 0.6:0.2 X.07 Fluopyram 3:1 6:2 X.07 Fluopyram 30:1 .sup.6:0.2 X.07 Fluopyram .sup.1:3.3 0.6:2.sup. X.07 Fluopyram 3:1 0.6:0.2 X.07 Isopyrazam 3:1 6:2 X.07 Isopyrazam 30:1 .sup.6:0.2 X.07 Isopyrazam .sup.1:3.3 0.6:2.sup. X.07 Isopyrazam 3:1 0.6:0.2 X.07 Sedaxane 3:1 6:2 X.07 Sedaxane 30:1 .sup.6:0.2 X.07 Sedaxane .sup.1:3.3 0.6:2.sup. X.07 Sedaxane 3:1 0.6:0.2 X.07 Benzovindiflupyr 3:1 6:2 X.07 Benzovindiflupyr 30:1 .sup.6:0.2 X.07 Benzovindiflupyr .sup.1:3.3 0.6:2.sup. X.07 Benzovindiflupyr 3:1 0.6:0.2 X.07 Pydiflumetofen 3:1 6:2 X.07 Pydiflumetofen 30:1 .sup.6:0.2 X.07 Pydiflumetofen .sup.1:3.3 0.6:2.sup. X.07 Pydiflumetofen 3:1 0.6:0.2 X.07 Isoflucypram 3:1 6:2 X.07 Isoflucypram 30:1 .sup.6:0.2 X.07 Isoflucypram .sup.1:3.3 0.6:2.sup. X.07 Isoflucypram 3:1 0.6:0.2 X.07 Isofetamid 3:1 6:2 X.07 Isofetamid 30:1 .sup.6:0.2 X.07 Isofetamid .sup.1:3.3 0.6:2.sup. X.07 Isofetamid 3:1 0.6:0.2 X.07 Pyrapropoyne 3:1 6:2 X.07 Pyrapropoyne 30:1 .sup.6:0.2 X.07 Pyrapropoyne .sup.1:3.3 0.6:2.sup. X.07 Pyrapropoyne 3:1 0.6:0.2 X.07 Fluindapyr 3:1 6:2 X.07 Fluindapyr 30:1 .sup.6:0.2 X.07 Fluindapyr .sup.1:3.3 0.6:2.sup. X.07 Fluindapyr 3:1 0.6:0.2 X.07 Fenpicoxamid 1:1 6:6 X.07 Fenpicoxamid 10:1 .sup.6:0.6 X.07 Fenpicoxamid 1:10 0.6:6.sup. X.07 Fenpicoxamid 1:1 0.6:0.6 X.07 Florylpicoxamid 3:1 6:2 X.07 Florylpicoxamid 30:1 .sup.6:0.2 X.07 Florylpicoxamid .sup.1:3.3 0.6:2.sup. X.07 Florylpicoxamid 3:1 0.6:0.2 X.07 Chlorothalonil 1:1 6:6 X.07 Chlorothalonil 10:1 .sup.6:0.6 X.07 Chlorothalonil 1:10 0.6:6.sup. X.07 Chlorothalonil 1:1 0.6:0.6 X.07 Mancozeb .sup.1:3.3 6:20 X.07 Mancozeb 1:1 6:6 X.07 Mancozeb 1:33.3 0.6:20 X.07 Mancozeb 1:10 0.6:6.sup. X.07 Mandipropamid .sup.1:3.3 6:20 X.07 Mandipropamid 1:1 6:6 X.07 Mandipropamid 1:33.3 0.6:20 X.07 Mandipropamid 1:10 0.6:6.sup. X.07 Oxathiapiprolin .sup.1:3.3 6:20 X.07 Oxathiapiprolin 1:1 6:6 X.07 Oxathiapiprolin 1:33.3 0.6:20 X.07 Oxathiapiprolin 1:10 0.6:6.sup. X.07 Fluazinam 3:1 6:2 X.07 Fluazinam 30:1 .sup.6:0.2 X.07 Fluazinam .sup.1:3.3 0.6:2.sup. X.07 Fluazinam 3:1 0.6:0.2 X.07 Fludioxonil 1:1 6:6 X.07 Fludioxonil 10:1 .sup.6:0.6 X.07 Fludioxonil 1:10 0.6:6.sup. X.07 Fludioxonil 1:1 0.6:0.6 X.07 Cyprodinil 1:1 6:6 X.07 Cyprodinil 10:1 .sup.6:0.6 X.07 Cyprodinil 1:10 0.6:6.sup. X.07 Cyprodinil 1:1 0.6:0.6 X.07 Metalaxyl-M .sup.1:3.3 6:20 X.07 Metalaxyl-M 1:1 6:6 X.07 Metalaxyl-M 1:33.3 0.6:20 X.07 Metalaxyl-M 1:10 0.6:6.sup. X.07 Aminopyrifen 3:1 6:2 X.07 Aminopyrifen 30:1 .sup.6:0.2 X.07 Aminopyrifen .sup.1:3.3 0.6:2.sup. X.07 Aminopyrifen 3:1 0.6:0.2 X.07 Folpet 1:1 6:6 X.07 Folpet 3:1 6:2 X.07 Folpet 1:10 0.6:6.sup. X.07 Folpet .sup.1:3.3 0.6:2.sup. X.07 Ipflufenoquin 3:1 6:2 X.07 Ipflufenoquin 30:1 .sup.6:0.2 X.07 Ipflufenoquin .sup.1:3.3 0.6:2.sup. X.07 Ipflufenoquin 3:1 0.6:0.2 X.07 Quinofumelin 3:1 6:2 X.07 Quinofumelin 30:1 .sup.6:0.2 X.07 Quinofumelin .sup.1:3.3 0.6:2.sup. X.07 Quinofumelin 3:1 0.6:0.2 X.07 Tricyclazole .sup.1:3.3 6:20 X.07 Tricyclazole 1:1 6:6 X.07 Tricyclazole 1:33.3 0.6:20 X.07 Tricyclazole 1:10 0.6:6.sup. X.07 Pyroquilon .sup.1:3.3 6:20 X.07 Pyroquilon 1:1 6:6 X.07 Pyroquilon 1:33.3 0.6:20 X.07 Pyroquilon 1:10 0.6:6.sup. X.07 N-(1-benzyl-1,3-dimethyl-butyl)- 3:1 6:2 8-fluoro-quinoline-3- carboxamide X.07 N-(1-benzyl-1,3-dimethyl-butyl)- 30:1 .sup.6:0.2 8-fluoro-quinoline-3- carboxamide X.07 N-(1-benzyl-1,3-dimethyl-butyl)- .sup.1:3.3 0.6:2.sup. 8-fluoro-quinoline-3- carboxamide X.07 N-(1-benzyl-1,3-dimethyl-butyl)- 3:1 0.6:0.2 8-fluoro-quinoline-3- carboxamide X.07 N-(1-benzyl-3,3,3-trifluoro-1- 3:1 6:2 methyl-propyl)-8-fluoro- quinoline-3-carboxamide X.07 N-(1-benzyl-3,3,3-trifluoro-1- 30:1 .sup.6:0.2 methyl-propyl)-8-fluoro- quinoline-3-carboxamide X.07 N-(1-benzyl-3,3,3-trifluoro-1- .sup.1:3.3 0.6:2.sup. methyl-propyl)-8-fluoro- quinoline-3-carboxamide X.07 N-(1-benzyl-3,3,3-trifluoro-1- 3:1 0.6:0.2 methyl-propyl)-8-fluoro- quinoline-3-carboxamide X.07 1-(6,7-dimethylpyrazolo[1,5- 3:1 6:2 a]pyridin-3-yl)-4,4,5-trifluoro-3,3- dimethyl-isoquinoline X.07 1-(6,7-dimethylpyrazolo[1,5- 30:1 .sup.6:0.2 a]pyridin-3-yl)-4,4,5-trifluoro-3,3- dimethyl-isoquinoline X.07 1-(6,7-dimethylpyrazolo[1,5- .sup.1:3.3 0.6:2.sup. a]pyridin-3-yl)-4,4,5-trifluoro-3,3- dimethyl-isoquinoline X.07 1-(6,7-dimethylpyrazolo[1,5- 3:1 0.6:0.2 a]pyridin-3-yl)-4,4,5-trifluoro-3,3- dimethyl-isoquinoline X.07 4,4-difluoro-3,3-dimethyl-1-(7- 3:1 6:2 methylpyrazolo[1,5-a]pyridin-3- yl)isoquinoline X.07 4,4-difluoro-3,3-dimethyl-1-(7- 30:1 .sup.6:0.2 methylpyrazolo[1,5-a]pyridin-3- yl)isoquinoline X.07 4,4-difluoro-3,3-dimethyl-1-(7- .sup.1:3.3 0.6:2.sup. methylpyrazolo[1,5-a]pyridin-3- yl)isoquinoline X.07 4,4-difluoro-3,3-dimethyl-1-(7- 3:1 0.6:0.2 methylpyrazolo[1,5-a]pyridin-3- yl)isoquinoline X.07 1-(4,5-dimethylbenzimidazol-1- 3:1 6:2 yl)-4,4,5-trifluoro-3,3-dimethyl- isoquinoline X.07 1-(4,5-dimethylbenzimidazol-1- 30:1 .sup.6:0.2 yl)-4,4,5-trifluoro-3,3-dimethyl- isoquinoline X.07 1-(4,5-dimethylbenzimidazol-1- .sup.1:3.3 0.6:2.sup. yl)-4,4,5-trifluoro-3,3-dimethyl- isoquinoline X.07 1-(4,5-dimethylbenzimidazol-1- 3:1 0.6:0.2 yl)-4,4,5-trifluoro-3,3-dimethyl- isoquinoline X.07 1-(4,5-dimethylbenzimidazol-1- 3:1 6:2 yl)-4,4-difluoro-3,3-dimethyl- isoquinoline X.07 1-(4,5-dimethylbenzimidazol-1- 30:1 .sup.6:0.2 yl)-4,4-difluoro-3,3-dimethyl- isoquinoline X.07 1-(4,5-dimethylbenzimidazol-1- .sup.1:3.3 0.6:2.sup. yl)-4,4-difluoro-3,3-dimethyl- isoquinoline X.07 1-(4,5-dimethylbenzimidazol-1- 3:1 0.6:0.2 yl)-4,4-difluoro-3,3-dimethyl- isoquinoline

(71) TABLE-US-00020 Component A Ratio Conc. (ppm) (Compound) Component B A:B (A:B) X.14 Azoxystrobin 3:1 6:2 X.14 Azoxystrobin 30:1 .sup.6:0.2 X.14 Azoxystrobin .sup.1:3.3 0.6:2.sup. X.14 Azoxystrobin 3:1 0.6:0.2 X.14 Trifloxystrobin 3:1 6:2 X.14 Trifloxystrobin 30:1 .sup.6:0.2 X.14 Trifloxystrobin .sup.1:3.3 0.6:2.sup. X.14 Trifloxystrobin 3:1 0.6:0.2 X.14 Metyltetraprole 3:1 6:2 X.14 Metyltetraprole 30:1 .sup.6:0.2 X.14 Metyltetraprole .sup.1:3.3 0.6:2.sup. X.14 Metyltetraprole 3:1 0.6:0.2 X.14 Difenoconazole 1:1 6:6 X.14 Difenoconazole 10:1 .sup.6:0.6 X.14 Difenoconazole 1:10 0.6:6.sup. X.14 Hexaconazole 1:1 6:6 X.14 Hexaconazole 10:1 .sup.6:0.6 X.14 Propiconazole 1:1 6:6 X.14 Propiconazole 10:1 .sup.6:0.6 X.14 Propiconazole 1:10 0.6:6.sup. X.14 Prothioconazole 1:1 6:6 X.14 Prothioconazole 10:1 .sup.6:0.6 X.14 Prothioconazole 1:10 0.6:6.sup. X.14 Prothioconazole 1:1 0.6:0.6 X.14 Mefentrifluconazole 1:1 6:6 X.14 Mefentrifluconazole 10:1 .sup.6:0.6 X.14 Mefentrifluconazole 1:10 0.6:6.sup. X.14 Fenpropidin .sup.1:3.3 6:20 X.14 Fenpropidin 3:1 6:2 X.14 Fenpropimorph .sup.1:3.3 6:20 X.14 Fenpropimorph 3:1 6:2 X.14 Fenpropimorph 1:33.3 0.6:20 X.14 Fluxapyroxad 3:1 6:2 X.14 Fluxapyroxad 30:1 .sup.6:0.2 X.14 Fluopyram 3:1 6:2 X.14 Fluopyram 30:1 .sup.6:0.2 X.14 Isopyrazam 3:1 6:2 X.14 Isopyrazam 30:1 .sup.6:0.2 X.14 Sedaxane 3:1 6:2 X.14 Sedaxane 30:1 .sup.6:0.2 X.14 Benzovindiflupyr 3:1 6:2 X.14 Benzovindiflupyr 30:1 .sup.6:0.2 X.14 Benzovindiflupyr .sup.1:3.3 0.6:2.sup. X.14 Benzovindiflupyr 3:1 0.6:0.2 X.14 Pydiflumetofen 3:1 6:2 X.14 Pydiflumetofen 30:1 .sup.6:0.2 X.14 Isoflucypram 3:1 6:2 X.14 Isoflucypram 30:1 .sup.6:0.2 X.14 Isofetamid 3:1 6:2 X.14 Isofetamid 30:1 .sup.6:0.2 X.14 Pyrapropoyne 3:1 6:2 X.14 Pyrapropoyne 30:1 .sup.6:0.2 X.14 Fluindapyr 3:1 6:2 X.14 Fluindapyr 30:1 .sup.6:0.2 X.14 Fluindapyr .sup.1:3.3 0.6:2.sup. X.14 Fenpicoxamid 1:1 6:6 X.14 Fenpicoxamid 10:1 .sup.6:0.6 X.14 Fenpicoxamid 1:10 0.6:6.sup. X.14 Fenpicoxamid 1:1 0.6:0.6 X.14 Florylpicoxamid 3:1 6:2 X.14 Florylpicoxamid 30:1 .sup.6:0.2 X.14 Florylpicoxamid .sup.1:3.3 0.6:2.sup. X.14 Chlorothalonil 1:1 6:6 X.14 Chlorothalonil 10:1 .sup.6:0.6 X.14 Chlorothalonil 1:10 0.6:6.sup. X.14 Mancozeb .sup.1:3.3 6:20 X.14 Mancozeb 1:1 6:6 X.14 Mancozeb 1:33.3 0.6:20 X.14 Mancozeb 1:10 0.6:6.sup. X.14 Mandipropamid .sup.1:3.3 6:20 X.14 Mandipropamid 1:1 6:6 X.14 Mandipropamid 1:33.3 0.6:20 X.14 Oxathiapiprolin .sup.1:3.3 6:20 X.14 Oxathiapiprolin 1:1 6:6 X.14 Fluazinam 3:1 6:2 X.14 Fluazinam 30:1 .sup.6:0.2 X.14 Fluazinam .sup.1:3.3 0.6:2.sup. X.14 Fluazinam 3:1 0.6:0.2 X.14 Fludioxonil 1:1 6:6 X.14 Fludioxonil 10:1 .sup.6:0.6 X.14 Fludioxonil 1:10 0.6:6.sup. X.14 Fludioxonil 1:1 0.6:0.6 X.14 Cyprodinil 1:1 6:6 X.14 Cyprodinil 10:1 .sup.6:0.6 X.14 Cyprodinil 1:10 0.6:6.sup. X.14 Metalaxyl-M .sup.1:3.3 6:20 X.14 Metalaxyl-M 1:1 6:6 X.14 Aminopyrifen 3:1 6:2 X.14 Aminopyrifen 30:1 .sup.6:0.2 X.14 Aminopyrifen .sup.1:3.3 0.6:2.sup. X.14 Aminopyrifen 3:1 0.6:0.2 X.14 Folpet 1:1 6:6 X.14 Folpet 3:1 6:2 X.14 Folpet 1:10 0.6:6.sup. X.14 Folpet .sup.1:3.3 0.6:2.sup. X.14 Ipflufenoquin 3:1 6:2 X.14 Ipflufenoquin 30:1 .sup.6:0.2 X.14 Ipflufenoquin .sup.1:3.3 0.6:2.sup. X.14 Ipflufenoquin 3:1 0.6:0.2 X.14 Quinofumelin 3:1 6:2 X.14 Quinofumelin 30:1 .sup.6:0.2 X.14 Quinofumelin .sup.1:3.3 0.6:2.sup. X.14 Quinofumelin 3:1 0.6:0.2 X.14 Tricyclazole .sup.1:3.3 6:20 X.14 Tricyclazole 1:1 6:6 X.14 Pyroquilon .sup.1:3.3 6:20 X.14 Pyroquilon 1:1 6:6 X.14 N-(1-benzyl-1,3-dimethyl-butyl)- 3:1 6:2 8-fluoro-quinoline-3- carboxamide X.14 N-(1-benzyl-1,3-dimethyl-butyl)- 30:1 .sup.6:0.2 8-fluoro-quinoline-3- carboxamide X.14 N-(1-benzyl-1,3-dimethyl-butyl)- .sup.1:3.3 0.6:2.sup. 8-fluoro-quinoline-3- carboxamide X.14 N-(1-benzyl-1,3-dimethyl-butyl)- 3:1 0.6:0.2 8-fluoro-quinoline-3- carboxamide X.14 N-(1-benzyl-3,3,3-trifluoro-1- 3:1 6:2 methyl-propyl)-8-fluoro- quinoline-3-carboxamide X.14 N-(1-benzyl-3,3,3-trifluoro-1 30:1 .sup.6:0.2 methyl-propyl)-8-fluoro- quinoline-3-carboxamide X.14 N-(1-benzyl-3,3,3-trifluoro-1- .sup.1:3.3 0.6:2.sup. methyl-propyl)-8-fluoro- quinoline-3-carboxamide X.14 1-(6,7-dimethylpyrazolo[1,5- 3:1 6:2 a]pyridin-3-yl)-4,4,5-trifluoro-3,3- dimethyl-isoquinoline X.14 1-(6,7-dimethylpyrazolo[1,5- 30:1 .sup.6:0.2 a]pyridin-3-yl)-4,4,5-trifluoro-3,3- dimethyl-isoquinoline X.14 1-(6,7-dimethylpyrazolo[1,5 .sup.1:3.3 0.6:2.sup. a]pyridin-3-yl)-4,4,5-trifluoro-3,3- dimethyl-isoquinoline X.14 1-(6,7-dimethylpyrazolo[1,5- 3:1 0.6:0.2 a]pyridin-3-yl)-4,4,5-trifluoro-3,3- dimethyl-isoquinoline X.14 4,4-difluoro-3,3-dimethyl-1-(7- 3:1 6:2 methylpyrazolo[1,5-a]pyridin-3- yl)isoquinoline X.14 4,4-difluoro-3,3-dimethyl-1-(7- 30:1 .sup.6:0.2 methylpyrazolo[1,5-a]pyridin-3- yl)isoquinoline X.14 4,4-difluoro-3,3-dimethyl-1-(7- .sup.1:3.3 0.6:2.sup. methylpyrazolo[1,5-a]pyridin-3- yl)isoquinoline X.14 4,4-difluoro-3,3-dimethyl-1-(7- 3:1 0.6:0.2 methylpyrazolo[1,5-a]pyridin-3- yl)isoquinoline X.14 1-(4,5-dimethylbenzimidazol-1- 3:1 6:2 yl)-4,4,5-trifluoro-3,3-dimethyl- isoquinoline X.14 1-(4,5-dimethylbenzimidazol-1- 30:1 .sup.6:0.2 yl)-4,4,5-trifluoro-3,3-dimethyl- isoquinoline X.14 1-(4,5-dimethylbenzimidazol-1- .sup.1:3.3 0.6:2.sup. yl)-4,4,5-trifluoro-3,3-dimethyl- isoquinoline X.14 1-(4,5-dimethylbenzimidazol-1- 3:1 0.6:0.2 yl)-4,4,5-trifluoro-3,3-dimethyl- isoquinoline X.14 1-(4,5-dimethylbenzimidazol-1- 3:1 6:2 yl)-4,4-difluoro-3,3-dimethyl- isoquinoline X.14 1-(4,5-dimethylbenzimidazol-1- 30:1 .sup.6:0.2 yl)-4,4-difluoro-3,3-dimethyl- isoquinoline X.14 1-(4,5-dimethylbenzimidazol-1- .sup.1:3.3 0.6:2.sup. yl)-4,4-difluoro-3,3-dimethyl- isoquinoline X.14 1-(4,5-dimethylbenzimidazol-1- 3:1 0.6:0.2 yl)-4,4-difluoro-3,3-dimethyl- isoquinoline

Activity Against Mycosphaerella arachidis syn. Cercospora arachidicola (Brown Leaf Spot of Peanut)

(72) Conidia of the fungus from cryogenic storage were directly mixed into nutrient broth (PDB potato dextrose broth). A DMSO solution of the test compounds was placed into a microtiter plate (96-well format) and the nutrient broth containing the fungal spores was added to it. The test plates were incubated at 24 C. and the inhibition of growth was determined photometrically after approximately 5-6 days at 620 nm. The following mixture compositions (A:B) at the reported concentration (in ppm) gave at least 70% disease control in this test.

(73) TABLE-US-00021 Component A Ratio Conc. (ppm) (Compound) Component B A:B (A:B) X.05 Azoxystrobin 3:1 6:2 X.05 Azoxystrobin 30:1 .sup.6:0.2 X.05 Azoxystrobin .sup.1:3.3 0.6:2.sup. X.05 Azoxystrobin 3:1 0.6:0.2 X.05 Trifloxystrobin 3:1 6:2 X.05 Trifloxystrobin 30:1 .sup.6:0.2 X.05 Trifloxystrobin .sup.1:3.3 0.6:2.sup. X.05 Trifloxystrobin 3:1 0.6:0.2 X.05 Metyltetraprole 3:1 6:2 X.05 Metyltetraprole 30:1 .sup.6:0.2 X.05 Metyltetraprole .sup.1:3.3 0.6:2.sup. X.05 Metyltetraprole 3:1 0.6:0.2 X.05 Difenoconazole 1:1 6:6 X.05 Difenoconazole 10:1 .sup.6:0.6 X.05 Difenoconazole 1:10 0.6:6.sup. X.05 Difenoconazole 1:1 0.6:0.6 X.05 Hexaconazole 1:1 6:6 X.05 Hexaconazole 10:1 .sup.6:0.6 X.05 Hexaconazole 1:10 0.6:6.sup. X.05 Hexaconazole 1:1 0.6:0.6 X.05 Propiconazole 1:1 6:6 X.05 Propiconazole 10:1 .sup.6:0.6 X.05 Propiconazole 1:10 0.6:6.sup. X.05 Propiconazole 1:1 0.6:0.6 X.05 Prothioconazole 1:1 6:6 X.05 Prothioconazole 10:1 .sup.6:0.6 X.05 Prothioconazole 1:10 0.6:6.sup. X.05 Prothioconazole 1:1 0.6:0.6 X.05 Mefentrifluconazole 1:1 6:6 X.05 Mefentrifluconazole 10:1 .sup.6:0.6 X.05 Mefentrifluconazole 1:10 0.6:6.sup. X.05 Mefentrifluconazole 1:1 0.6:0.6 X.05 Fenpropidin .sup.1:3.3 6:20 X.05 Fenpropidin 3:1 6:2 X.05 Fenpropidin 1:33.3 0.6:20 X.05 Fenpropimorph .sup.1:3.3 6:20 X.05 Fenpropimorph 3:1 6:2 X.05 Fenpropimorph 1:33.3 0.6:20 X.05 Fenpropimorph .sup.1:3.3 0.6:2.sup. X.05 Fluxapyroxad 3:1 6:2 X.05 Fluxapyroxad 30:1 .sup.6:0.2 X.05 Fluopyram 3:1 6:2 X.05 Fluopyram 30:1 .sup.6:0.2 X.05 Fluopyram .sup.1:3.3 0.6:2.sup. X.05 Isopyrazam 3:1 6:2 X.05 Isopyrazam 30:1 .sup.6:0.2 X.05 Isopyrazam .sup.1:3.3 0.6:2.sup. X.05 Isopyrazam 3:1 0.6:0.2 X.05 Sedaxane 3:1 6:2 X.05 Sedaxane 30:1 .sup.6:0.2 X.05 Benzovindiflupyr 3:1 6:2 X.05 Benzovindiflupyr 30:1 .sup.6:0.2 X.05 Benzovindiflupyr .sup.1:3.3 0.6:2.sup. X.05 Benzovindiflupyr 3:1 0.6:0.2 X.05 Pydiflumetofen 3:1 6:2 X.05 Pydiflumetofen 30:1 .sup.6:0.2 X.05 Pydiflumetofen .sup.1:3.3 0.6:2.sup. X.05 Pydiflumetofen 3:1 0.6:0.2 X.05 Isoflucypram 3:1 6:2 X.05 Isoflucypram 30:1 .sup.6:0.2 X.05 Isoflucypram .sup.1:3.3 0.6:2.sup. X.05 Isoflucypram 3:1 0.6:0.2 X.05 Isofetamid 3:1 6:2 X.05 Isofetamid 30:1 .sup.6:0.2 X.05 Isofetamid .sup.1:3.3 0.6:2.sup. X.05 Pyrapropoyne 3:1 6:2 X.05 Pyrapropoyne 30:1 .sup.6:0.2 X.05 Pyrapropoyne .sup.1:3.3 0.6:2.sup. X.05 Pyrapropoyne 3:1 0.6:0.2 X.05 Fluindapyr 3:1 6:2 X.05 Fluindapyr 30:1 .sup.6:0.2 X.05 Fluindapyr .sup.1:3.3 0.6:2.sup. X.05 Fenpicoxamid 1:1 6:6 X.05 Fenpicoxamid 10:1 .sup.6:0.6 X.05 Fenpicoxamid 1:10 0.6:6.sup. X.05 Florylpicoxamid 3:1 6:2 X.05 Florylpicoxamid 30:1 .sup.6:0.2 X.05 Florylpicoxamid .sup.1:3.3 0.6:2.sup. X.05 Florylpicoxamid 3:1 0.6:0.2 X.05 Chlorothalonil 1:1 6:6 X.05 Chlorothalonil 10:1 .sup.6:0.6 X.05 Chlorothalonil 1:10 0.6:6.sup. X.05 Mancozeb .sup.1:3.3 6:20 X.05 Mancozeb 1:1 6:6 X.05 Mandipropamid .sup.1:3.3 6:20 X.05 Mandipropamid 1:1 6:6 X.05 Oxathiapiprolin .sup.1:3.3 6:20 X.05 Oxathiapiprolin 1:1 6:6 X.05 Fluazinam 3:1 6:2 X.05 Fluazinam 30:1 .sup.6:0.2 X.05 Fluazinam .sup.1:3.3 0.6:2.sup. X.05 Fludioxonil 1:1 6:6 X.05 Fludioxonil 1:10 0.6:6.sup. X.05 Cyprodinil 1:1 6:6 X.05 Cyprodinil 10:1 .sup.6:0.6 X.05 Metalaxyl-M .sup.1:3.3 6:20 X.05 Metalaxyl-M 1:1 6:6 X.05 Aminopyrifen 3:1 6:2 X.05 Aminopyrifen 30:1 .sup.6:0.2 X.05 Aminopyrifen .sup.1:3.3 0.6:2.sup. X.05 Aminopyrifen 3:1 0.6:0.2 X.05 Folpet 1:1 6:6 X.05 Folpet 3:1 6:2 X.05 Ipflufenoquin 3:1 6:2 X.05 Ipflufenoquin 30:1 .sup.6:0.2 X.05 Quinofumelin 3:1 6:2 X.05 Quinofumelin 30:1 .sup.6:0.2 X.05 Tricyclazole .sup.1:3.3 6:20 X.05 Tricyclazole 1:1 6:6 X.05 Pyroquilon .sup.1:3.3 6:20 X.05 Pyroquilon 1:1 6:6 X.05 N-(1-benzyl-1,3-dimethyl-butyl)- 3:1 6:2 8-fluoro-quinoline-3- carboxamide X.05 N-(1-benzyl-1,3-dimethyl-butyl)- 30:1 .sup.6:0.2 8-fluoro-quinoline-3- carboxamide X.05 N-(1-benzyl-3,3,3-trifluoro-1- 3:1 6:2 methyl-propyl)-8-fluoro- quinoline-3-carboxamide X.05 N-(1-benzyl-3,3,3-trifluoro-1- 30:1 .sup.6:0.2 methyl-propyl)-8-fluoro- quinoline-3-carboxamide X.05 1-(6,7-dimethylpyrazolo[1,5- 3:1 6:2 a]pyridin-3-yl)-4,4,5-trifluoro-3,3- dimethyl-isoquinoline X.05 1-(6,7-dimethylpyrazolo[1,5- 30:1 .sup.6:0.2 a]pyridin-3-yl)-4,4,5-trifluoro-3,3- dimethyl-isoquinoline X.05 4,4-difluoro-3,3-dimethyl-1-(7- 3:1 6:2 methylpyrazolo[1,5-a]pyridin-3- yl)isoquinoline X.05 4,4-difluoro-3,3-dimethyl-1-(7- 30:1 .sup.6:0.2 methylpyrazolo[1,5-a]pyridin-3- yl)isoquinoline X.05 1-(4,5-dimethylbenzimidazol-1- 3:1 6:2 yl)-4,4,5-trifluoro-3,3-dimethyl- isoquinoline X.05 1-(4,5-dimethylbenzimidazol-1- 30:1 .sup.6:0.2 yl)-4,4,5-trifluoro-3,3-dimethyl- isoquinoline X.05 1-(4,5-dimethylbenzimidazol-1- 3:1 6:2 yl)-4,4-difluoro-3,3-dimethyl- isoquinoline X.05 1-(4,5-dimethylbenzimidazol-1- 30:1 .sup.6:0.2 yl)-4,4-difluoro-3,3-dimethyl- isoquinoline

(74) TABLE-US-00022 Component A Ratio Conc. (ppm) (Compound) Component B A:B (A:B) X.07 Azoxystrobin 3:1 6:2 X.07 Azoxystrobin 30:1 .sup.6:0.2 X.07 Azoxystrobin .sup.1:3.3 0.6:2.sup. X.07 Azoxystrobin 3:1 0.6:0.2 X.07 Trifloxystrobin 3:1 6:2 X.07 Trifloxystrobin 30:1 .sup.6:0.2 X.07 Trifloxystrobin .sup.1:3.3 0.6:2.sup. X.07 Trifloxystrobin 3:1 0.6:0.2 X.07 Metyltetraprole 3:1 6:2 X.07 Metyltetraprole 30:1 .sup.6:0.2 X.07 Metyltetraprole .sup.1:3.3 0.6:2.sup. X.07 Metyltetraprole 3:1 0.6:0.2 X.07 Difenoconazole 1:1 6:6 X.07 Difenoconazole 10:1 .sup.6:0.6 X.07 Difenoconazole 1:10 0.6:6.sup. X.07 Difenoconazole 1:1 0.6:0.6 X.07 Hexaconazole 1:1 6:6 X.07 Hexaconazole 10:1 .sup.6:0.6 X.07 Hexaconazole 1:10 0.6:6.sup. X.07 Hexaconazole 1:1 0.6:0.6 X.07 Propiconazole 1:1 6:6 X.07 Propiconazole 10:1 .sup.6:0.6 X.07 Propiconazole 1:10 0.6:6.sup. X.07 Propiconazole 1:1 0.6:0.6 X.07 Prothioconazole 1:1 6:6 X.07 Prothioconazole 10:1 .sup.6:0.6 X.07 Prothioconazole 1:10 0.6:6.sup. X.07 Prothioconazole 1:1 0.6:0.6 X.07 Mefentrifluconazole 1:1 6:6 X.07 Mefentrifluconazole 10:1 .sup.6:0.6 X.07 Mefentrifluconazole 1:10 0.6:6.sup. X.07 Mefentrifluconazole 1:1 0.6:0.6 X.07 Fenpropidin .sup.1:3.3 6:20 X.07 Fenpropidin 3:1 6:2 X.07 Fenpropidin 1:33.3 0.6:20 X.07 Fenpropimorph .sup.1:3.3 6:20 X.07 Fenpropimorph 3:1 6:2 X.07 Fenpropimorph 1:33.3 0.6:20 X.07 Fenpropimorph .sup.1:3.3 0.6:2.sup. X.07 Fluxapyroxad 3:1 6:2 X.07 Fluxapyroxad 30:1 .sup.6:0.2 X.07 Fluopyram 3:1 6:2 X.07 Fluopyram 30:1 .sup.6:0.2 X.07 Fluopyram .sup.1:3.3 0.6:2.sup. X.07 Isopyrazam 3:1 6:2 X.07 Isopyrazam 30:1 .sup.6:0.2 X.07 Isopyrazam .sup.1:3.3 0.6:2.sup. X.07 Isopyrazam 3:1 0.6:0.2 X.07 Sedaxane 3:1 6:2 X.07 Sedaxane 30:1 .sup.6:0.2 X.07 Benzovindiflupyr 3:1 6:2 X.07 Benzovindiflupyr 30:1 .sup.6:0.2 X.07 Benzovindiflupyr .sup.1:3.3 0.6:2.sup. X.07 Benzovindiflupyr 3:1 0.6:0.2 X.07 Pydiflumetofen 3:1 6:2 X.07 Pydiflumetofen 30:1 .sup.6:0.2 X.07 Pydiflumetofen .sup.1:3.3 0.6:2.sup. X.07 Pydiflumetofen 3:1 0.6:0.2 X.07 Isoflucypram 3:1 6:2 X.07 Isoflucypram 30:1 .sup.6:0.2 X.07 Isoflucypram .sup.1:3.3 0.6:2.sup. X.07 Isoflucypram 3:1 0.6:0.2 X.07 Isofetamid 3:1 6:2 X.07 Isofetamid 30:1 .sup.6:0.2 X.07 Isofetamid .sup.1:3.3 0.6:2.sup. X.07 Pyrapropoyne 3:1 6:2 X.07 Pyrapropoyne 30:1 .sup.6:0.2 X.07 Pyrapropoyne .sup.1:3.3 0.6:2.sup. X.07 Pyrapropoyne 3:1 0.6:0.2 X.07 Fluindapyr 3:1 6:2 X.07 Fluindapyr 30:1 .sup.6:0.2 X.07 Fluindapyr .sup.1:3.3 0.6:2.sup. X.07 Fenpicoxamid 1:1 6:6 X.07 Fenpicoxamid 10:1 .sup.6:0.6 X.07 Fenpicoxamid 1:10 0.6:6.sup. X.07 Florylpicoxamid 3:1 6:2 X.07 Florylpicoxamid 30:1 .sup.6:0.2 X.07 Florylpicoxamid .sup.1:3.3 0.6:2.sup. X.07 Florylpicoxamid 3:1 0.6:0.2 X.07 Chlorothalonil 1:1 6:6 X.07 Chlorothalonil 10:1 .sup.6:0.6 X.07 Chlorothalonil 1:10 0.6:6.sup. X.07 Mancozeb .sup.1:3.3 6:20 X.07 Mancozeb 1:1 6:6 X.07 Oxathiapiprolin .sup.1:3.3 6:20 X.07 Oxathiapiprolin 1:1 6:6 X.07 Fluazinam 3:1 6:2 X.07 Fluazinam 30:1 .sup.6:0.2 X.07 Fluazinam .sup.1:3.3 0.6:2.sup. X.07 Fludioxonil 1:1 6:6 X.07 Fludioxonil 1:10 0.6:6.sup. X.07 Cyprodinil 1:1 6:6 X.07 Cyprodinil 10:1 .sup.6:0.6 X.07 Metalaxyl-M .sup.1:3.3 6:20 X.07 Metalaxyl-M 1:1 6:6 X.07 Aminopyrifen 3:1 6:2 X.07 Aminopyrifen 30:1 .sup.6:0.2 X.07 Aminopyrifen .sup.1:3.3 0.6:2.sup. X.07 Aminopyrifen 3:1 0.6:0.2 X.07 Folpet 1:1 6:6 X.07 Folpet 3:1 6:2 X.07 Ipflufenoquin 3:1 6:2 X.07 Ipflufenoquin 30:1 .sup.6:0.2 X.07 Quinofumelin 3:1 6:2 X.07 Quinofumelin 30:1 .sup.6:0.2 X.07 Tricyclazole .sup.1:3.3 6:20 X.07 Tricyclazole 1:1 6:6 X.07 Pyroquilon .sup.1:3.3 6:20 X.07 Pyroquilon 1:1 6:6 X.07 N-(1-benzyl-1,3-dimethyl-butyl)- 3:1 6:2 8-fluoro-quinoline-3- carboxamide X.07 N-(1-benzyl-1,3-dimethyl-butyl)- 30:1 .sup.6:0.2 8-fluoro-quinoline-3- carboxamide X.07 N-(1-benzyl-3,3,3-trifluoro-1- 3:1 6:2 methyl-propyl)-8-fluoro- quinoline-3-carboxamide X.07 N-(1-benzyl-3,3,3-trifluoro-1- 30:1 .sup.6:0.2 methyl-propyl)-8-fluoro- quinoline-3-carboxamide X.07 1-(6,7-dimethylpyrazolo[1,5- 3:1 6:2 a]pyridin-3-yl)-4,4,5-trifluoro-3,3- dimethyl-isoquinoline X.07 1-(6,7-dimethylpyrazolo[1,5- 30:1 .sup.6:0.2 a]pyridin-3-yl)-4,4,5-trifluoro-3,3- dimethyl-isoquinoline X.07 4,4-difluoro-3,3-dimethyl-1-(7- 3:1 6:2 methylpyrazolo[1,5-a]pyridin-3- yl)isoquinoline X.07 4,4-difluoro-3,3-dimethyl-1-(7- 30:1 .sup.6:0.2 methylpyrazolo[1,5-a]pyridin-3- yl)isoquinoline X.07 1-(4,5-dimethylbenzimidazol-1- 3:1 6:2 yl)-4,4,5-trifluoro-3,3-dimethyl- isoquinoline X.07 1-(4,5-dimethylbenzimidazol-1- 30:1 .sup.6:0.2 yl)-4,4,5-trifluoro-3,3-dimethyl- isoquinoline X.07 1-(4,5-dimethylbenzimidazol-1- 3:1 6:2 yl)-4,4-difluoro-3,3-dimethyl- isoquinoline X.07 1-(4,5-dimethylbenzimidazol-1- 30:1 .sup.6:0.2 yl)-4,4-difluoro-3,3-dimethyl- isoquinoline

(75) TABLE-US-00023 Component A Ratio Conc. (ppm) (Compound) Component B A:B (A:B) X.14 Azoxystrobin 3:1 6:2 X.14 Azoxystrobin 30:1 .sup.6:0.2 X.14 Azoxystrobin .sup.1:3.3 0.6:2.sup. X.14 Azoxystrobin 3:1 0.6:0.2 X.14 Trifloxystrobin 3:1 6:2 X.14 Trifloxystrobin 30:1 .sup.6:0.2 X.14 Trifloxystrobin .sup.1:3.3 0.6:2.sup. X.14 Trifloxystrobin 3:1 0.6:0.2 X.14 Metyltetraprole 3:1 6:2 X.14 Metyltetraprole 30:1 .sup.6:0.2 X.14 Metyltetraprole .sup.1:3.3 0.6:2.sup. X.14 Metyltetraprole 3:1 0.6:0.2 X.14 Difenoconazole 1:1 6:6 X.14 Difenoconazole 10:1 .sup.6:0.6 X.14 Difenoconazole 1:10 0.6:6.sup. X.14 Difenoconazole 1:1 0.6:0.6 X.14 Hexaconazole 1:1 6:6 X.14 Hexaconazole 10:1 .sup.6:0.6 X.14 Hexaconazole 1:10 0.6:6.sup. X.14 Hexaconazole 1:1 0.6:0.6 X.14 Propiconazole 1:1 6:6 X.14 Propiconazole 10:1 .sup.6:0.6 X.14 Propiconazole 1:10 0.6:6.sup. X.14 Propiconazole 1:1 0.6:0.6 X.14 Prothioconazole 1:1 6:6 X.14 Prothioconazole 10:1 .sup.6:0.6 X.14 Prothioconazole 1:10 0.6:6.sup. X.14 Prothioconazole 1:1 0.6:0.6 X.14 Mefentrifluconazole 1:1 6:6 X.14 Mefentrifluconazole 10:1 .sup.6:0.6 X.14 Mefentrifluconazole 1:10 0.6:6.sup. X.14 Mefentrifluconazole 1:1 0.6:0.6 X.14 Fenpropidin .sup.1:3.3 6:20 X.14 Fenpropidin 3:1 6:2 X.14 Fenpropidin 1:33.3 0.6:20 X.14 Fenpropimorph .sup.1:3.3 6:20 X.14 Fenpropimorph 3:1 6:2 X.14 Fenpropimorph 1:33.3 0.6:20 X.14 Fenpropimorph .sup.1:3.3 0.6:2.sup. X.14 Fluxapyroxad 3:1 6:2 X.14 Fluxapyroxad 30:1 .sup.6:0.2 X.14 Fluopyram 3:1 6:2 X.14 Fluopyram .sup.1:3.3 0.6:2.sup. X.14 Isopyrazam 3:1 6:2 X.14 Isopyrazam 30:1 .sup.6:0.2 X.14 Isopyrazam .sup.1:3.3 0.6:2.sup. X.14 Isopyrazam 3:1 0.6:0.2 X.14 Sedaxane 3:1 6:2 X.14 Sedaxane 30:1 .sup.6:0.2 X.14 Benzovindiflupyr 3:1 6:2 X.14 Benzovindiflupyr 30:1 .sup.6:0.2 X.14 Benzovindiflupyr .sup.1:3.3 0.6:2.sup. X.14 Benzovindiflupyr 3:1 0.6:0.2 X.14 Pydiflumetofen 3:1 6:2 X.14 Pydiflumetofen 30:1 .sup.6:0.2 X.14 Pydiflumetofen .sup.1:3.3 0.6:2.sup. X.14 Pydiflumetofen 3:1 0.6:0.2 X.14 Isoflucypram 3:1 6:2 X.14 Isoflucypram 30:1 .sup.6:0.2 X.14 Isoflucypram .sup.1:3.3 0.6:2.sup. X.14 Isoflucypram 3:1 0.6:0.2 X.14 Isofetamid 3:1 6:2 X.14 Isofetamid 30:1 .sup.6:0.2 X.14 Isofetamid .sup.1:3.3 0.6:2.sup. X.14 Pyrapropoyne 3:1 6:2 X.14 Pyrapropoyne 30:1 .sup.6:0.2 X.14 Pyrapropoyne .sup.1:3.3 0.6:2.sup. X.14 Pyrapropoyne 3:1 0.6:0.2 X.14 Fluindapyr 3:1 6:2 X.14 Fluindapyr 30:1 .sup.6:0.2 X.14 Fluindapyr .sup.1:3.3 0.6:2.sup. X.14 Fenpicoxamid 1:1 6:6 X.14 Fenpicoxamid 10:1 .sup.6:0.6 X.14 Fenpicoxamid 1:10 0.6:6.sup. X.14 Florylpicoxamid 3:1 6:2 X.14 Florylpicoxamid 30:1 .sup.6:0.2 X.14 Florylpicoxamid .sup.1:3.3 0.6:2.sup. X.14 Florylpicoxamid 3:1 0.6:0.2 X.14 Chlorothalonil 1:1 6:6 X.14 Chlorothalonil 10:1 .sup.6:0.6 X.14 Chlorothalonil 1:10 0.6:6.sup. X.14 Mancozeb .sup.1:3.3 6:20 X.14 Mancozeb 1:1 6:6 X.14 Mandipropamid .sup.1:3.3 6:20 X.14 Mandipropamid 1:1 6:6 X.14 Oxathiapiprolin .sup.1:3.3 6:20 X.14 Oxathiapiprolin 1:1 6:6 X.14 Fluazinam 3:1 6:2 X.14 Fluazinam 30:1 .sup.6:0.2 X.14 Fluazinam .sup.1:3.3 0.6:2.sup. X.14 Fludioxonil 1:1 6:6 X.14 Fludioxonil 1:10 0.6:6.sup. X.14 Cyprodinil 1:1 6:6 X.14 Cyprodinil 10:1 .sup.6:0.6 X.14 Metalaxyl-M .sup.1:3.3 6:20 X.14 Metalaxyl-M 1:1 6:6 X.14 Aminopyrifen 3:1 6:2 X.14 Aminopyrifen 30:1 .sup.6:0.2 X.14 Aminopyrifen .sup.1:3.3 0.6:2.sup. X.14 Aminopyrifen 3:1 0.6:0.2 X.14 Folpet 1:1 6:6 X.14 Folpet 3:1 6:2 X.14 Ipflufenoquin 3:1 6:2 X.14 Ipflufenoquin 30:1 .sup.6:0.2 X.14 Quinofumelin 3:1 6:2 X.14 Quinofumelin 30:1 .sup.6:0.2 X.14 Tricyclazole .sup.1:3.3 6:20 X.14 Tricyclazole 1:1 6:6 X.14 Pyroquilon .sup.1:3.3 6:20 X.14 N-(1-benzyl-1,3-dimethyl-butyl)- 3:1 6:2 8-fluoro-quinoline-3- carboxamide X.14 N-(1-benzyl-1,3-dimethyl-butyl)- 30:1 .sup.6:0.2 8-fluoro-quinoline-3- carboxamide X.14 N-(1-benzyl-3,3,3-trifluoro-1- 3:1 6:2 methyl-propyl)-8-fluoro- quinoline-3-carboxamide X.14 N-(1-benzyl-3,3,3-trifluoro-1- 30:1 .sup.6:0.2 methyl-propyl)-8-fluoro- quinoline-3-carboxamide X.14 1-(6,7-dimethylpyrazolo[1,5- 3:1 6:2 a]pyridin-3-yl)-4,4,5-trifluoro-3,3- dimethyl-isoquinoline X.14 1-(6,7-dimethylpyrazolo[1,5- 30:1 .sup.6:0.2 a]pyridin-3-yl)-4,4,5-trifluoro-3,3- dimethyl-isoquinoline X.14 4,4-difluoro-3,3-dimethyl-1-(7- 3:1 6:2 methylpyrazolo[1,5-a]pyridin-3- yl)isoquinoline X.14 4,4-difluoro-3,3-dimethyl-1-(7- 30:1 .sup.6:0.2 methylpyrazolo[1,5-a]pyridin-3- yl)isoquinoline X.14 1-(4,5-dimethylbenzimidazol-1- 3:1 6:2 yl)-4,4,5-trifluoro-3,3-dimethyl- isoquinoline X.14 1-(4,5-dimethylbenzimidazol-1- 30:1 .sup.6:0.2 yl)-4,4,5-trifluoro-3,3-dimethyl- isoquinoline X.14 1-(4,5-dimethylbenzimidazol-1- 3:1 6:2 yl)-4,4-difluoro-3,3-dimethyl- isoquinoline X.14 1-(4,5-dimethylbenzimidazol-1- 30:1 .sup.6:0.2 yl)-4,4-difluoro-3,3-dimethyl- isoquinoline

Example B5: Activity Against Pyricularia oryzae (Rice Blast)

(76) Conidia of the fungus from cryogenic; storage were directly mixed into nutrient broth (PDB potato dextrose broth). A DMSO solution of the test compounds was placed into a microtiter plate (96-well format) and the nutrient broth containing the fungal spores was added to it. The test plates were incubated at 24 C. and the inhibition of growth was determined photometrically after 72 hrs. The following mixture compositions (A:B) at the reported concentration (in ppm) gave at least 80% disease control in this test.

(77) TABLE-US-00024 Component A Ratio Conc. (ppm) (Compound) Component B A:B (A:B) X.05 Azoxystrobin 3:1 6:2 X.05 Azoxystrobin 30:1 .sup.6:0.2 X.05 Azoxystrobin .sup.1:3.3 0.6:2.sup. X.05 Azoxystrobin 3:1 0.6:0.2 X.05 Trifloxystrobin 3:1 6:2 X.05 Trifloxystrobin 30:1 .sup.6:0.2 X.05 Trifloxystrobin .sup.1:3.3 0.6:2.sup. X.05 Trifloxystrobin 3:1 0.6:0.2 X.05 Metyltetraprole 3:1 6:2 X.05 Metyltetraprole 30:1 .sup.6:0.2 X.05 Metyltetraprole .sup.1:3.3 0.6:2.sup. X.05 Metyltetraprole 3:1 0.6:0.2 X.05 Difenoconazole 1:1 6:6 X.05 Difenoconazole 10:1 .sup.6:0.6 X.05 Difenoconazole 1:10 0.6:6.sup. X.05 Difenoconazole 1:1 0.6:0.6 X.05 Hexaconazole 1:1 6:6 X.05 Hexaconazole 10:1 .sup.6:0.6 X.05 Hexaconazole 1:10 0.6:6.sup. X.05 Hexaconazole 1:1 0.6:0.6 X.05 Propiconazole 1:1 6:6 X.05 Propiconazole 10:1 .sup.6:0.6 X.05 Propiconazole 1:10 0.6:6.sup. X.05 Propiconazole 1:1 0.6:0.6 X.05 Prothioconazole 1:1 6:6 X.05 Prothioconazole 10:1 .sup.6:0.6 X.05 Prothioconazole 1:10 0.6:6.sup. X.05 Prothioconazole 1:1 0.6:0.6 X.05 Mefentrifluconazole 1:1 6:6 X.05 Mefentrifluconazole 10:1 .sup.6:0.6 X.05 Mefentrifluconazole 1:10 0.6:6.sup. X.05 Mefentrifluconazole 1:1 0.6:0.6 X.05 Fenpropidin .sup.1:3.3 6:20 X.05 Fenpropidin 3:1 6:2 X.05 Fenpropidin 1:33.3 0.6:20 X.05 Fenpropidin .sup.1:3.3 0.6:2.sup. X.05 Fenpropimorph .sup.1:3.3 6:20 X.05 Fenpropimorph 3:1 6:2 X.05 Fenpropimorph 1:33.3 0.6:20 X.05 Fenpropimorph .sup.1:3.3 0.6:2.sup. X.05 Fluxapyroxad 3:1 6:2 X.05 Fluxapyroxad 30:1 .sup.6:0.2 X.05 Fluxapyroxad .sup.1:3.3 0.6:2.sup. X.05 Fluxapyroxad 3:1 0.6:0.2 X.05 Fluopyram 3:1 6:2 X.05 Fluopyram 30:1 .sup.6:0.2 X.05 Fluopyram .sup.1:3.3 0.6:2.sup. X.05 Fluopyram 3:1 0.6:0.2 X.05 Isopyrazam 3:1 6:2 X.05 Isopyrazam 30:1 .sup.6:0.2 X.05 Isopyrazam .sup.1:3.3 0.6:2.sup. X.05 Isopyrazam 3:1 0.6:0.2 X.05 Sedaxane 3:1 6:2 X.05 Sedaxane 30:1 .sup.6:0.2 X.05 Sedaxane .sup.1:3.3 0.6:2.sup. X.05 Sedaxane 3:1 0.6:0.2 X.05 Benzovindiflupyr 3:1 6:2 X.05 Benzovindiflupyr 30:1 .sup.6:0.2 X.05 Benzovindiflupyr .sup.1:3.3 0.6:2.sup. X.05 Benzovindiflupyr 3:1 0.6:0.2 X.05 Pydiflumetofen 3:1 6:2 X.05 Pydiflumetofen 30:1 .sup.6:0.2 X.05 Pydiflumetofen .sup.1:3.3 0.6:2.sup. X.05 Pydiflumetofen 3:1 0.6:0.2 X.05 Isoflucypram 3:1 6:2 X.05 Isoflucypram 30:1 .sup.6:0.2 X.05 Isoflucypram .sup.1:3.3 0.6:2.sup. X.05 Isoflucypram 3:1 0.6:0.2 X.05 Isofetamid 3:1 6:2 X.05 Isofetamid 30:1 .sup.6:0.2 X.05 Isofetamid .sup.1:3.3 0.6:2.sup. X.05 Isofetamid 3:1 0.6:0.2 X.05 Pyrapropoyne 3:1 6:2 X.05 Pyrapropoyne 30:1 .sup.6:0.2 X.05 Pyrapropoyne .sup.1:3.3 0.6:2.sup. X.05 Pyrapropoyne 3:1 0.6:0.2 X.05 Fluindapyr 3:1 6:2 X.05 Fluindapyr 30:1 .sup.6:0.2 X.05 Fluindapyr .sup.1:3.3 0.6:2.sup. X.05 Fluindapyr 3:1 0.6:0.2 X.05 Fenpicoxamid 1:1 6:6 X.05 Fenpicoxamid 10:1 .sup.6:0.6 X.05 Fenpicoxamid 1:10 0.6:6.sup. X.05 Fenpicoxamid 1:1 0.6:0.6 X.05 Florylpicoxamid 3:1 6:2 X.05 Florylpicoxamid 30:1 .sup.6:0.2 X.05 Florylpicoxamid .sup.1:3.3 0.6:2.sup. X.05 Florylpicoxamid 3:1 0.6:0.2 X.05 Chlorothalonil 1:1 6:6 X.05 Chlorothalonil 10:1 .sup.6:0.6 X.05 Chlorothalonil 1:10 0.6:6.sup. X.05 Chlorothalonil 1:1 0.6:0.6 X.05 Mancozeb .sup.1:3.3 6:20 X.05 Mancozeb 1:1 6:6 X.05 Mancozeb 1:33.3 0.6:20 X.05 Mancozeb 1:10 0.6:6.sup. X.05 Mandipropamid .sup.1:3.3 6:20 X.05 Mandipropamid 1:1 6:6 X.05 Mandipropamid 1:33.3 0.6:20 X.05 Mandipropamid 1:10 0.6:6.sup. X.05 Oxathiapiprolin .sup.1:3.3 6:20 X.05 Oxathiapiprolin 1:1 6:6 X.05 Oxathiapiprolin 1:33.3 0.6:20 X.05 Oxathiapiprolin 1:10 0.6:6.sup. X.05 Fluazinam 3:1 6:2 X.05 Fluazinam 30:1 .sup.6:0.2 X.05 Fluazinam .sup.1:3.3 0.6:2.sup. X.05 Fluazinam 3:1 0.6:0.2 X.05 Fludioxonil 1:1 6:6 X.05 Fludioxonil 10:1 .sup.6:0.6 X.05 Fludioxonil 1:10 0.6:6.sup. X.05 Fludioxonil 1:1 0.6:0.6 X.05 Cyprodinil 1:1 6:6 X.05 Cyprodinil 10:1 .sup.6:0.6 X.05 Cyprodinil 1:10 0.6:6.sup. X.05 Cyprodinil 1:1 0.6:0.6 X.05 Metalaxyl-M .sup.1:3.3 6:20 X.05 Metalaxyl-M 1:1 6:6 X.05 Metalaxyl-M 1:33.3 0.6:20 X.05 Metalaxyl-M 1:10 0.6:6.sup. X.05 Aminopyrifen 3:1 6:2 X.05 Aminopyrifen 30:1 .sup.6:0.2 X.05 Aminopyrifen .sup.1:3.3 0.6:2.sup. X.05 Aminopyrifen 3:1 0.6:0.2 X.05 Folpet 1:1 6:6 X.05 Folpet 3:1 6:2 X.05 Folpet 1:10 0.6:6.sup. X.05 Folpet .sup.1:3.3 0.6:2.sup. X.05 Ipflufenoquin 3:1 6:2 X.05 Ipflufenoquin 30:1 .sup.6:0.2 X.05 Ipflufenoquin .sup.1:3.3 0.6:2.sup. X.05 Ipflufenoquin 3:1 0.6:0.2 X.05 Quinofumelin 3:1 6:2 X.05 Quinofumelin 30:1 .sup.6:0.2 X.05 Quinofumelin .sup.1:3.3 0.6:2.sup. X.05 Quinofumelin 3:1 0.6:0.2 X.05 Tricyclazole .sup.1:3.3 6:20 X.05 Tricyclazole 1:1 6:6 X.05 Tricyclazole 1:33.3 0.6:20 X.05 Tricyclazole 1:10 0.6:6.sup. X.05 Pyroquilon .sup.1:3.3 6:20 X.05 Pyroquilon 1:1 6:6 X.05 Pyroquilon 1:33.3 0.6:20 X.05 Pyroquilon 1:10 0.6:6.sup. X.05 N-(1-benzyl-1,3-dimethyl-butyl)- 3:1 6:2 8-fluoro-quinoline-3- carboxamide X.05 N-(1-benzyl-1,3-dimethyl-butyl)- 30:1 .sup.6:0.2 8-fluoro-quinoline-3- carboxamide X.05 N-(1-benzyl-1,3-dimethyl-butyl)- .sup.1:3.3 0.6:2.sup. 8-fluoro-quinoline-3- carboxamide X.05 N-(1-benzyl-1,3-dimethyl-butyl)- 3:1 0.6:0.2 8-fluoro-quinoline-3- carboxamide X.05 N-(1-benzyl-3,3,3-trifluoro-1- 3:1 6:2 methyl-propyl)-8-fluoro- quinoline-3-carboxamide X.05 N-(1-benzyl-3,3,3-trifluoro-1- 30:1 .sup.6:0.2 methyl-propyl)-8-fluoro- quinoline-3-carboxamide X.05 N-(1-benzyl-3,3,3-trifluoro-1- .sup.1:3.3 0.6:2.sup. methyl-propyl)-8-fluoro- quinoline-3-carboxamide X.05 N-(1-benzyl-3,3,3-trifluoro-1- 3:1 0.6:0.2 methyl-propyl)-8-fluoro- quinoline-3-carboxamide X.05 1-(6,7-dimethylpyrazolo[1,5- 3:1 6:2 a]pyridin-3-yl)-4,4,5-trifluoro-3,3- dimethyl-isoquinoline X.05 1-(6,7-dimethylpyrazolo[1,5- 30:1 .sup.6:0.2 a]pyridin-3-yl)-4,4,5-trifluoro-3,3- dimethyl-isoquinoline X.05 1-(6,7-dimethylpyrazolo[1,5- .sup.1:3.3 0.6:2.sup. a]pyridin-3-yl)-4,4,5-trifluoro-3,3- dimethyl-isoquinoline X.05 1-(6,7-dimethylpyrazolo[1,5- 3:1 0.6:0.2 a]pyridin-3-yl)-4,4,5-trifluoro-3,3- dimethyl-isoquinoline X.05 4,4-difluoro-3,3-dimethyl-1-(7- 3:1 6:2 methylpyrazolo[1,5-a]pyridin-3- yl)isoquinoline X.05 4,4-difluoro-3,3-dimethyl-1-(7- 30:1 .sup.6:0.2 methylpyrazolo[1,5-a]pyridin-3- yl)isoquinoline X.05 4,4-difluoro-3,3-dimethyl-1-(7- .sup.1:3.3 0.6:2.sup. methylpyrazolo[1,5-a]pyridin-3- yl)isoquinoline X.05 4,4-difluoro-3,3-dimethyl-1-(7- 3:1 0.6:0.2 methylpyrazolo[1,5-a]pyridin-3- yl)isoquinoline X.05 1-(4,5-dimethylbenzimidazol-1- 3:1 6:2 yl)-4,4,5-trifluoro-3,3-dimethyl- isoquinoline X.05 1-(4,5-dimethylbenzimidazol-1- 30:1 .sup.6:0.2 yl)-4,4,5-trifluoro-3,3-dimethyl- isoquinoline X.05 1-(4,5-dimethylbenzimidazol-1- .sup.1:3.3 0.6:2.sup. yl)-4,4,5-trifluoro-3,3-dimethyl- isoquinoline X.05 1-(4,5-dimethylbenzimidazol-1- 3:1 0.6:0.2 yl)-4,4,5-trifluoro-3,3-dimethyl- isoquinoline X.05 1-(4,5-dimethylbenzimidazol-1- 3:1 6:2 yl)-4,4-difluoro-3,3-dimethyl- isoquinoline X.05 1-(4,5-dimethylbenzimidazol-1- 30:1 .sup.6:0.2 yl)-4,4-difluoro-3,3-dimethyl- isoquinoline X.05 1-(4,5-dimethylbenzimidazol-1- .sup.1:3.3 0.6:2.sup. yl)-4,4-difluoro-3,3-dimethyl- isoquinoline X.05 1-(4,5-dimethylbenzimidazol-1- 3:1 0.6:0.2 yl)-4,4-difluoro-3,3-dimethyl- isoquinoline

(78) TABLE-US-00025 Component A Ratio Conc. (ppm) (Compound) Component B A:B (A:B) X.07 Azoxystrobin 3:1 6:2 X.07 Azoxystrobin 30:1 .sup.6:0.2 X.07 Azoxystrobin .sup.1:3.3 0.6:2.sup. X.07 Azoxystrobin 3:1 0.6:0.2 X.07 Trifloxystrobin 3:1 6:2 X.07 Trifloxystrobin 30:1 .sup.6:0.2 X.07 Trifloxystrobin .sup.1:3.3 0.6:2.sup. X.07 Trifloxystrobin 3:1 0.6:0.2 X.07 Metyltetraprole 3:1 6:2 X.07 Metyltetraprole 30:1 .sup.6:0.2 X.07 Metyltetraprole .sup.1:3.3 0.6:2.sup. X.07 Metyltetraprole 3:1 0.6:0.2 X.07 Difenoconazole 1:1 6:6 X.07 Difenoconazole 10:1 .sup.6:0.6 X.07 Difenoconazole 1:10 0.6:6.sup. X.07 Difenoconazole 1:1 0.6:0.6 X.07 Hexaconazole 1:1 6:6 X.07 Hexaconazole 10:1 .sup.6:0.6 X.07 Hexaconazole 1:10 0.6:6.sup. X.07 Hexaconazole 1:1 0.6:0.6 X.07 Propiconazole 1:1 6:6 X.07 Propiconazole 10:1 .sup.6:0.6 X.07 Propiconazole 1:10 0.6:6.sup. X.07 Propiconazole 1:1 0.6:0.6 X.07 Prothioconazole 1:1 6:6 X.07 Prothioconazole 10:1 .sup.6:0.6 X.07 Prothioconazole 1:10 0.6:6.sup. X.07 Prothioconazole 1:1 0.6:0.6 X.07 Mefentrifluconazole 1:1 6:6 X.07 Mefentrifluconazole 10:1 .sup.6:0.6 X.07 Mefentrifluconazole 1:10 0.6:6.sup. X.07 Mefentrifluconazole 1:1 0.6:0.6 X.07 Fenpropidin .sup.1:3.3 6:20 X.07 Fenpropidin 3:1 6:2 X.07 Fenpropidin 1:33.3 0.6:20 X.07 Fenpropidin .sup.1:3.3 0.6:2.sup. X.07 Fenpropimorph .sup.1:3.3 6:20 X.07 Fenpropimorph 3:1 6:2 X.07 Fenpropimorph 1:33.3 0.6:20 X.07 Fenpropimorph .sup.1:3.3 0.6:2.sup. X.07 Fluxapyroxad 3:1 6:2 X.07 Fluxapyroxad 30:1 .sup.6:0.2 X.07 Fluxapyroxad .sup.1:3.3 0.6:2.sup. X.07 Fluxapyroxad 3:1 0.6:0.2 X.07 Fluopyram 3:1 6:2 X.07 Fluopyram 30:1 .sup.6:0.2 X.07 Fluopyram .sup.1:3.3 0.6:2.sup. X.07 Fluopyram 3:1 0.6:0.2 X.07 Isopyrazam 3:1 6:2 X.07 Isopyrazam 30:1 .sup.6:0.2 X.07 Isopyrazam .sup.1:3.3 0.6:2.sup. X.07 Isopyrazam 3:1 0.6:0.2 X.07 Sedaxane 3:1 6:2 X.07 Sedaxane 30:1 .sup.6:0.2 X.07 Sedaxane .sup.1:3.3 0.6:2.sup. X.07 Sedaxane 3:1 0.6:0.2 X.07 Benzovindiflupyr 3:1 6:2 X.07 Benzovindiflupyr 30:1 .sup.6:0.2 X.07 Benzovindiflupyr .sup.1:3.3 0.6:2.sup. X.07 Benzovindiflupyr 3:1 0.6:0.2 X.07 Pydiflumetofen 3:1 6:2 X.07 Pydiflumetofen 30:1 .sup.6:0.2 X.07 Pydiflumetofen .sup.1:3.3 0.6:2.sup. X.07 Pydiflumetofen 3:1 0.6:0.2 X.07 Isoflucypram 3:1 6:2 X.07 Isoflucypram 30:1 .sup.6:0.2 X.07 Isoflucypram .sup.1:3.3 0.6:2.sup. X.07 Isoflucypram 3:1 0.6:0.2 X.07 Isofetamid 3:1 6:2 X.07 Isofetamid 30:1 .sup.6:0.2 X.07 Isofetamid .sup.1:3.3 0.6:2.sup. X.07 Isofetamid 3:1 0.6:0.2 X.07 Pyrapropoyne 3:1 6:2 X.07 Pyrapropoyne 30:1 .sup.6:0.2 X.07 Pyrapropoyne .sup.1:3.3 0.6:2.sup. X.07 Pyrapropoyne 3:1 0.6:0.2 X.07 Fluindapyr 3:1 6:2 X.07 Fluindapyr 30:1 .sup.6:0.2 X.07 Fluindapyr .sup.1:3.3 0.6:2.sup. X.07 Fluindapyr 3:1 0.6:0.2 X.07 Fenpicoxamid 1:1 6:6 X.07 Fenpicoxamid 10:1 .sup.6:0.6 X.07 Fenpicoxamid 1:10 0.6:6.sup. X.07 Fenpicoxamid 1:1 0.6:0.6 X.07 Florylpicoxamid 3:1 6:2 X.07 Florylpicoxamid 30:1 .sup.6:0.2 X.07 Florylpicoxamid .sup.1:3.3 0.6:2.sup. X.07 Florylpicoxamid 3:1 0.6:0.2 X.07 Chlorothalonil 1:1 6:6 X.07 Chlorothalonil 10:1 .sup.6:0.6 X.07 Chlorothalonil 1:10 0.6:6.sup. X.07 Chlorothalonil 1:1 0.6:0.6 X.07 Mancozeb .sup.1:3.3 6:20 X.07 Mancozeb 1:1 6:6 X.07 Mancozeb 1:33.3 0.6:20 X.07 Mancozeb 1:10 0.6:6.sup. X.07 Mandipropamid .sup.1:3.3 6:20 X.07 Mandipropamid 1:1 6:6 X.07 Mandipropamid 1:33.3 0.6:20 X.07 Mandipropamid 1:10 0.6:6.sup. X.07 Oxathiapiprolin .sup.1:3.3 6:20 X.07 Oxathiapiprolin 1:1 6:6 X.07 Oxathiapiprolin 1:33.3 0.6:20 X.07 Oxathiapiprolin 1:10 0.6:6.sup. X.07 Fluazinam 3:1 6:2 X.07 Fluazinam 30:1 .sup.6:0.2 X.07 Fluazinam .sup.1:3.3 0.6:2.sup. X.07 Fluazinam 3:1 0.6:0.2 X.07 Fludioxonil 1:1 6:6 X.07 Fludioxonil 10:1 .sup.6:0.6 X.07 Fludioxonil 1:10 0.6:6.sup. X.07 Fludioxonil 1:1 0.6:0.6 X.07 Cyprodinil 1:1 6:6 X.07 Cyprodinil 10:1 .sup.6:0.6 X.07 Cyprodinil 1:10 0.6:6.sup. X.07 Cyprodinil 1:1 0.6:0.6 X.07 Metalaxyl-M .sup.1:3.3 6:20 X.07 Metalaxyl-M 1:1 6:6 X.07 Metalaxyl-M 1:33.3 0.6:20 X.07 Metalaxyl-M 1:10 0.6:6.sup. X.07 Aminopyrifen 3:1 6:2 X.07 Aminopyrifen 30:1 .sup.6:0.2 X.07 Aminopyrifen .sup.1:3.3 0.6:2.sup. X.07 Aminopyrifen 3:1 0.6:0.2 X.07 Folpet 1:1 6:6 X.07 Folpet 3:1 6:2 X.07 Folpet 1:10 0.6:6.sup. X.07 Folpet .sup.1:3.3 0.6:2.sup. X.07 Ipflufenoquin 3:1 6:2 X.07 Ipflufenoquin 30:1 .sup.6:0.2 X.07 Ipflufenoquin .sup.1:3.3 0.6:2.sup. X.07 Ipflufenoquin 3:1 0.6:0.2 X.07 Quinofumelin 3:1 6:2 X.07 Quinofumelin 30:1 .sup.6:0.2 X.07 Quinofumelin .sup.1:3.3 0.6:2.sup. X.07 Quinofumelin 3:1 0.6:0.2 X.07 Tricyclazole .sup.1:3.3 6:20 X.07 Tricyclazole 1:1 6:6 X.07 Tricyclazole 1:33.3 0.6:20 X.07 Tricyclazole 1:10 0.6:6.sup. X.07 Pyroquilon .sup.1:3.3 6:20 X.07 Pyroquilon 1:1 6:6 X.07 Pyroquilon 1:33.3 0.6:20 X.07 Pyroquilon 1:10 0.6:6.sup. X.07 N-(1-benzyl-1,3-dimethyl-butyl)- 3:1 6:2 8-fluoro-quinoline-3- carboxamide X.07 N-(1-benzyl-1,3-dimethyl-butyl)- 30:1 .sup.6:0.2 8-fluoro-quinoline-3- carboxamide X.07 N-(1-benzyl-1,3-dimethyl-butyl)- .sup.1:3.3 0.6:2.sup. 8-fluoro-quinoline-3- carboxamide X.07 N-(1-benzyl-1,3-dimethyl-butyl)- 3:1 0.6:0.2 8-fluoro-quinoline-3- carboxamide X.07 N-(1-benzyl-3,3,3-trifluoro-1- 3:1 6:2 methyl-propyl)-8-fluoro- quinoline-3-carboxamide X.07 N-(1-benzyl-3,3,3-trifluoro-1- 30:1 .sup.6:0.2 methyl-propyl)-8-fluoro- quinoline-3-carboxamide X.07 N-(1-benzyl-3,3,3-trifluoro-1- .sup.1:3.3 0.6:2.sup. methyl-propyl)-8-fluoro- quinoline-3-carboxamide X.07 N-(1-benzyl-3,3,3-trifluoro-1- 3:1 0.6:0.2 methyl-propyl)-8-fluoro- quinoline-3-carboxamide X.07 1-(6,7-dimethylpyrazolo[1,5- 3:1 6:2 a]pyridin-3-yl)-4,4,5-trifluoro-3,3- dimethyl-isoquinoline X.07 1-(6,7-dimethylpyrazolo[1,5- 30:1 .sup.6:0.2 a]pyridin-3-yl)-4,4,5-trifluoro-3,3- dimethyl-isoquinoline X.07 1-(6,7-dimethylpyrazolo[1,5- .sup.1:3.3 0.6:2.sup. a]pyridin-3-yl)-4,4,5-trifluoro-3,3- dimethyl-isoquinoline X.07 1-(6,7-dimethylpyrazolo[1,5- 3:1 0.6:0.2 a]pyridin-3-yl)-4,4,5-trifluoro-3,3- dimethyl-isoquinoline X.07 4,4-difluoro-3,3-dimethyl-1-(7- 3:1 6:2 methylpyrazolo[1,5-a]pyridin-3- yl)isoquinoline X.07 4,4-difluoro-3,3-dimethyl-1-(7- 30:1 .sup.6:0.2 methylpyrazolo[1,5-a]pyridin-3- yl)isoquinoline X.07 4,4-difluoro-3,3-dimethyl-1-(7- .sup.1:3.3 0.6:2.sup. methylpyrazolo[1,5-a]pyridin-3- yl)isoquinoline X.07 4,4-difluoro-3,3-dimethyl-1-(7- 3:1 0.6:0.2 methylpyrazolo[1,5-a]pyridin-3- yl)isoquinoline X.07 1-(4,5-dimethylbenzimidazol-1- 3:1 6:2 yl)-4,4,5-trifluoro-3,3-dimethyl- isoquinoline X.07 1-(4,5-dimethylbenzimidazol-1- 30:1 .sup.6:0.2 yl)-4,4,5-trifluoro-3,3-dimethyl- isoquinoline X.07 1-(4,5-dimethylbenzimidazol-1- .sup.1:3.3 0.6:2.sup. yl)-4,4,5-trifluoro-3,3-dimethyl- isoquinoline X.07 1-(4,5-dimethylbenzimidazol-1- 3:1 0.6:0.2 yl)-4,4,5-trifluoro-3,3-dimethyl- isoquinoline X.07 1-(4,5-dimethylbenzimidazol-1- 3:1 6:2 yl)-4,4-difluoro-3,3-dimethyl- isoquinoline X.07 1-(4,5-dimethylbenzimidazol-1- 30:1 .sup.6:0.2 yl)-4,4-difluoro-3,3-dimethyl- isoquinoline X.07 1-(4,5-dimethylbenzimidazol-1- .sup.1:3.3 0.6:2.sup. yl)-4,4-difluoro-3,3-dimethyl- isoquinoline X.07 1-(4,5-dimethylbenzimidazol-1- 3:1 0.6:0.2 yl)-4,4-difluoro-3,3-dimethyl- isoquinoline

(79) TABLE-US-00026 Component A Ratio Conc. (ppm) (Compound) Component B A:B (A:B) X.14 Azoxystrobin 3:1 6:2 X.14 Azoxystrobin 30:1 .sup.6:0.2 X.14 Azoxystrobin .sup.1:3.3 0.6:2.sup. X.14 Azoxystrobin 3:1 0.6:0.2 X.14 Trifloxystrobin 3:1 6:2 X.14 Trifloxystrobin 30:1 .sup.6:0.2 X.14 Trifloxystrobin .sup.1:3.3 0.6:2.sup. X.14 Trifloxystrobin 3:1 0.6:0.2 X.14 Metyltetraprole 3:1 6:2 X.14 Metyltetraprole 30:1 .sup.6:0.2 X.14 Metyltetraprole .sup.1:3.3 0.6:2.sup. X.14 Metyltetraprole 3:1 0.6:0.2 X.14 Difenoconazole 1:1 6:6 X.14 Difenoconazole 10:1 .sup.6:0.6 X.14 Difenoconazole 1:10 0.6:6.sup. X.14 Difenoconazole 1:1 0.6:0.6 X.14 Hexaconazole 1:1 6:6 X.14 Hexaconazole 10:1 .sup.6:0.6 X.14 Hexaconazole 1:10 0.6:6.sup. X.14 Hexaconazole 1:1 0.6:0.6 X.14 Propiconazole 1:1 6:6 X.14 Propiconazole 10:1 .sup.6:0.6 X.14 Propiconazole 1:10 0.6:6.sup. X.14 Propiconazole 1:1 0.6:0.6 X.14 Prothioconazole 1:1 6:6 X.14 Prothioconazole 10:1 .sup.6:0.6 X.14 Prothioconazole 1:10 0.6:6.sup. X.14 Prothioconazole 1:1 0.6:0.6 X.14 Mefentrifluconazole 1:1 6:6 X.14 Mefentrifluconazole 10:1 .sup.6:0.6 X.14 Mefentrifluconazole 1:10 0.6:6.sup. X.14 Mefentrifluconazole 1:1 0.6:0.6 X.14 Fenpropidin .sup.1:3.3 6:20 X.14 Fenpropidin 3:1 6:2 X.14 Fenpropidin 1:33.3 0.6:20 X.14 Fenpropidin .sup.1:3.3 0.6:2.sup. X.14 Fenpropimorph .sup.1:3.3 6:20 X.14 Fenpropimorph 3:1 6:2 X.14 Fenpropimorph 1:33.3 0.6:20 X.14 Fenpropimorph .sup.1:3.3 0.6:2.sup. X.14 Fluxapyroxad 3:1 6:2 X.14 Fluxapyroxad 30:1 .sup.6:0.2 X.14 Fluxapyroxad .sup.1:3.3 0.6:2.sup. X.14 Fluxapyroxad 3:1 0.6:0.2 X.14 Fluopyram 3:1 6:2 X.14 Fluopyram 30:1 .sup.6:0.2 X.14 Fluopyram .sup.1:3.3 0.6:2.sup. X.14 Fluopyram 3:1 0.6:0.2 X.14 Isopyrazam 3:1 6:2 X.14 Isopyrazam 30:1 .sup.6:0.2 X.14 Isopyrazam .sup.1:3.3 0.6:2.sup. X.14 Isopyrazam 3:1 0.6:0.2 X.14 Sedaxane 3:1 6:2 X.14 Sedaxane 30:1 .sup.6:0.2 X.14 Sedaxane .sup.1:3.3 0.6:2.sup. X.14 Sedaxane 3:1 0.6:0.2 X.14 Benzovindiflupyr 3:1 6:2 X.14 Benzovindiflupyr 30:1 .sup.6:0.2 X.14 Benzovindiflupyr .sup.1:3.3 0.6:2.sup. X.14 Benzovindiflupyr 3:1 0.6:0.2 X.14 Pydiflumetofen 3:1 6:2 X.14 Pydiflumetofen 30:1 .sup.6:0.2 X.14 Pydiflumetofen .sup.1:3.3 0.6:2.sup. X.14 Pydiflumetofen 3:1 0.6:0.2 X.14 Isoflucypram 3:1 6:2 X.14 Isoflucypram 30:1 .sup.6:0.2 X.14 Isoflucypram .sup.1:3.3 0.6:2.sup. X.14 Isoflucypram 3:1 0.6:0.2 X.14 Isofetamid 3:1 6:2 X.14 Isofetamid 30:1 .sup.6:0.2 X.14 Isofetamid .sup.1:3.3 0.6:2.sup. X.14 Isofetamid 3:1 0.6:0.2 X.14 Pyrapropoyne 3:1 6:2 X.14 Pyrapropoyne 30:1 .sup.6:0.2 X.14 Pyrapropoyne .sup.1:3.3 0.6:2.sup. X.14 Pyrapropoyne 3:1 0.6:0.2 X.14 Fluindapyr 3:1 6:2 X.14 Fluindapyr 30:1 .sup.6:0.2 X.14 Fluindapyr .sup.1:3.3 0.6:2.sup. X.14 Fluindapyr 3:1 0.6:0.2 X.14 Fenpicoxamid 1:1 6:6 X.14 Fenpicoxamid 10:1 .sup.6:0.6 X.14 Fenpicoxamid 1:10 0.6:6.sup. X.14 Fenpicoxamid 1:1 0.6:0.6 X.14 Florylpicoxamid 3:1 6:2 X.14 Florylpicoxamid 30:1 .sup.6:0.2 X.14 Florylpicoxamid .sup.1:3.3 0.6:2.sup. X.14 Florylpicoxamid 3:1 0.6:0.2 X.14 Chlorothalonil 1:1 6:6 X.14 Chlorothalonil 10:1 .sup.6:0.6 X.14 Chlorothalonil 1:10 0.6:6.sup. X.14 Chlorothalonil 1:1 0.6:0.6 X.14 Mancozeb .sup.1:3.3 6:20 X.14 Mancozeb 1:1 6:6 X.14 Mancozeb 1:33.3 0.6:20 X.14 Mancozeb 1:10 0.6:6.sup. X.14 Mandipropamid .sup.1:3.3 6:20 X.14 Mandipropamid 1:1 6:6 X.14 Mandipropamid 1:33.3 0.6:20 X.14 Mandipropamid 1:10 0.6:6.sup. X.14 Oxathiapiprolin .sup.1:3.3 6:20 X.14 Oxathiapiprolin 1:1 6:6 X.14 Oxathiapiprolin 1:33.3 0.6:20 X.14 Oxathiapiprolin 1:10 0.6:6.sup. X.14 Fluazinam 3:1 6:2 X.14 Fluazinam 30:1 .sup.6:0.2 X.14 Fluazinam .sup.1:3.3 0.6:2.sup. X.14 Fluazinam 3:1 0.6:0.2 X.14 Fludioxonil 1:1 6:6 X.14 Fludioxonil 10:1 .sup.6:0.6 X.14 Fludioxonil 1:10 0.6:6.sup. X.14 Fludioxonil 1:1 0.6:0.6 X.14 Cyprodinil 1:1 6:6 X.14 Cyprodinil 10:1 .sup.6:0.6 X.14 Cyprodinil 1:10 0.6:6.sup. X.14 Cyprodinil 1:1 0.6:0.6 X.14 Metalaxyl-M .sup.1:3.3 6:20 X.14 Metalaxyl-M 1:1 6:6 X.14 Metalaxyl-M 1:33.3 0.6:20 X.14 Metalaxyl-M 1:10 0.6:6.sup. X.14 Aminopyrifen 3:1 6:2 X.14 Aminopyrifen 30:1 .sup.6:0.2 X.14 Aminopyrifen .sup.1:3.3 0.6:2.sup. X.14 Aminopyrifen 3:1 0.6:0.2 X.14 Folpet 1:1 6:6 X.14 Folpet 3:1 6:2 X.14 Folpet 1:10 0.6:6.sup. X.14 Folpet .sup.1:3.3 0.6:2.sup. X.14 Ipflufenoquin 3:1 6:2 X.14 Ipflufenoquin 30:1 .sup.6:0.2 X.14 Ipflufenoquin .sup.1:3.3 0.6:2.sup. X.14 Ipflufenoquin 3:1 0.6:0.2 X.14 Quinofumelin 3:1 6:2 X.14 Quinofumelin 30:1 .sup.6:0.2 X.14 Quinofumelin .sup.1:3.3 0.6:2.sup. X.14 Quinofumelin 3:1 0.6:0.2 X.14 Tricyclazole .sup.1:3.3 6:20 X.14 Tricyclazole 1:1 6:6 X.14 Tricyclazole 1:33.3 0.6:20 X.14 Tricyclazole 1:10 0.6:6.sup. X.14 Pyroquilon .sup.1:3.3 6:20 X.14 Pyroquilon 1:1 6:6 X.14 Pyroquilon 1:33.3 0.6:20 X.14 Pyroquilon 1:10 0.6:6.sup. X.14 N-(1-benzyl-1,3-dimethyl-butyl)- 3:1 6:2 8-fluoro-quinoline-3- carboxamide X.14 N-(1-benzyl-1,3-dimethyl-butyl)- 30:1 .sup.6:0.2 8-fluoro-quinoline-3- carboxamide X.14 N-(1-benzyl-1,3-dimethyl-butyl)- .sup.1:3.3 0.6:2.sup. 8-fluoro-quinoline-3- carboxamide X.14 N-(1-benzyl-1,3-dimethyl-butyl)- 3:1 0.6:0.2 8-fluoro-quinoline-3- carboxamide X.14 N-(1-benzyl-3,3,3-trifluoro-1- 3:1 6:2 methyl-propyl)-8-fluoro- quinoline-3-carboxamide X.14 N-(1-benzyl-3,3,3-trifluoro-1- 30:1 .sup.6:0.2 methyl-propyl)-8-fluoro- quinoline-3-carboxamide X.14 N-(1-benzyl-3,3,3-trifluoro-1- .sup.1:3.3 0.6:2.sup. methyl-propyl)-8-fluoro- quinoline-3-carboxamide X.14 N-(1-benzyl-3,3,3-trifluoro-1- 3:1 0.6:0.2 methyl-propyl)-8-fluoro- quinoline-3-carboxamide X.14 1-(6,7-dimethylpyrazolo[1,5- 3:1 6:2 a]pyridin-3-yl)-4,4,5-trifluoro-3,3- dimethyl-isoquinoline X.14 1-(6,7-dimethylpyrazolo[1,5- 30:1 .sup.6:0.2 a]pyridin-3-yl)-4,4,5-trifluoro-3,3- dimethyl-isoquinoline X.14 1-(6,7-dimethylpyrazolo[1,5- .sup.1:3.3 0.6:2.sup. a]pyridin-3-yl)-4,4,5-trifluoro-3,3- dimethyl-isoquinoline X.14 1-(6,7-dimethylpyrazolo[1,5- 3:1 0.6:0.2 a]pyridin-3-yl)-4,4,5-trifluoro-3,3- dimethyl-isoquinoline X.14 4,4-difluoro-3,3-dimethyl-1-(7- 3:1 6:2 methylpyrazolo[1,5-a]pyridin-3- yl)isoquinoline X.14 4,4-difluoro-3,3-dimethyl-1-(7- 30:1 .sup.6:0.2 methylpyrazolo[1,5-a]pyridin-3- yl)isoquinoline X.14 4,4-difluoro-3,3-dimethyl-1-(7- .sup.1:3.3 0.6:2.sup. methylpyrazolo[1,5-a]pyridin-3- yl)isoquinoline X.14 4,4-difluoro-3,3-dimethyl-1-(7- 3:1 0.6:0.2 methylpyrazolo[1,5-a]pyridin-3- yl)isoquinoline X.14 1-(4,5-dimethylbenzimidazol-1- 3:1 6:2 yl)-4,4,5-trifluoro-3,3-dimethyl- isoquinoline X.14 1-(4,5-dimethylbenzimidazol-1- 30:1 .sup.6:0.2 yl)-4,4,5-trifluoro-3,3-dimethyl- isoquinoline X.14 1-(4,5-dimethylbenzimidazol-1- .sup.1:3.3 0.6:2.sup. yl)-4,4,5-trifluoro-3,3-dimethyl- isoquinoline X.14 1-(4,5-dimethylbenzimidazol-1- 3:1 0.6:0.2 yl)-4,4,5-trifluoro-3,3-dimethyl- isoquinoline X.14 1-(4,5-dimethylbenzimidazol-1- 3:1 6:2 yl)-4,4-difluoro-3,3-dimethyl- isoquinoline X.14 1-(4,5-dimethylbenzimidazol-1- 30:1 .sup.6:0.2 yl)-4,4-difluoro-3,3-dimethyl- isoquinoline X.14 1-(4,5-dimethylbenzimidazol-1- .sup.1:3.3 0.6:2.sup. yl)-4,4-difluoro-3,3-dimethyl- isoquinoline X.14 1-(4,5-dimethylbenzimidazol-1- 3:1 0.6:0.2 yl)-4,4-difluoro-3,3-dimethyl- isoquinoline

Example B6: Activity Against Monographaella nivalis syn. Microdochium nivale (Snow Mould, Foot Rot of Cereals)

(80) Conidia of the fungus from cryogenic storage were directly mixed into nutrient broth (PDB potato dextrose broth). A DMSO solution of the test compounds was placed into a microtiter plate (96-well format) and the nutrient broth containing the fungal spores was added to it. The test plates were incubated at 24 C. and the inhibition of growth was determined photometrically after 72 hrs at 620 nm. The following mixture compositions (A:B) at the reported concentration (in ppm) gave at least 80% disease control in this test.

(81) TABLE-US-00027 Component A Ratio Conc. (ppm) (Compound) Component B A:B (A:B) X.05 Azoxystrobin 3:1 6:2 X.05 Azoxystrobin 30:1 .sup.6:0.2 X.05 Azoxystrobin .sup.1:3.3 0.6:2.sup. X.05 Azoxystrobin 3:1 0.6:0.2 X.05 Trifloxystrobin 3:1 6:2 X.05 Trifloxystrobin 30:1 .sup.6:0.2 X.05 Trifloxystrobin .sup.1:3.3 0.6:2.sup. X.05 Trifloxystrobin 3:1 0.6:0.2 X.05 Metyltetraprole 3:1 6:2 X.05 Metyltetraprole 30:1 .sup.6:0.2 X.05 Metyltetraprole .sup.1:3.3 0.6:2.sup. X.05 Metyltetraprole 3:1 0.6:0.2 X.05 Difenoconazole 1:1 6:6 X.05 Difenoconazole 10:1 .sup.6:0.6 X.05 Difenoconazole 1:10 0.6:6.sup. X.05 Difenoconazole 1:1 0.6:0.6 X.05 Hexaconazole 1:1 6:6 X.05 Hexaconazole 10:1 .sup.6:0.6 X.05 Hexaconazole 1:10 0.6:6.sup. X.05 Hexaconazole 1:1 0.6:0.6 X.05 Propiconazole 1:1 6:6 X.05 Propiconazole 10:1 .sup.6:0.6 X.05 Propiconazole 1:10 0.6:6.sup. X.05 Propiconazole 1:1 0.6:0.6 X.05 Prothioconazole 1:1 6:6 X.05 Prothioconazole 10:1 .sup.6:0.6 X.05 Prothioconazole 1:10 0.6:6.sup. X.05 Prothioconazole 1:1 0.6:0.6 X.05 Mefentrifluconazole 1:1 6:6 X.05 Mefentrifluconazole 10:1 .sup.6:0.6 X.05 Mefentrifluconazole 1:10 0.6:6.sup. X.05 Mefentrifluconazole 1:1 0.6:0.6 X.05 Fenpropidin .sup.1:3.3 6:20 X.05 Fenpropidin 3:1 6:2 X.05 Fenpropidin 1:33.3 0.6:20 X.05 Fenpropidin .sup.1:3.3 0.6:2.sup. X.05 Fenpropimorph .sup.1:3.3 6:20 X.05 Fenpropimorph 3:1 6:2 X.05 Fenpropimorph 1:33.3 0.6:20 X.05 Fenpropimorph .sup.1:3.3 0.6:2.sup. X.05 Fluxapyroxad 3:1 6:2 X.05 Fluxapyroxad 30:1 .sup.6:0.2 X.05 Fluxapyroxad .sup.1:3.3 0.6:2.sup. X.05 Fluxapyroxad 3:1 0.6:0.2 X.05 Fluopyram 3:1 6:2 X.05 Fluopyram 30:1 .sup.6:0.2 X.05 Fluopyram .sup.1:3.3 0.6:2.sup. X.05 Fluopyram 3:1 0.6:0.2 X.05 Isopyrazam 3:1 6:2 X.05 Isopyrazam 30:1 .sup.6:0.2 X.05 Isopyrazam .sup.1:3.3 0.6:2.sup. X.05 Isopyrazam 3:1 0.6:0.2 X.05 Sedaxane 3:1 6:2 X.05 Sedaxane 30:1 .sup.6:0.2 X.05 Sedaxane .sup.1:3.3 0.6:2.sup. X.05 Sedaxane 3:1 0.6:0.2 X.05 Benzovindiflupyr 3:1 6:2 X.05 Benzovindiflupyr 30:1 .sup.6:0.2 X.05 Benzovindiflupyr .sup.1:3.3 0.6:2.sup. X.05 Benzovindiflupyr 3:1 0.6:0.2 X.05 Pydiflumetofen 3:1 6:2 X.05 Pydiflumetofen 30:1 .sup.6:0.2 X.05 Pydiflumetofen .sup.1:3.3 0.6:2.sup. X.05 Pydiflumetofen 3:1 0.6:0.2 X.05 Isoflucypram 3:1 6:2 X.05 Isoflucypram 30:1 .sup.6:0.2 X.05 Isoflucypram .sup.1:3.3 0.6:2.sup. X.05 Isoflucypram 3:1 0.6:0.2 X.05 Isofetamid 3:1 6:2 X.05 Isofetamid 30:1 .sup.6:0.2 X.05 Isofetamid .sup.1:3.3 0.6:2.sup. X.05 Isofetamid 3:1 0.6:0.2 X.05 Pyrapropoyne 3:1 6:2 X.05 Pyrapropoyne 30:1 .sup.6:0.2 X.05 Pyrapropoyne .sup.1:3.3 0.6:2.sup. X.05 Pyrapropoyne 3:1 0.6:0.2 X.05 Fluindapyr 3:1 6:2 X.05 Fluindapyr 30:1 .sup.6:0.2 X.05 Fluindapyr .sup.1:3.3 0.6:2.sup. X.05 Fluindapyr 3:1 0.6:0.2 X.05 Fenpicoxamid 1:1 6:6 X.05 Fenpicoxamid 10:1 .sup.6:0.6 X.05 Fenpicoxamid 1:10 0.6:6.sup. X.05 Fenpicoxamid 1:1 0.6:0.6 X.05 Florylpicoxamid 3:1 6:2 X.05 Florylpicoxamid 30:1 .sup.6:0.2 X.05 Florylpicoxamid .sup.1:3.3 0.6:2.sup. X.05 Florylpicoxamid 3:1 0.6:0.2 X.05 Chlorothalonil 1:1 6:6 X.05 Chlorothalonil 10:1 .sup.6:0.6 X.05 Chlorothalonil 1:10 0.6:6.sup. X.05 Chlorothalonil 1:1 0.6:0.6 X.05 Mancozeb .sup.1:3.3 6:20 X.05 Mancozeb 1:1 6:6 X.05 Mancozeb 1:33.3 0.6:20 X.05 Mancozeb 1:10 0.6:6.sup. X.05 Mandipropamid .sup.1:3.3 6:20 X.05 Mandipropamid 1:1 6:6 X.05 Mandipropamid 1:33.3 0.6:20 X.05 Mandipropamid 1:10 0.6:6.sup. X.05 Oxathiapiprolin .sup.1:3.3 6:20 X.05 Oxathiapiprolin 1:1 6:6 X.05 Oxathiapiprolin 1:33.3 0.6:20 X.05 Oxathiapiprolin 1:10 0.6:6.sup. X.05 Fluazinam 3:1 6:2 X.05 Fluazinam 30:1 .sup.6:0.2 X.05 Fluazinam .sup.1:3.3 0.6:2.sup. X.05 Fluazinam 3:1 0.6:0.2 X.05 Fludioxonil 1:1 6:6 X.05 Fludioxonil 10:1 .sup.6:0.6 X.05 Fludioxonil 1:10 0.6:6.sup. X.05 Fludioxonil 1:1 0.6:0.6 X.05 Cyprodinil 1:1 6:6 X.05 Cyprodinil 10:1 .sup.6:0.6 X.05 Cyprodinil 1:10 0.6:6.sup. X.05 Cyprodinil 1:1 0.6:0.6 X.05 Metalaxyl-M .sup.1:3.3 6:20 X.05 Metalaxyl-M 1:1 6:6 X.05 Metalaxyl-M 1:33.3 0.6:20 X.05 Metalaxyl-M 1:10 0.6:6.sup. X.05 Aminopyrifen 3:1 6:2 X.05 Aminopyrifen 30:1 .sup.6:0.2 X.05 Aminopyrifen .sup.1:3.3 0.6:2.sup. X.05 Aminopyrifen 3:1 0.6:0.2 X.05 Folpet 1:1 6:6 X.05 Folpet 3:1 6:2 X.05 Folpet 1:10 0.6:6.sup. X.05 Folpet .sup.1:3.3 0.6:2.sup. X.05 Ipflufenoquin 3:1 6:2 X.05 Ipflufenoquin 30:1 .sup.6:0.2 X.05 Ipflufenoquin .sup.1:3.3 0.6:2.sup. X.05 Ipflufenoquin 3:1 0.6:0.2 X.05 Quinofumelin 3:1 6:2 X.05 Quinofumelin 30:1 .sup.6:0.2 X.05 Quinofumelin .sup.1:3.3 0.6:2.sup. X.05 Quinofumelin 3:1 0.6:0.2 X.05 Tricyclazole .sup.1:3.3 6:20 X.05 Tricyclazole 1:1 6:6 X.05 Tricyclazole 1:33.3 0.6:20 X.05 Tricyclazole 1:10 0.6:6.sup. X.05 Pyroquilon .sup.1:3.3 6:20 X.05 Pyroquilon 1:1 6:6 X.05 Pyroquilon 1:33.3 0.6:20 X.05 Pyroquilon 1:10 0.6:6.sup. X.05 N-(1-benzyl-1,3-dimethyl-butyl)- 3:1 6:2 8-fluoro-quinoline-3- carboxamide X.05 N-(1-benzyl-1,3-dimethyl-butyl)- 30:1 .sup.6:0.2 8-fluoro-quinoline-3- carboxamide X.05 N-(1-benzyl-1,3-dimethyl-butyl)- .sup.1:3.3 0.6:2.sup. 8-fluoro-quinoline-3- carboxamide X.05 N-(1-benzyl-1,3-dimethyl-butyl)- 3:1 0.6:0.2 8-fluoro-quinoline-3- carboxamide X.05 N-(1-benzyl-3,3,3-trifluoro-1- 3:1 6:2 methyl-propyl)-8-fluoro- quinoline-3-carboxamide X.05 N-(1-benzyl-3,3,3-trifluoro-1- 30:1 .sup.6:0.2 methyl-propyl)-8-fluoro- quinoline-3-carboxamide X.05 N-(1-benzyl-3,3,3-trifluoro-1- .sup.1:3.3 0.6:2.sup. methyl-propyl)-8-fluoro- quinoline-3-carboxamide X.05 N-(1-benzyl-3,3,3-trifluoro-1- 3:1 0.6:0.2 methyl-propyl)-8-fluoro- quinoline-3-carboxamide X.05 1-(6,7-dimethylpyrazolo[1,5- 3:1 6:2 a]pyridin-3-yl)-4,4,5-trifluoro-3,3- dimethyl-isoquinoline X.05 1-(6,7-dimethylpyrazolo[1,5- 30:1 .sup.6:0.2 a]pyridin-3-yl)-4,4,5-trifluoro-3,3- dimethyl-isoquinoline X.05 1-(6,7-dimethylpyrazolo[1,5- .sup.1:3.3 0.6:2.sup. a]pyridin-3-yl)-4,4,5-trifluoro-3,3- dimethyl-isoquinoline X.05 1-(6,7-dimethylpyrazolo[1,5- 3:1 0.6:0.2 a]pyridin-3-yl)-4,4,5-trifluoro-3,3- dimethyl-isoquinoline X.05 4,4-difluoro-3,3-dimethyl-1-(7- 3:1 6:2 methylpyrazolo[1,5-a]pyridin-3- yl)isoquinoline X.05 4,4-difluoro-3,3-dimethyl-1-(7- 30:1 .sup.6:0.2 methylpyrazolo[1,5-a]pyridin-3- yl)isoquinoline X.05 4,4-difluoro-3,3-dimethyl-1-(7- .sup.1:3.3 0.6:2.sup. methylpyrazolo[1,5-a]pyridin-3- yl)isoquinoline X.05 4,4-difluoro-3,3-dimethyl-1-(7- 3:1 0.6:0.2 methylpyrazolo[1,5-a]pyridin-3- yl)isoquinoline X.05 1-(4,5-dimethylbenzimidazol-1- 3:1 6:2 yl)-4,4,5-trifluoro-3,3-dimethyl- isoquinoline X.05 1-(4,5-dimethylbenzimidazol-1- 30:1 .sup.6:0.2 yl)-4,4,5-trifluoro-3,3-dimethyl- isoquinoline X.05 1-(4,5-dimethylbenzimidazol-1- .sup.1:3.3 0.6:2.sup. yl)-4,4,5-trifluoro-3,3-dimethyl- isoquinoline X.05 1-(4,5-dimethylbenzimidazol-1- 3:1 0.6:0.2 yl)-4,4,5-trifluoro-3,3-dimethyl- isoquinoline X.05 1-(4,5-dimethylbenzimidazol-1- 3:1 6:2 yl)-4,4-difluoro-3,3-dimethyl- isoquinoline X.05 1-(4,5-dimethylbenzimidazol-1- 30:1 .sup.6:0.2 yl)-4,4-difluoro-3,3-dimethyl- isoquinoline X.05 1-(4,5-dimethylbenzimidazol-1- .sup.1:3.3 0.6:2.sup. yl)-4,4-difluoro-3,3-dimethyl- isoquinoline X.05 1-(4,5-dimethylbenzimidazol-1- 3:1 0.6:0.2 yl)-4,4-difluoro-3,3-dimethyl- isoquinoline

(82) TABLE-US-00028 Component A Ratio Conc. (ppm) (Compound) Component B A:B (A:B) X.07 Azoxystrobin 3:1 6:2 X.07 Azoxystrobin 30:1 .sup.6:0.2 X.07 Azoxystrobin .sup.1:3.3 0.6:2.sup. X.07 Azoxystrobin 3:1 0.6:0.2 X.07 Trifloxystrobin 3:1 6:2 X.07 Trifloxystrobin 30:1 .sup.6:0.2 X.07 Trifloxystrobin .sup.1:3.3 0.6:2.sup. X.07 Trifloxystrobin 3:1 0.6:0.2 X.07 Metyltetraprole 3:1 6:2 X.07 Metyltetraprole 30:1 .sup.6:0.2 X.07 Metyltetraprole .sup.1:3.3 0.6:2.sup. X.07 Metyltetraprole 3:1 0.6:0.2 X.07 Difenoconazole 1:1 6:6 X.07 Difenoconazole 10:1 .sup.6:0.6 X.07 Difenoconazole 1:10 0.6:6.sup. X.07 Difenoconazole 1:1 0.6:0.6 X.07 Hexaconazole 1:1 6:6 X.07 Hexaconazole 10:1 .sup.6:0.6 X.07 Hexaconazole 1:10 0.6:6.sup. X.07 Hexaconazole 1:1 0.6:0.6 X.07 Propiconazole 1:1 6:6 X.07 Propiconazole 10:1 .sup.6:0.6 X.07 Propiconazole 1:10 0.6:6.sup. X.07 Propiconazole 1:1 0.6:0.6 X.07 Prothioconazole 1:1 6:6 X.07 Prothioconazole 10:1 .sup.6:0.6 X.07 Prothioconazole 1:10 0.6:6.sup. X.07 Prothioconazole 1:1 0.6:0.6 X.07 Mefentrifluconazole 1:1 6:6 X.07 Mefentrifluconazole 10:1 .sup.6:0.6 X.07 Mefentrifluconazole 1:10 0.6:6.sup. X.07 Mefentrifluconazole 1:1 0.6:0.6 X.07 Fenpropidin .sup.1:3.3 6:20 X.07 Fenpropidin 3:1 6:2 X.07 Fenpropidin 1:33.3 0.6:20 X.07 Fenpropidin .sup.1:3.3 0.6:2.sup. X.07 Fenpropimorph .sup.1:3.3 6:20 X.07 Fenpropimorph 3:1 6:2 X.07 Fenpropimorph 1:33.3 0.6:20 X.07 Fenpropimorph .sup.1:3.3 0.6:2.sup. X.07 Fluxapyroxad 3:1 6:2 X.07 Fluxapyroxad 30:1 .sup.6:0.2 X.07 Fluxapyroxad .sup.1:3.3 0.6:2.sup. X.07 Fluxapyroxad 3:1 0.6:0.2 X.07 Fluopyram 3:1 6:2 X.07 Fluopyram 30:1 .sup.6:0.2 X.07 Fluopyram .sup.1:3.3 0.6:2.sup. X.07 Fluopyram 3:1 0.6:0.2 X.07 Isopyrazam 3:1 6:2 X.07 Isopyrazam 30:1 .sup.6:0.2 X.07 Isopyrazam .sup.1:3.3 0.6:2.sup. X.07 Isopyrazam 3:1 0.6:0.2 X.07 Sedaxane 3:1 6:2 X.07 Sedaxane 30:1 .sup.6:0.2 X.07 Sedaxane .sup.1:3.3 0.6:2.sup. X.07 Sedaxane 3:1 0.6:0.2 X.07 Benzovindiflupyr 3:1 6:2 X.07 Benzovindiflupyr 30:1 .sup.6:0.2 X.07 Benzovindiflupyr .sup.1:3.3 0.6:2.sup. X.07 Benzovindiflupyr 3:1 0.6:0.2 X.07 Pydiflumetofen 3:1 6:2 X.07 Pydiflumetofen 30:1 .sup.6:0.2 X.07 Pydiflumetofen .sup.1:3.3 0.6:2.sup. X.07 Pydiflumetofen 3:1 0.6:0.2 X.07 Isoflucypram 3:1 6:2 X.07 Isoflucypram 30:1 .sup.6:0.2 X.07 Isoflucypram .sup.1:3.3 0.6:2.sup. X.07 Isoflucypram 3:1 0.6:0.2 X.07 Isofetamid 3:1 6:2 X.07 Isofetamid 30:1 .sup.6:0.2 X.07 Isofetamid .sup.1:3.3 0.6:2.sup. X.07 Isofetamid 3:1 0.6:0.2 X.07 Pyrapropoyne 3:1 6:2 X.07 Pyrapropoyne 30:1 .sup.6:0.2 X.07 Pyrapropoyne .sup.1:3.3 0.6:2.sup. X.07 Pyrapropoyne 3:1 0.6:0.2 X.07 Fluindapyr 3:1 6:2 X.07 Fluindapyr 30:1 .sup.6:0.2 X.07 Fluindapyr .sup.1:3.3 0.6:2.sup. X.07 Fluindapyr 3:1 0.6:0.2 X.07 Fenpicoxamid 1:1 6:6 X.07 Fenpicoxamid 10:1 .sup.6:0.6 X.07 Fenpicoxamid 1:10 0.6:6.sup. X.07 Fenpicoxamid 1:1 0.6:0.6 X.07 Florylpicoxamid 3:1 6:2 X.07 Florylpicoxamid 30:1 .sup.6:0.2 X.07 Florylpicoxamid .sup.1:3.3 0.6:2.sup. X.07 Florylpicoxamid 3:1 0.6:0.2 X.07 Chlorothalonil 1:1 6:6 X.07 Chlorothalonil 10:1 .sup.6:0.6 X.07 Chlorothalonil 1:10 0.6:6.sup. X.07 Chlorothalonil 1:1 0.6:0.6 X.07 Mancozeb .sup.1:3.3 6:20 X.07 Mancozeb 1:1 6:6 X.07 Mancozeb 1:33.3 0.6:20 X.07 Mancozeb 1:10 0.6:6.sup. X.07 Mandipropamid .sup.1:3.3 6:20 X.07 Mandipropamid 1:1 6:6 X.07 Mandipropamid 1:33.3 0.6:20 X.07 Mandipropamid 1:10 0.6:6.sup. X.07 Oxathiapiprolin .sup.1:3.3 6:20 X.07 Oxathiapiprolin 1:1 6:6 X.07 Oxathiapiprolin 1:33.3 0.6:20 X.07 Oxathiapiprolin 1:10 0.6:6.sup. X.07 Fluazinam 3:1 6:2 X.07 Fluazinam 30:1 .sup.6:0.2 X.07 Fluazinam .sup.1:3.3 0.6:2.sup. X.07 Fluazinam 3:1 0.6:0.2 X.07 Fludioxonil 1:1 6:6 X.07 Fludioxonil 10:1 .sup.6:0.6 X.07 Fludioxonil 1:10 0.6:6.sup. X.07 Fludioxonil 1:1 0.6:0.6 X.07 Cyprodinil 1:1 6:6 X.07 Cyprodinil 10:1 .sup.6:0.6 X.07 Cyprodinil 1:10 0.6:6.sup. X.07 Cyprodinil 1:1 0.6:0.6 X.07 Metalaxyl-M .sup.1:3.3 6:20 X.07 Metalaxyl-M 1:1 6:6 X.07 Metalaxyl-M 1:33.3 0.6:20 X.07 Metalaxyl-M 1:10 0.6:6.sup. X.07 Aminopyrifen 3:1 6:2 X.07 Aminopyrifen 30:1 .sup.6:0.2 X.07 Aminopyrifen .sup.1:3.3 0.6:2.sup. X.07 Aminopyrifen 3:1 0.6:0.2 X.07 Folpet 1:1 6:6 X.07 Folpet 3:1 6:2 X.07 Folpet 1:10 0.6:6.sup. X.07 Folpet .sup.1:3.3 0.6:2.sup. X.07 Ipflufenoquin 3:1 6:2 X.07 Ipflufenoquin 30:1 .sup.6:0.2 X.07 Ipflufenoquin .sup.1:3.3 0.6:2.sup. X.07 Ipflufenoquin 3:1 0.6:0.2 X.07 Quinofumelin 3:1 6:2 X.07 Quinofumelin 30:1 .sup.6:0.2 X.07 Quinofumelin .sup.1:3.3 0.6:2.sup. X.07 Quinofumelin 3:1 0.6:0.2 X.07 Tricyclazole .sup.1:3.3 6:20 X.07 Tricyclazole 1:1 6:6 X.07 Tricyclazole 1:33.3 0.6:20 X.07 Tricyclazole 1:10 0.6:6.sup. X.07 Pyroquilon .sup.1:3.3 6:20 X.07 Pyroquilon 1:1 6:6 X.07 Pyroquilon 1:33.3 0.6:20 X.07 Pyroquilon 1:10 0.6:6.sup. X.07 N-(1-benzyl-1,3-dimethyl-butyl)- 3:1 6:2 8-fluoro-quinoline-3- carboxamide X.07 N-(1-benzyl-1,3-dimethyl-butyl)- 30:1 .sup.6:0.2 8-fluoro-quinoline-3- carboxamide X.07 N-(1-benzyl-1,3-dimethyl-butyl)- .sup.1:3.3 0.6:2.sup. 8-fluoro-quinoline-3- carboxamide X.07 N-(1-benzyl-1,3-dimethyl-butyl)- 3:1 0.6:0.2 8-fluoro-quinoline-3- carboxamide X.07 N-(1-benzyl-3,3,3-trifluoro-1- 3:1 6:2 methyl-propyl)-8-fluoro- quinoline-3-carboxamide X.07 N-(1-benzyl-3,3,3-trifluoro-1- 30:1 .sup.6:0.2 methyl-propyl)-8-fluoro- quinoline-3-carboxamide X.07 N-(1-benzyl-3,3,3-trifluoro-1- .sup.1:3.3 0.6:2.sup. methyl-propyl)-8-fluoro- quinoline-3-carboxamide X.07 N-(1-benzyl-3,3,3-trifluoro-1- 3:1 0.6:0.2 methyl-propyl)-8-fluoro- quinoline-3-carboxamide X.07 1-(6,7-dimethylpyrazolo[1,5- 3:1 6:2 a]pyridin-3-yl)-4,4,5-trifluoro-3,3- dimethyl-isoquinoline X.07 1-(6,7-dimethylpyrazolo[1,5- 30:1 .sup.6:0.2 a]pyridin-3-yl)-4,4,5-trifluoro-3,3- dimethyl-isoquinoline X.07 1-(6,7-dimethylpyrazolo[1,5- .sup.1:3.3 0.6:2.sup. a]pyridin-3-yl)-4,4,5-trifluoro-3,3- dimethyl-isoquinoline X.07 1-(6,7-dimethylpyrazolo[1,5- 3:1 0.6:0.2 a]pyridin-3-yl)-4,4,5-trifluoro-3,3- dimethyl-isoquinoline X.07 4,4-difluoro-3,3-dimethyl-1-(7- 3:1 6:2 methylpyrazolo[1,5-a]pyridin-3- yl)isoquinoline X.07 4,4-difluoro-3,3-dimethyl-1-(7- 30:1 .sup.6:0.2 methylpyrazolo[1,5-a]pyridin-3- yl)isoquinoline X.07 4,4-difluoro-3,3-dimethyl-1-(7- .sup.1:3.3 0.6:2.sup. methylpyrazolo[1,5-a]pyridin-3- yl)isoquinoline X.07 4,4-difluoro-3,3-dimethyl-1-(7- 3:1 0.6:0.2 methylpyrazolo[1,5-a]pyridin-3- yl)isoquinoline X.07 1-(4,5-dimethylbenzimidazol-1- 3:1 6:2 yl)-4,4,5-trifluoro-3,3-dimethyl- isoquinoline X.07 1-(4,5-dimethylbenzimidazol-1- 30:1 .sup.6:0.2 yl)-4,4,5-trifluoro-3,3-dimethyl- isoquinoline X.07 1-(4,5-dimethylbenzimidazol-1- .sup.1:3.3 0.6:2.sup. yl)-4,4,5-trifluoro-3,3-dimethyl- isoquinoline X.07 1-(4,5-dimethylbenzimidazol-1- 3:1 0.6:0.2 yl)-4,4,5-trifluoro-3,3-dimethyl- isoquinoline X.07 1-(4,5-dimethylbenzimidazol-1- 3:1 6:2 yl)-4,4-difluoro-3,3-dimethyl- isoquinoline X.07 1-(4,5-dimethylbenzimidazol-1- 30:1 .sup.6:0.2 yl)-4,4-difluoro-3,3-dimethyl- isoquinoline X.07 1-(4,5-dimethylbenzimidazol-1- .sup.1:3.3 0.6:2.sup. yl)-4,4-difluoro-3,3-dimethyl- isoquinoline X.07 1-(4,5-dimethylbenzimidazol-1- 3:1 0.6:0.2 yl)-4,4-difluoro-3,3-dimethyl- isoquinoline

(83) TABLE-US-00029 Component A Ratio Conc. (ppm) (Compound) Component B A:B (A:B) X.14 Azoxystrobin 3:1 6:2 X.14 Azoxystrobin 30:1 .sup.6:0.2 X.14 Azoxystrobin .sup.1:3.3 0.6:2.sup. X.14 Azoxystrobin 3:1 0.6:0.2 X.14 Trifloxystrobin 3:1 6:2 X.14 Trifloxystrobin 30:1 .sup.6:0.2 X.14 Trifloxystrobin .sup.1:3.3 0.6:2.sup. X.14 Trifloxystrobin 3:1 0.6:0.2 X.14 Metyltetraprole 3:1 6:2 X.14 Metyltetraprole 30:1 .sup.6:0.2 X.14 Metyltetraprole .sup.1:3.3 0.6:2.sup. X.14 Metyltetraprole 3:1 0.6:0.2 X.14 Difenoconazole 1:1 6:6 X.14 Difenoconazole 10:1 .sup.6:0.6 X.14 Difenoconazole 1:10 0.6:6.sup. X.14 Difenoconazole 1:1 0.6:0.6 X.14 Hexaconazole 1:1 6:6 X.14 Hexaconazole 10:1 .sup.6:0.6 X.14 Hexaconazole 1:10 0.6:6.sup. X.14 Hexaconazole 1:1 0.6:0.6 X.14 Propiconazole 1:1 6:6 X.14 Propiconazole 10:1 .sup.6:0.6 X.14 Propiconazole 1:10 0.6:6.sup. X.14 Propiconazole 1:1 0.6:0.6 X.14 Prothioconazole 1:1 6:6 X.14 Prothioconazole 10:1 .sup.6:0.6 X.14 Prothioconazole 1:10 0.6:6.sup. X.14 Prothioconazole 1:1 0.6:0.6 X.14 Mefentrifluconazole 1:1 6:6 X.14 Mefentrifluconazole 10:1 .sup.6:0.6 X.14 Mefentrifluconazole 1:10 0.6:6.sup. X.14 Mefentrifluconazole 1:1 0.6:0.6 X.14 Fenpropidin .sup.1:3.3 6:20 X.14 Fenpropidin 3:1 6:2 X.14 Fenpropidin 1:33.3 0.6:20 X.14 Fenpropidin .sup.1:3.3 0.6:2.sup. X.14 Fenpropimorph .sup.1:3.3 6:20 X.14 Fenpropimorph 3:1 6:2 X.14 Fenpropimorph 1:33.3 0.6:20 X.14 Fenpropimorph .sup.1:3.3 0.6:2.sup. X.14 Fluxapyroxad 3:1 6:2 X.14 Fluxapyroxad 30:1 .sup.6:0.2 X.14 Fluxapyroxad .sup.1:3.3 0.6:2.sup. X.14 Fluxapyroxad 3:1 0.6:0.2 X.14 Fluopyram 3:1 6:2 X.14 Fluopyram 30:1 .sup.6:0.2 X.14 Fluopyram .sup.1:3.3 0.6:2.sup. X.14 Fluopyram 3:1 0.6:0.2 X.14 Isopyrazam 3:1 6:2 X.14 Isopyrazam 30:1 .sup.6:0.2 X.14 Isopyrazam .sup.1:3.3 0.6:2.sup. X.14 Isopyrazam 3:1 0.6:0.2 X.14 Sedaxane 3:1 6:2 X.14 Sedaxane 30:1 .sup.6:0.2 X.14 Sedaxane .sup.1:3.3 0.6:2.sup. X.14 Sedaxane 3:1 0.6:0.2 X.14 Benzovindiflupyr 3:1 6:2 X.14 Benzovindiflupyr 30:1 .sup.6:0.2 X.14 Benzovindiflupyr .sup.1:3.3 0.6:2.sup. X.14 Benzovindiflupyr 3:1 0.6:0.2 X.14 Pydiflumetofen 3:1 6:2 X.14 Pydiflumetofen 30:1 .sup.6:0.2 X.14 Pydiflumetofen .sup.1:3.3 0.6:2.sup. X 14 Pydiflumetofen 3:1 0.6:0.2 X.14 Isoflucypram 3:1 6:2 X.14 Isoflucypram 30:1 .sup.6:0.2 X.14 Isoflucypram .sup.1:3.3 0.6:2.sup. X.14 Isoflucypram 3:1 0.6:0.2 X.14 Isofetamid 3:1 6:2 X.14 Isofetamid 30:1 .sup.6:0.2 X.14 Isofetamid .sup.1:3.3 0.6:2.sup. X.14 Isofetamid 3:1 0.6:0.2 X.14 Pyrapropoyne 3:1 6:2 X.14 Pyrapropoyne 30:1 .sup.6:0.2 X.14 Pyrapropoyne .sup.1:3.3 0.6:2.sup. X.14 Pyrapropoyne 3:1 0.6:0.2 X.14 Fluindapyr 3:1 6:2 X.14 Fluindapyr 30:1 .sup.6:0.2 X.14 Fluindapyr .sup.1:3.3 0.6:2.sup. X.14 Fluindapyr 3:1 0.6:0.2 X.14 Fenpicoxamid 1:1 6:6 X.14 Fenpicoxamid 10:1 .sup.6:0.6 X.14 Fenpicoxamid 1:10 0.6:6.sup. X.14 Fenpicoxamid 1:1 0.6:0.6 X.14 Florylpicoxamid 3:1 6:2 X.14 Florylpicoxamid 30:1 .sup.6:0.2 X.14 Florylpicoxamid .sup.1:3.3 0.6:2.sup. X.14 Florylpicoxamid 3:1 0.6:0.2 X.14 Chlorothalonil 1:1 6:6 X.14 Chlorothalonil 10:1 .sup.6:0.6 X.14 Chlorothalonil 1:10 0.6:6.sup. X.14 Chlorothalonil 1:1 0.6:0.6 X.14 Mancozeb .sup.1:3.3 6:20 X.14 Mancozeb 1:1 6:6 X.14 Mancozeb 1:33.3 0.6:20 X.14 Mancozeb 1:10 0.6:6.sup. X.14 Mandipropamid .sup.1:3.3 6:20 X.14 Mandipropamid 1:1 6:6 X.14 Mandipropamid 1:33.3 0.6:20 X.14 Mandipropamid 1:10 0.6:6.sup. X.14 Oxathiapiprolin .sup.1:3.3 6:20 X.14 Oxathiapiprolin 1:1 6:6 X.14 Oxathiapiprolin 1:33.3 0.6:20 X.14 Oxathiapiprolin 1:10 0.6:6.sup. X.14 Fluazinam 3:1 6:2 X.14 Fluazinam 30:1 .sup.6:0.2 X.14 Fluazinam .sup.1:3.3 0.6:2.sup. X.14 Fluazinam 3:1 0.6:0.2 X.14 Fludioxonil 1:1 6:6 X.14 Fludioxonil 10:1 .sup.6:0.6 X.14 Fludioxonil 1:10 0.6:6.sup. X.14 Fludioxonil 1:1 0.6:0.6 X.14 Cyprodinil 1:1 6:6 X.14 Cyprodinil 10:1 .sup.6:0.6 X.14 Cyprodinil 1:10 0.6:6.sup. X.14 Cyprodinil 1:1 0.6:0.6 X.14 Metalaxyl-M .sup.1:3.3 6:20 X.14 Metalaxyl-M 1:1 6:6 X.14 Metalaxyl-M 1:33.3 0.6:20 X.14 Metalaxyl-M 1:10 0.6:6.sup. X.14 Aminopyrifen 3:1 6:2 X.14 Aminopyrifen 30:1 .sup.6:0.2 X.14 Aminopyrifen .sup.1:3.3 0.6:2.sup. X.14 Aminopyrifen 3:1 0.6:0.2 X.14 Folpet 1:1 6:6 X.14 Folpet 3:1 6:2 X.14 Folpet 1:10 0.6:6.sup. X.14 Folpet .sup.1:3.3 0.6:2.sup. X.14 Ipflufenoquin 3:1 6:2 X.14 Ipflufenoquin 30:1 .sup.6:0.2 X.14 Ipflufenoquin .sup.1:3.3 0.6:2.sup. X.14 Ipflufenoquin 3:1 0.6:0.2 X.14 Quinofumelin 3:1 6:2 X.14 Quinofumelin 30:1 .sup.6:0.2 X.14 Quinofumelin .sup.1:3.3 0.6:2.sup. X.14 Quinofumelin 3:1 0.6:0.2 X.14 Tricyclazole .sup.1:3.3 6:20 X.14 Tricyclazole 1:1 6:6 X.14 Tricyclazole 1:33.3 0.6:20 X.14 Tricyclazole 1:10 0.6:6.sup. X.14 Pyroquilon .sup.1:3.3 6:20 X.14 Pyroquilon 1:1 6:6 X.14 Pyroquilon 1:33.3 0.6:20 X.14 Pyroquilon 1:10 0.6:6.sup. X.14 N-(1-benzyl-1,3-dimethyl-butyl)- 3:1 6:2 8-fluoro-quinoline-3- carboxamide X.14 N-(1-benzyl-1,3-dimethyl-butyl)- 30:1 .sup.6:0.2 8-fluoro-quinoline-3- carboxamide X.14 N-(1-benzyl-1,3-dimethyl-butyl)- .sup.1:3.3 0.6:2.sup. 8-fluoro-quinoline-3- carboxamide X.14 N-(1-benzyl-1,3-dimethyl-butyl)- 3:1 0.6:0.2 8-fluoro-quinoline-3- carboxamide X.14 N-(1-benzyl-3,3,3-trifluoro-1- 3:1 6:2 methyl-propyl)-8-fluoro- quinoline-3-carboxamide X.14 N-(1-benzyl-3,3,3-trifluoro-1- 30:1 .sup.6:0.2 methyl-propyl)-8-fluoro- quinoline-3-carboxamide X.14 N-(1-benzyl-3,3,3-trifluoro-1- .sup.1:3.3 0.6:2.sup. methyl-propyl)-8-fluoro- quinoline-3-carboxamide X.14 N-(1-benzyl-3,3,3-trifluoro-1- 3:1 0.6:0.2 methyl-propyl)-8-fluoro- quinoline-3-carboxamide X.14 1-(6,7-dimethylpyrazolo[1,5- 3:1 6:2 a]pyridin-3-yl)-4,4,5-trifluoro-3,3- dimethyl-isoquinoline X.14 1-(6,7-dimethylpyrazolo[1,5- 30:1 .sup.6:0.2 a]pyridin-3-yl)-4,4,5-trifluoro-3,3- dimethyl-isoquinoline X.14 1-(6,7-dimethylpyrazolo[1,5- .sup.1:3.3 0.6:2.sup. a]pyridin-3-yl)-4,4,5-trifluoro-3,3- dimethyl-isoquinoline X.14 1-(6,7-dimethylpyrazolo[1,5- 3:1 0.6:0.2 a]pyridin-3-yl)-4,4,5-trifluoro-3,3- dimethyl-isoquinoline X.14 4,4-difluoro-3,3-dimethyl-1-(7- 3:1 6:2 methylpyrazolo[1,5-a]pyridin-3- yl)isoquinoline X.14 4,4-difluoro-3,3-dimethyl-1-(7- 30:1 .sup.6:0.2 methylpyrazolo[1,5-a]pyridin-3- yl)isoquinoline X.14 4,4-difluoro-3,3-dimethyl-1-(7- .sup.1:3.3 0.6:2.sup. methylpyrazolo[1,5-a]pyridin-3- yl)isoquinoline X.14 4,4-difluoro-3,3-dimethyl-1-(7- 3:1 0.6:0.2 methylpyrazolo[1,5-a]pyridin-3- yl)isoquinoline X.14 1-(4,5-dimethylbenzimidazol-1- 3:1 6:2 yl)-4,4,5-trifluoro-3,3-dimethyl- isoquinoline X.14 1-(4,5-dimethylbenzimidazol-1- 30:1 .sup.6:0.2 yl)-4,4,5-trifluoro-3,3-dimethyl- isoquinoline X.14 1-(4,5-dimethylbenzimidazol-1- .sup.1:3.3 0.6:2.sup. yl)-4,4,5-trifluoro-3,3-dimethyl- isoquinoline X.14 1-(4,5-dimethylbenzimidazol-1- 3:1 0.6:0.2 yl)-4,4,5-trifluoro-3,3-dimethyl- isoquinoline X.14 1-(4,5-dimethylbenzimidazol-1- 3:1 6:2 yl)-4,4-difluoro-3,3-dimethyl- isoquinoline X.14 1-(4,5-dimethylbenzimidazol-1- 30:1 .sup.6:0.2 yl)-4,4-difluoro-3,3-dimethyl- isoquinoline X.14 1-(4,5-dimethylbenzimidazol-1- .sup.1:3.3 0.6:2.sup. yl)-4,4-difluoro-3,3-dimethyl- isoquinoline X.14 1-(4,5-dimethylbenzimidazol-1- 3:1 0.6:0.2 yl)-4,4-difluoro-3,3-dimethyl- isoquinoline

Example B7: Activity Against Cercospora beticola (Leaf Spot)

(84) Conidia of the fungus from cryogenic storage were directly mixed into nutrient broth (PDB potato dextrose broth). A DMSO is solution of the test compounds was placed into a microtiter plate (96-well format) and the nutrient broth containing the fungal spores was added to it. The test plates were incubated at 24 C. and the inhibition of growth was determined photometrically after 3-4 days at 620 nm. The following mixture compositions (A:B) at the reported concentration (in ppm) gave at least 70% disease control in this test.

(85) TABLE-US-00030 Component A Ratio Conc. (ppm) (Compound) Component B A:B (A:B) X.05 Azoxystrobin 3.3:1 20:6 X.05 Azoxystrobin 33.3:1 20:0.6 X.05 Azoxystrobin .sup.1:3 2:6 X.05 Trifloxystrobin 3.3:1 20:6 X.05 Trifloxystrobin 33.3:1 20:0.6 X.05 Trifloxystrobin .sup.1:3 2:6 X.05 Metyltetraprole 3.3:1 20:6 X.05 Metyltetraprole 33.3:1 20:0.6 X.05 Metyltetraprole .sup.1:3 2:6 X.05 Metyltetraprole 3.3:1 .sup.2:0.6 X.05 Difenoconazole 3.3:1 20:6 X.05 Difenoconazole 33.3:1 20:0.6 X.05 Difenoconazole .sup.1:3 2:6 X.05 Difenoconazole 3.3:1 .sup.2:0.6 X.05 Hexaconazole 3.3:1 20:6 X.05 Hexaconazole 33.3:1 20:0.6 X.05 Hexaconazole .sup.1:3 2:6 X.05 Hexaconazole 3.3:1 .sup.2:0.6 X.05 Propiconazole 3.3:1 20:6 X.05 Propiconazole 33.3:1 20:0.6 X.05 Propiconazole .sup.1:3 2:6 X.05 Propiconazole 3.3:1 .sup.2:0.6 X.05 Prothioconazole 3.3:1 20:6 X.05 Prothioconazole 33.3:1 20:0.6 X.05 Prothioconazole .sup.1:3 2:6 X.05 Prothioconazole 3.3:1 .sup.2:0.6 X.05 Mefentrifluconazole 3.3:1 20:6 X.05 Mefentrifluconazole 33.3:1 20:0.6 X.05 Mefentrifluconazole .sup.1:3 2:6 X.05 Mefentrifluconazole 3.3:1 .sup.2:0.6 X.05 Fenpropidin .sup.1:1 20:20 X.05 Fenpropidin 3.3:1 20:6 X.05 Fenpropidin 1:10 2:20 X.05 Fenpropidin .sup.1:3 2:6 X.05 Fenpropimorph .sup.1:1 20:20 X.05 Fenpropimorph 3.3:1 20:6 X.05 Fenpropimorph 1:10 2:20 X.05 Fenpropimorph .sup.1:3 2:6 X.05 Fluxapyroxad 3.3:1 20:6 X.05 Fluxapyroxad 33.3:1 20:0.6 X.05 Fluxapyroxad .sup.1:3 2:6 X.05 Fluxapyroxad 3.3:1 .sup.2:0.6 X.05 Fluopyram 3.3:1 20:6 X.05 Fluopyram 33.3:1 20:0.6 X.05 Fluopyram .sup.1:3 2:6 X.05 Fluopyram 3.3:1 .sup.2:0.6 X.05 Benzovindiflupyr 3.3:1 20:6 X.05 Benzovindiflupyr 33.3:1 20:0.6 X.05 Benzovindiflupyr .sup.1:3 2:6 X.05 Benzovindiflupyr 3.3:1 .sup.2:0.6 X.05 Pydiflumetofen 3.3:1 20:6 X.05 Pydiflumetofen 33.3:1 20:0.6 X.05 Pydiflumetofen .sup.1:3 2:6 X.05 Pydiflumetofen 3.3:1 .sup.2:0.6 X.05 Isoflucypram 3.3:1 20:6 X.05 Isoflucypram 33.3:1 20:0.6 X.05 Isoflucypram .sup.1:3 2:6 X.05 Isoflucypram 3.3:1 .sup.2:0.6 X.05 Fluindapyr 3.3:1 20:6 X.05 Florylpicoxamid 3.3:1 20:6 X.05 Florylpicoxamid 33.3:1 20:0.6 X.05 Florylpicoxamid .sup.1:3 2:6 X.05 Florylpicoxamid 3.3:1 .sup.2:0.6 X.05 Metarylpicoxamid 3.3:1 20:6 X.05 Metarylpicoxamid 33.3:1 20:0.6 X.05 Metarylpicoxamid .sup.1:3 2:6 X.05 Metarylpicoxamid 3.3:1 .sup.2:0.6 X.05 Chlorothalonil 3.3:1 20:6 X.05 Chlorothalonil 33.3:1 20:0.6 X.05 Chlorothalonil .sup.1:3 2:6 X.05 Chlorothalonil 3.3:1 .sup.2:0.6 X.05 Mancozeb .sup.1:1 20:20 X.05 Mancozeb 3.3:1 20:6 X.05 Oxathiapiprolin .sup.1:1 20:20 X.05 Fluazinam 3.3:1 20:6 X.05 Fluazinam 33.3:1 20:0.6 X.05 Fluazinam .sup.1:3 2:6 X.05 Fluazinam 3.3:1 .sup.2:0.6 X.05 Fludioxonil 3.3:1 20:6 X.05 Fludioxonil 33.3:1 20:0.6 X.05 Fludioxonil .sup.1:3 2:6 X.05 Fludioxonil 3.3:1 .sup.2:0.6 X.05 Cyprodinil 3.3:1 20:6 X.05 Cyprodinil 33.3:1 20:0.6 X.05 Cyprodinil .sup.1:3 2:6 X.05 Cyprodinil 3.3:1 .sup.2:0.6 X.05 Folpet 3.3:1 20:6 X.05 Folpet 10:1 20:2 X.05 Folpet .sup.1:3 2:6 X.05 Folpet .sup.1:1 2:2 X.05 Aminopyrifen 3.3:1 20:6 X.05 Aminopyrifen 33.3:1 20:0.6 X.05 Aminopyrifen .sup.1:3 2:6 X.05 Aminopyrifen 3.3:1 .sup.2:0.6 X.05 N-(1-benzyl-1,3-dimethyl-butyl)- 3.3:1 20:6 8-fluoro-quinoline-3- carboxamide X.05 N-(1-benzyl-1,3-dimethyl-butyl)- .sup.1:3 2:6 8-fluoro-quinoline-3- carboxamide X.05 N-(1-benzyl-3,3,3-trifluoro-1- 3.3:1 20:6 methyl-propyl)-8-fluoro- quinoline-3-carboxamide X.05 N-(1-benzyl-3,3,3-trifluoro-1- 33.3:1 20:0.6 methyl-propyl)-8-fluoro- quinoline-3-carboxamide X.05 1-(6,7-dimethylpyrazolo[1,5- 3.3:1 20:6 a]pyridin-3-yl)-4,4,5-trifluoro-3,3- dimethyl-isoquinoline X.05 1-(6,7-dimethylpyrazolo[1,5- 33.3:1 20:0.6 a]pyridin-3-yl)-4,4,5-trifluoro-3,3- dimethyl-isoquinoline X.05 1-(6,7-dimethylpyrazolo[1,5- .sup.1:3 2:6 a]pyridin-3-yl)-4,4,5-trifluoro-3,3- dimethyl-isoquinoline X.05 1-(6,7-dimethylpyrazolo[1,5- 3.3:1 .sup.2:0.6 a]pyridin-3-yl)-4,4,5-trifluoro-3,3- dimethyl-isoquinoline X.05 4,4-difluoro-3,3-dimethyl-1-(7- 3.3:1 20:6 methylpyrazolo[1,5-a]pyridin-3- yl)isoquinoline X.05 4,4-difluoro-3,3-dimethyl-1-(7- 33.3:1 20:0.6 methylpyrazolo[1,5-a]pyridin-3- yl)isoquinoline X.05 4,4-difluoro-3,3-dimethyl-1-(7- .sup.1:3 2:6 methylpyrazolo[1,5-a]pyridin-3- yl)isoquinoline X.05 4,4-difluoro-3,3-dimethyl-1-(7- 3.3:1 .sup.2:0.6 methylpyrazolo[1,5-a]pyridin-3- yl)isoquinoline X.05 1-(4,5-dimethylbenzimidazol-1- 3.3:1 20:6 yl)-4,4,5-trifluoro-3,3-dimethyl- isoquinoline X.05 1-(4,5-dimethylbenzimidazol-1- 33.3:1 20:0.6 yl)-4,4,5-trifluoro-3,3-dimethyl- isoquinoline X.05 1-(4,5-dimethylbenzimidazol-1- .sup.1:3 2:6 yl)-4,4,5-trifluoro-3,3-dimethyl- isoquinoline X.05 1-(4,5-dimethylbenzimidazol-1- 3.3:1 20:6 yl)-4,4-difluoro-3,3-dimethyl- isoquinoline X.05 1-(4,5-dimethylbenzimidazol-1- 33.3:1 20:0.6 yl)-4,4-difluoro-3,3-dimethyl- isoquinoline X.05 1-(4,5-dimethylbenzimidazol-1- .sup.1:3 2:6 yl)-4,4-difluoro-3,3-dimethyl- isoquinoline X.05 1-(4,5-dimethylbenzimidazol-1- 3.3:1 .sup.2:0.6 yl)-4,4-difluoro-3,3-dimethyl- isoquinoline X.05 Isopyrazam 3.3:1 20:6 X.05 Isopyrazam 33.3:1 20:0.6 X.05 Isopyrazam .sup.1:3 2:6 X.05 Isopyrazam 3.3:1 .sup.2:0.6 X.05 Sedaxane 3.3:1 20:6 X.05 Sedaxane 33.3:1 20:0.6 X.05 Sedaxane .sup.1:3 2:6 X.05 Sedaxane 3.3:1 .sup.2:0.6 X.05 Isofetamid 3.3:1 20:6 X.05 Isofetamid 33.3:1 20:0.6 X.05 Isofetamid .sup.1:3 2:6 X.05 Isofetamid 3.3:1 .sup.2:0.6 X.05 Ipflufenoquin 3.3:1 20:6 X.05 Ipflufenoquin 33.3:1 20:0.6 X.05 Ipflufenoquin .sup.1:3 2:6 X.05 Ipflufenoquin 3.3:1 .sup.2:0.6 X.05 Quinofumelin 3.3:1 20:6 X.05 Quinofumelin 33.3:1 20:0.6 X.05 Quinofumelin .sup.1:3 2:6 X.05 Quinofumelin 3.3:1 .sup.2:0.6

(86) TABLE-US-00031 Component A Ratio Conc. (ppm) (Compound) Component B A:B (A:B) X.07 Metyltetraprole 3.3:1 20:6 X.07 Metyltetraprole 33.3:1 20:0.6 X.07 Metyltetraprole .sup.1:3 2:6 X.07 Metyltetraprole 3.3:1 .sup.2:0.6 X.07 Difenoconazole 3.3:1 20:6 X.07 Difenoconazole .sup.1:3 2:6 X.07 Hexaconazole 3.3:1 20:6 X.07 Hexaconazole .sup.1:3 2:6 X.07 Propiconazole 3.3:1 20:6 X.07 Propiconazole 33.3:1 20:0.6 X.07 Propiconazole .sup.1:3 2:6 X.07 Propiconazole 3.3:1 .sup.2:0.6 X.07 Prothioconazole 3.3:1 20:6 X.07 Prothioconazole 33.3:1 20:0.6 X.07 Prothioconazole .sup.1:3 2:6 X.07 Prothioconazole 3.3:1 .sup.2:0.6 X.07 Mefentrifluconazole 3.3:1 20:6 X.07 Mefentrifluconazole .sup.1:3 2:6 X.07 Mefentrifluconazole 3.3:1 .sup.2:0.6 X.07 Fenpropidin .sup.1:1 20:20 X.07 Fenpropidin 3.3:1 20:6 X.07 Fenpropidin 1:10 2:20 X.07 Fenpropidin .sup.1:3 2:6 X.07 Fenpropimorph .sup.1:1 20:20 X.07 Fenpropimorph 3.3:1 20:6 X.07 Fenpropimorph 1:10 2:20 X.07 Fenpropimorph .sup.1:3 2:6 X.07 Benzovindiflupyr .sup.1:3 2:6 X.07 Pydiflumetofen 3.3:1 20:6 X.07 Pydiflumetofen 33.3:1 20:0.6 X.07 Pydiflumetofen .sup.1:3 2:6 X.07 Pydiflumetofen 3.3:1 .sup.2:0.6 X.07 Isoflucypram 3.3:1 20:6 X.07 Isoflucypram 33.3:1 20:0.6 X.07 Isoflucypram .sup.1:3 2:6 X.07 Isoflucypram 3.3:1 .sup.2:0.6 X.07 Florylpicoxamid 3.3:1 20:6 X.07 Florylpicoxamid 33.3:1 20:0.6 X.07 Florylpicoxamid .sup.1:3 2:6 X.07 Florylpicoxamid 3.3:1 .sup.2:0.6 X.07 Metarylpicoxamid 3.3:1 20:6 X.07 Metarylpicoxamid 33.3:1 20:0.6 X.07 Metarylpicoxamid .sup.1:3 2:6 X.07 Metarylpicoxamid 3.3:1 .sup.2:0.6 X.07 Chlorothalonil 3.3:1 20:6 X.07 Chlorothalonil .sup.1:3 2:6 X.07 Mancozeb .sup.1:1 20:20 X.07 Mancozeb 3.3:1 20:6 X.07 Mancozeb 1:10 2:20 X.07 Mancozeb .sup.1:3 2:6 X.07 Fluazinam 3.3:1 20:6 X.07 Fluazinam 33.3:1 20:0.6 X.07 Fluazinam .sup.1:3 2:6 X.07 Fluazinam 3.3:1 .sup.2:0.6 X.07 Fludioxonil 3.3:1 20:6 X.07 Fludioxonil 33.3:1 20:0.6 X.07 Fludioxonil .sup.1:3 2:6 X.07 Fludioxonil 3.3:1 .sup.2:0.6 X.07 Cyprodinil 3.3:1 20:6 X.07 Cyprodinil .sup.1:3 2:6 X.07 Folpet 3.3:1 20:6 X.07 Folpet 10:1 20:2 X.07 Folpet .sup.1:3 2:6 X.07 Folpet .sup.1:1 2:2 X.07 Aminopyrifen 3.3:1 20:6 X.07 Aminopyrifen 33.3:1 20:0.6 X.07 Aminopyrifen .sup.1:3 2:6 X.07 Aminopyrifen 3.3:1 .sup.2:0.6 X.07 N-(1-benzyl-1,3-dimethyl-butyl)- 3.3:1 20:6 8-fluoro-quinoline-3- carboxamide X.07 N-(1-benzyl-1,3-dimethyl-butyl)- .sup.1:3 2:6 8-fluoro-quinoline-3- carboxamide X.07 1-(6,7-dimethylpyrazolo[1,5- 3.3:1 20:6 a]pyridin-3-yl)-4,4,5-trifluoro-3,3- dimethyl-isoquinoline X.07 1-(6,7-dimethylpyrazolo[1,5- 33.3:1 20:0.6 a]pyridin-3-yl)-4,4,5-trifluoro-3,3- dimethyl-isoquinoline X.07 1-(6,7-dimethylpyrazolo[1,5- .sup.1:3 2:6 a]pyridin-3-yl)-4,4,5-trifluoro-3,3- dimethyl-isoquinoline X.07 1-(6,7-dimethylpyrazolo[1,5- 3.3:1 .sup.2:0.6 a]pyridin-3-yl)-4,4,5-trifluoro-3,3- dimethyl-isoquinoline X.07 4,4-difluoro-3,3-dimethyl-1-(7- 3.3:1 20:6 methylpyrazolo[1,5-a]pyridin-3- yl)isoquinoline X.07 4,4-difluoro-3,3-dimethyl-1-(7- 33.3:1 20:0.6 methylpyrazolo[1,5-a]pyridin-3- yl)isoquinoline X.07 4,4-difluoro-3,3-dimethyl-1-(7- .sup.1:3 2:6 methylpyrazolo[1,5-a]pyridin-3- y)isoquinoline X.07 1-(4,5-dimethylbenzimidazol-1- 3.3:1 20:6 yl)-4,4,5-trifluoro-3,3-dimethyl- isoquinoline X.07 1-(4,5-dimethylbenzimidazol-1- 33.3:1 20:0.6 yl)-4,4,5-trifluoro-3,3-dimethyl- isoquinoline X.07 1-(4,5-dimethylbenzimidazol-1- .sup.1:3 2:6 yl)-4,4,5-trifluoro-3,3-dimethyl- isoquinoline X.07 1-(4,5-dimethylbenzimidazol-1- 3.3:1 .sup.2:0.6 yl)-4,4,5-trifluoro-3,3-dimethyl- isoquinoline X.07 1-(4,5-dimethylbenzimidazol-1- 3.3:1 20:6 yl)-4,4-difluoro-3,3-dimethyl- isoquinoline X.07 1-(4,5-dimethylbenzimidazol-1- 33.3:1 20:0.6 yl)-4,4-difluoro-3,3-dimethyl- isoquinoline X.07 1-(4,5-dimethylbenzimidazol-1- .sup.1:3 2:6 yl)-4,4-difluoro-3,3-dimethyl- isoquinoline X.07 1-(4,5-dimethylbenzimidazol-1- 3.3:1 .sup.2:0.6 yl)-4,4-difluoro-3,3-dimethyl- isoquinoline X.07 Ipflufenoquin 3.3:1 20:6 X.07 Ipflufenoquin 33.3:1 20:0.6 X.07 Ipflufenoquin .sup.1:3 2:6 X.07 Ipflufenoquin 3.3:1 .sup.2:0.6 X.07 Quinofumelin 3.3:1 20:6 X.07 Quinofumelin .sup.1:3 2:6 X.07 Quinofumelin 3.3:1 .sup.2:0.6

(87) TABLE-US-00032 Component A Ratio Conc. (ppm) (Compound) Component B A:B (A:B) X.14 Azoxystrobin 3.3:1 20:6 X.14 Azoxystrobin 33.3:1 .sup.20:0.6 X.14 Trifloxystrobin 3.3:1 20:6 X.14 Trifloxystrobin 33.3:1 .sup.20:0.6 X.14 Metyltetraprole 3.3:1 20:6 X.14 Metyltetraprole 33.3:1 .sup.20:0.6 X.14 Metyltetraprole .sup.1:3 2:6 X.14 Metyltetraprole 3.3:1 2:0.6 X.14 Difenoconazole 3.3:1 20:6 X.14 Difenoconazole 33.3:1 .sup.20:0.6 X.14 Difenoconazole .sup.1:3 2:6 X.14 Difenoconazole 3.3:1 2:0.6 X.14 Hexaconazole 3.3:1 20:6 X.14 Hexaconazole 33.3:1 .sup.20:0.6 X.14 Hexaconazole .sup.1:3 2:6 X.14 Hexaconazole 3.3:1 2:0.6 X.14 Propiconazole 3.3:1 20:6 X.14 Propiconazole 33.3:1 .sup.20:0.6 X.14 Propiconazole .sup.1:3 2:6 X.14 Propiconazole 3.3:1 2:0.6 X.14 Prothioconazole 3.3:1 20:6 X.14 Prothioconazole 33.3:1 .sup.20:0.6 X.14 Prothioconazole .sup.1:3 2:6 X.14 Prothioconazole 3.3:1 2:0.6 X.14 Mefentrifluconazole 3.3:1 20:6 X.14 Mefentrifluconazole 33.3:1 .sup.20:0.6 X.14 Mefentrifluconazole .sup.1:3 2:6 X.14 Mefentrifluconazole 3.3:1 2:0.6 X.14 Fenpropidin .sup.1:1 20:20 X.14 Fenpropidin 3.3:1 20:6 X.14 Fenpropidin 1:10 2:20 X.14 Fenpropidin .sup.1:3 2:6 X.14 Fenpropimorph .sup.1:1 20:20 X.14 Fenpropimorph 3.3:1 20:6 X.14 Fenpropimorph 1:10 2:20 X.14 Fenpropimorph .sup.1:3 2:6 X.14 Fluxapyroxad 3.3:1 20:6 X.14 Fluxapyroxad 33.3:1 .sup.20:0.6 X.14 Fluxapyroxad .sup.1:3 2:6 X.14 Fluopyram 3.3:1 20:6 X.14 Fluopyram 33.3:1 .sup.20:0.6 X.14 Benzovindiflupyr 3.3:1 20:6 X.14 Benzovindiflupyr 33.3:1 .sup.20:0.6 X.14 Benzovindiflupyr .sup.1:3 2:6 X.14 Pydiflumetofen 3.3:1 20:6 X.14 Pydiflumetofen 33.3:1 .sup.20:0.6 X.14 Pydiflumetofen .sup.1:3 2:6 X.14 Pydiflumetofen 3.3:1 2:0.6 X.14 Isoflucypram 3.3:1 20:6 X.14 Isoflucypram 33.3:1 .sup.20:0.6 X.14 Isoflucypram .sup.1:3 2:6 X.14 Isoflucypram 3.3:1 2:0.6 X.14 Fluindapyr 3.3:1 20:6 X.14 Fluindapyr 33.3:1 .sup.20:0.6 X.14 Florylpicoxamid 3.3:1 20:6 X.14 Florylpicoxamid 33.3:1 .sup.20:0.6 X.14 Florylpicoxamid .sup.1:3 2:6 X.14 Florylpicoxamid 3.3:1 2:0.6 X.14 Metarylpicoxamid 3.3:1 20:6 X.14 Metarylpicoxamid 33.3:1 .sup.20:0.6 X.14 Metarylpicoxamid .sup.1:3 2:6 X.14 Metarylpicoxamid 3.3:1 2:0.6 X.14 Chlorothalonil 3.3:1 20:6 X.14 Chlorothalonil 33.3:1 .sup.20:0.6 X.14 Chlorothalonil .sup.1:3 2:6 X.14 Chlorothalonil 3.3:1 2:0.6 X.14 Mancozeb .sup.1:1 20:20 X.14 Mancozeb 3.3:1 20:6 X.14 Mancozeb 1:10 2:20 X.14 Mancozeb .sup.1:3 2:6 X.14 Fluazinam 3.3:1 20:6 X.14 Fluazinam 33.3:1 .sup.20:0.6 X.14 Fluazinam .sup.1:3 2:6 X.14 Fluazinam 3.3:1 2:0.6 X.14 Fludioxonil 3.3:1 20:6 X.14 Fludioxonil 33.3:1 .sup.20:0.6 X.14 Fludioxonil .sup.1:3 2:6 X.14 Fludioxonil 3.3:1 2:0.6 X.14 Cyprodinil 3.3:1 20:6 X.14 Cyprodinil 33.3:1 .sup.20:0.6 X.14 Cyprodinil .sup.1:3 2:6 X.14 Metalaxyl-M .sup.1:1 20:20 X.14 Folpet 3.3:1 20:6 X.14 Folpet 10:1 20:2 X.14 Folpet .sup.1:3 2:6 X.14 Folpet .sup.1:1 2:2 X.14 Aminopyrifen 3.3:1 20:6 X.14 Aminopyrifen 33.3:1 .sup.20:0.6 X.14 Aminopyrifen .sup.1:3 2:6 X.14 Aminopyrifen 3.3:1 2:0.6 X.14 1-(6,7-dimethylpyrazolo[1,5- 3.3:1 20:6 a]pyridin-3-yl)-4,4,5-trifluoro-3,3- dimethyl-isoquinoline X.14 1-(6,7-dimethylpyrazolo[1,5- 33.3:1 .sup.20:0.6 a]pyridin-3-yl)-4,4,5-trifluoro-3,3- dimethyl-isoquinoline X.14 1-(6,7-dimethylpyrazolo[1,5- .sup.1:3 2:6 a]pyridin-3-yl)-4,4,5-trifluoro-3,3- dimethyl-isoquinoline X.14 1-(6,7-dimethylpyrazolo[1,5- 3.3:1 2:0.6 a]pyridin-3-yl)-4,4,5-trifluoro-3,3- dimethyl-isoquinoline X.14 4,4-difluoro-3,3-dimethyl-1-(7- 3.3:1 20:6 methylpyrazolo[1,5-a]pyridin-3- yl)isoquinoline X.14 4,4-difluoro-3,3-dimethyl-1-(7- .sup.1:3 2:6 methylpyrazolo[1,5-a]pyridin-3- yl)isoquinoline X.14 4,4-difluoro-3,3-dimethyl-1-(7- 3.3:1 2:0.6 methylpyrazolo[1,5-a]pyridin-3- yl)isoquinoline X.14 1-(4,5-dimethylbenzimidazol-1- 3.3:1 20:6 yl)-4,4,5-trifluoro-3,3-dimethyl- isoquinoline X.14 1-(4,5-dimethylbenzimidazol-1- 33.3:1 .sup.20:0.6 yl)-4,4,5-trifluoro-3,3-dimethyl- isoquinoline X.14 1-(4,5-dimethylbenzimidazol-1- .sup.1:3 2:6 yl)-4,4,5-trifluoro-3,3-dimethyl- isoquinoline X.14 1-(4,5-dimethylbenzimidazol-1- 3.3:1 2:0.6 yl)-4,4,5-trifluoro-3,3-dimethyl- isoquinoline X.14 1-(4,5-dimethylbenzimidazol-1- 3.3:1 20:6 yl)-4,4-difluoro-3,3-dimethyl- isoquinoline X.14 1-(4,5-dimethylbenzimidazol-1- 33.3:1 .sup.20:0.6 yl)-4,4-difluoro-3,3-dimethyl- isoquinoline X.14 1-(4,5-dimethylbenzimidazol-1- .sup.1:3 2:6 yl)-4,4-difluoro-3,3-dimethyl- isoquinoline X.14 1-(4,5-dimethylbenzimidazol-1- 3.3:1 2:0.6 yl)-4,4-difluoro-3,3-dimethyl- isoquinoline X.14 Isopyrazam 3.3:1 20:6 X.14 Isopyrazam 33.3:1 .sup.20:0.6 X.14 Isopyrazam .sup.1:3 2:6 X.14 Isopyrazam 3.3.1 2:0.6 X.14 Sedaxane 3.3:1 20:6 X.14 Sedaxane 33.3:1 .sup.20:0.6 X.14 Isofetamid 3.3:1 20:6 X.14 Isofetamid 33.3:1 .sup.20:0.6 X.14 Isofetamid .sup.1:3 2:6 X.14 Ipflufenoquin 3.3:1 20:6 X.14 Ipflufenoquin 33.3:1 .sup.20:0.6 X.14 Ipflufenoquin .sup.1:3 2:6 X.14 Ipflufenoquin 3.3:1 2:0.6 X.14 Quinofumelin 3.3:1 20:6 X.14 Quinofumelin 33.3:1 .sup.20:0.6 X.14 Quinofumelin .sup.1:3 2:6

Example B8: Activity Against Pyrenapehora teres (Net Blotch)

(88) Conidia of the fungus from cryogenic storage were directly mixed into nutrient broth (PDB potato dextrose broth). A DMSO solution of the test compounds was placed into a microtiter plate (96-well format) and the nutrient broth containing the fungal spores was added to it. The test plates were incubated at 24 C. and the inhibition of growth was determined photometrically after 72 hrs at 620 nm. The following mixture compositions (A:B) at the reported concentration (in ppm) gave at least 70% disease control in this test.

(89) TABLE-US-00033 Component A Ratio Conc. (ppm) (Compound) Component B A:B (A:B) X.05 Azoxystrobin 3:1 6:2 X.05 Azoxystrobin 30:1 .sup.6:0.2 X.05 Azoxystrobin .sup.1:3.3 0.6:2.sup. X.05 Azoxystrobin 3:1 0.6:0.2 X.05 Trifloxystrobin 3:1 6:2 X.05 Trifloxystrobin 30:1 .sup.6:0.2 X.05 Trifloxystrobin .sup.1:3.3 0.6:2.sup. X.05 Trifloxystrobin 3:1 0.6:0.2 X.05 Metyltetraprole 3:1 6:2 X.05 Metyltetraprole 30:1 .sup.6:0.2 X.05 Metyltetraprole .sup.1:3.3 0.6:2.sup. X.05 Metyltetraprole 3:1 0.6:0.2 X.05 Difenoconazole 1:1 6:6 X.05 Difenoconazole 10:1 .sup.6:0.6 X.05 Difenoconazole 1:10 0.6:6.sup. X.05 Difenoconazole 1:1 0.6:0.6 X.05 Hexaconazole 1:1 6:6 X.05 Hexaconazole 10:1 .sup.6:0.6 X.05 Hexaconazole 1:10 0.6:6.sup. X.05 Propiconazole 1:1 6:6 X.05 Propiconazole 10:1 .sup.6:0.6 X.05 Propiconazole 1:10 0.6:6.sup. X.05 Prothioconazole 1:1 6:6 X.05 Prothioconazole 10:1 .sup.6:0.6 X.05 Prothioconazole 1:10 0.6:6.sup. X.05 Prothioconazole 1:1 0.6:0.6 X.05 Mefentrifluconazole 1:1 6:6 X.05 Mefentrifluconazole 10:1 .sup.6:0.6 X.05 Fenpropidin .sup.1:3.3 6:20 X.05 Fenpropidin 3:1 6:2 X.05 Fenpropimorph .sup.1:3.3 6:20 X.05 Fenpropimorph 3:1 6:2 X.05 Fluxapyroxad 3:1 6:2 X.05 Fluxapyroxad 30:1 .sup.6:0.2 X.05 Fluopyram 3:1 6:2 X.05 Fluopyram 30:1 .sup.6:0.2 X.05 Fluopyram .sup.1:3.3 0.6:2.sup. X.05 Isopyrazam 3:1 6:2 X.05 Isopyrazam 30:1 .sup.6:0.2 X.05 Isopyrazam .sup.1:3.3 0.6:2.sup. X.05 Sedaxane 3:1 6:2 X.05 Sedaxane 30:1 .sup.6:0.2 X.05 Benzovindiflupyr 3:1 6:2 X.05 Benzovindiflupyr 30:1 .sup.6:0.2 X.05 Benzovindiflupyr .sup.1:3.3 0.6:2.sup. X.05 Pydiflumetofen 3:1 6:2 X.05 Pydiflumetofen 30:1 .sup.6:0.2 X.05 Pydiflumetofen .sup.1:3.3 0.6:2.sup. X.05 Pydiflumetofen 3:1 0.6:0.2 X.05 Isoflucypram 3:1 6:2 X.05 Isoflucypram 30:1 .sup.6:0.2 X.05 Isoflucypram .sup.1:3.3 0.6:2.sup. X.05 Isoflucypram 3:1 0.6:0.2 X.05 Isofetamid 3:1 6:2 X.05 Isofetamid 30:1 .sup.6:0.2 X.05 Pyrapropoyne 3:1 6:2 X.05 Pyrapropoyne 30:1 .sup.6:0.2 X.05 Pyrapropoyne .sup.1:3.3 0.6:2.sup. X.05 Pyrapropoyne 3:1 0.6:0.2 X.05 Fluindapyr 3:1 6:2 X.05 Fluindapyr 30:1 .sup.6:0.2 X.05 Fenpicoxamid 1:1 6:6 X.05 Fenpicoxamid 10:1 .sup.6:0.6 X.05 Fenpicoxamid 1:10 0.6:6.sup. X.05 Florylpicoxamid 3:1 6:2 X.05 Florylpicoxamid 30:1 .sup.6:0.2 X.05 Chlorothalonil 1:1 6:6 X.05 Chlorothalonil 10:1 .sup.6:0.6 X.05 Chlorothalonil 1:10 0.6:6.sup. X.05 Mancozeb 1:1 6:6 X.05 Mandipropamid .sup.1:3.3 6:20 X.05 Mandipropamid 1:1 6:6 X.05 Oxathiapiprolin .sup.1:3.3 6:20 X.05 Oxathiapiprolin 1:1 6:6 X.05 Fluazinam 3:1 6:2 X.05 Fluazinam 30:1 .sup.6:0.2 X.05 Fluazinam .sup.1:3.3 0.6:2.sup. X.05 Fluazinam 3:1 0.6:0.2 X.05 Fludioxonil 1:1 6:6 X.05 Fludioxonil 10:1 .sup.6:0.6 X.05 Fludioxonil 1:10 0.6:6.sup. X.05 Fludioxonil 1:1 0.6:0.6 X.05 Cyprodinil 1:1 6:6 X.05 Cyprodinil 10:1 .sup.6:0.6 X.05 Cyprodinil 1:10 0.6:6.sup. X.05 Cyprodinil 1:1 0.6:0.6 X.05 Metalaxyl-M .sup.1:3.3 6:20 X.05 Metalaxyl-M 1:1 6:6 X.05 Aminopyrifen 3:1 6:2 X.05 Aminopyrifen 30:1 .sup.6:0.2 X.05 Folpet 1:1 6:6 X.05 Folpet 3:1 6:2 X.05 Ipflufenoquin 3:1 6:2 X.05 Ipflufenoquin 30:1 .sup.6:0.2 X.05 Ipflufenoquin .sup.1:3.3 0.6:2.sup. X.05 Ipflufenoquin 3:1 0.6:0.2 X.05 Quinofumelin 3:1 6:2 X.05 Quinofumelin 30:1 .sup.6:0.2 X.05 Quinofumelin .sup.1:3.3 0.6:2.sup. X.05 Quinofumelin 3:1 0.6:0.2 X.05 Tricyclazole .sup.1:3.3 6:20 X.05 Tricyclazole 1:1 6:6 X.05 Pyroquilon .sup.1:3.3 6:20 X.05 Pyroquilon 1:1 6:6 X.05 N-(1-benzyl-1,3-dimethyl-butyl)- 3:1 6:2 8-fluoro-quinoline-3- carboxamide X.05 N-(1-benzyl-1,3-dimethyl-butyl)- 30:1 .sup.6:0.2 8-fluoro-quinoline-3- carboxamide X.05 N-(1-benzyl-1,3-dimethyl-butyl)- .sup.1:3.3 0.6:2.sup. 8-fluoro-quinoline-3- carboxamide X.05 N-(1-benzyl-3,3,3-trifluoro-1- 3:1 6:2 methyl-propyl)-8-fluoro- quinoline-3-carboxamide X.05 N-(1-benzyl-3,3,3-trifluoro-1- 30:1 .sup.6:0.2 methyl-propyl)-8-fluoro- quinoline-3-carboxamide X.05 N-(1-benzyl-3,3,3-trifluoro-1- .sup.1:3.3 0.6:2.sup. methyl-propyl)-8-fluoro- quinoline-3-carboxamide X.05 1-(6,7-dimethylpyrazolo[1,5- 3:1 6:2 a]pyridin-3-yl)-4,4,5-trifluoro-3,3- dimethyl-isoquinoline X.05 1-(6,7-dimethylpyrazolo[1,5- 30:1 .sup.6:0.2 a]pyridin-3-yl)-4,4,5-trifluoro-3,3- dimethyl-isoquinoline X.05 1-(6,7-dimethylpyrazolo[1,5- .sup.1:3.3 0.6:2.sup. a]pyridin-3-yl)-4,4,5-trifluoro-3,3- dimethyl-isoquinoline X.05 1-(6,7-dimethylpyrazolo[1,5- 3:1 0.6:0.2 a]pyridin-3-yl)-4,4,5-trifluoro-3,3- dimethyl-isoquinoline X.05 4,4-difluoro-3,3-dimethyl-1-(7- 3:1 6:2 methylpyrazolo[1,5-a]pyridin-3- yl)isoquinoline X.05 4,4-difluoro-3,3-dimethyl-1-(7- 30:1 .sup.6:0.2 methylpyrazolo[1,5-a]pyridin-3- yl)isoquinoline X.05 4,4-difluoro-3,3-dimethyl-1-(7- .sup.1:3.3 0.6:2.sup. methylpyrazolo[1,5-a]pyridin-3- yl)isoquinoline X.05 4,4-difluoro-3,3-dimethyl-1-(7- 3:1 0.6:0.2 methylpyrazolo[1,5-a]pyridin-3- yl)isoquinoline X.05 1-(4,5-dimethylbenzimidazol-1- 3:1 6:2 yl)-4,4,5-trifluoro-3,3-dimethyl- isoquinoline X.05 1-(4,5-dimethylbenzimidazol-1- 30:1 .sup.6:0.2 yl)-4,4,5-trifluoro-3,3-dimethyl- isoquinoline X.05 1-(4,5-dimethylbenzimidazol-1- .sup.1:3.3 0.6:2.sup. yl)-4,4,5-trifluoro-3,3-dimethyl- isoquinoline X.05 1-(4,5-dimethylbenzimidazol-1- 3:1 0.6:0.2 yl)-4,4,5-trifluoro-3,3-dimethyl- isoquinoline X.05 1-(4,5-dimethylbenzimidazol-1- 3:1 6:2 yl)-4,4-difluoro-3,3-dimethyl- isoquinoline X.05 1-(4,5-dimethylbenzimidazol-1- 30:1 .sup.6:0.2 yl)-4,4-difluoro-3,3-dimethyl- isoquinoline X.05 1-(4,5-dimethylbenzimidazol-1- .sup.1:3.3 0.6:2.sup. yl)-4,4-difluoro-3,3-dimethyl- isoquinoline X.05 1-(4,5-dimethylbenzimidazol-1- 3:1 0.6:0.2 yl)-4,4-difluoro-3,3-dimethyl- isoquinoline

(90) TABLE-US-00034 Component A Ratio Conc. (ppm) (Compound) Component B A:B (A:B) X.07 Azoxystrobin 3:1 6:2 X.07 Azoxystrobin 30:1 .sup.6:0.2 X.07 Azoxystrobin .sup.1:3.3 0.6:2.sup. X.07 Azoxystrobin 3:1 0.6:0.2 X.07 Trifloxystrobin 3:1 6:2 X.07 Trifloxystrobin 30:1 .sup.6:0.2 X.07 Trifloxystrobin .sup.1:3.3 0.6:2.sup. X.07 Trifloxystrobin 3:1 0.6:0.2 X.07 Metyltetraprole 3:1 6:2 X.07 Metyltetraprole 30:1 .sup.6:0.2 X.07 Metyltetraprole .sup.1:3.3 0.6:2.sup. X.07 Metyltetraprole 3:1 0.6:0.2 X.07 Difenoconazole 1:1 6:6 X.07 Difenoconazole 10:1 .sup.6:0.6 X.07 Difenoconazole 1:10 0.6:6.sup. X.07 Difenoconazole 1:1 0.6:0.6 X.07 Hexaconazole 1:1 6:6 X.07 Hexaconazole 10:1 .sup.6:0.6 X.07 Hexaconazole 1:10 0.6:6.sup. X.07 Propiconazole 1:1 6:6 X.07 Propiconazole 10:1 .sup.6:0.6 X.07 Propiconazole 1:10 0.6:6.sup. X.07 Prothioconazole 1:1 6:6 X.07 Prothioconazole 10:1 .sup.6:0.6 X.07 Prothioconazole 1:10 0.6:6.sup. X.07 Prothioconazole 1:1 0.6:0.6 X.07 Mefentrifluconazole 1:1 6:6 X.07 Mefentrifluconazole 10:1 .sup.6:0.6 X.07 Fenpropidin .sup.1:3.3 6:20 X.07 Fenpropidin 3:1 6:2 X.07 Fenpropimorph .sup.1:3.3 6:20 X.07 Fenpropimorph 3:1 6:2 X.07 Fluxapyroxad 3:1 6:2 X.07 Fluxapyroxad 30:1 .sup.6:0.2 X.07 Fluopyram 3:1 6:2 X.07 Fluopyram 30:1 .sup.6:0.2 X.07 Fluopyram .sup.1:3.3 0.6:2.sup. X.07 Isopyrazam 3:1 6:2 X.07 Isopyrazam 30:1 .sup.6:0.2 X.07 Isopyrazam .sup.1:3.3 0.6:2.sup. X.07 Sedaxane 3:1 6:2 X.07 Sedaxane 30:1 .sup.6:0.2 X.07 Benzovindiflupyr 3:1 6:2 X.07 Benzovindiflupyr 30:1 .sup.6:0.2 X.07 Benzovindiflupyr .sup.1:3.3 0.6:2.sup. X.07 Pydiflumetofen 3:1 6:2 X.07 Pydiflumetofen 30:1 .sup.6:0.2 X.07 Pydiflumetofen .sup.1:3.3 0.6:2.sup. X.07 Pydiflumetofen 3:1 0.6:0.2 X.07 Isoflucypram 3:1 6:2 X.07 Isoflucypram 30:1 .sup.6:0.2 X.07 Isoflucypram .sup.1:3.3 0.6:2.sup. X.07 Isoflucypram 3:1 0.6:0.2 X.07 Isofetamid 3:1 6:2 X.07 Isofetamid 30:1 .sup.6:0.2 X.07 Pyrapropoyne 3:1 6:2 X.07 Pyrapropoyne 30:1 .sup.6:0.2 X.07 Pyrapropoyne .sup.1:3.3 0.6:2.sup. X.07 Pyrapropoyne 3:1 0.6:0.2 X.07 Fluindapyr 3:1 6:2 X.07 Fluindapyr 30:1 .sup.6:0.2 X.07 Fenpicoxamid 1:1 6:6 X.07 Fenpicoxamid 10:1 .sup.6:0.6 X.07 Fenpicoxamid 1:10 0.6:6.sup. X.07 Florylpicoxamid 3:1 6:2 X.07 Florylpicoxamid 30:1 .sup.6:0.2 X.07 Chlorothalonil 1:1 6:6 X.07 Chlorothalonil 10:1 .sup.6:0.6 X.07 Mancozeb 1:1 6:6 X.07 Mandipropamid .sup.1:3.3 6:20 X.07 Mandipropamid 1:1 6:6 X.07 Oxathiapiprolin .sup.1:3.3 6:20 X.07 Oxathiapiprolin 1:1 6:6 X.07 Fluazinam 3:1 6:2 X.07 Fluazinam 30:1 .sup.6:0.2 X.07 Fluazinam .sup.1:3.3 0.6:2.sup. X.07 Fluazinam 3:1 0.6:0.2 X.07 Fludioxonil 1:1 6:6 X.07 Fludioxonil 10:1 .sup.6:0.6 X.07 Fludioxonil 1:10 0.6:6.sup. X.07 Cyprodinil 1:1 6:6 X.07 Cyprodinil 10:1 .sup.6:0.6 X.07 Cyprodinil 1:10 0.6:6.sup. X.07 Cyprodinil 1:1 0.6:0.6 X.07 Metalaxyl-M .sup.1:3.3 6:20 X.07 Metalaxyl-M 1:1 6:6 X.07 Aminopyrifen 3:1 6:2 X.07 Aminopyrifen 30:1 .sup.6:0.2 X.07 Folpet 1:1 6:6 X.07 Folpet 3:1 6:2 X.07 Ipflufenoquin 3:1 6:2 X.07 Ipflufenoquin 30:1 .sup.6:0.2 X.07 Ipflufenoquin .sup.1:3.3 0.6:2.sup. X.07 Ipflufenoquin 3:1 0.6:0.2 X.07 Quinofumelin 3:1 6:2 X.07 Quinofumelin 30:1 .sup.6:0.2 X.07 Quinofumelin .sup.1:3.3 0.6:2.sup. X.07 Quinofumelin 3:1 0.6:0.2 X.07 Tricyclazole .sup.1:3.3 6:20 X.07 Tricyclazole 1:1 6:6 X.07 Pyroquilon .sup.1:3.3 6:20 X.07 Pyroquilon 1:1 6:6 X.07 N-(1-benzyl-1,3-dimethyl-butyl)- 3:1 6:2 8-fluoro-quinoline-3- carboxamide X.07 N-(1-benzyl-1,3-dimethyl-butyl)- 30:1 .sup.6:0.2 8-fluoro-quinoline-3- carboxamide X.07 N-(1-benzyl-1,3-dimethyl-butyl)- .sup.1:3.3 0.6:2.sup. 8-fluoro-quinoline-3- carboxamide X.07 N-(1-benzyl-3,3,3-trifluoro-1- 3:1 6:2 methyl-propyl)-8-fluoro- quinoline-3-carboxamide X.07 N-(1-benzyl-3,3,3-trifluoro-1- 30:1 .sup.6:0.2 methyl-propyl)-8-fluoro- quinoline-3-carboxamide X.07 N-(1-benzyl-3,3,3-trifluoro-1- .sup.1:3.3 0.6:2.sup. methyl-propyl)-8-fluoro- quinoline-3-carboxamide X.07 1-(6,7-dimethylpyrazolo[1,5- 3:1 6:2 a]pyridin-3-yl)-4,4,5-trifluoro-3,3- dimethyl-isoquinoline X.07 1-(6,7-dimethylpyrazolo[1,5- 30:1 .sup.6:0.2 a]pyridin-3-yl)-4,4,5-trifluoro-3,3- dimethyl-isoquinoline X.07 1-(6,7-dimethylpyrazolo[1,5- .sup.1:3.3 0.6:2.sup. a]pyridin-3-yl)-4,4,5-trifluoro-3,3- dimethyl-isoquinoline X.07 1-(6,7-dimethylpyrazolo[1,5- 3:1 0.6:0.2 a]pyridin-3-yl)-4,4,5-trifluoro-3,3- dimethyl-isoquinoline X.07 4,4-difluoro-3,3-dimethyl-1-(7- 3:1 6:2 methylpyrazolo[1,5-a]pyridin-3- yl)isoquinoline X.07 4,4-difluoro-3,3-dimethyl-1-(7- 30:1 .sup.6:0.2 methylpyrazolo[1,5-a]pyridin-3- yl)isoquinoline X.07 4,4-difluoro-3,3-dimethyl-1-(7- .sup.1:3.3 0.6:2.sup. methylpyrazolo[1,5-a]pyridin-3- yl)isoquinoline X.07 1-(4,5-dimethylbenzimidazol-1- 3:1 6:2 yl)-4,4,5-trifluoro-3,3-dimethyl- isoquinoline X.07 1-(4,5-dimethylbenzimidazol-1- 30:1 .sup.6:0.2 yl)-4,4,5-trifluoro-3,3-dimethyl- isoquinoline X.07 1-(4,5-dimethylbenzimidazol-1- .sup.1:3.3 0.6:2.sup. yl)-4,4,5-trifluoro-3,3-dimethyl- isoquinoline X.07 1-(4,5-dimethylbenzimidazol-1- 3:1 0.6:0.2 yl)-4,4,5-trifluoro-3,3-dimethyl- isoquinoline X.07 1-(4,5-dimethylbenzimidazol-1- 3:1 6:2 yl)-4,4-difluoro-3,3-dimethyl- isoquinoline X.07 1-(4,5-dimethylbenzimidazol-1- 30:1 .sup.6:0.2 yl)-4,4-difluoro-3,3-dimethyl- isoquinoline X.07 1-(4,5-dimethylbenzimidazol-1- .sup.1:3.3 0.6:2.sup. yl)-4,4-difluoro-3,3-dimethyl- isoquinoline X.07 1-(4,5-dimethylbenzimidazol-1- 3:1 0.6:0.2 yl)-4,4-difluoro-3,3-dimethyl- isoquinoline

(91) TABLE-US-00035 Component A Ratio Conc. (ppm) (Compound) Component B A:B (A:B) X.14 Azoxystrobin 3:1 6:2 X.14 Azoxystrobin 30:1 .sup.6:0.2 X.14 Azoxystrobin .sup.1:3.3 0.6:2.sup. X.14 Azoxystrobin 3:1 0.6:0.2 X.14 Trifloxystrobin 3:1 6:2 X.14 Trifloxystrobin 30:1 .sup.6:0.2 X.14 Trifloxystrobin .sup.1:3.3 0.6:2.sup. X.14 Trifloxystrobin 3:1 0.6:0.2 X.14 Metyltetraprole 3:1 6:2 X.14 Metyltetraprole 30:1 .sup.6:0.2 X.14 Metyltetraprole .sup.1:3.3 0.6:2.sup. X.14 Metyltetraprole 3:1 0.6:0.2 X.14 Difenoconazole 1:1 6:6 X.14 Difenoconazole 10:1 .sup.6:0.6 X.14 Difenoconazole 1:10 0.6:6.sup. X.14 Hexaconazole 1:1 6:6 X.14 Hexaconazole 1:10 0.6:6.sup. X.14 Propiconazole 1:1 6:6 X.14 Propiconazole 1:10 0.6:6.sup. X.14 Prothioconazole 1:1 6:6 X.14 Prothioconazole 10:1 .sup.6:0.6 X.14 Prothioconazole 1:10 0.6:6.sup. X.14 Prothioconazole 1:1 0.6:0.6 X.14 Fluopyram 3:1 6:2 X.14 Isopyrazam 3:1 6:2 X.14 Isopyrazam .sup.1:3.3 0.6:2.sup. X.14 Benzovindiflupyr 3:1 6:2 X.14 Benzovindiflupyr .sup.1:3.3 0.6:2.sup. X.14 Pydiflumetofen 3:1 6:2 X.14 Pydiflumetofen 30:1 .sup.6:0.2 X.14 Pydiflumetofen .sup.1:3.3 0.6:2.sup. X.14 Pydiflumetofen 3:1 0.6:0.2 X.14 Isoflucypram 3:1 6:2 X.14 Isoflucypram 30:1 .sup.6:0.2 X.14 Isoflucypram .sup.1:3.3 0.6:2.sup. X.14 Pyrapropoyne 3:1 6:2 X.14 Pyrapropoyne 30:1 .sup.6:0.2 X.14 Pyrapropoyne .sup.1:3.3 0.6:2.sup. X.14 Fenpicoxamid 1:1 6:6 X.14 Fenpicoxamid 1:10 0.6:6.sup. X.14 Fluazinam 3:1 6:2 X.14 Fluazinam 30:1 .sup.6:0.2 X.14 Fluazinam .sup.1:3.3 0.6:2.sup. X.14 Fluazinam 3:1 0.6:0.2 X.14 Fludioxonil 1:1 6:6 X.14 Fludioxonil 10:1 .sup.6:0.6 X.14 Fludioxonil 1:10 0.6:6.sup. X.14 Cyprodinil 1:1 6:6 X.14 Cyprodinil 10:1 .sup.6:0.6 X.14 Cyprodinil 1:10 0.6:6.sup. X.14 Cyprodinil 1:1 0.6:0.6 X.14 Ipflufenoquin 3:1 6:2 X.14 Ipflufenoquin 30:1 .sup.6:0.2 X.14 Quinofumelin 3:1 6:2 X.14 Quinofumelin 30:1 .sup.6:0.2 X.14 N-(1-benzyl-1,3-dimethyl-butyl)- 3:1 6:2 8-fluoro-quinoline-3- carboxamide X.14 N-(1-benzyl-3,3,3-trifluoro-1- 3:1 6:2 methyl-propyl)-8-fluoro- quinoline-3-carboxamide X.14 1-(6,7-dimethylpyrazolo[1,5- 3:1 6:2 a]pyridin-3-yl)-4,4,5-trifluoro-3,3- dimethyl-isoquinoline X.14 1-(6,7-dimethylpyrazolo[1,5- 30:1 .sup.6:0.2 a]pyridin-3-yl)-4,4,5-trifluoro-3,3- dimethyl-isoquinoline X.14 4,4-difluoro-3,3-dimethyl-1-(7- 3:1 6:2 methylpyrazolo[1,5-a]pyridin-3- yl)isoquinoline X.14 4,4-difluoro-3,3-dimethyl-1-(7- 30:1 .sup.6:0.2 methylpyrazolo[1,5-a]pyridin-3- yl)isoquinoline X.14 1-(4,5-dimethylbenzimidazol-1- 3:1 6:2 yl)-4,4,5-trifluoro-3,3-dimethyl- isoquinoline X.14 1-(4,5-dimethylbenzimidazol-1- 30:1 .sup.6:0.2 yl)-4,4,5-trifluoro-3,3-dimethyl- isoquinoline X.14 1-(4,5-dimethylbenzimidazol-1- 3:1 6:2 yl)-4,4-difluoro-3,3-dimethyl- isoquinoline X.14 1-(4,5-dimethylbenzimidazol-1- 30:1 .sup.6:0.2 yl)-4,4-difluoro-3,3-dimethyl- isoquinoline

Example B9: Activity Against Alternaria solani (Early Blight of Tomato/Potato)

(92) Conidia of the fungus from cryogenic storage were directly mixed into nutrient broth (PDB potato dextrose broth). A DMSO) solution of the test compounds was placed into a microtiter plate (96-well format) and the nutrient broth containing the fungal spores was added to it. The test plates were incubated at 24 C. and the inhibition of growth was determined photometrically after 48 hrs. The following mixture compositions (A:6) at the reported concentration (in ppm) gave at least 70% disease control in this test.

(93) TABLE-US-00036 Component A Ratio Conc. (ppm) (Compound) Component B A:B (A:B) X.05 Azoxystrobin 3:1 6:2 X.05 Azoxystrobin 30:1 .sup.6:0.2 X.05 Azoxystrobin .sup.1:3.3 0.6:2.sup. X.05 Azoxystrobin 3:1 0.6:0.2 X.05 Trifloxystrobin 3:1 6:2 X.05 Trifloxystrobin 30:1 .sup.6:0.2 X.05 Trifloxystrobin .sup.1:3.3 0.6:2.sup. X.05 Trifloxystrobin 3:1 0.6:0.2 X.05 Metyltetraprole 3:1 6:2 X.05 Metyltetraprole 30:1 .sup.6:0.2 X.05 Metyltetraprole .sup.1:3.3 0.6:2.sup. X.05 Difenoconazole 1:1 6:6 X.05 Difenoconazole 10:1 .sup.6:0.6 X.05 Difenoconazole 1:10 0.6:6.sup. X.05 Hexaconazole 1:1 6:6 X.05 Hexaconazole 10:1 .sup.6:0.6 X.05 Hexaconazole 1:10 0.6:6.sup. X.05 Propiconazole 1:1 6:6 X.05 Propiconazole 10:1 .sup.6:0.6 X.05 Propiconazole 1:10 0.6:6.sup. X.05 Propiconazole 1:1 0.6:0.6 X.05 Prothioconazole 1:1 6:6 X.05 Prothioconazole 10:1 .sup.6:0.6 X.05 Prothioconazole 1:10 0.6:6.sup. X.05 Mefentrifluconazole 1:1 6:6 X.05 Mefentrifluconazole 10:1 .sup.6:0.6 X.05 Mefentrifluconazole 1:10 0.6:6.sup. X.05 Mefentrifluconazole 1:1 0.6:0.6 X.05 Fenpropidin .sup.1:3.3 6:20 X.05 Fenpropidin 3:1 6:2 X.05 Fenpropimorph .sup.1:3.3 6:20 X.05 Fenpropimorph 3:1 6:2 X.05 Fenpropimorph 1:33.3 0.6:20 X.05 Fluxapyroxad 3:1 6:2 X.05 Fluxapyroxad 30:1 .sup.6:0.2 X.05 Fluopyram 3:1 6:2 X.05 Fluopyram 30:1 .sup.6:0.2 X.05 Fluopyram .sup.1:3.3 0.6:2.sup. X.05 Fluopyram 3:1 0.6:0.2 X.05 Isopyrazam 3:1 6:2 X.05 Isopyrazam 30:1 .sup.6:0.2 X.05 Isopyrazam .sup.1:3.3 0.6:2.sup. X.05 Isopyrazam 3:1 0.6:0.2 X.05 Sedaxane 3:1 6:2 X.05 Sedaxane 30:1 .sup.6:0.2 X.05 Sedaxane .sup.1:3.3 0.6:2.sup. X.05 Benzovindiflupyr 3:1 6:2 X.05 Benzovindiflupyr 30:1 .sup.6:0.2 X.05 Benzovindiflupyr .sup.1:3.3 0.6:2.sup. X.05 Benzovindiflupyr 3:1 0.6:0.2 X.05 Pydiflumetofen 3:1 6:2 X.05 Pydiflumetofen 30:1 .sup.6:0.2 X.05 Pydiflumetofen .sup.1:3.3 0.6:2.sup. X.05 Pydiflumetofen 3:1 0.6:0.2 X.05 Isoflucypram 3:1 6:2 X.05 Isoflucypram 30:1 .sup.6:0.2 X.05 Isoflucypram .sup.1:3.3 0.6:2.sup. X.05 Isoflucypram 3:1 0.6:0.2 X.05 Isofetamid 3:1 6:2 X.05 Isofetamid 30:1 .sup.6:0.2 X.05 Isofetamid .sup.1:3.3 0.6:2.sup. X.05 Pyrapropoyne 3:1 6:2 X.05 Pyrapropoyne 30:1 .sup.6:0.2 X.05 Pyrapropoyne .sup.1:3.3 0.6:2.sup. X.05 Pyrapropoyne 3:1 0.6:0.2 X.05 Fluindapyr 3:1 6:2 X.05 Fluindapyr 30:1 .sup.6:0.2 X.05 Fluindapyr .sup.1:3.3 0.6:2.sup. X.05 Fenpicoxamid 1:1 6:6 X.05 Fenpicoxamid 1:10 0.6:6.sup. X.05 Florylpicoxamid 3:1 6:2 X.05 Chlorothalonil 1:1 6:6 X.05 Chlorothalonil 10:1 .sup.6:0.6 X.05 Chlorothalonil 1:10 0.6:6.sup. X.05 Mancozeb .sup.1:3.3 6:20 X.05 Mancozeb 1:1 6:6 X.05 Mandipropamid .sup.1:3.3 6:20 X.05 Mandipropamid 1:1 6:6 X.05 Oxathiapiprolin .sup.1:3.3 6:20 X.05 Oxathiapiprolin 1:1 6:6 X.05 Fluazinam 3:1 6:2 X.05 Fluazinam 30:1 .sup.6:0.2 X.05 Fluazinam .sup.1:3.3 0.6:2.sup. X.05 Fludioxonil 1:1 6:6 X.05 Fludioxonil 10:1 .sup.6:0.6 X.05 Fludioxonil 1:10 0.6:6.sup. X.05 Fludioxonil 1:1 0.6:0.6 X.05 Cyprodinil 1:1 6:6 X.05 Cyprodinil 10:1 .sup.6:0.6 X.05 Cyprodinil 1:10 0.6:6.sup. X.05 Cyprodinil 1:1 0.6:0.6 X.05 Metalaxyl-M .sup.1:3.3 6:20 X.05 Metalaxyl-M 1:1 6:6 X.05 Metalaxyl-M 1:33.3 0.6:20 X.05 Metalaxyl-M 1:10 0.6:6.sup. X.05 Aminopyrifen 3:1 6:2 X.05 Aminopyrifen 30:1 .sup.6:0.2 X.05 Folpet 1:1 6:6 X.05 Folpet 3:1 6:2 X.05 Folpet 1:10 0.6:6.sup. X.05 Ipflufenoquin 3:1 6:2 X.05 Ipflufenoquin 30:1 .sup.6:0.2 X.05 Ipflufenoquin .sup.1:3.3 0.6:2.sup. X.05 Ipflufenoquin 3:1 0.6:0.2 X.05 Quinofumelin 3:1 6:2 X.05 Quinofumelin 30:1 .sup.6:0.2 X.05 Quinofumelin .sup.1:3.3 0.6:2.sup. X.05 Quinofumelin 3:1 0.6:0.2 X.05 Tricyclazole .sup.1:3.3 6:20 X.05 Tricyclazole 1:1 6:6 X.05 Tricyclazole 1:33.3 0.6:20 X.05 Pyroquilon .sup.1:3.3 6:20 X.05 Pyroquilon 1:1 6:6 X.05 Pyroquilon 1:33.3 0.6:20 X.05 Pyroquilon 1:10 0.6:6.sup. X.05 N-(1-benzyl-1,3-dimethyl-butyl)- 3:1 6:2 8-fluoro-quinoline-3- carboxamide X.05 N-(1-benzyl-1,3-dimethyl-butyl)- 30:1 .sup.6:0.2 8-fluoro-quinoline-3- carboxamide X.05 N-(1-benzyl-1,3-dimethyl-butyl)- .sup.1:3.3 0.6:2.sup. 8-fluoro-quinoline-3- carboxamide X.05 N-(1-benzyl-1,3-dimethyl-butyl)- 3:1 0.6:0.2 8-fluoro-quinoline-3- carboxamide X.05 N-(1-benzyl-3,3,3-trifluoro-1- 3:1 6:2 methyl-propyl)-8-fluoro- quinoline-3-carboxamide X.05 N-(1-benzyl-3,3,3-trifluoro-1- 30:1 .sup.6:0.2 methyl-propyl)-8-fluoro- quinoline-3-carboxamide X.05 N-(1-benzyl-3,3,3-trifluoro-1- .sup.1:3.3 0.6:2.sup. methyl-propyl)-8-fluoro- quinoline-3-carboxamide X.05 N-(1-benzyl-3,3,3-trifluoro-1- 3:1 0.6:0.2 methyl-propyl)-8-fluoro- quinoline-3-carboxamide X.05 1-(6,7-dimethylpyrazolo[1,5- 3:1 6:2 a]pyridin-3-yl)-4,4,5-trifluoro-3,3- dimethyl-isoquinoline X.05 1-(6,7-dimethylpyrazolo[1,5- 30:1 .sup.6:0.2 a]pyridin-3-yl)-4,4,5-trifluoro-3,3- dimethyl-isoquinoline X.05 1-(6,7-dimethylpyrazolo[1,5- .sup.1:3.3 0.6:2.sup. a]pyridin-3-yl)-4,4,5-trifluoro-3,3- dimethyl-isoquinoline X.05 1-(6,7-dimethylpyrazolo[1,5- 3:1 0.6:0.2 a]pyridin-3-yl)-4,4,5-trifluoro-3,3- dimethyl-isoquinoline X.05 4,4-difluoro-3,3-dimethyl-1-(7- 3:1 6:2 methylpyrazolo[1,5-a]pyridin-3- yl)isoquinoline X.05 4,4-difluoro-3,3-dimethyl-1-(7- 30:1 .sup.6:0.2 methylpyrazolo[1,5-a]pyridin-3- yl)isoquinoline X.05 4,4-difluoro-3,3-dimethyl-1-(7- .sup.1:3.3 0.6:2.sup. methylpyrazolo[1,5-a]pyridin-3- yl)isoquinoline X.05 4,4-difluoro-3,3-dimethyl-1-(7- 3:1 0.6:0.2 methylpyrazolo[1,5-a]pyridin-3- yl)isoquinoline X.05 1-(4,5-dimethylbenzimidazol-1- 3:1 6:2 yl)-4,4,5-trifluoro-3,3-dimethyl- isoquinoline X.05 1-(4,5-dimethylbenzimidazol-1- 30:1 .sup.6:0.2 yl)-4,4,5-trifluoro-3,3-dimethyl- isoquinoline X.05 1-(4,5-dimethylbenzimidazol-1- .sup.1:3.3 0.6:2.sup. yl)-4,4,5-trifluoro-3,3-dimethyl- isoquinoline X.05 1-(4,5-dimethylbenzimidazol-1- 3:1 0.6:0.2 yl)-4,4,5-trifluoro-3,3-dimethyl- isoquinoline X.05 1-(4,5-dimethylbenzimidazol-1- 3:1 6:2 yl)-4,4-difluoro-3,3-dimethyl- isoquinoline X.05 1-(4,5-dimethylbenzimidazol-1- 30:1 .sup.6:0.2 yl)-4,4-difluoro-3,3-dimethyl- isoquinoline X.05 1-(4,5-dimethylbenzimidazol-1- .sup.1:3.3 0.6:2.sup. yl)-4,4-difluoro-3,3-dimethyl- isoquinoline X.05 1-(4,5-dimethylbenzimidazol-1- 3:1 0.6:0.2 yl)-4,4-difluoro-3,3-dimethyl- isoquinoline

(94) TABLE-US-00037 Component A Ratio Conc. (ppm) (Compound) Component B A:B (A:B) X.07 Azoxystrobin 3:1 6:2 X.07 Azoxystrobin 30:1 .sup.6:0.2 X.07 Azoxystrobin .sup.1:3.3 0.6:2.sup. X.07 Azoxystrobin 3:1 0.6:0.2 X.07 Trifloxystrobin 3:1 6:2 X.07 Trifloxystrobin 30:1 .sup.6:0.2 X.07 Trifloxystrobin .sup.1:3.3 0.6:2.sup. X.07 Metyltetraprole 3:1 6:2 X.07 Metyltetraprole 30:1 .sup.6:0.2 X.07 Metyltetraprole .sup.1:3.3 0.6:2.sup. X.07 Difenoconazole 1:1 6:6 X.07 Difenoconazole 10:1 .sup.6:0.6 X.07 Difenoconazole 1:10 0.6:6.sup. X.07 Hexaconazole 1:1 6:6 X.07 Hexaconazole 10:1 .sup.6:0.6 X.07 Hexaconazole 1:10 0.6:6.sup. X.07 Propiconazole 1:1 6:6 X.07 Propiconazole 10:1 .sup.6:0.6 X.07 Propiconazole 1:10 0.6:6.sup. X.07 Prothioconazole 1:1 6:6 X.07 Prothioconazole 10:1 .sup.6:0.6 X.07 Prothioconazole 1:10 0.6:6.sup. X.07 Mefentrifluconazole 1:1 6:6 X.07 Mefentrifluconazole 10:1 .sup.6:0.6 X.07 Mefentrifluconazole 1:10 0.6:6.sup. X.07 Fenpropidin .sup.1:3.3 6:20 X.07 Fenpropidin 3:1 6:2 X.07 Fenpropidin 1:33.3 0.6:20 X.07 Fenpropimorph .sup.1:3.3 6:20 X.07 Fenpropimorph 3:1 6:2 X.07 Fluxapyroxad 3:1 6:2 X.07 Fluxapyroxad 30:1 .sup.6:0.2 X.07 Fluopyram 3:1 6:2 X.07 Fluopyram 30:1 .sup.6:0.2 X.07 Fluopyram .sup.1:3.3 0.6:2.sup. X.07 Fluopyram 3:1 0.6:0.2 X.07 Isopyrazam 3:1 6:2 X.07 Isopyrazam 30:1 .sup.6:0.2 X.07 Isopyrazam .sup.1:3.3 0.6:2.sup. X.07 Isopyrazam 3:1 0.6:0.2 X.07 Sedaxane 3:1 6:2 X.07 Sedaxane 30:1 .sup.6:0.2 X.07 Sedaxane .sup.1:3.3 0.6:2.sup. X.07 Benzovindiflupyr 3:1 6:2 X.07 Benzovindiflupyr 30:1 .sup.6:0.2 X.07 Benzovindiflupyr .sup.1:3.3 0.6:2.sup. X.07 Benzovindiflupyr 3:1 0.6:0.2 X.07 Pydiflumetofen 3:1 6:2 X.07 Pydiflumetofen 30:1 .sup.6:0.2 X.07 Pydiflumetofen .sup.1:3.3 0.6:2.sup. X.07 Pydiflumetofen 3:1 0.6:0.2 X.07 Isoflucypram 3:1 6:2 X.07 Isoflucypram 30:1 .sup.6:0.2 X.07 Isoflucypram .sup.1:3.3 0.6:2.sup. X.07 Isoflucypram 3:1 0.6:0.2 X.07 Isofetamid 3:1 6:2 X.07 Isofetamid 30:1 .sup.6:0.2 X.07 Isofetamid .sup.1:3.3 0.6:2.sup. X.07 Pyrapropoyne 3:1 6:2 X.07 Pyrapropoyne 30:1 .sup.6:0.2 X.07 Pyrapropoyne .sup.1:3.3 0.6:2.sup. X.07 Pyrapropoyne 3:1 0.6:0.2 X.07 Fluindapyr 3:1 6:2 X.07 Fluindapyr 30:1 .sup.6:0.2 X.07 Fluindapyr .sup.1:3.3 0.6:2.sup. X.07 Fenpicoxamid 1:1 6:6 X.07 Fenpicoxamid 10:1 .sup.6:0.6 X.07 Florylpicoxamid 3:1 6:2 X.07 Florylpicoxamid 30:1 .sup.6:0.2 X.07 Chlorothalonil 1:1 6:6 X.07 Chlorothalonil 10:1 .sup.6:0.6 X.07 Mancozeb .sup.1:3.3 6:20 X.07 Mancozeb 1:1 6:6 X.07 Mandipropamid .sup.1:3.3 6:20 X.07 Mandipropamid 1:1 6:6 X.07 Oxathiapiprolin .sup.1:3.3 6:20 X.07 Oxathiapiprolin 1:1 6:6 X.07 Fluazinam 3:1 6:2 X.07 Fluazinam 30:1 .sup.6:0.2 X.07 Fluazinam .sup.1:3.3 0.6:2.sup. X.07 Fludioxonil 1:1 6:6 X.07 Fludioxonil 10:1 .sup.6:0.6 X.07 Fludioxonil 1:10 0.6:6.sup. X.07 Fludioxonil 1:1 0.6:0.6 X.07 Cyprodinil 1:1 6:6 X.07 Cyprodinil 10:1 .sup.6:0.6 X.07 Cyprodinil 1:10 0.6:6.sup. X.07 Cyprodinil 1:1 0.6:0.6 X.07 Metalaxyl-M .sup.1:3.3 6:20 X.07 Metalaxyl-M 1:1 6:6 X.07 Metalaxyl-M 1:33.3 0.6:20 X.07 Metalaxyl-M 1:10 0.6:6.sup. X.07 Aminopyrifen 3:1 6:2 X.07 Aminopyrifen 30:1 .sup.6:0.2 X.07 Folpet 1:1 6:6 X.07 Folpet 3:1 6:2 X.07 Ipflufenoquin 3:1 6:2 X.07 Ipflufenoquin 30:1 .sup.6:0.2 X.07 Ipflufenoquin .sup.1:3.3 0.6:2.sup. X.07 Ipflufenoquin 3:1 0.6:0.2 X.07 Quinofumelin 3:1 6:2 X.07 Quinofumelin 30:1 .sup.6:0.2 X.07 Quinofumelin .sup.1:3.3 0.6:2.sup. X.07 Quinofumelin 3:1 0.6:0.2 X.07 Tricyclazole .sup.1:3.3 6:20 X.07 Tricyclazole 1:1 6:6 X.07 Tricyclazole 1:33.3 0.6:20 X.07 Pyroquilon .sup.1:3.3 6:20 X.07 Pyroquilon 1:1 6:6 X.07 N-(1-benzyl-1,3-dimethyl-butyl)- 3:1 6:2 8-fluoro-quinoline-3- carboxamide X.07 N-(1-benzyl-1,3-dimethyl-butyl)- 30:1 .sup.6:0.2 8-fluoro-quinoline-3- carboxamide X.07 N-(1-benzyl-1,3-dimethyl-butyl)- .sup.1:3.3 0.6:2.sup. 8-fluoro-quinoline-3- carboxamide X.07 N-(1-benzyl-1,3-dimethyl-butyl)- 3:1 0.6:0.2 8-fluoro-quinoline-3- carboxamide X.07 N-(1-benzyl-3,3,3-trifluoro-1- 3:1 6:2 methyl-propyl)-8-fluoro- quinoline-3-carboxamide X.07 N-(1-benzyl-3,3,3-trifluoro-1- 30:1 .sup.6:0.2 methyl-propyl)-8-fluoro- quinoline-3-carboxamide X.07 N-(1-benzyl-3,3,3-trifluoro-1- .sup.1:3.3 0.6:2.sup. methyl-propyl)-8-fluoro- quinoline-3-carboxamide X.07 N-(1-benzyl-3,3,3-trifluoro-1- 3:1 0.6:0.2 methyl-propyl)-8-fluoro- quinoline-3-carboxamide X.07 1-(6,7-dimethylpyrazolo[1,5- 3:1 6:2 a]pyridin-3-yl)-4,4,5-trifluoro-3,3- dimethyl-isoquinoline X.07 1-(6,7-dimethylpyrazolo[1,5- 30:1 .sup.6:0.2 a]pyridin-3-yl)-4,4,5-trifluoro-3,3- dimethyl-isoquinoline X.07 1-(6,7-dimethylpyrazolo[1,5- .sup.1:3.3 0.6:2.sup. a]pyridin-3-yl)-4,4,5-trifluoro-3,3- dimethyl-isoquinoline X.07 1-(6,7-dimethylpyrazolo[1,5- 3:1 0.6:0.2 a]pyridin-3-yl)-4,4,5-trifluoro-3,3- dimethyl-isoquinoline X.07 4,4-difluoro-3,3-dimethyl-1-(7- 3:1 6:2 methylpyrazolo[1,5-a]pyridin-3- yl)isoquinoline X.07 4,4-difluoro-3,3-dimethyl-1-(7- 30:1 .sup.6:0.2 methylpyrazolo[1,5-a]pyridin-3- yl)isoquinoline X.07 4,4-difluoro-3,3-dimethyl-1-(7- .sup.1:3.3 0.6:2.sup. methylpyrazolo[1,5-a]pyridin-3- yl)isoquinoline X.07 4,4-difluoro-3,3-dimethyl-1-(7- 3:1 0.6:0.2 methylpyrazolo[1,5-a]pyridin-3- yl)isoquinoline X.07 1-(4,5-dimethylbenzimidazol-1- 3:1 6:2 yl)-4,4,5-trifluoro-3,3-dimethyl- isoquinoline X.07 1-(4,5-dimethylbenzimidazol-1- 30:1 .sup.6:0.2 yl)-4,4,5-trifluoro-3,3-dimethyl- isoquinoline X.07 1-(4,5-dimethylbenzimidazol-1- .sup.1:3.3 0.6:2.sup. yl)-4,4,5-trifluoro-3,3-dimethyl- isoquinoline X.07 1-(4,5-dimethylbenzimidazol-1- 3:1 0.6:0.2 yl)-4,4,5-trifluoro-3,3-dimethyl- isoquinoline X.07 1-(4,5-dimethylbenzimidazol-1- 3:1 6:2 yl)-4,4-difluoro-3,3-dimethyl- isoquinoline X.07 1-(4,5-dimethylbenzimidazol-1- 30:1 .sup.6:0.2 yl)-4,4-difluoro-3,3-dimethyl- isoquinoline X.07 1-(4,5-dimethylbenzimidazol-1- .sup.1:3.3 0.6:2.sup. yl)-4,4-difluoro-3,3-dimethyl- isoquinoline X.07 1-(4,5-dimethylbenzimidazol-1- 3:1 0.6:0.2 yl)-4,4-difluoro-3,3-dimethyl- isoquinoline

(95) TABLE-US-00038 Component A Ratio Conc. (ppm) (Compound) Component B A:B (A:B) X.14 Azoxystrobin 3:1 6:2 X.14 Azoxystrobin 30:1 .sup.6:0.2 X.14 Azoxystrobin .sup.1:3.3 0.6:2.sup. X.14 Trifloxystrobin 3:1 6:2 X.14 Trifloxystrobin 30:1 .sup.6:0.2 X.14 Trifloxystrobin .sup.1:3.3 0.6:2.sup. X.14 Metyltetraprole 3:1 6:2 X.14 Metyltetraprole .sup.1:3.3 0.6:2.sup. X.14 Difenoconazole 1:1 6:6 X.14 Difenoconazole 1:10 0.6:6.sup. X.14 Hexaconazole 1:1 6:6 X.14 Hexaconazole 1:10 0.6:6.sup. X.14 Prothioconazole 1:1 6:6 X.14 Prothioconazole 1:10 0.6:6.sup. X.14 Mefentrifluconazole 1:1 6:6 X.14 Mefentrifluconazole 1:10 0.6:6.sup. X.14 Fluopyram 3:1 6:2 X.14 Fluopyram .sup.1:3.3 0.6:2.sup. X.14 Isopyrazam 3:1 6:2 X.14 Isopyrazam .sup.1:3.3 0.6:2.sup. X.14 Benzovindiflupyr 3:1 6:2 X.14 Benzovindiflupyr .sup.1:3.3 0.6:2.sup. X.14 Pydiflumetofen 3:1 6:2 X.14 Pydiflumetofen 30:1 .sup.6:0.2 X.14 Pydiflumetofen .sup.1:3.3 0.6:2.sup. X.14 Pydiflumetofen 3:1 0.6:0.2 X.14 Isoflucypram 3:1 6:2 X.14 Isoflucypram 30:1 .sup.6:0.2 X.14 Isoflucypram .sup.1:3.3 0.6:2.sup. X.14 Isoflucypram 3:1 0.6:0.2 X.14 Pyrapropoyne 3:1 6:2 X.14 Pyrapropoyne 30:1 .sup.6:0.2 X 14 Pyrapropoyne .sup.1:3.3 0.6:2.sup. X.14 Pyrapropoyne 3:1 0.6:0.2 X.14 Fenpicoxamid 1:1 6:6 X.14 Fenpicoxamid 10:1 .sup.6:0.6 X.14 Fenpicoxamid 1:10 0.6:6.sup. X.14 Florylpicoxamid 3:1 6:2 X.14 Fluazinam 3:1 6:2 X.14 Fluazinam .sup.1:3.3 0.6:2.sup. X.14 Fludioxonil 1:1 6:6 X.14 Fludioxonil 1:10 0.6:6.sup. X.14 Cyprodinil 1:1 6:6 X.14 Cyprodinil 10:1 .sup.6:0.6 X.14 Cyprodinil 1:10 0.6:6.sup. X.14 Cyprodinil 1:1 0.6:0.6 X.14 Metalaxyl-M .sup.1:3.3 6:20 X.14 Ipflufenoquin 3:1 6:2 X.14 Ipflufenoquin 30:1 .sup.6:0.2 X.14 Ipflufenoquin .sup.1:3.3 0.6:2.sup. X.14 Quinofumelin 3:1 6:2 X.14 Quinofumelin 30:1 .sup.6:0.2 X14 Quinofumelin .sup.1:3.3 0.6:2.sup. X.14 N-(1-benzyl-1,3-dimethyl-butyl)- 3:1 6:2 8-fluoro-quinoline-3- carboxamide X.14 N-(1-benzyl-1,3-dimethyl-butyl)- 30:1 .sup.6:0.2 8-fluoro-quinoline-3- carboxamide X.14 N-(1-benzyl-1,3-dimethyl-butyl)- .sup.1:3.3 0.6:2.sup. 8-fluoro-quinoline-3- carboxamide X.14 N-(1-benzyl-3,3,3-trifluoro-1- 3:1 6:2 methyl-propyl)-8-fluoro- quinoline-3-carboxamide X.14 N-(1-benzyl-3,3,3-trifluoro-1- 30:1 .sup.6:0.2 methyl-propyl)-8-fluoro- quinoline-3-carboxamide X.14 N-(1-benzyl-3,3,3-trifluoro-1- .sup.1:3.3 0.6:2.sup. methyl-propyl)-8-fluoro- quinoline-3-carboxamide X.14 1-(6,7-dimethylpyrazolo[1,5- 3:1 6:2 a]pyridin-3-yl)-4,4,5-trifluoro-3,3- dimethyl-isoquinoline X.14 1-(6,7-dimethylpyrazolo[1,5- 30:1 .sup.6:0.2 a]pyridin-3-yl)-4,4,5-trifluoro-3,3- dimethyl-isoquinoline X.14 1-(6,7-dimethylpyrazolo[1,5- .sup.1:3.3 0.6:2.sup. a]pyridin-3-yl)-4,4,5-trifluoro-3,3- dimethyl-isoquinoline X.14 1-(6,7-dimethylpyrazolo[1,5- 3:1 0.6:0.2 a]pyridin-3-yl)-4,4,5-trifluoro-3,3- dimethyl-isoquinoline X.14 4,4-difluoro-3,3-dimethyl-1-(7- 3:1 6:2 methylpyrazolo[1,5-a]pyridin-3- yl)isoquinoline X.14 4,4-difluoro-3,3-dimethyl-1-(7- 30:1 .sup.6:0.2 methylpyrazolo[1,5-a]pyridin-3- yl)isoquinoline X.14 4,4-difluoro-3,3-dimethyl-1-(7- .sup.1:3.3 0.6:2.sup. methylpyrazolo[1,5-a]pyridin-3- yl)isoquinoline X.14 1-(4,5-dimethylbenzimidazol-1- 3:1 6:2 yl)-4,4,5-trifluoro-3,3-dimethyl- isoquinoline X.14 1-(4,5-dimethylbenzimidazol-1- 30:1 .sup.6:0.2 yl)-4,4,5-trifluoro-3,3-dimethyl- isoquinoline X.14 1-(4,5-dimethylbenzimidazol-1- .sup.1:3.3 0.6:2.sup. yl)-4,4,5-trifluoro-3,3-dimethyl- isoquinoline X.14 1-(4,5-dimethylbenzimidazol-1- 3:1 0.6:0.2 yl)-4,4,5-trifluoro-3,3-dimethyl- isoquinoline X.14 1-(4,5-dimethylbenzimidazol-1- 3:1 6:2 yl)-4,4-difluoro-3,3-dimethyl- isoquinoline X.14 1-(4,5-dimethylbenzimidazol-1- 30:1 .sup.6:0.2 yl)-4,4-difluoro-3,3-dimethyl- isoquinoline X.14 1-(4,5-dimethylbenzimidazol-1- .sup.1:3.3 0.6:2.sup. yl)-4,4-difluoro-3,3-dimethyl- isoquinoline X.14 1-(4,5-dimethylbenzimidazol-1- 3:1 0.6:0.2 yl)-4,4-difluoro-3,3-dimethyl- isoquinoline

Example B10: Sclerotinia sclerotiorum/Liquid Culture (Cottony Rot)

(96) Mycelia Fragments of a newly grown liquid culture of the fungus are directly mixed into nutrient broth (Vogel's minimal media) containing 200 Mol SHAM. After placing a (DMSO) solution of test compounds into a microtiter plate (96-well format) the nutrient broth containing the fungal material is added. The test plates are incubated at 24 C. and the inhibition of growth is determined photometrically 3-4 days after application. The following mixture compositions (A:B) at the reported concentration (in ppm) gave at least 80% disease control in this test when compared to the untreated control under the same conditions, which showed extensive disease development.

(97) TABLE-US-00039 Component A Ratio Conc. (ppm) (Compound) Component B A:B (A:B) X.05 Azoxystrobin 3.3:1 20:6 X.05 Azoxystrobin 33.3:1 20:0.6 X.05 Azoxystrobin .sup.1:3 2:6 X.05 Azoxystrobin 3.3:1 .sup.2:0.6 X.05 Trifloxystrobin 3.3:1 20:6 X.05 Trifloxystrobin 33.3:1 20:0.6 X.05 Trifloxystrobin .sup.1:3 2:6 X.05 Trifloxystrobin 3.3:1 .sup.2:0.6 X.05 Metyltetraprole 3.3:1 20:6 X.05 Metyltetraprole 33.3:1 20:0.6 X.05 Metyltetraprole .sup.1:3 2:6 X.05 Metyltetraprole 3.3:1 .sup.2:0.6 X.05 Difenoconazole 3.3:1 20:6 X.05 Difenoconazole 33.3:1 20:0.6 X.05 Difenoconazole .sup.1:3 2:6 X.05 Difenoconazole 3.3:1 .sup.2:0.6 X.05 Hexaconazole 3.3:1 20:6 X.05 Hexaconazole 33.3:1 20:0.6 X.05 Hexaconazole .sup.1:3 2:6 X.05 Hexaconazole 3.3:1 .sup.2:0.6 X.05 Propiconazole 3.3:1 20:6 X.05 Propiconazole 33.3:1 20:0.6 X.05 Propiconazole .sup.1:3 2:6 X.05 Propiconazole 3.3:1 .sup.2:0.6 X.05 Prothioconazole 3.3:1 20:6 X.05 Prothioconazole 33.3:1 20:0.6 X.05 Prothioconazole .sup.1:3 2:6 X.05 Prothioconazole 3.3:1 .sup.2:0.6 X.05 Mefentrifluconazole 3.3:1 20:6 X.05 Mefentrifluconazole 33.3:1 20:0.6 X.05 Mefentrifluconazole .sup.1:3 2:6 X.05 Mefentrifluconazole 3.3:1 .sup.2:0.6 X.05 Fenpropidin .sup.1:1 20:20 X.05 Fenpropidin 3.3:1 20:6 X.05 Fenpropidin 1:10 2:20 X.05 Fenpropidin .sup.1:3 2:6 X.05 Fenpropimorph .sup.1:1 20:20 X.05 Fenpropimorph 3.3:1 20:6 X.05 Fenpropimorph 1:10 2:20 X.05 Fenpropimorph .sup.1:3 2:6 X.05 Fluxapyroxad 3.3:1 20:6 X.05 Fluxapyroxad 33.3:1 20:0.6 X.05 Fluxapyroxad .sup.1:3 2:6 X.05 Fluxapyroxad 3.3:1 .sup.2:0.6 X.05 Fluopyram 3.3:1 20:6 X.05 Fluopyram 33.3:1 20:0.6 X.05 Fluopyram .sup.1:3 2:6 X.05 Fluopyram 3.3:1 .sup.2:0.6 X.05 Benzovindiflupyr 3.3:1 20:6 X.05 Benzovindiflupyr 33.3:1 20:0.6 X.05 Benzovindiflupyr .sup.1:3 2:6 X.05 Benzovindiflupyr 3.3:1 .sup.2:0.6 X.05 Pydiflumetofen 3.3:1 20:6 X.05 Pydiflumetofen 33.3:1 20:0.6 X.05 Pydiflumetofen .sup.1:3 2:6 X.05 Pydiflumetofen 3.3:1 .sup.2:0.6 X.05 Isoflucypram 3.3:1 20:6 X.05 Isoflucypram 33.3:1 20:0.6 X.05 Isoflucypram .sup.1:3 2:6 X.05 Isoflucypram 3.3:1 .sup.2:0.6 X.05 Fluindapyr 3.3:1 20:6 X.05 Fluindapyr 33.3:1 20:0.6 X.05 Fluindapyr .sup.1:3 2:6 X.05 Fluindapyr 3.3:1 .sup.2:0.6 X.05 Florylpicoxamid 3.3:1 20:6 X.05 Florylpicoxamid 33.3:1 20:0.6 X.05 Florylpicoxamid .sup.1:3 2:6 X.05 Florylpicoxamid 3.3:1 .sup.2:0.6 X.05 Metarylpicoxamid 3.3:1 20:6 X.05 Metarylpicoxamid 33.3:1 20:0.6 X.05 Metarylpicoxamid .sup.1:3 2:6 X.05 Metarylpicoxamid 3.3:1 .sup.2:0.6 X.05 Chlorothalonil 3.3:1 20:6 X.05 Chlorothalonil 33.3:1 20:0.6 X.05 Chlorothalonil .sup.1:3 2:6 X.05 Chlorothalonil 3.3:1 .sup.2:0.6 X.05 Mancozeb .sup.1:1 20:20 X.05 Mancozeb 3.3:1 20:6 X.05 Mancozeb 1:10 2:20 X.05 Mancozeb .sup.1:3 2:6 X.05 Mandipropamid .sup.1:1 20:20 X.05 Mandipropamid 3.3:1 20:6 X.05 Mandipropamid 1:10 2:20 X.05 Mandipropamid .sup.1:3 2:6 X.05 Oxathiapiprolin .sup.1:1 20:20 X.05 Oxathiapiprolin 3.3:1 20:6 X.05 Oxathiapiprolin 1:10 2:20 X.05 Oxathiapiprolin .sup.1:3 2:6 X.05 Fluazinam 3.3:1 20:6 X.05 Fluazinam 33.3:1 20:0.6 X.05 Fluazinam .sup.1:3 2:6 X.05 Fluazinam 3.3:1 .sup.2:0.6 X.05 Fludioxonil 3.3:1 20:6 X.05 Fludioxonil 33.3:1 20:0.6 X.05 Fludioxonil .sup.1:3 2:6 X.05 Fludioxonil 3.3:1 .sup.2:0.6 X.05 Cyprodinil 3.3:1 20:6 X.05 Cyprodinil 33.3:1 20:0.6 X.05 Cyprodinil .sup.1:3 2:6 X.05 Cyprodinil 3.3:1 .sup.2:0.6 X.05 Metalaxyl-M .sup.1:1 20:20 X.05 Metalaxyl-M 3.3:1 20:6 X.05 Metalaxyl-M 1:10 2:20 X.05 Metalaxyl-M .sup.1:3 2:6 X.05 Folpet 3.3:1 20:6 X.05 Folpet 10:1 20:2 X.05 Folpet .sup.1:3 2:6 X.05 Folpet .sup.1:1 2:2 X.05 Aminopyrifen 3.3:1 20:6 X.05 Aminopyrifen 33.3:1 20:0.6 X.05 Aminopyrifen .sup.1:3 2:6 X.05 Aminopyrifen 3.3:1 .sup.2:0.6 X.05 N-(1-benzyl-1,3-dimethyl-butyl)- 3.3:1 20:6 8-fluoro-quinoline-3- carboxamide X.05 N-(1-benzyl-1,3-dimethyl-butyl)- 33.3:1 20:0.6 8-fluoro-quinoline-3- carboxamide X.05 N-(1-benzyl-1,3-dimethyl-butyl)- .sup.1:3 2:6 8-fluoro-quinoline-3- carboxamide X.05 N-(1-benzyl-1,3-dimethyl-butyl)- 3.3:1 .sup.2:0.6 8-fluoro-quinoline-3- carboxamide X.05 N-(1-benzyl-3,3,3-trifluoro-1- 3.3:1 20:6 methyl-propyl)-8-fluoro- quinoline-3-carboxamide X.05 N-(1-benzyl-3,3,3-trifluoro-1- 33.3:1 20:0.6 methyl-propyl)-8-fluoro- quinoline-3-carboxamide X.05 N-(1-benzyl-3,3,3-trifluoro-1- .sup.1:3 2:6 methyl-propyl)-8-fluoro- quinoline-3-carboxamide X.05 N-(1-benzyl-3,3,3-trifluoro-1- 3.3:1 .sup.2:0.6 methyl-propyl)-8-fluoro- quinoline-3-carboxamide X.05 1-(6,7-dimethylpyrazolo[1,5- 3.3:1 20:6 a]pyridin-3-yl)-4,4,5-trifluoro-3,3- dimethyl-isoquinoline X.05 1-(6,7-dimethylpyrazolo[1,5- 33.3:1 20:0.6 a]pyridin-3-yl)-4,4,5-trifluoro-3,3- dimethyl-isoquinoline X.05 1-(6,7-dimethylpyrazolo[1,5- .sup.1:3 2:6 a]pyridin-3-yl)-4,4,5-trifluoro-3,3- dimethyl-isoquinoline X.05 1-(6,7-dimethylpyrazolo[1,5- 3.3:1 .sup.2:0.6 a]pyridin-3-yl)-4,4,5-trifluoro-3,3- dimethyl-isoquinoline X.05 4,4-difluoro-3,3-dimethyl-1-(7- 3.3:1 20:6 methylpyrazolo[1,5-a]pyridin-3- yl)isoquinoline X.05 4,4-difluoro-3,3-dimethyl-1-(7- 33.3:1 20:0.6 methylpyrazolo[1,5-a]pyridin-3- yl)isoquinoline X.05 4,4-difluoro-3,3-dimethyl-1-(7- .sup.1:3 2:6 methylpyrazolo[1,5-a]pyridin-3- yl)isoquinoline X.05 4,4-difluoro-3,3-dimethyl-1-(7- 3.3:1 .sup.2:0.6 methylpyrazolo[1,5-a]pyridin-3- yl)isoquinoline X.05 1-(4,5-dimethylbenzimidazol-1- 3.3:1 20:6 yl)-4,4,5-trifluoro-3,3-dimethyl- isoquinoline X.05 1-(4,5-dimethylbenzimidazol-1- 33.3:1 20:0.6 yl)-4,4,5-trifluoro-3,3-dimethyl- isoquinoline X.05 1-(4,5-dimethylbenzimidazol-1- .sup.1:3 2:6 yl)-4,4,5-trifluoro-3,3-dimethyl- isoquinoline X.05 1-(4,5-dimethylbenzimidazol-1- 3.3:1 .sup.2:0.6 yl)-4,4,5-trifluoro-3,3-dimethyl- isoquinoline X.05 1-(4,5-dimethylbenzimidazol-1- 3.3:1 20:6 yl)-4,4-difluoro-3,3-dimethyl- isoquinoline X.05 1-(4,5-dimethylbenzimidazol-1- 33.3:1 20:0.6 yl)-4,4-difluoro-3,3-dimethyl- isoquinoline X.05 1-(4,5-dimethylbenzimidazol-1- .sup.1:3 2:6 yl)-4,4-difluoro-3,3-dimethyl- isoquinoline X.05 1-(4,5-dimethylbenzimidazol-1- 3.3:1 .sup.2:0.6 yl)-4,4-difluoro-3,3-dimethyl- isoquinoline X.05 Isopyrazam 3.3:1 20:6 X.05 Isopyrazam 33.3:1 20:0.6 X.05 Isopyrazam .sup.1:3 2:6 X.05 Isopyrazam 3.3:1 .sup.2:0.6 X.05 Sedaxane 3.3:1 20:6 X.05 Sedaxane 33.3:1 20:0.6 X.05 Sedaxane .sup.1:3 2:6 X.05 Sedaxane 3.3:1 .sup.2:0.6 X.05 Isofetamid 3.3:1 20:6 X.05 Isofetamid 33.3:1 20:0.6 X.05 Isofetamid .sup.1:3 2:6 X.05 Isofetamid 3.3:1 .sup.2:0.6 X.05 Ipflufenoquin 3.3:1 20:6 X.05 Ipflufenoquin 33.3:1 20:0.6 X.05 Ipflufenoquin .sup.1:3 2:6 X.05 Ipflufenoquin 3.3:1 .sup.2:0.6 X.05 Quinofumelin 3.3:1 20:6 X.05 Quinofumelin 33.3:1 20:0.6 X.05 Quinofumelin .sup.1:3 2:6 X.05 Quinofumelin 3.3:1 .sup.2:0.6 X.07 Azoxystrobin 3.3:1 20:6 X.07 Azoxystrobin 33.3:1 20:0.6 X.07 Azoxystrobin .sup.1:3 2:6 X.07 Azoxystrobin 3.3:1 .sup.2:0.6 X.07 Trifloxystrobin 3.3:1 20:6 X.07 Trifloxystrobin 33.3:1 20:0.6 X.07 Trifloxystrobin .sup.1:3 2:6 X.07 Trifloxystrobin 3.3:1 .sup.2:0.6 X.07 Metyltetraprole 3.3:1 20:6 X.07 Metyltetraprole 33.3:1 20:0.6 X.07 Metyltetraprole .sup.1:3 2:6 X.07 Metyltetraprole 3.3:1 .sup.2:0.6 X.07 Difenoconazole 3.3:1 20:6 X.07 Difenoconazole 33.3:1 20:0.6 X.07 Difenoconazole .sup.1:3 2:6 X.07 Difenoconazole 3.3:1 .sup.2:0.6 X.07 Hexaconazole 3.3:1 20:6 X.07 Hexaconazole 33.3:1 20:0.6 X.07 Hexaconazole .sup.1:3 2:6 X.07 Hexaconazole 3.3:1 .sup.2:0.6 X.07 Propiconazole 3.3:1 20:6 X.07 Propiconazole 33.3:1 20:0.6 X.07 Propiconazole .sup.1:3 2:6 X.07 Propiconazole 3.3:1 .sup.2:0.6 X.07 Prothioconazole 3.3:1 20:6 X.07 Prothioconazole 33.3:1 20:0.6 X.07 Prothioconazole .sup.1:3 2:6 X.07 Prothioconazole 3.3:1 .sup.2:0.6 X.07 Mefentrifluconazole 3.3:1 20:6 X.07 Mefentrifluconazole 33.3:1 20:0.6 X.07 Mefentrifluconazole .sup.1:3 2:6 X.07 Mefentrifluconazole 3.3:1 .sup.2:0.6 X.07 Fenpropidin .sup.1:1 20:20 X.07 Fenpropidin 3.3:1 20:6 X.07 Fenpropidin 1:10 2:20 X.07 Fenpropidin .sup.1:3 2:6 X.07 Fenpropimorph .sup.1:1 20:20 X.07 Fenpropimorph 3.3:1 20:6 X.07 Fenpropimorph 1:10 2:20 X.07 Fenpropimorph .sup.1:3 2:6 X.07 Fluxapyroxad 3.3:1 20:6 X.07 Fluxapyroxad 33.3:1 20:0.6 X.07 Fluxapyroxad .sup.1:3 2:6 X.07 Fluxapyroxad 3.3:1 .sup.2:0.6 X.07 Fluopyram 3.3:1 20:6 X.07 Fluopyram 33.3:1 20:0.6 X.07 Fluopyram .sup.1:3 2:6 X.07 Fluopyram 3.3:1 .sup.2:0.6 X.07 Benzovindiflupyr 3.3:1 20:6 X.07 Benzovindiflupyr 33.3:1 20:0.6 X.07 Benzovindiflupyr .sup.1:3 2:6 X.07 Benzovindiflupyr 3.3:1 .sup.2:0.6 X.07 Pydiflumetofen 3.3:1 20:6 X.07 Pydiflumetofer 33.3:1 20:0.6 X.07 Pydiflumetofen .sup.1:3 2:6 X.07 Pydiflumetofen 3.3:1 .sup.2:0.6 X.07 Isoflucypram 3.3:1 20:6 X.07 Isoflucypram 33.3:1 20:0.6 X.07 Isoflucypram .sup.1:3 2:6 X.07 Isoflucypram 3.3:1 .sup.2:0.6 X.07 Fluindapyr 3.3:1 20:6 X.07 Fluindapyr 33.3:1 20:0.6 X.07 Fluindapyr .sup.1:3 2:6 X.07 Fluindapyr 3.3:1 .sup.2:0.6 X.07 Florylpicoxamid 3.3:1 20:6 X.07 Florylpicoxamid 33.3:1 20:0.6 X.07 Florylpicoxamid .sup.1:3 2:6 X.07 Florylpicoxamid 3.3:1 .sup.2:0.6 X.07 Metarylpicoxamid 3.3:1 20:6 X.07 Metarylpicoxamid 33.3:1 20:0.6 X.07 Metarylpicoxamid .sup.1:3 2:6 X.07 Metarylpicoxamid 3.3:1 .sup.2:0.6 X.07 Chlorothalonil 3.3:1 20:6 X.07 Chlorothalonil 33.3:1 20:0.6 X.07 Chlorothalonil .sup.1:3 2:6 X.07 Chlorothalonil 3.3:1 .sup.2:0.6 X.07 Mancozeb .sup.1:1 20:20 X.07 Mancozeb 3.3:1 20:6 X.07 Mancozeb 1:10 2:20 X.07 Mancozeb .sup.1:3 2:6 X.07 Mandipropamid .sup.1:1 20:20 X.07 Mandipropamid 3.3:1 20:6 X.07 Mandipropamid 1:10 2:20 X.07 Mandipropamid .sup.1:3 2:6 X.07 Oxathiapiprolin .sup.1:1 20:20 X.07 Oxathiapiprolin 3.3:1 20:6 X.07 Oxathiapiprolin 1:10 2:20 X.07 Oxathiapiprolin .sup.1:3 2:6 X.07 Fluazinam 3.3:1 20:6 X.07 Fluazinam 33.3:1 20:0.6 X.07 Fluazinam .sup.1:3 2:6 X.07 Fluazinam 3.3:1 .sup.2:0.6 X.07 Fludioxonil 3.3:1 20:6 X.07 Fludioxonil 33.3:1 20:0.6 X.07 Fludioxonil .sup.1:3 2:6 X.07 Fludioxonil 3.3:1 .sup.2:0.6 X.07 Cyprodinil 3.3:1 20:6 X.07 Cyprodinil 33.3:1 20:0.6 X.07 Cyprodinil .sup.1:3 2:6 X.07 Cyprodinil 3.3:1 .sup.2:0.6 X.07 Metalaxyl-M .sup.1:1 20:20 X.07 Metalaxyl-M 3.3:1 20:6 X.07 Metalaxyl-M 1:10 2:20 X.07 Metalaxyl-M .sup.1:3 2:6 X.07 Folpet 3.3:1 20:6 X.07 Folpet 10:1 20:2 X.07 Folpet .sup.1:3 2:6 X.07 Folpet .sup.1:1 2:2 X.07 Aminopyrifen 3.3:1 20:6 X.07 Aminopyrifen 33.3:1 20:0.6 X.07 Aminopyrifen .sup.1:3 2:6 X.07 Aminopyrifen 3.3:1 .sup.2:0.6 X.07 N-(1-benzyl-1,3-dimethyl-butyl)- 3.3:1 20:6 8-fluoro-quinoline-3- carboxamide X.07 N-(1-benzyl-1,3-dimethyl-butyl)- 33.3:1 20:0.6 8-fluoro-quinoline-3- carboxamide X.07 N-(1-benzyl-1,3-dimethyl-butyl)- .sup.1:3 2:6 8-fluoro-quinoline-3- carboxamide X.07 N-(1-benzyl-1,3-dimethyl-butyl)- 3.3:1 .sup.2:0.6 8-fluoro-quinoline-3- carboxamide X.07 N-(1-benzyl-3,3,3-trifluoro-1- 3.3:1 20:6 methyl-propyl)-8-fluoro- quinoline-3-carboxamide X.07 N-(1-benzyl-3,3,3-trifluoro-1- 33.3:1 20:0.6 methyl-propyl)-8-fluoro- quinoline-3-carboxamide X.07 N-(1-benzyl-3,3,3-trifluoro-1- .sup.1:3 2:6 methyl-propyl)-8-fluoro- quinoline-3-carboxamide X.07 N-(1-benzyl-3,3,3-trifluoro-1- 3.3:1 .sup.2:0.6 methyl-propyl)-8-fluoro- quinoline-3-carboxamide X.07 1-(6,7-dimethylpyrazolo[1,5- 3.3:1 20:6 a]pyridin-3-yl)-4,4,5-trifluoro-3,3- dimethyl-isoquinoline X.07 1-(6,7-dimethylpyrazolo[1,5- 33.3:1 20:0.6 a]pyridin-3-yl)-4,4,5-trifluoro-3,3- dimethyl-isoquinoline X.07 1-(6,7-dimethylpyrazolo[1,5- .sup.1:3 2:6 a]pyridin-3-yl)-4,4,5-trifluoro-3,3- dimethyl-isoquinoline X.07 1-(6,7-dimethylpyrazolo[1,5- 3.3:1 .sup.2:0.6 a]pyridin-3-yl)-4,4,5-trifluoro-3,3- dimethyl-isoquinoline X.07 4,4-difluoro-3,3-dimethyl-1-(7- 3.3:1 20:6 methylpyrazolo[1,5-a]pyridin-3- yl)isoquinoline X.07 4,4-difluoro-3,3-dimethyl-1-(7- 33.3:1 20:0.6 methylpyrazolo[1,5-a]pyridin-3- yl)isoquinoline X.07 4,4-difluoro-3,3-dimethyl-1-(7- .sup.1:3 2:6 methylpyrazolo[1,5-a]pyridin-3- yl)isoquinoline X.07 4,4-difluoro-3,3-dimethyl-1-(7- 3.3:1 .sup.2:0.6 methylpyrazolo[1,5-a]pyridin-3- y))isoquinoline X.07 1-(4,5-dimethylbenzimidazol-1- 3.3:1 20:6 yl)-4,4,5-trifluoro-3,3-dimethyl- isoquinoline X.07 1-(4,5-dimethylbenzimidazol-1- 33.3:1 20:0.6 yl)-4,4,5-trifluoro-3,3-dimethyl- isoquinoline X.07 1-(4,5-dimethylbenzimidazol-1- .sup.1:3 2:6 yl)-4,4,5-trifluoro-3,3-dimethyl- isoquinoline X.07 1-(4,5-dimethylbenzimidazol-1- 3.3:1 .sup.2:0.6 yl)-4,4,5-trifluoro-3,3-dimethyl- isoquinoline X.07 1-(4,5-dimethylbenzimidazol-1- 3.3:1 20:6 yl)-4,4-difluoro-3,3-dimethyl- isoquinoline X.07 1-(4,5-dimethylbenzimidazol-1- 33.3:1 20:0.6 yl)-4,4-difluoro-3,3-dimethyl- isoquinoline X.07 1-(4,5-dimethylbenzimidazol-1- .sup.1:3 2:6 yl)-4,4-difluoro-3,3-dimethyl- isoquinoline X.07 1-(4,5-dimethylbenzimidazol-1- 3.3:1 .sup.2:0.6 yl)-4,4-difluoro-3,3-dimethyl- isoquinoline X.07 Isopyrazam 3.3:1 20:6 X.07 Isopyrazam 33.3:1 20:0.6 X.07 Isopyrazam .sup.1:3 2:6 X.07 Isopyrazam 3.3:1 .sup.2:0.6 X.07 Sedaxane 3.3:1 20:6 X.07 Sedaxane 33.3:1 20:0.6 X.07 Sedaxane .sup.1:3 2:6 X.07 Sedaxane 3.3:1 .sup.2:0.6 X.07 Isofetamid 3.3:1 20:6 X.07 Isofetamid 33.3:1 20:0.6 X.07 Isofetamid .sup.1:3 2:6 X.07 Isofetamid 3.3:1 .sup.2:0.6 X.07 Ipflufenoquin 3.3:1 20:6 X.07 Ipflufenoquin 33.3:1 20:0.6 X.07 Ipflufenoquin .sup.1:3 2:6 X.07 Ipflufenoquin 3.3:1 .sup.2:0.6 X.07 Quinofumelin 3.3:1 20:6 X.07 Quinofumelin 33.3:1 20:0.6 X.07 Quinofumelin .sup.1:3 2:6 X.07 Quinofumelin 3.3:1 .sup.2:0.6

(98) TABLE-US-00040 Component A Ratio Conc. (ppm) (Compound) Component B A:B (A:B) X.14 Azoxystrobin 3.3:1 20:6 X.14 Azoxystrobin 33.3:1 20:0.6 X.14 Azoxystrobin .sup.1:3 2:6 X.14 Azoxystrobin 3.3:1 .sup.2:0.6 X.14 Trifloxystrobin 3.3:1 20:6 X.14 Trifloxystrobin 33.3:1 20:0.6 X.14 Trifloxystrobin .sup.1:3 2:6 X.14 Trifloxystrobin 3.3:1 .sup.2:0.6 X.14 Metyltetraprole 3.3:1 20:6 X.14 Metyltetraprole 33.3:1 20:0.6 X.14 Metyltetraprole .sup.1:3 2:6 X.14 Metyltetraprole 3.3:1 .sup.2:0.6 X.14 Difenoconazole 3.3:1 20:6 X.14 Difenoconazole 33.3:1 20:0.6 X.14 Difenoconazole .sup.1:3 2:6 X.14 Difenoconazole 3.3:1 .sup.2:0.6 X.14 Hexaconazole 3.3:1 20:6 X.14 Hexaconazole 33.3:1 20:0.6 X.14 Hexaconazole .sup.1:3 2:6 X.14 Hexaconazole 3.3:1 .sup.2:0.6 X.14 Propiconazole 3.3:1 20:6 X.14 Propiconazole 33.3:1 20:0.6 X.14 Propiconazole .sup.1:3 2:6 X.14 Propiconazole 3.3:1 .sup.2:0.6 X.14 Prothioconazole 3.3:1 20:6 X.14 Prothioconazole 33.3:1 20:0.6 X.14 Prothioconazole .sup.1:3 2:6 X.14 Prothioconazole 3.3:1 .sup.2:0.6 X.14 Mefentrifluconazole 3.3:1 20:6 X.14 Mefentrifluconazole 33.3:1 20:0.6 X.14 Mefentrifluconazole .sup.1:3 2:6 X.14 Mefentrifluconazole 3.3:1 .sup.2:0.6 X.14 Fenpropidin .sup.1:1 20:20 X.14 Fenpropidin 3.3:1 20:6 X.14 Fenpropidin 1:10 2:20 X.14 Fenpropidin .sup.1:3 2:6 X.14 Fenpropimorph .sup.1:1 20:20 X.14 Fenpropimorph 3.3:1 20:6 X.14 Fenpropimorph 1:10 2:20 X.14 Fenpropimorph .sup.1:3 2:6 X.14 Fluxapyroxad 3.3:1 20:6 X.14 Fluxapyroxad 33.3:1 20:0.6 X.14 Fluxapyroxad .sup.1:3 2:6 X.14 Fluxapyroxad 3.3:1 .sup.2:0.6 X.14 Fluopyram 3.3:1 20:6 X.14 Fluopyram 33.3:1 20:0.6 X.14 Fluopyram .sup.1:3 2:6 X.14 Fluopyram 3.3:1 .sup.2:0.6 X.14 Benzovindiflupyr 3.3:1 20:6 X.14 Benzovindiflupyr 33.3:1 20:0.6 X.14 Benzovindiflupyr .sup.1:3 2:6 X.14 Benzovindiflupyr 3.3:1 .sup.2:0.6 X.14 Pydiflumetofen 3.3:1 20:6 X.14 Pydiflumetofen 33.3:1 20:0.6 X.14 Pydiflumetofen .sup.1:3 2:6 X.14 Pydiflumetofen 3.3:1 .sup.2:0.6 X.14 Isoflucypram 3.3:1 20:6 X.14 Isoflucypram 33.3:1 20:0.6 X.14 Isoflucypram .sup.1:3 2:6 X.14 Isoflucypram 3.3:1 .sup.2:0.6 X.14 Fluindapyr 3.3:1 20:6 X.14 Fluindapyr 33.3:1 20:0.6 X.14 Fluindapyr .sup.1:3 2:6 X.14 Fluindapyr 3.3:1 .sup.2:0.6 X.14 Florylpicoxamid 3.3:1 20:6 X.14 Florylpicoxamid 33.3:1 20:0.6 X.14 Florylpicoxamid .sup.1:3 2:6 X.14 Florylpicoxamid 3.3:1 .sup.2:0.6 X.14 Metarylpicoxamid 3.3:1 20:6 X.14 Metarylpicoxamid 33.3:1 20:0.6 X.14 Metarylpicoxamid .sup.1:3 2:6 X.14 Metarylpicoxamid 3.3:1 .sup.2:0.6 X.14 Chlorothalonil 3.3:1 20:6 X.14 Chlorothalonil 33.3:1 20:0.6 X.14 Chlorothalonil .sup.1:3 2:6 X.14 Chlorothalonil 3.3:1 .sup.2:0.6 X.14 Mancozeb .sup.1:1 20:20 X.14 Mancozeb 3.3:1 20:6 X.14 Mancozeb 1:10 2:20 X.14 Mancozeb .sup.1:3 2:6 X.14 Mandipropamid .sup.1:1 20:20 X.14 Mandipropamid 3.3:1 20:6 X.14 Mandipropamid 1:10 2:20 X.14 Mandipropamid .sup.1:3 2:6 X.14 Oxathiapiprolin .sup.1:1 20:20 X.14 Oxathiapiprolin 3.3:1 20:6 X.14 Oxathiapiprolin 1:10 2:20 X.14 Oxathiapiprolin .sup.1:3 2:6 X.14 Fluazinam 3.3:1 20:6 X.14 Fluazinam 33.3:1 20:0.6 X.14 Fluazinam .sup.1:3 2:6 X.14 Fluazinam 3.3:1 .sup.2:0.6 X.14 Fludioxonil 3.3:1 20:6 X.14 Fludioxonil 33.3:1 20:0.6 X.14 Fludioxonil .sup.1:3 2:6 X.14 Fludioxonil 3.3:1 .sup.2:0.6 X.14 Cyprodinil 3.3:1 20:6 X.14 Cyprodinil 33.3:1 20:0.6 X.14 Cyprodinil .sup.1:3 2:6 X.14 Cyprodinil 3.3:1 .sup.2:0.6 X.14 Metalaxyl-M .sup.1:1 20:20 X.14 Metalaxyl-M 3.3:1 20:6 X.14 Metalaxyl-M 1:10 2:20 X.14 Metalaxyl-M .sup.1:3 2:6 X.14 Folpet 3.3:1 20:6 X.14 Folpet 10:1 20:2 X.14 Folpet .sup.1:3 2:6 X.14 Folpet .sup.1:1 2:2 X.14 Aminopyrifen 3.3:1 20:6 X.14 Aminopyrifen 33.3:1 20:0.6 X.14 Aminopyrifen .sup.1:3 2:6 X.14 Aminopyrifen 3.3:1 .sup.2:0.6 X.14 N-(1-benzyl-1,3-dimethyl-butyl)- 3.3:1 20:6 8-fluoro-quinoline-3- carboxamide X.14 N-(1-benzyl-1,3-dimethyl-butyl)- 33.3:1 20:0.6 8-fluoro-quinoline-3- carboxamide X.14 N-(1-benzyl-1,3-dimethyl-butyl)- .sup.1:3 2:6 8-fluoro-quinoline-3- carboxamide X.14 N-(1-benzyl-1,3-dimethyl-butyl)- 3.3:1 .sup.2:0.6 8-fluoro-quinoline-3- carboxamide X.14 N-(1-benzyl-3,3,3-trifluoro-1- 3.3:1 20:6 methyl-propyl)-8-fluoro- quinoline-3-carboxamide X.14 N-(1-benzyl-3,3,3-trifluoro-1- 33.3:1 20:0.6 methyl-propyl)-8-fluoro- quinoline-3-carboxamide X.14 N-(1-benzyl-3,3,3-trifluoro-1- .sup.1:3 2:6 methyl-propyl)-8-fluoro- quinoline-3-carboxamide X.14 N-(1-benzyl-3,3,3-trifluoro-1- 3.3:1 .sup.2:0.6 methyl-propyl)-8-fluoro- quinoline-3-carboxamide X.14 1-(6,7-dimethylpyrazolo[1,5- 3.3:1 20:6 a]pyridin-3-yl)-4,4,5-trifluoro-3,3- dimethyl-isoquinoline X.14 1-(6,7-dimethylpyrazolo[1,5- 33.3:1 20:0.6 a]pyridin-3-yl)-4,4,5-trifluoro-3,3- dimethyl-isoquinoline X.14 1-(6,7-dimethylpyrazolo[1,5- .sup.1:3 2:6 a]pyridin-3-yl)-4,4,5-trifluoro-3,3- dimethyl-isoquinoline X.14 1-(6,7-dimethylpyrazolo[1,5- 3.3:1 .sup.2:0.6 a]pyridin-3-yl)-4,4,5-trifluoro-3,3- dimethyl-isoquinoline X.14 4,4-difluoro-3,3-dimethyl-1-(7- 3.3:1 20:6 methylpyrazolo[1,5-a]pyridin-3- yl)isoquinoline X.14 4,4-difluoro-3,3-dimethyl-1-(7- 33.3:1 20:0.6 methylpyrazolo[1,5-a]pyridin-3- yl)isoquinoline X.14 4,4-difluoro-3,3-dimethyl-1-(7- .sup.1:3 2:6 methylpyrazolo[1,5-a]pyridin-3- yl)isoquinoline X.14 4,4-difluoro-3,3-dimethyl-1-(7- 3.3:1 .sup.2:0.6 methylpyrazolo[1,5-a]pyridin-3- yl)isoquinoline X.14 1-(4,5-dimethylbenzimidazol-1- 3.3:1 20:6 yl)-4,4,5-trifluoro-3,3-dimethyl- isoquinoline X.14 1-(4,5-dimethylbenzimidazol-1- 33.3:1 20:0.6 yl)-4,4,5-trifluoro-3,3-dimethyl- isoquinoline X.14 1-(4,5-dimethylbenzimidazol-1- .sup.1:3 2:6 yl)-4,4,5-trifluoro-3,3-dimethyl- isoquinoline X.14 1-(4,5-dimethylbenzimidazol-1- 3.3:1 .sup.2:0.6 yl)-4,4,5-trifluoro-3,3-dimethyl- isoquinoline X.14 1-(4,5-dimethylbenzimidazol-1- 3.3:1 20:6 yl)-4,4-difluoro-3,3-dimethyl- isoquinoline X.14 1-(4,5-dimethylbenzimidazol-1- 33.3:1 20:0.6 yl)-4,4-difluoro-3,3-dimethyl- isoquinoline X.14 1-(4,5-dimethylbenzimidazol-1- .sup.1:3 2:6 yl)-4,4-difluoro-3,3-dimethyl- isoquinoline X.14 1-(4,5-dimethylbenzimidazol-1- 3.3:1 .sup.2:0.6 yl)-4,4-difluoro-3,3-dimethyl- isoquinoline X.14 Isopyrazam 3.3:1 20:6 X.14 Isopyrazam 33.3:1 20:0.6 X.14 Isopyrazam .sup.1:3 2:6 X.14 Isopyrazam 3.3:1 .sup.2:0.6 X.14 Sedaxane 3.3:1 20:6 X.14 Sedaxane 33.3:1 20:0.6 X.14 Sedaxane .sup.1:3 2:6 X.14 Sedaxane 3.3:1 .sup.2:0.6 X.14 Isofetamid 3.3:1 20:6 X.14 Isofetamid 33.3:1 20:0.6 X.14 Isofetamid .sup.1:3 2:6 X.14 Isofetamid 3.3:1 .sup.2:0.6 X.14 Ipflufenoquin 3.3:1 20:6 X.14 Ipflufenoquin 33.3:1 20:0.6 X.14 Ipflufenoquin .sup.1:3 2:6 X.14 Ipflufenoquin 3.3:1 .sup.2:0.6 X.14 Quinofumelin 3.3:1 20:6 X.14 Quinofumelin 33.3:1 20:0.6 X.14 Quinofumelin .sup.1:3 2:6 X.14 Quinofumelin 3.3:1 .sup.2:0.6

Example B11: Blumeria graminis f. sp. tritici (Erysiphe graminis f. sp. tritici)/Wheat/Leaf Disc Preventative (Powdery Mildew on Wheat)

(99) Wheat leaf segments cv. Kanzler are placed on agar in a multiwell plate (24-well format) and sprayed with the formulated test compounds diluted in water. The leaf disks are inoculated by shaking powdery mildew infected plants above the test plates 1 day after application. The inoculated leaf disks are incubated at 20 C. and 60% rh under a light regime of 24 h darkness followed by 12 h light/12 h darkness in a climate chamber and the activity of the compounds is assessed as percent disease control compared to untreated when an appropriate level of disease damage appears on untreated check leaf segments (6-8 days after application). The following mixture compositions (A:B) at the reported concentration (in ppm) gave at least 80% disease control in this test when compared to the untreated control Under the same conditions, which showed extensive disease development.

(100) TABLE-US-00041 Component A Ratio Conc. (ppm) (Compound) Component B A:B (A:B) X.05 Azoxystrobin 1.6:1.sup. 100:60 X.05 Azoxystrobin 5:1 100:20 X.05 Azoxystrobin 1:2 30:60 X.05 Azoxystrobin 3:2 30:20 X.05 Trifloxystrobin 1.6:1.sup. 100:60 X.05 Trifloxystrobin 5:1 100:20 X.05 Trifloxystrobin 1:2 30:60 X.05 Trifloxystrobin 3:2 30:20 X.05 Metyltetraprole 1.6:1.sup. 100:60 X.05 Metyltetraprole 5:1 100:20 X.05 Metyltetraprole 1:2 30:60 X.05 Metyltetraprole 3:2 30:20 X.05 Difenoconazole 1.6:1.sup. 100:60 X.05 Difenoconazole 5:1 100:20 X.05 Difenoconazole 1:2 30:60 X.05 Difenoconazole 3:2 30:20 X.05 Hexaconazole 1.6:1.sup. 100:60 X.05 Hexaconazole 5:1 100:20 X.05 Hexaconazole 1:2 30:60 X.05 Hexaconazole 3:2 30:20 X.05 Propiconazole 1.6:1.sup. 100:60 X.05 Propiconazole 5:1 100:20 X.05 Propiconazole 1:2 30:60 X.05 Propiconazole 3:2 30:20 X.05 Prothioconazole 1.6:1.sup. 100:60 X.05 Prothioconazole 5:1 100:20 X.05 Prothioconazole 1:2 30:60 X.05 Prothioconazole 3:2 30:20 X.05 Mefentrifluconazole 1.6:1.sup. 100:60 X.05 Mefentrifluconazole 5:1 100:20 X.05 Mefentrifluconazole 1:2 30:60 X.05 Mefentrifluconazole 3:2 30:20 X.05 Fenpropidin 1:1 100:100 X.05 Fenpropidin 3.3:1.sup. 100:30 X.05 Fenpropidin .sup.1:3.3 30:100 X.05 Fenpropidin 1:1 30:30 X.05 Fenpropimorph 1.6:1.sup. 100:60 X.05 Fenpropimorph 5:1 100:20 X.05 Fenpropimorph 1:2 30:60 X.05 Fenpropimorph 3:2 30:20 X.05 Fluxapyroxad 1.6:1.sup. 100:60 X.05 Fluxapyroxad 5:1 100:20 X.05 Fluxapyroxad 1:2 30:60 X.05 Fluxapyroxad 3:2 30:20 X.05 Fluopyram 1:1 100:100 X.05 Fluopyram 3.3:1.sup. 100:30 X.05 Fluopyram .sup.1:3.3 30:100 X.05 Fluopyram 1:1 30:30 X.05 Benzovindiflupyr 1.6:1.sup. 100:60 X.05 Benzovindiflupyr 5:1 100:20 X.05 Benzovindiflupyr 1:2 30:60 X.05 Benzovindiflupyr 3:2 30:20 X.05 Pydiflumetofen 1.6:1.sup. 100:60 X.05 Pydiflumetofen 5:1 100:20 X.05 Pydiflumetofen 1:2 30:60 X.05 Pydiflumetofen 3:2 30:20 X.05 Isoflucypram 1.6:1.sup. 100:60 X.05 Isoflucypram 5:1 100:20 X.05 Isoflucypram 1:2 30:60 X.05 Isoflucypram 3:2 30:20 X.05 Florylpicoxamid 1.6:1.sup. 100:60 X.05 Florylpicoxamid 5:1 100:20 X.05 Florylpicoxamid 1:2 30:60 X.05 Florylpicoxamid 3:2 30:20 X.05 Metarylpicoxamid 1:1 100:100 X.05 Metarylpicoxamid 3.3:1.sup. 100:30 X.05 Metarylpicoxamid .sup.1:3.3 30:100 X.05 Metarylpicoxamid 1:1 30:30 X.05 Fosetyl-aluminium 1:1 100:100 X.05 Fosetyl-aluminium 3.3:1.sup. 100:30 X.05 Fosetyl-aluminium .sup.1:3.3 30:100 X.05 Fosetyl-aluminium 1:1 30:30 X.05 Chlorothalonil 1:1 100:100 X.05 Chlorothalonil 3.3:1.sup. 100:30 X.05 Chlorothalonil .sup.1:3.3 30:100 X.05 Chlorothalonil 1:1 30:30 X.05 Mancozeb 1:1 100:100 X.05 Mancozeb 3.3:1.sup. 100:30 X.05 Mancozeb .sup.1:3.3 30:100 X.05 Mancozeb 1:1 30:30 X.05 Mandipropamid 1:1 100:100 X.05 Mandipropamid 3.3:1.sup. 100:30 X.05 Mandipropamid .sup.1:3.3 30:100 X.05 Mandipropamid 1:1 30:30 X.05 Oxathiapiprolin 1:1 100:100 X.05 Oxathiapiprolin 3.3:1.sup. 100:30 X.05 Oxathiapiprolin .sup.1:3.3 30:100 X.05 Oxathiapiprolin 1:1 30:30 X.05 Fluazinam 1:1 100:100 X.05 Fluazinam 3.3:1.sup. 100:30 X.05 Fluazinam .sup.1:3.3 30:100 X.05 Fluazinam 1:1 30:30 X.05 Fludioxonil 1:1 100:100 X.05 Fludioxonil 3.3:1.sup. 100:30 X.05 Fludioxonil .sup.1:3.3 30:100 X.05 Fludioxonil 1:1 30:30 X.05 Cyprodinil 1:1 100:100 X.05 Cyprodinil 3.3:1.sup. 100:30 X.05 Cyprodinil .sup.1:3.3 30:100 X.05 Cyprodinil 1:1 30:30 X.05 Metalaxyl-M 1:1 100:100 X.05 Metalaxyl-M 3.3:1.sup. 100:30 X.05 Metalaxyl-M .sup.1:3.3 30:100 X.05 Metalaxyl-M 1:1 30:30 X.05 Folpet 1:1 100:100 X.05 Folpet 3.3:1.sup. 100:30 X.05 Folpet .sup.1:3.3 30:100 X.05 Folpet 1:1 30:30 X.05 N-[5-bromo-2-methyl-6-(1-methyl-2-propoxy- 1:1 100:100 ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidine X.05 N-[5-bromo-2-methyl-6-(1-methyl-2-propoxy- 3.3:1.sup. 100:30 ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidine X.05 N-[5-bromo-2-methyl-6-(1-methyl-2-propoxy- .sup.1:3.3 30:100 ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidine X.05 N-[5-bromo-2-methyl-6-(1-methyl-2-propoxy- 1:1 30:30 ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidine X.05 N-isopropyl-N-[5-methoxy-2-methyl-4-(2,2,2- 3:1 100:100 trifluoro-1-hydroxy-1-phenyl-ethyl)phenyl]-N- methyl-formamidine X.05 N-isopropyl-N-[5-methoxy-2-methyl-4-(2,2,2- 3.3:1.sup. 100:30 trifluoro-1-hydroxy-1-phenyl-ethyl)phenyl]-N- methyl-formamidine X.05 N-isopropyl-N-[5-methoxy-2-methyl-4-(2,2,2- .sup.1:3.3 30:100 trifluoro-1-hydroxy-1-phenyl-ethyl)phenyl]-N- methyl-formamidine X.05 N-isopropyl-N-[5-methoxy-2-methyl-4-(2,2,2- 1:1 30:30 trifluoro-1-hydroxy-1-phenyl-ethyl)phenyl]-N- methyl-formamidine X.05 TAEGRO 1:1 100:100 X.05 TAEGRO 3.3:1.sup. 100:30 X.05 TAEGRO .sup.1:3.3 30:100 X.05 TAEGRO 1:1 30:30 X.05 Timorex GoldTM 1:1 100:100 X.05 Timorex GoldTM 3.3:1.sup. 100:30 X.05 Timorex GoldTM .sup.1:3.3 30:100 X.05 Timorex GoldTM 1:1 30:30 X.05 Isofetamid 1.6:1.sup. 100:60 X.05 Isofetamid 5:1 100:20 X.05 Isofetamid 1:2 30:60 X.05 Isofetamid 3:2 30:20 X.05 Acibenzolar-S-methyl 1:1 100:100 X.05 Acibenzolar-S-methyl 3.3:1.sup. 100:30 X.05 Acibenzolar-S-methyl .sup.1:3.3 30:100 X.05 Acibenzolar-S-methyl 1:1 30:30 X.05 Aminopyrifen 1:1 100:100 X.05 Aminopyrifen 3.3:1.sup. 100:30 X.05 Aminopyrifen .sup.1:3.3 30:100 X.05 Aminopyrifen 1:1 30:30 X.05 Cyflufenamid 5:1 100:20 X.05 Cyflufenamid 50:1 100:2 X.05 Cyflufenamid 3:2 30:20 X.05 Cyflufenamid 15:1 30:2 X.05 Metrafenone 5:1 100:20 X.05 Metrafenone 50:1 100:2 X.05 Metrafenone 3:2 30:20 X.05 Metrafenone 15:1 30:2 X.05 N-(1-benzyl-1,3-dimethyl-butyl)- 1:1 100:100 8-fluoro-quinoline-3- carboxamide X.05 N-(1-benzyl-1,3-dimethyl-butyl)- 3.3:1.sup. 100:30 8-fluoro-quinoline-3- carboxamide X.05 N-(1-benzyl-1,3-dimethyl-butyl)- .sup.1:3.3 30:100 8-fluoro-quinoline-3- carboxamide X.05 N-(1-benzyl-1,3-dimethyl-butyl)- 1:1 30:30 8-fluoro-quinoline-3- carboxamide X.05 N-(1-benzyl-3,3,3-trifluoro-1- 1:1 100:100 methyl-propyl)-8-fluoro- quinoline-3-carboxamide X.05 N-(1-benzyl-3,3,3-trifluoro-1- 3.3:1.sup. 100:30 methyl-propyl)-8-fluoro- quinoline-3-carboxamide X.05 N-(1-benzyl-3,3,3-trifluoro-1- .sup.1:3.3 30:100 methyl-propyl)-8-fluoro- quinoline-3-carboxamide X.05 N-(1-benzyl-3,3,3-trifluoro-1- 1:1 30:30 methyl-propyl)-8-fluoro- quinoline-3-carboxamide X.05 1-(6,7-dimethylpyrazolo[1,5- 1:1 100:100 a]pyridin-3-yl)-4,4,5-trifluoro-3,3- dimethyl-isoquinoline X.05 1-(6,7-dimethylpyrazolo[1,5- 3.3:1.sup. 100:30 a]pyridin-3-yl)-4,4,5-trifluoro-3,3- dimethyl-isoquinoline X.05 1-(6,7-dimethylpyrazolo[1,5- .sup.1:3.3 30:100 a]pyridin-3-yl)-4,4,5-trifluoro-3,3- dimethyl-isoquinoline X.05 1-(6,7-dimethylpyrazolo[1,5- 1:1 30:30 a]pyridin-3-yl)-4,4,5-trifluoro-3,3- dimethyl-isoquinoline X.05 4,4-difluoro-3,3-dimethyl-1-(7- 1:1 100:100 methylpyrazolo[1,5-a]pyridin-3- yl)isoquinoline X.05 4,4-difluoro-3,3-dimethyl-1-(7- 3.3:1.sup. 100:30 methylpyrazolo[1,5-a]pyridin-3- yl)isoquinoline X.05 4,4-difluoro-3,3-dimethyl-1-(7- .sup.1:3.3 30:100 methylpyrazolo[1,5-a]pyridin-3- yl)isoquinoline X.05 4,4-difluoro-3,3-dimethyl-1-(7- 1:1 30:30 methylpyrazolo[1,5-a]pyridin-3- yl)isoquinoline X.05 1-(4,5-dimethylbenzimidazol-1- 1:1 100:100 yl)-4,4,5-trifluoro-3,3-dimethyl- isoquinoline X.05 1-(4,5-dimethylbenzimidazol-1- 3.3:1.sup. 100:30 yl)-4,4,5-trifluoro-3,3-dimethyl- isoquinoline X.05 1-(4,5-dimethylbenzimidazol-1- .sup.1:3.3 30:100 yl)-4,4,5-trifluoro-3,3-dimethyl- isoquinoline X.05 1-(4,5-dimethylbenzimidazol-1- 1:1 30:30 yl)-4,4,5-trifluoro-3,3-dimethyl- isoquinoline X.05 1-(4,5-dimethylbenzimidazol-1- 1:1 100:100 yl)-4,4-difluoro-3,3-dimethyl- isoquinoline X.05 1-(4,5-dimethylbenzimidazol-1- 3.3:1.sup. 100:30 yl)-4,4-difluoro-3,3-dimethyl- isoquinoline X.05 1-(4,5-dimethylbenzimidazol-1- .sup.1:3.3 30:100 yl)-4,4-difluoro-3,3-dimethyl- isoquinoline X.05 1-(4,5-dimethylbenzimidazol-1- 1:1 30:30 yl)-4,4-difluoro-3,3-dimethyl- isoquinoline

(101) TABLE-US-00042 Component A Ratio Conc. (ppm) (Compound) Component B A:B (A:B) X.07 Azoxystrobin 1.6:1.sup. 100:60 X.07 Azoxystrobin 5:1 100:20 X.07 Azoxystrobin 1:2 30:60 X.07 Azoxystrobin 3:2 30:20 X.07 Trifloxystrobin 1.6:1.sup. 100:60 X.07 Trifloxystrobin 5:1 100:20 X.07 Trifloxystrobin 1:2 30:60 X.07 Trifloxystrobin 3:2 30:20 X.07 Metyltetraprole 1.6:1.sup. 100:60 X.07 Metyltetraprole 5:1 100:20 X.07 Metyltetraprole 1:2 30:60 X.07 Metyltetraprole 3:2 30:20 X.07 Difenoconazole 1.6:1.sup. 100:60 X.07 Difenoconazole 5:1 100:20 X.07 Difenoconazole 1:2 30:60 X.07 Difenoconazole 3:2 30:20 X.07 Hexaconazole 1.6:1.sup. 100:60 X.07 Hexaconazole 5:1 100:20 X.07 Hexaconazole 1:2 30:60 X.07 Hexaconazole 3:2 30:20 X.07 Propiconazole 1.6:1.sup. 100:60 X.07 Propiconazole 5:1 100:20 X.07 Propiconazole 1:2 30:60 X.07 Propiconazole 3:2 30:20 X.07 Prothioconazole 1.6:1.sup. 100:60 X.07 Prothioconazole 5:1 100:20 X.07 Prothioconazole 1:2 30:60 X.07 Prothioconazole 3:2 30:20 X.07 Mefentrifluconazole 1.6:1.sup. 100:60 X.07 Mefentrifluconazole 5:1 100:20 X.07 Mefentrifluconazole 1:2 30:60 X.07 Mefentrifluconazole 3:2 30:20 X.07 Fenpropidin 1:1 100:100 X.07 Fenpropidin 3.3:1.sup. 100:30 X.07 Fenpropidin .sup.1:3.3 30:100 X.07 Fenpropidin 1:1 30:30 X.07 Fenpropimorph 1.6:1.sup. 100:60 X.07 Fenpropimorph 5:1 100:20 X.07 Fenpropimorph 1:2 30:60 X.07 Fenpropimorph 3:2 30:20 X.07 Fluxapyroxad 1.6:1.sup. 100:60 X.07 Fluxapyroxad 5:1 100:20 X.07 Fluxapyroxad 1:2 30:60 X.07 Fluxapyroxad 3:2 30:20 X.07 Fluopyram 1:1 100:100 X.07 Fluopyram 3.3:1.sup. 100:30 X.07 Fluopyram .sup.1:3.3 30:100 X.07 Fluopyram 1:1 30:30 X.07 Benzovindiflupyr 1.6:1.sup. 100:60 X.07 Benzovindiflupyr 5:1 100:20 X.07 Benzovindiflupyr 1:2 30:60 X.07 Benzovindiflupyr 3:2 30:20 X.07 Pydiflumetofen 1.6:1.sup. 100:60 X.07 Pydiflumetofen 5:1 100:20 X.07 Pydiflumetofen 1:2 30:60 X.07 Pydiflumetofen 3:2 30:20 X.07 Isoflucypram 1.6:1.sup. 100:60 X.07 Isoflucypram 5:1 100:20 X.07 Isoflucypram 1:2 30:60 X.07 Isoflucypram 3:2 30:20 X.07 Florylpicoxamid 1.6:1.sup. 100:60 X.07 Florylpicoxamid 5:1 100:20 X.07 Florylpicoxamid 1:2 30:60 X.07 Florylpicoxamid 3:2 30:20 X.07 Metarylpicoxamid 1:1 100:100 X.07 Metarylpicoxamid 3.3:1.sup. 100:30 X.07 Metarylpicoxamid .sup.1:3.3 30:100 X.07 Metarylpicoxamid 1:1 30:30 X.07 Fosetyl-aluminium 1:1 100:100 X.07 Fosetyl-aluminium 3.3:1.sup. 100:30 X.07 Fosetyl-aluminium .sup.1:3.3 30:100 X.07 Fosetyl-aluminium 1:1 30:30 X.07 Chlorothalonil 1:1 100:100 X.07 Chlorothalonil 3.3:1.sup. 100:30 X.07 Chlorothalonil .sup.1:3.3 30:100 X.07 Chlorothalonil 1:1 30:30 X.07 Mancozeb 1:1 100:100 X.07 Mancozeb 3.3:1.sup. 100:30 X.07 Mancozeb .sup.1:3.3 30:100 X.07 Mancozeb 1:1 30:30 X.07 Mandipropamid 1:1 100:100 X.07 Mandipropamid 3.3:1.sup. 100:30 X.07 Mandipropamid .sup.1:3.3 30:100 X.07 Mandipropamid 1:1 30:30 X.07 Oxathiapiprolin 1:1 100:100 X.07 Oxathiapiprolin 3.3:1.sup. 100:30 X.07 Oxathiapiprolin .sup.1:3.3 30:100 X.07 Oxathiapiprolin 1:1 30:30 X.07 Fluazinam 1:1 100:100 X.07 Fluazinam 3.3:1.sup. 100:30 X.07 Fluazinam .sup.1:3.3 30:100 X.07 Fluazinam 1:1 30:30 X.07 Fludioxonil 1:1 100:100 X.07 Fludioxonil 3.3:1.sup. 100:30 X.07 Fludioxonil .sup.1:3.3 30:100 X.07 Fludioxonil 1:1 30:30 X.07 Cyprodinil 1:1 100:100 X.07 Cyprodinil 3.3:1.sup. 100:30 X.07 Cyprodinil .sup.1:3.3 30:100 X.07 Cyprodinil 1:1 30:30 X.07 Metalaxyl-M 1:1 100:100 X.07 Metalaxyl-M 3.3:1.sup. 100:30 X.07 Metalaxyl-M .sup.1:3.3 30:100 X.07 Metalaxyl-M 1:1 30:30 X.07 Folpet 1:1 100:100 X.07 Folpet 3.3:1.sup. 100:30 X.07 Folpet .sup.1:3.3 30:100 X.07 Folpet 1:1 30:30 X.07 N-[5-bromo-2-methyl-6-(1-methyl-2-propoxy- 1:1 100:100 ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidine X.07 N-[5-bromo-2-methyl-6-(1-methyl-2-propoxy- 3.3:1.sup. 100:30 ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidine X.07 N-[5-bromo-2-methyl-6-(1-methyl-2-propoxy- .sup.1:3.3 30:100 ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidine X.07 N-[5-bromo-2-methyl-6-(1-methyl-2-propoxy- 1:1 30:30 ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidine X.07 N-isopropyl-N-[5-methoxy-2-methyl-4-(2,2,2- 1:1 100:100 trifluoro-1-hydroxy-1-phenyl-ethyl)phenyl]-N- methyl-formamidine X.07 N-isopropyl-N-[5-methoxy-2-methyl-4-(2,2,2- 3.3:1.sup. 100:30 trifluoro-1-hydroxy-1-phenyl-ethyl)phenyl]-N- methyl-formamidine X.07 N-isopropyl-N-[5-methoxy-2-methyl-4-(2,2,2- .sup.1:3.3 30:100 trifluoro-1-hydroxy-1-phenyl-ethyl)phenyl]-N- methyl-formamidine X.07 N-isopropyl-N-[5-methoxy-2-methyl-4-(2,2,2- 1:1 30:30 trifluoro-1-hydroxy-1-phenyl-ethyl)phenyl]-N- methyl-formamidine X.07 TAEGRO 1:1 100:100 X.07 TAEGRO 3.3:1.sup. 100:30 X.07 TAEGRO .sup.1:3.3 30:100 X.07 TAEGRO 1:1 30:30 X.07 Timorex GoldTM 1:1 100:100 X.07 Timorex GoldTM 3.3:1.sup. 100:30 X.07 Timorex GoldTM .sup.1:3.3 30:100 X.07 Timorex GoldTM 1:1 30:30 X.07 Isofetamid 1.6:1.sup. 100:60 X.07 Isofetamid 5:1 100:20 X.07 Isofetamid 1:2 30:60 X.07 Isofetamid 3:2 30:20 X.07 Acibenzolar-S-methyl 1:1 100:100 X.07 Acibenzolar-S-methyl 3.3:1.sup. 100:30 X.07 Acibenzolar-S-methyl .sup.1:3.3 30:100 x.07 Acibenzolar-S-methyl 1:1 30:30 X.07 Aminopyrifen 1:1 100:100 X.07 Aminopyrifen 3.3:1.sup. 100:30 X.07 Aminopyrifen .sup.1:3.3 30:100 X.07 Aminopyrifen 1:1 30:30 X.07 Cyflufenamid 5:1 100:20 X.07 Cyflufenamid 50:1 100:2 X.07 Cyflufenamid 3:2 30:20 X.07 Cyflufenamid 15:1 30:2 X.07 Metrafenone 5:1 100:20 X.07 Metrafenone 50:1 100:2 X.07 Metrafenone 3:2 30:20 X.07 Metrafenone 15:1 30:2 X.07 N-(1-benzyl-1,3-dimethyl-butyl)- 1:1 100:100 8-fluoro-quinoline-3- carboxamide X.07 N-(1-benzyl-1,3-dimethyl-butyl)- 3.3:1.sup. 100:30 8-fluoro-quinoline-3- carboxamide X.07 N-(1-benzyl-1,3-dimethyl-butyl)- .sup.1:3.3 30:100 8-fluoro-quinoline-3- carboxamide X.07 N-(1-benzyl-1,3-dimethyl-butyl)- 1:1 30:30 8-fluoro-quinoline-3- carboxamide X.07 N-(1-benzyl-3,3,3-trifluoro-1- 1:1 100:100 methyl-propyl)-8-fluoro- quinoline-3-carboxamide X.07 N-(1-benzyl-3,3,3-trifluoro-1- 3.3:1.sup. 100:30 methyl-propyl)-8-fluoro- quinoline-3-carboxamide X.07 N-(1-benzyl-3,3,3-trifluoro-1- .sup.1:3.3 30:100 methyl-propyl)-8-fluoro- quinoline-3-carboxamide X.07 N-(1-benzyl-3,3,3-trifluoro-1- 1:1 30:30 methyl-propyl)-8-fluoro- quinoline-3-carboxamide X.07 1-(6,7-dimethylpyrazolo[1,5- 1:1 100:100 a]pyridin-3-yl)-4,4,5-trifluoro-3,3- dimethyl-isoquinoline X.07 1-(6,7-dimethylpyrazolo[1,5- 3.3:1.sup. 100:30 a]pyridin-3-yl)-4,4,5-trifluoro-3,3- dimethyl-isoquinoline X.07 1-(6,7-dimethylpyrazolo[1,5- .sup.1:3.3 30:100 a]pyridin-3-yl)-4,4,5-trifluoro-3,3- dimethyl-isoquinoline X.07 1-(6,7-dimethylpyrazolo[1,5- 1:1 30:30 a]pyridin-3-yl)-4,4,5-trifluoro-3,3- dimethyl-isoquinoline X.07 4,4-difluoro-3,3-dimethyl-1-(7- 1:1 100:100 methylpyrazolo[1,5-a]pyridin-3- yl)isoquinoline X.07 4,4-difluoro-3,3-dimethyl-1-(7- 3.3:1.sup. 100:30 methylpyrazolo[1,5-a]pyridin-3- yl)isoquinoline X.07 4,4-difluoro-3,3-dimethyl-1-(7- .sup.1:3.3 30:100 methylpyrazolo[1,5-a]pyridin-3- yl)isoquinoline X.07 4,4-difluoro-3,3-dimethyl-1-(7- 1:1 30:30 methylpyrazolo[1,5-a]pyridin-3- yl)isoquinoline X.07 1-(4,5-dimethylbenzimidazol-1- 1:1 100:100 yl)-4,4,5-trifluoro-3,3-dimethyl- isoquinoline X.07 1-(4,5-dimethylbenzimidazol-1- 3.3:1.sup. 100:30 yl)-4,4,5-trifluoro-3,3-dimethyl- isoquinoline X.07 1-(4,5-dimethylbenzimidazol-1- .sup.1:3.3 30:100 yl)-4,4,5-trifluoro-3,3-dimethyl- isoquinoline X.07 1-(4,5-dimethylbenzimidazol-1- 1:1 30:30 yl)-4,4,5-trifluoro-3,3-dimethyl- isoquinoline X.07 1-(4,5-dimethylbenzimidazol-1- 1:1 100:100 yl)-4,4-difluoro-3,3-dimethyl- isoquinoline X.07 1-(4,5-dimethylbenzimidazol-1- 3.3:1.sup. 100:30 yl)-4,4-difluoro-3,3-dimethyl- isoquinoline X.07 1-(4,5-dimethylbenzimidazol-1- .sup.1:3.3 30:100 yl)-4,4-difluoro-3,3-dimethyl- isoquinoline X.07 1-(4,5-dimethylbenzimidazol-1- 1:1 30:30 yl)-4,4-difluoro-3,3-dimethyl- isoquinoline

(102) TABLE-US-00043 Component A Ratio Conc. (ppm) (Compound) Component B A:B (A:B) X.14 Azoxystrobin 1.6:1.sup. 100:60 X.14 Azoxystrobin 5:1 100:20 X.14 Azoxystrobin 1:2 30:60 X.14 Azoxystrobin 3:2 30:20 X.14 Trifloxystrobin 1.6:1.sup. 100:60 X.14 Trifloxystrobin 5:1 100:20 X.14 Trifloxystrobin 1:2 30:60 X.14 Trifloxystrobin 3:2 30:20 X.14 Metyltetraprole 1.6:1.sup. 100:60 X.14 Metyltetraprole 5:1 100:20 X.14 Metyltetraprole 1:2 30:60 X.14 Metyltetraprole 3:2 30:20 X.14 Difenoconazole 1.6:1.sup. 100:60 X.14 Difenoconazole 5:1 100:20 X.14 Difenoconazole 1:2 30:60 X.14 Difenoconazole 3:2 30:20 X.14 Hexaconazole 1.6:1.sup. 100:60 X.14 Hexaconazole 5:1 100:20 X.14 Hexaconazole 1:2 30:60 X.14 Hexaconazole 3:2 30:20 X.14 Propiconazole 1.6:1.sup. 100:60 X.14 Propiconazole 5:1 100:20 X.14 Propiconazole 1:2 30:60 X.14 Propiconazole 3:2 30:20 X.14 Prothioconazole 1.6:1.sup. 100:60 X.14 Prothioconazole 5:1 100:20 X.14 Prothioconazole 1:2 30:60 X.14 Prothioconazole 3:2 30:20 X.14 Mefentrifluconazole 1.6:1.sup. 100:60 X.14 Mefentrifluconazole 5:1 100:20 X.14 Mefentrifluconazole 1:2 30:60 X.14 Mefentrifluconazole 3:2 30:20 X.14 Fenpropidin 1:1 100:100 X.14 Fenpropidin 3.3:1.sup. 100:30 X.14 Fenpropidin .sup.1:3.3 30:100 X.14 Fenpropidin 1:1 30:30 X.14 Fenpropimorph 1.6:1.sup. 100:60 X.14 Fenpropimorph 5:1 100:20 X.14 Fenpropimorph 1:2 30:60 X.14 Fenpropimorph 3:2 30:20 X.14 Fluxapyroxad 1.6:1.sup. 100:60 X.14 Fluxapyroxad 5:1 100:20 X.14 Fluxapyroxad 1:2 30:60 X.14 Fluxapyroxad 3:2 30:20 X.14 Fluopyram 1:1 100:100 X.14 Fluopyram 3.3:1.sup. 100:30 X.14 Fluopyram .sup.1:3.3 30:100 X.14 Fluopyram 1:1 30:30 X.14 Benzovindiflupyr 1.6:1.sup. 100:60 X.14 Benzovindiflupyr 5:1 100:20 X.14 Benzovindiflupyr 1:2 30:60 X.14 Benzovindiflupyr 3:2 30:20 X.14 Pydiflumetofen 1.6:1.sup. 100:60 X.14 Pydiflumetofen 5:1 100:20 X.14 Pydiflumetofen 1:2 30:60 X.14 Pydiflumetofen 3:2 30:20 X.14 Isoflucypram 1.6:1.sup. 100:60 X.14 Isoflucypram 5:1 100:20 X.14 Isoflucypram 1:2 30:60 X.14 Isoflucypram 3:2 30:20 X.14 Florylpicoxamid 1.6:1.sup. 100:60 X.14 Florylpicoxamid 5:1 100:20 X.14 Florylpicoxamid 1:2 30:60 X.14 Florylpicoxamid 3:2 30:20 X.14 Metarylpicoxamid 1:1 100:100 X.14 Metarylpicoxamid 3.3:1.sup. 100:30 X.14 Metarylpicoxamid .sup.1:3.3 30:100 X.14 Metarylpicoxamid 1:1 30:30 X.14 Fosetyl-aluminium 1:1 100:100 X.14 Fosetyl-aluminium 3.3:1.sup. 100:30 X.14 Fosetyl-aluminium .sup.1:3.3 30:100 X.14 Fosetyl-aluminium 1:1 30:30 X.14 Chlorothalonil 1:1 100:100 X.14 Chlorothalonil 3.3:1.sup. 100:30 X.14 Chlorothalonil .sup.1:3.3 30:100 X.14 Chlorothalonil 1:1 30:30 X.14 Mancozeb 1:1 100:100 X.14 Mancozeb 3.3:1.sup. 100:30 X.14 Mancozeb .sup.1:3.3 30:100 X.14 Mancozeb 1:1 30:30 X.14 Mandipropamid 1:1 100:100 X.14 Mandipropamid 3.3:1.sup. 100:30 X.14 Mandipropamid .sup.1:3.3 30:100 X.14 Mandipropamid 1:1 30:30 X.14 Oxathiapiprolin 1:1 100:100 X.14 Oxathiapiprolin 3.3:1.sup. 100:30 X.14 Oxathiapiprolin .sup.1:3.3 30:100 X.14 Oxathiapiprolin 1:1 30:30 X.14 Fluazinam 1:1 100:100 X.14 Fluazinam 3.3:1.sup. 100:30 X.14 Fluazinam .sup.1:3.3 30:100 X.14 Fluazinam 1:1 30:30 X.14 Fludioxonil 1:1 100:100 X.14 Fludioxonil 3.3:1.sup. 100:30 X.14 Fludioxonil .sup.1:3.3 30:100 X.14 Fludioxonil 1:1 30:30 X.14 Cyprodinil 1:1 100:100 X.14 Cyprodinil 3.3:1.sup. 100:30 X.14 Cyprodinil .sup.1:3.3 30:100 X.14 Cyprodinil 1:1 30:30 X.14 Metalaxyl-M 1:1 100:100 X.14 Metalaxyl-M 3.3:1.sup. 100:30 X.14 Metalaxyl-M .sup.1:3.3 30:100 X.14 Metalaxyl-M 1:1 30:30 X.14 Folpet 1:1 100:100 X.14 Folpet 3.3:1.sup. 100:30 X.14 Folpet .sup.1:3.3 30:100 X.14 Folpet 1:1 30:30 X.14 N-[5-bromo-2-methyl-6-(1-methyl-2-propoxy- 1:1 100:100 ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidine X.14 N-[5-bromo-2-methyl-6-(1-methyl-2-propoxy- 3.3:1.sup. 100:30 ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidine X.14 N-[5-bromo-2-methyl-6-(1-methyl-2-propoxy- .sup.1:3.3 30:100 ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidine X.14 N-[5-bromo-2-methyl-6-(1-methyl-2-propoxy- 1:1 30:30 ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidine X.14 N-isopropyl-N-[5-methoxy-2-methyl-4-(2,2,2- 1:1 100:100 trifluoro-1-hydroxy-1-phenyl-ethyl)phenyl]-N- methyl-formamidine X.14 N-isopropyl-N-[5-methoxy-2-methyl-4-(2,2,2- 3.3:1.sup. 100:30 trifluoro-1-hydroxy-1-phenyl-ethyl)phenyl]-N- methyl-formamidine X.14 N-isopropyl-N-[5-methoxy-2-methyl-4-(2,2,2- .sup.1:3.3 30:100 trifluoro-1-hydroxy-1-phenyl-ethyl)phenyl]-N- methyl-formamidine X.14 N-isopropyl-N-[5-methoxy-2-methyl-4-(2,2,2- 1:1 30:30 trifluoro-1-hydroxy-1-phenyl-ethyl)phenyl]-N- methyl-formamidine X.14 TAEGRO 1:1 100:100 X.14 TAEGRO 3.3:1.sup. 100:30 X.14 TAEGRO .sup.1:3.3 30:100 X.14 TAEGRO@ 1:1 30:30 X.14 Timorex GoldTM 1:1 100:100 X.14 Timorex GoldTM 3.3:1.sup. 100:30 X.14 Timorex GoldTM .sup.1:3.3 30:100 X.14 Timorex GoldTM 1:1 30:30 X.14 Isofetamid 1.6:1.sup. 100:60 X.14 Isofetamid 5:1 100:20 X.14 Isofetamid 1:2 30:60 X.14 Isofetamid 3:2 30:20 X.14 Acibenzolar-S-methyl 1:1 100:100 X.14 Acibenzolar-S-methyl 3.3:1.sup. 100:30 X.14 Acibenzolar-S-methyl .sup.1:3.3 30:100 X.14 Acibenzolar-S-methyl 1:1 30:30 X.14 Aminopyrifen 1:1 100:100 X.14 Aminopyrifen 3.3:1.sup. 100:30 X.14 Aminopyrifen .sup.1:3.3 30:100 X.14 Aminopyrifen 1:1 30:30 X.14 Cyflufenamid 5:1 100:20 X.14 Cyflufenamid 50:1 100:2 X.14 Cyflufenamid 3:2 30:20 X.14 Cyflufenamid 15:1 30:2 X.14 Metrafenone 5:1 100:20 X.14 Metrafenone 50:1 100:2 X.14 Metrafenone 3:2 30:20 X.14 Metrafenone 15:1 30:2 X.14 N-(1-benzyl-1,3-dimethyl-butyl)- 1:1 100:100 8-fluoro-quinoline-3- carboxamide X.14 N-(1-benzyl-1,3-dimethyl-butyl)- 3.3:1.sup. 100:30 8-fluoro-quinoline-3- carboxamide X.14 N-(1-benzyl-1,3-dimethyl-butyl)- .sup.1:3.3 30:100 8-fluoro-quinoline-3- carboxamide X.14 N-(1-benzyl-1,3-dimethyl-butyl)- 1:1 30:30 8-fluoro-quinoline-3- carboxamide X.14 N-(1-benzyl-3,3,3-trifluoro-1- 1:1 100:100 methyl-propyl)-8-fluoro- quinoline-3-carboxamide X.14 N-(1-benzyl-3,3,3-trifluoro-1- 3.3:1.sup. 100:30 methyl-propyl)-8-fluoro- quinoline-3-carboxamide X.14 N-(1-benzyl-3,3,3-trifluoro-1- .sup.1:3.3 30:100 methyl-propyl)-8-fluoro- quinoline-3-carboxamide X.14 N-(1-benzyl-3,3,3-trifluoro-1- 1:1 30:30 methyl-propyl)-8-fluoro- quinoline-3-carboxamide X.14 1-(6,7-dimethylpyrazolo[1,5- 1:1 100:100 a]pyridin-3-yl)-4,4,5-trifluoro-3,3- dimethyl-isoquinoline X.14 1-(6,7-dimethylpyrazolo[1,5- 3.3:1.sup. 100:30 a]pyridin-3-yl)-4,4,5-trifluoro-3,3- dimethyl-isoquinoline X.14 1-(6,7-dimethylpyrazolo[1,5- .sup.1:3.3 30:100 a]pyridin-3-yl)-4,4,5-trifluoro-3,3- dimethyl-isoquinoline X.14 1-(6,7-dimethylpyrazolo[1,5- 1:1 30:30 a]pyridin-3-yl)-4,4,5-trifluoro-3,3- dimethyl-isoquinoline X.14 4,4-difluoro-3,3-dimethyl-1-(7- 1:1 100:100 methylpyrazolo[1,5-a]pyridin-3- yl)isoquinoline X.14 4,4-difluoro-3,3-dimethyl-1-(7- 3.3:1.sup. 100:30 methylpyrazolo[1,5-a]pyridin-3- yl)isoquinoline X.14 4,4-difluoro-3,3-dimethyl-1-(7- .sup.1:3.3 30:100 methylpyrazolo[1,5-a]pyridin-3- yl)isoquinoline X.14 4,4-difluoro-3,3-dimethyl-1-(7- 1:1 30:30 methylpyrazolo[1,5-a]pyridin-3- yl)isoquinoline X.14 1-(4,5-dimethylbenzimidazol-1- 1:1 100:100 yl)-4,4,5-trifluoro-3,3-dimethyl- isoquinoline X.14 1-(4,5-dimethylbenzimidazol-1- 3.3:1.sup. 100:30 yl)-4,4,5-trifluoro-3,3-dimethyl- isoquinoline X.14 1-(4,5-dimethylbenzimidazol-1- .sup.1:3.3 30:100 yl)-4,4,5-trifluoro-3,3-dimethyl- isoquinoline X.14 1-(4,5-dimethylbenzimidazol-1- 1:1 30:30 yl)-4,4,5-trifluoro-3,3-dimethyl- isoquinoline X.14 1-(4,5-dimethylbenzimidazol-1- 1:1 100:100 yl)-4,4-difluoro-3,3-dimethyl- isoquinoline X.14 1-(4,5-dimethylbenzimidazol-1- 3.3:1.sup. 100:30 yl)-4,4-difluoro-3,3-dimethyl- isoquinoline X.14 1-(4,5-dimethylbenzimidazol-1- .sup.1:3.3 30:100 yl)-4,4-difluoro-3,3-dimethyl- isoquinoline X.14 1-(4,5-dimethylbenzimidazol-1- 1:1 30:30 yl)-4,4-difluoro-3,3-dimethyl- isoquinoline

Example B12: Puccinia recondita f. sp. tritici/Wheat/Leaf Disc Preventative (Brown Rust)

(103) Wheat leaf segments cv. Kanzler are placed on agar in multiwell plates (24-well format) and sprayed with the formulated test compounds diluted in water. The leaf disks are inoculated with a Spore suspension of the fungus day after application. The inoculated leaf segments are incubated at 19 C. and 75% rh under a light regime of 12 h light/12 h darkness in a climate cabinet and the activity of a compound is assessed as percent disease control compared to untreated when an appropriate level of disease damage appears in untreated check leaf segments (7-9 days after application), The following mixture compositions (A:B) at the reported concentration (n ppm) gave at least 80% disease control in this test when compared to the untreated control under the same conditions, which showed extensive disease development.

(104) TABLE-US-00044 Component A Ratio Conc. (ppm) (Compound) Component B A:B (A:B) X.05 Azoxystrobin 1.6:1.sup. 100:60 X.05 Azoxystrobin 5:1 100:20 X.05 Azoxystrobin 1:2 30:60 X.05 Azoxystrobin 3:2 30:20 X.05 Trifloxystrobin 1.6:1.sup. 100:60 X.05 Trifloxystrobin 5:1 100:20 X.05 Trifloxystrobin 1:2 30:60 X.05 Trifloxystrobin 3:2 30:20 X.05 Metyltetraprole 1.6:1.sup. 100:60 X.05 Metyltetraprole 5:1 100:20 X.05 Metyltetraprole 1:2 30:60 X.05 Metyltetraprole 3:2 30:20 X.05 Cyproconazole 1.6:1.sup. 100:60 X.05 Cyproconazole 5:1 100:20 X.05 Cyproconazole 1:2 30:60 X.05 Cyproconazole 3:2 30:20 X.05 Difenoconazole 1:1 100:100 X.05 Difenoconazole 3.3:1.sup. 100:30 X.05 Difenoconazole .sup.1:3.3 30:100 X.05 Difenoconazole 1:1 30:30 X.05 Hexaconazole 1:1 100:100 X.05 Hexaconazole 3.3:1.sup. 100:30 X.05 Hexaconazole .sup.1:3.3 30:100 X.05 Hexaconazole 1:1 30:30 X.05 Propiconazole 1:1 100:100 X.05 Propiconazole 3.3:1.sup. 100:30 X.05 Propiconazole .sup.1:3.3 30:100 X.05 Propiconazole 1:1 30:30 X.05 Prothioconazole 1:1 100:100 X.05 Prothioconazole 3.3:1.sup. 100:30 X.05 Prothioconazole .sup.1:3.3 30:100 X.05 Prothioconazole 1:1 30:30 X.05 Mefentrifluconazole 1.6:1.sup. 100:60 X.05 Mefentrifluconazole 5:1 100:20 X.05 Mefentrifluconazole 1:2 30:60 X.05 Mefentrifluconazole 3:2 30:20 X.05 Fenpropidin 1:1 100:100 X.05 Fenpropidin 3.3:1.sup. 100:30 X.05 Fenpropidin .sup.1:3.3 30:100 X.05 Fenpropidin 1:1 30:30 X.05 Fenpropimorph 1:1 100:100 X.05 Fenpropimorph 3.3:1.sup. 100:30 X.05 Fenpropimorph .sup.1:3.3 30:100 X.05 Fenpropimorph 1:1 30:30 X.05 Bixafen 1:1 100:60 X.05 Bixafen 3.3:1.sup. 100:20 X.05 Bixafen 1:2 30:60 X.05 Bixafen 3:2 30:20 X.05 Fluxapyroxad 1.6:1.sup. 100:60 X.05 Fluxapyroxad 5:1 100:20 X.05 Fluxapyroxad 1:2 30:60 X.05 Fluxapyroxad 3:2 30:20 X.05 Fluopyram 1:1 100:100 X.05 Fluopyram 3.3:1.sup. 100:30 X.05 Fluopyram .sup.1:3.3 30:100 X.05 Fluopyram 1:1 30:30 X.05 Benzovindiflupyr 1.6:1.sup. 100:60 X.05 Benzovindiflupyr 5:1 100:20 X.05 Benzovindiflupyr 1:2 30:60 X.05 Benzovindiflupyr 3:2 30:20 X.05 Pydiflumetofen 1:1 100:100 X.05 Pydiflumetofen 3.3:1.sup. 100:30 X.05 Pydiflumetofen .sup.1:3.3 30:100 X.05 Pydiflumetofen 1:1 30:30 X.05 Isoflucypram 1.6:1.sup. 100:60 X.05 Isoflucypram 5:1 100:20 X.05 Isoflucypram 1:2 30:60 X.05 Isoflucypram 3:2 30:20 X.05 Fluindapyr 1.6:1.sup. 100:60 X.05 Fluindapyr 5:1 100:20 X.05 Fluindapyr 1:2 30:60 X.05 Fluindapyr 3:2 30:20 X.05 Florylpicoxamid 1:1 100:100 X.05 Florylpicoxamid 3.3:1.sup. 100:30 X.05 Florylpicoxamid .sup.1:3.3 30:100 X.05 Florylpicoxamid 1:1 30:30 X.05 Metarylpicoxamid 1.6:1.sup. 100:60 X.05 Metarylpicoxamid 5:1 100:20 X.05 Metarylpicoxamid 1:2 30:60 X.05 Metarylpicoxamid 3:2 30:20 X.05 Fosetyl-aluminium 1:1 100:100 X.05 Fosetyl-aluminium 3.3:1.sup. 100:30 X.05 Fosetyl-aluminium .sup.1:3.3 30:100 X.05 Fosetyl-aluminium 1:1 30:30 X.05 Chlorothalonil 1:1 100:100 X.05 Chlorothalonil 3.3:1.sup. 100:30 X.05 Chlorothalonil .sup.1:3.3 30:100 X.05 Chlorothalonil 1:1 30:30 X.05 Mancozeb 1:1 100:100 X.05 Mancozeb 3.3:1.sup. 100:30 X.05 Mancozeb .sup.1:3.3 30:100 X.05 Mancozeb 1:1 30:30 X.05 Mandipropamid 1:1 100:100 X.05 Mandipropamid 3.3:1.sup. 100:30 X.05 Mandipropamid .sup.1:3.3 30:100 X.05 Mandipropamid 1:1 30:30 X.05 Oxathiapiprolin 1:1 100:100 X.05 Oxathiapiprolin 3.3:1.sup. 100:30 X.05 Oxathiapiprolin .sup.1:3.3 30:100 X.05 Oxathiapiprolin 1:1 30:30 X.05 Fluazinam 1:1 100:100 X.05 Fluazinam 3.3:1.sup. 100:30 X.05 Fluazinam .sup.1:3.3 30:100 X.05 Fluazinam 1:1 30:30 X.05 Fludioxonil 1:1 100:100 X.05 Fludioxonil 3.3:1.sup. 100:30 X.05 Fludioxonil .sup.1:3.3 30:100 X.05 Fludioxonil 1:1 30:30 X.05 Cyprodinil 1:1 100:100 X.05 Cyprodinil 3.3:1.sup. 100:30 X.05 Cyprodinil .sup.1:3.3 30:100 X.05 Cyprodinil 1:1 30:30 X.05 Metalaxyl-M 1:1 100:100 X.05 Metalaxyl-M 3.3:1.sup. 100:30 X.05 Metalaxyl-M .sup.1:3.3 30:100 X.05 Metalaxyl-M 1:1 30:30 X.05 Folpet 1:1 100:100 X.05 Folpet 3.3:1.sup. 100:30 X.05 Folpet .sup.1:3.3 30:100 X.05 Folpet 1:1 30:30 X.05 N-[5-bromo-2-methyl-6-(1-methyl-2-propoxy- 1.6:1.sup. 100:60 ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidine X.05 N-[5-bromo-2-methyl-6-(1-methyl-2-propoxy- 5:1 100:20 ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidine X.05 N-[5-bromo-2-methyl-6-(1-methyl-2-propoxy- 1:2 30:60 ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidine X.05 N-[5-bromo-2-methyl-6-(1-methyl-2-propoxy- 3:2 30:20 ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidine X.05 N-isopropyl-N-[5-methoxy-2-methyl-4-(2,2,2- 1.6:1.sup. 100:60 trifluoro-1-hydroxy-1-phenyl-ethyl)phenyl]-N- methyl-formamidine X.05 N-isopropyl-N-[5-methoxy-2-methyl-4-(2,2,2- 5:1 100:20 trifluoro-1-hydroxy-1-phenyl-ethyl)phenyl]-N- methyl-formamidine X.05 N-isopropyl-N-[5-methoxy-2-methyl-4-(2,2,2- 1:2 30:60 trifluoro-1-hydroxy-1-phenyl-ethyl)phenyl]-N- methyl-formamidine X.05 N-isopropyl-N-[5-methoxy-2-methyl-4-(2,2,2- 3:2 30:20 trifluoro-1-hydroxy-1-phenyl-ethyl)phenyl]-N- methyl-formamidine X.05 methyl (Z)-3-methoxy-2-[2-methyl-5-[3- 1.6:1.sup. 100:60 (trifluoromethyl)pyrazol-1-yl]phenoxy]prop-2- enoate X.05 methyl (Z)-3-methoxy-2-[2-methyl-5-[3- 5:1 100:20 (trifluoromethyl)pyrazol-1-yl]phenoxy]prop-2- enoate X.05 methyl (Z)-3-methoxy-2-[2-methyl-5-[3- 1:2 30:60 (trifluoromethyl)pyrazol-1-yl]phenoxy]prop-2- enoate X.05 methyl (Z)-3-methoxy-2-[2-methyl-5-[3- 3:2 30:20 (trifluoromethyl)pyrazol-1-yl]phenoxy]prop-2- enoate X.05 methyl (Z)-3-methoxy-2-[2-methyl-5-(3- 1.6:1.sup. 100:60 propylpyrazol-1-yl)phenoxy]prop-2-enoate X.05 methyl (Z)-3-methoxy-2-[2-methyl-5-(3- 5:1 100:20 propylpyrazol-1-yl)phenoxy]prop-2-enoate X.05 methyl (Z)-3-methoxy-2-[2-methyl-5-(3- 1:2 30:60 propylpyrazol-1-yl)phenoxy]prop-2-enoate X.05 methyl (Z)-3-methoxy-2-[2-methyl-5-(3- 3:2 30:20 propylpyrazol-1-yl)phenoxy]prop-2-enoate X.05 methyl (Z)-2-(5-cyclohexyl-2-methyl-phenoxy)-3- 1.6:1.sup. 100:60 methoxy-prop-2-enoate X.05 methyl (Z)-2-(5-cyclohexyl-2-methyl-phenoxy)-3- 5:1 100:20 methoxy-prop-2-enoate X.05 methyl (Z)-2-(5-cyclohexyl-2-methyl-phenoxy)-3- 1:2 30:60 methoxy-prop-2-enoate X.05 methyl (Z)-2-(5-cyclohexyl-2-methyl-phenoxy)-3- 3:2 30:20 methoxy-prop-2-enoate X.05 methyl (Z)-2-(5-cyclopentyl-2-methyl-phenoxy)- 1.6:1.sup. 100:60 3-methoxy-prop-2-enoate X.05 methyl (Z)-2-(5-cyclopentyl-2-methyl-phenoxy)- 5:1 100:20 3-methoxy-prop-2-enoate X.05 methyl (Z)-2-(5-cyclopentyl-2-methyl-phenoxy)- 1:2 30:60 3-methoxy-prop-2-enoate X.05 methyl (Z)-2-(5-cyclopentyl-2-methyl-phenoxy)- 3:2 30:20 3-methoxy-prop-2-enoate X.05 methyl (Z)-2-[5-(3-isopropylpyrazol-1-yl)-2- 1.6:1.sup. 100:60 methyl-phenoxy]-3-methoxy-prop-2-enoate X.05 methyl (Z)-2-[5-(3-isopropylpyrazol-1-yl)-2- 5:1 100:20 methyl-phenoxy]-3-methoxy-prop-2-enoate X.05 methyl (Z)-2-[5-(3-isopropylpyrazol-1-yl)-2- 1:2 30:60 methyl-phenoxy]-3-methoxy-prop-2-enoate X.05 methyl (Z)-2-[5-(3-isopropylpyrazol-1-yl)-2- 3:2 30:20 methyl-phenoxy]-3-methoxy-prop-2-enoate X.05 methyl (Z)-3-methoxy-2-[2-methyl-5-(4- 1.6:1.sup. 100:60 propyltriazol-2-yl)phenoxy]prop-2-enoate X.05 methyl (Z)-3-methoxy-2-[2-methyl-5-(4- 5:1 100:20 propyltriazol-2-yl)phenoxy]prop-2-enoate X.05 methyl (Z)-3-methoxy-2-[2-methyl-5-(4- 1:2 30:60 propyltriazol-2-yl)phenoxy]prop-2-enoate X.05 methyl (Z)-3-methoxy-2-[2-methyl-5-(4- 3:2 30:20 propyltriazol-2-yl)phenoxy]prop-2-enoate X.05 methyl (Z)-3-methoxy-2-[2-methyl-5-[4- 1.6:1.sup. 100:60 (trifluoromethyl)triazol-2-yl]phenoxy]prop-2- enoate X.05 methyl (Z)-3-methoxy-2-[2-methyl-5-[4- 5:1 100:20 (trifluoromethyl)triazol-2-yl]phenoxy]prop-2- enoate X.05 methyl (Z)-3-methoxy-2-[2-methyl-5-[4- 1:2 30:60 (trifluoromethyl)triazol-2-yl]phenoxy]prop-2- enoate X.05 methyl (Z)-3-methoxy-2-[2-methyl-5-[4- 3:2 30:20 (trifluoromethyl)triazol-2-yl]phenoxy]prop-2- enoate

(105) TABLE-US-00045 Component A Ratio Conc. (ppm) (Compound) Component B A:B (A:B) X.07 Azoxystrobin 1.6:1.sup. 100:60 X.07 Azoxystrobin 5:1 100:20 X.07 Azoxystrobin 1:2 30:60 X.07 Azoxystrobin 3:2 30:20 X.07 Trifloxystrobin 1.6:1.sup. 100:60 X.07 Trifloxystrobin 5:1 100:20 X.07 Trifloxystrobin 1:2 30:60 X.07 Trifloxystrobin 3:2 30:20 X.07 Metyltetraprole 1.6:1.sup. 100:60 X.07 Metyltetraprole 5:1 100:20 X.07 Metyltetraprole 1:2 30:60 X.07 Metyltetraprole 3:2 30:20 X.07 Cyproconazole 1.6:1.sup. 100:60 X.07 Cyproconazole 5:1 100:20 X.07 Cyproconazole 1:2 30:60 X.07 Cyproconazole 3:2 30:20 X.07 Difenoconazole 1:1 100:100 X.07 Difenoconazole 3.3:1.sup. 100:30 X.07 Difenoconazole .sup.1:3.3 30:100 X.07 Difenoconazole 1:1 30:30 X.07 Hexaconazole 1:1 100:100 X.07 Hexaconazole 3.3:1.sup. 100:30 X.07 Hexaconazole .sup.1:3.3 30:100 X.07 Hexaconazole 1:1 30:30 X.07 Propiconazole 1:1 100:100 X.07 Propiconazole 3.3:1.sup. 100:30 X.07 Propiconazole .sup.1:3.3 30:100 X.07 Propiconazole 1:1 30:30 X.07 Prothioconazole 1:1 100:100 X.07 Prothioconazole 3.3:1.sup. 100:30 X.07 Prothioconazole .sup.1:3.3 30:100 X.07 Prothioconazole 1:1 30:30 X.07 Mefentrifluconazole 1.6:1.sup. 100:60 X.07 Mefentrifluconazole 5:1 100:20 X.07 Mefentrifluconazole 1:2 30:60 X.07 Mefentrifluconazole 3:2 30:20 X.07 Fenpropidin 1:1 100:100 X.07 Fenpropidin 3.3:1.sup. 100:30 X.07 Fenpropidin .sup.1:3.3 30:100 X.07 Fenpropidin 1:1 30:30 X.07 Fenpropimorph 1:1 100:100 X.07 Fenpropimorph 3.3:1.sup. 100:30 X.07 Fenpropimorph .sup.1:3.3 30:100 X.07 Fenpropimorph 1:1 30:30 X.07 Bixafen 1:1 100:60 X.07 Bixafen 3.3:1.sup. 100:20 X.07 Bixafen 1:2 30:60 X.07 Bixafen 3:2 30:20 X.07 Fluxapyroxad 1.6:1.sup. 100:60 X.07 Fluxapyroxad 5:1 100:20 X.07 Fluxapyroxad 1:2 30:60 X.07 Fluxapyroxad 3:2 30:20 X.07 Fluopyram 1:1 100:100 X.07 Fluopyram 3.3:1.sup. 100:30 X.07 Fluopyram .sup.1:3.3 30:100 X.07 Fluopyram 1:1 30:30 X.07 Benzovindiflupyr 1.6:1.sup. 100:60 X.07 Benzovindiflupyr 5:1 100:20 X.07 Benzovindiflupyr 1:2 30:60 X.07 Benzovindiflupyr 3:2 30:20 X.07 Pydiflumetofen 1:1 100:100 X.07 Pydiflumetofen 3.3:1.sup. 100:30 X.07 Pydiflumetofen .sup.1:3.3 30:100 X.07 Pydiflumetofen 1:1 30:30 X.07 Isoflucypram 1.6:1.sup. 100:60 X.07 Isoflucypram 5:1 100:20 X.07 Isoflucypram 1:2 30:60 X.07 Isoflucypram 3:2 30:20 X.07 Fluindapyr 1.6:1.sup. 100:60 X.07 Fluindapyr 5:1 100:20 X.07 Fluindapyr 1:2 30:60 X.07 Fluindapyr 3:2 30:20 X.07 Florylpicoxamid 1:1 100:100 X.07 Florylpicoxamid 3.3:1.sup. 100:30 X.07 Florylpicoxamid .sup.1:3.3 30:100 X.07 Florylpicoxamid 1:1 30:30 X.07 Metarylpicoxamid 1.6:1.sup. 100:60 X.07 Metarylpicoxamid 5:1 100:20 X.07 Metarylpicoxamid 1:2 30:60 X.07 Metarylpicoxamid 3:2 30:20 X.07 Fosetyl-aluminium 1:1 100:100 X.07 Fosetyl-aluminium 3.3:1.sup. 100:30 X.07 Fosetyl-aluminium .sup.1:3.3 30:100 X.07 Fosetyl-aluminium 1:1 30:30 X.07 Chlorothalonil 1:1 100:100 X.07 Chlorothalonil 3.3:1.sup. 100:30 X.07 Chlorothalonil .sup.1:3.3 30:100 X.07 Chlorothalonil 1:1 30:30 X.07 Mancozeb 1:1 100:100 X.07 Mancozeb 3.3:1.sup. 100:30 X.07 Mancozeb .sup.1:3.3 30:100 X.07 Mancozeb 1:1 30:30 X.07 Mandipropamid 1:1 100:100 X.07 Mandipropamid 3.3:1.sup. 100:30 X.07 Mandipropamid .sup.1:3.3 30:100 X.07 Mandipropamid 1:1 30:30 X.07 Oxathiapiprolin 1:1 100:100 X.07 Oxathiapiprolin 3.3:1.sup. 100:30 X.07 Oxathiapiprolin .sup.1:3.3 30:100 X.07 Oxathiapiprolin 1:1 30:30 X.07 Fluazinam 1:1 100:100 X.07 Fluazinam 3.3:1.sup. 100:30 X.07 Fluazinam .sup.1:3.3 30:100 X.07 Fluazinam 1:1 30:30 X.07 Fludioxonil 1:1 100:100 X.07 Fludioxonil 3.3:1.sup. 100:30 X.07 Fludioxonil .sup.1:3.3 30:100 X.07 Fludioxonil 1:1 30:30 X.07 Cyprodinil 1:1 100:100 X.07 Cyprodinil 3.3:1.sup. 100:30 X.07 Cyprodinil .sup.1:3.3 30:100 X.07 Cyprodinil 1:1 30:30 X.07 Metalaxyl-M 1:1 100:100 X.07 Metalaxyl-M 3.3:1.sup. 100:30 X.07 Metalaxyl-M .sup.1:3.3 30:100 X.07 Metalaxyl-M 1:1 30:30 X.07 Folpet 1:1 100:100 X.07 Folpet 3.3:1.sup. 100:30 X.07 Folpet .sup.1:3.3 30:100 X.07 Folpet 1:1 30:30 X.07 N-[5-bromo-2-methyl-6-(1-methyl-2-propoxy- 1.6:1.sup. 100:60 ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidine X.07 N-[5-bromo-2-methyl-6-(1-methyl-2-propoxy- 5:1 100:20 ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidine X.07 N-[5-bromo-2-methyl-6-(1-methyl-2-propoxy- 1:2 30:60 ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidine X.07 N-[5-bromo-2-methyl-6-(1-methyl-2-propoxy- 3:2 30:20 ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidine X.07 N-isopropyl-N-[5-methoxy-2-methyl-4-(2,2,2- 1.6:1.sup. 100:60 trifluoro-1-hydroxy-1-phenyl-ethyl)phenyl]-N- methyl-formamidine X.07 N-isopropyl-N-[5-methoxy-2-methyl-4-(2,2,2- 5:1 100:20 trifluoro-1-hydroxy-1-phenyl-ethyl)phenyl]-N- methyl-formamidine X.07 N-isopropyl-N-[5-methoxy-2-methyl-4-(2,2,2- 1:2 30:60 trifluoro-1-hydroxy-1-phenyl-ethyl)phenyl]-N- methyl-formamidine X.07 N-isopropyl-N-[5-methoxy-2-methyl-4-(2,2,2- 3:2 30:20 trifluoro-1-hydroxy-1-phenyl-ethyl)phenyl]-N- methyl-formamidine X.07 methyl (Z)-3-methoxy-2-[2-methyl-5-[3- 1.6:1.sup. 100:60 (trifluoromethyl)pyrazol-1-yl]phenoxy]prop-2- enoate X.07 methyl (Z)-3-methoxy-2-[2-methyl-5-[3- 5:1 100:20 (trifluoromethyl)pyrazol-1-yl]phenoxy]prop-2- enoate X.07 methyl (Z)-3-methoxy-2-[2-methyl-5-[3- 1:2 30:60 (trifluoromethyl)pyrazol-1-yl]phenoxy]prop-2- enoate X.07 methyl (Z)-3-methoxy-2-[2-methyl-5-[3- 3:2 30:20 (trifluoromethyl)pyrazol-1-yl]phenoxy]prop-2- enoate X.07 methyl (Z)-3-methoxy-2-[2-methyl-5-(3- 1.6:1.sup. 100:60 propylpyrazol-1-yl)phenoxy]prop-2-enoate X.07 methyl (Z)-3-methoxy-2-[2-methyl-5-(3- 5:1 100:20 propylpyrazol-1-yl)phenoxy]prop-2-enoate X.07 methyl (Z)-3-methoxy-2-[2-methyl-5-(3- 1:2 30:60 propylpyrazol-1-yl)phenoxy]prop-2-enoate X.07 methyl (Z)-3-methoxy-2-[2-methyl-5-(3- 3:2 30:20 propylpyrazol-1-yl)phenoxy]prop-2-enoate X.07 methyl (Z)-2-(5-cyclohexyl-2-methyl-phenoxy)-3- 1.6:1.sup. 100:60 methoxy-prop-2-enoate X.07 methyl (Z)-2-(5-cyclohexyl-2-methyl-phenoxy)-3- 5:1 100:20 methoxy-prop-2-enoate X.07 methyl (Z)-2-(5-cyclohexyl-2-methyl-phenoxy)-3- 1:2 30:60 methoxy-prop-2-enoate X.07 methyl (Z)-2-(5-cyclohexyl-2-methyl-phenoxy)-3- 3:2 30:20 methoxy-prop-2-enoate X.07 methyl (Z)-2-(5-cyclopentyl-2-methyl-phenoxy)- 1.6:1.sup. 100:60 3-methoxy-prop-2-enoate X.07 methyl (Z)-2-(5-cyclopentyl-2-methyl-phenoxy)- 5:1 100:20 3-methoxy-prop-2-enoate X.07 methyl (Z)-2-(5-cyclopentyl-2-methyl-phenoxy)- 1:2 30:60 3-methoxy-prop-2-enoate X.07 methyl (Z)-2-(5-cyclopentyl-2-methyl-phenoxy)- 3:2 30:20 3-methoxy-prop-2-enoate X.07 methyl (Z)-2-[5-(3-isopropylpyrazol-1-yl)-2- 1.6:1.sup. 100:60 methyl-phenoxy]-3-methoxy-prop-2-enoate X.07 methyl (Z)-2-[5-(3-isopropylpyrazol-1-yl)-2- 5:1 100:20 methyl-phenoxy]-3-methoxy-prop-2-enoate X.07 methyl (Z)-2-[5-(3-isopropylpyrazol-1-yl)-2- 1:2 30:60 methyl-phenoxy]-3-methoxy-prop-2-enoate X.07 methyl (Z)-2-[5-(3-isopropylpyrazol-1-yl)-2- 3:2 30:20 methyl-phenoxy]-3-methoxy-prop-2-enoate X.07 methyl (Z)-3-methoxy-2-[2-methyl-5-(4- 1.6:1.sup. 100:60 propyltriazol-2-yl)phenoxy]prop-2-enoate X.07 methyl (Z)-3-methoxy-2-[2-methyl-5-(4- 5:1 100:20 propyltriazol-2-yl)phenoxy]prop-2-enoate X.07 methyl (Z)-3-methoxy-2-[2-methyl-5-(4- 1:2 30:60 propyltriazol-2-yl)phenoxy]prop-2-enoate X.07 methyl (Z)-3-methoxy-2-[2-methyl-5-(4- 3:2 30:20 propyltriazol-2-yl)phenoxy]prop-2-enoate X.07 methyl (Z)-3-methoxy-2-[2-methyl-5-[4- 1.6:1.sup. 100:60 (trifluoromethyl)triazol-2-yl]phenoxy]prop-2- enoate X.07 methyl (Z)-3-methoxy-2-[2-methyl-5-[4- 5:1 100:20 (trifluoromethyl)triazol-2-yl]phenoxy]prop-2- enoate X.07 methyl (Z)-3-methoxy-2-[2-methyl-5-[4- 1:2 30:60 (trifluoromethyl)triazol-2-yl]phenoxy]prop-2- enoate X.07 methyl (Z)-3-methoxy-2-[2-methyl-5-[4- 3:2 30:20 (trifluoromethyl)triazol-2-yl]phenoxy]prop-2- enoate

(106) TABLE-US-00046 Component A Ratio Conc. (ppm) (Compound) Component B A:B (A:B) X.14 Azoxystrobin 1.6:1.sup. 100:60 X.14 Azoxystrobin 5:1 100:20 X.14 Azoxystrobin 1:2 30:60 X.14 Azoxystrobin 3:2 30:20 X.14 Trifloxystrobin 1.6:1.sup. 100:60 X.14 Trifloxystrobin 5:1 100:20 X.14 Trifloxystrobin 1:2 30:60 X.14 Trifloxystrobin 3:2 30:20 X.14 Metyltetraprole 1.6:1.sup. 100:60 X.14 Metyltetraprole 5:1 100:20 X.14 Metyltetraprole 1:2 30:60 X.14 Metyltetraprole 3:2 30:20 X.14 Cyproconazole 1.6:1.sup. 100:60 X.14 Cyproconazole 5:1 100:20 X.14 Cyproconazole 1:2 30:60 X.14 Cyproconazole 3:2 30:20 X.14 Difenoconazole 1:1 100:100 X.14 Difenoconazole 3.3:1.sup. 100:30 X.14 Difenoconazole .sup.1:3.3 30:100 X.14 Difenoconazole 1:1 30:30 X.14 Hexaconazole 1:1 100:100 X.14 Hexaconazole 3.3:1.sup. 100:30 X.14 Hexaconazole .sup.1:3.3 30:100 X.14 Hexaconazole 1:1 30:30 X.14 Propiconazole 1:1 100:100 X.14 Propiconazole 3.3:1.sup. 100:30 X.14 Propiconazole .sup.1:3.3 30:100 X.14 Propiconazole 1:1 30:30 X.14 Prothioconazole 1:1 100:100 X.14 Prothioconazole 3.3:1.sup. 100:30 X.14 Prothioconazole .sup.1:3.3 30:100 X.14 Prothioconazole 1:1 30:30 X.14 Mefentrifluconazole 1.6:1.sup. 100:60 X.14 Mefentrifluconazole 5:1 100:20 X.14 Mefentrifluconazole 1:2 30:60 X.14 Mefentrifluconazole 3:2 30:20 X.14 Fenpropidin 1:1 100:100 X.14 Fenpropidin 3.3:1.sup. 100:30 X.14 Fenpropidin .sup.1:3.3 30:100 X.14 Fenpropidin 1:1 30:30 X.14 Fenpropimorph 1:1 100:100 X.14 Fenpropimorph 3.3:1.sup. 100:30 X.14 Fenpropimorph .sup.1:3.3 30:100 X.14 Fenpropimorph 1:1 30:30 X.14 Bixafen 1:1 100:60 X.14 Bixafen 3.3:1.sup. 100:20 X.14 Bixafen 1:2 30:60 X.14 Bixafen 3:2 30:20 X.14 Fluxapyroxad 1.6:1.sup. 100:60 X.14 Fluxapyroxad 5:1 100:20 X.14 Fluxapyroxad 1:2 30:60 X.14 Fluxapyroxad 3:2 30:20 X.14 Fluopyram 1:1 100:100 X.14 Fluopyram 3.3:1.sup. 100:30 X.14 Fluopyram .sup.1:3.3 30:100 X.14 Fluopyram 1:1 30:30 X.14 Benzovindiflupyr 1.6:1.sup. 100:60 X.14 Benzovindiflupyr 5:1 100:20 X.14 Benzovindiflupyr 1:2 30:60 X.14 Benzovindiflupyr 3:2 30:20 X.14 Pydiflumetofen 1:1 100:100 X.14 Pydiflumetofen 3.3:1.sup. 100:30 X.14 Pydiflumetofen .sup.1:3.3 30:100 X.14 Pydiflumetofen 1:1 30:30 X.14 Isoflucypram 1.6:1.sup. 100:60 X.14 Isoflucypram 5:1 100:20 X.14 Isoflucypram 1:2 30:60 X.14 Isoflucypram 3:2 30:20 X.14 Fluindapyr 1.6:1.sup. 100:60 X.14 Fluindapyr 5:1 100:20 X.14 Fluindapyr 1:2 30:60 X.14 Fluindapyr 3:2 30:20 X.14 Florylpicoxamid 1:1 100:100 X.14 Florylpicoxamid 3.3:1.sup. 100:30 X.14 Florylpicoxamid .sup.1:3.3 30:100 X.14 Florylpicoxamid 1:1 30:30 X.14 Metarylpicoxamid 1.6:1.sup. 100:60 X.14 Metarylpicoxamid 5:1 100:20 X.14 Metarylpicoxamid 1:2 30:60 X.14 Metarylpicoxamid 3:2 30:20 X.14 Fosetyl-aluminium 1:1 100:100 X.14 Fosetyl-aluminium 3.3:1.sup. 100:30 X.14 Fosetyl-aluminium .sup.1:3.3 30:100 X.14 Fosetyl-aluminium 1:1 30:30 X.14 Chlorothalonil 1:1 100:100 X.14 Chlorothalonil 3.3:1.sup. 100:30 X.14 Chlorothalonil .sup.1:3.3 30:100 X.14 Chlorothalonil 1:1 30:30 X.14 Mancozeb 1:1 100:100 X.14 Mancozeb 3.3:1.sup. 100:30 X.14 Mancozeb .sup.1:3.3 30:100 X.14 Mancozeb 1:1 30:30 X.14 Mandipropamid 1:1 100:100 X.14 Mandipropamid 3.3:1.sup. 100:30 X.14 Mandipropamid .sup.1:3.3 30:100 X.14 Mandipropamid 1:1 30:30 X.14 Oxathiapiprolin 1:1 100:100 X.14 Oxathiapiprolin 3.3:1.sup. 100:30 X.14 Oxathiapiprolin .sup.1:3.3 30:100 X.14 Oxathiapiprolin 1:1 30:30 X.14 Fluazinam 1:1 100:100 X.14 Fluazinam 3.3:1.sup. 100:30 X.14 Fluazinam .sup.1:3.3 30:100 X.14 Fluazinam 1:1 30:30 X.14 Fludioxonil 1:1 100:100 X.14 Fludioxonil 3.3:1.sup. 100:30 X.14 Fludioxonil .sup.1:3.3 30:100 X.14 Fludioxonil 1:1 30:30 X.14 Cyprodinil 1:1 100:100 X.14 Cyprodinil 3.3:1.sup. 100:30 X.14 Cyprodinil .sup.1:3.3 30:100 X.14 Cyprodinil 1:1 30:30 X.14 Metalaxyl-M 1:1 100:100 X.14 Metalaxyl-M 3.3:1.sup. 100:30 X.14 Metalaxyl-M .sup.1:3.3 30:100 X.14 Metalaxyl-M 1:1 30:30 X.14 Folpet 1:1 100:100 X.14 Folpet 3.3:1.sup. 100:30 X.14 Folpet .sup.1:3.3 30:100 X.14 Folpet 1:1 30:30 X.14 N-[5-bromo-2-methyl-6-(1-methyl-2-propoxy- 1.6:1.sup. 100:60 ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidine X.14 N-[5-bromo-2-methyl-6-(1-methyl-2-propoxy- 5:1 100:20 ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidine X.14 N-[5-bromo-2-methyl-6-(1-methyl-2-propoxy- 1:2 30:60 ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidine X.14 N-[5-bromo-2-methyl-6-(1-methyl-2-propoxy- 3:2 30:20 ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidine X.14 N-isopropyl-N-[5-methoxy-2-methyl-4-(2,2,2- 1.6:1.sup. 100:60 trifluoro-1-hydroxy-1-phenyl-ethyl)phenyl]-N- methyl-formamidine X.14 N-isopropyl-N-[5-methoxy-2-methyl-4-(2,2,2- 5:1 100:20 trifluoro-1-hydroxy-1-phenyl-ethyl)phenyl]-N- methyl-formamidine X.14 N-isopropyl-N-[5-methoxy-2-methyl-4-(2,2,2- 1:2 30:60 trifluoro-1-hydroxy-1-phenyl-ethyl)phenyl]-N- methyl-formamidine X.14 N-isopropyl-N-[5-methoxy-2-methyl-4-(2,2,2- 3:2 30:20 trifluoro-1-hydroxy-1-phenyl-ethyl)phenyl]-N- methyl-formamidine X.14 methyl (Z)-3-methoxy-2-[2-methyl-5-[3- 1.6:1.sup. 100:60 (trifluoromethyl)pyrazol-1-yl]phenoxy]prop-2- enoate X.14 methyl (Z)-3-methoxy-2-[2-methyl-5-[3- 5:1 100:20 (trifluoromethyl)pyrazol-1-yl]phenoxy]prop-2- enoate X.14 methyl (Z)-3-methoxy-2-[2-methyl-5-[3- 1:2 30:60 (trifluoromethyl)pyrazol-1-yl]phenoxy]prop-2- enoate X.14 methyl (Z)-3-methoxy-2-[2-methyl-5-[3- 3:2 30:20 (trifluoromethyl)pyrazol-1-yl]phenoxy]prop-2- enoate X.14 methyl (Z)-3-methoxy-2-[2-methyl-5-(3- 1.6:1.sup. 100:60 propylpyrazol-1-yl)phenoxy]prop-2-enoate X.14 methyl (Z)-3-methoxy-2-[2-methyl-5-(3- 5:1 100:20 propylpyrazol-1-yl)phenoxy]prop-2-enoate X.14 methyl (Z)-3-methoxy-2-[2-methyl-5-(3- 1:2 30:60 propylpyrazol-1-yl)phenoxy]prop-2-enoate X.14 methyl (Z)-3-methoxy-2-[2-methyl-5-(3- 3:2 30:20 propylpyrazol-1-yl)phenoxy]prop-2-enoate X.14 methyl (Z)-2-(5-cyclohexyl-2-methyl-phenoxy)-3- 1.6:1.sup. 100:60 methoxy-prop-2-enoate X.14 methyl (Z)-2-(5-cyclohexyl-2-methyl-phenoxy)-3- 5:1 100:20 methoxy-prop-2-enoate X.14 methyl (Z)-2-(5-cyclohexyl-2-methyl-phenoxy)-3- 1:2 30:60 methoxy-prop-2-enoate X.14 methyl (Z)-2-(5-cyclohexyl-2-methyl-phenoxy)-3- 3:2 30:20 methoxy-prop-2-enoate X.14 methyl (Z)-2-(5-cyclopentyl-2-methyl-phenoxy)- 1.6:1.sup. 100:60 3-methoxy-prop-2-enoate X.14 methyl (Z)-2-(5-cyclopentyl-2-methyl-phenoxy)- 5:1 100:20 3-methoxy-prop-2-enoate X.14 methyl (Z)-2-(5-cyclopentyl-2-methyl-phenoxy)- 1:2 30:60 3-methoxy-prop-2-enoate X.14 methyl (Z)-2-(5-cyclopentyl-2-methyl-phenoxy)- 3:2 30:20 3-methoxy-prop-2-enoate X.14 methyl (Z)-2-[5-(3-isopropylpyrazol-1-yl)-2- 1.6:1.sup. 100:60 methyl-phenoxy]-3-methoxy-prop-2-enoate X.14 methyl (Z)-2-[5-(3-isopropylpyrazol-1-yl)-2- 5:1 100:20 methyl-phenoxy]-3-methoxy-prop-2-enoate X.14 methyl (Z)-2-[5-(3-isopropylpyrazol-1-yl)-2- 1:2 30:60 methyl-phenoxy]-3-methoxy-prop-2-enoate X.14 methyl (Z)-2-[5-(3-isopropylpyrazol-1-yl)-2- 3:2 30:20 methyl-phenoxy]-3-methoxy-prop-2-enoate X.14 methyl (Z)-3-methoxy-2-[2-methyl-5-(4- 1.6:1.sup. 100:60 propyltriazol-2-yl)phenoxy]prop-2-enoate X.14 methyl (Z)-3-methoxy-2-[2-methyl-5-(4- 5:1 100:20 propyltriazol-2-yl)phenoxy]prop-2-enoate X.14 methyl (Z)-3-methoxy-2-[2-methyl-5-(4- 1:2 30:60 propyltriazol-2-yl)phenoxy]prop-2-enoate X.14 methyl (Z)-3-methoxy-2-[2-methyl-5-(4- 3:2 30:20 propyltriazol-2-yl)phenoxy]prop-2-enoate X.14 methyl (Z)-3-methoxy-2-[2-methyl-5-[4- 1.6:1.sup. 100:60 (trifluoromethyl)triazol-2-yl]phenoxy]prop-2- enoate X.14 methyl (Z)-3-methoxy-2-[2-methyl-5-[4- 5:1 100:20 (trifluoromethyl)triazol-2-yl]phenoxy]prop-2- enoate X.14 methyl (Z)-3-methoxy-2-[2-methyl-5-[4- 1:2 30:60 (trifluoromethyl)triazol-2-yl]phenoxy]prop-2- enoate X.14 methyl (Z)-3-methoxy-2-[2-methyl-5-[4- 3:2 30:20 (trifluoromethyl)triazol-2-yl]phenoxy]prop-2- enoate

Example B13 Phakopsora pachyrhizi/Soybean Preventative (Soybean Rust)

(107) Soybean leaf disks are placed on water agar in multiwell plates (24-well format) and sprayed with the formulated test compounds diluted in water. One day after application leaf discs are inoculated by spraying a spore suspension on the lower leaf surface. After an incubation period in a climate cabinet of 24-36 hours in darkness at 20 C. and 75% rh leaf disc are kept at 20 C. with 12 h light/day and 75% rh. The activity of the mixture composition is assessed as percent disease control compared to untreated when an appropriate level of disease damage appears in untreated check leaf disks (12-14 days after application). The following mixture compositions (A:B) at the reported concentration (in ppm) gave at least 70% disease control in this test when compared to the untreated control under the same conditions, which showed extensive disease development.

(108) TABLE-US-00047 Component A Ratio Conc. (ppm) (Compound) Component B A:B (A:B) X.05 Azoxystrobin 2:1 200:100 X.05 Azoxystrobin 6.6:1.sup. 200:30 X.05 Azoxystrobin .sup.1:1.6 60:100 X.05 Azoxystrobin 2:1 60:30 X.05 Trifloxystrobin 2:1 200:100 X.05 Trifloxystrobin 6.6:1.sup. 200:30 X.05 Trifloxystrobin .sup.1:1.6 60:100 X.05 Trifloxystrobin 2:1 60:30 X.05 Metyltetraprole 2:1 200:100 X.05 Metyltetraprole 6.6:1.sup. 200:30 X.05 Metyltetraprole .sup.1:1.6 60:100 X.05 Metyltetraprole 2:1 60:30 X.05 Cyproconazole 2:1 200:100 X.05 Cyproconazole 6.6:1.sup. 200:30 X.05 Cyproconazole .sup.1:1.6 60:100 X.05 Cyproconazole 2:1 60:30 X.05 Difenoconazole 2:1 200:100 X.05 Difenoconazole 6.6:1.sup. 200:30 X.05 Difenoconazole .sup.1:1.6 60:100 X.05 Difenoconazole 2:1 60:30 X.05 Hexaconazole 2:1 200:100 X.05 Hexaconazole 6.6:1.sup. 200:30 X.05 Hexaconazole .sup.1:1.6 60:100 X.05 Hexaconazole 2:1 60:30 X.05 Prothioconazole 2:1 200:100 X.05 Prothioconazole 6.6:1.sup. 200:30 X.05 Prothioconazole .sup.1:1.6 60:100 X.05 Prothioconazole 2:1 60:30 X.05 Mefentrifluconazole 2:1 200:100 X.05 Mefentrifluconazole 6.6:1.sup. 200:30 X.05 Mefentrifluconazole .sup.1:1.6 60:100 X.05 Mefentrifluconazole 2:1 60:30 X.05 Fenpropidin 2:1 200:100 X.05 Fenpropidin 6.6:1.sup. 200:30 X.05 Fenpropidin .sup.1:1.6 60:100 X.05 Fenpropidin 2:1 60:30 X.05 Fenpropimorph 2:1 200:100 X.05 Fenpropimorph 6.6:1.sup. 200:30 X.05 Fenpropimorph .sup.1:1.6 60:100 X.05 Fenpropimorph 2:1 60:30 X.05 Fluxapyroxad 2:1 200:100 X.05 Fluxapyroxad 6.6:1.sup. 200:30 X.05 Fluxapyroxad .sup.1:1.6 60:100 X.05 Fluxapyroxad 2:1 60:30 X.05 Fluopyram 2:1 200:100 X.05 Fluopyram 6.6:1.sup. 200:30 X.05 Fluopyram .sup.1:1.6 60:100 X.05 Fluopyram 2:1 60:30 X.05 Benzovindiflupyr 33.3:1 200:6 X.05 Benzovindiflupyr 100:1 200:2 X.05 Benzovindiflupyr 10:1 60:6 X.05 Benzovindiflupyr 30:1 60:2 X.05 Pydiflumetofen 2:1 200:100 X.05 Pydiflumetofen 6.6:1.sup. 200:30 X.05 Pydiflumetofen .sup.1:1.6 60:100 X.05 Pydiflumetofen 2:1 60:30 X.05 Fluindapyr 3.3:1.sup. 200:60 X.05 Fluindapyr 33.3:1 200:6 X.05 Fluindapyr 1:1 60:60 X.05 Fluindapyr 10:1 60:6 X.05 Florylpicoxamid 2:1 200:100 X.05 Florylpicoxamid 6.6:1.sup. 200:30 X.05 Florylpicoxamid .sup.1:1.6 60:100 X.05 Florylpicoxamid 2:1 60:30 X.05 Metarylpicoxamid 3.3:1.sup. 200:60 X.05 Metarylpicoxamid 33.3:1 200:6 X.05 Metarylpicoxamid 1:1 60:60 X.05 Metarylpicoxamid 10:1 60:6 X.05 Chlorothalonil 2:1 200:100 X.05 Chlorothalonil 6.6:1.sup. 200:30 X.05 Chlorothalonil .sup.1:1.6 60:100 X.05 Chlorothalonil 2:1 60:30 X.05 Mancozeb 2:1 200:100 X.05 Mancozeb 6.6:1.sup. 200:30 X.05 Mancozeb .sup.1:1.6 60:100 X.05 Mancozeb 2:1 60:30 X.05 Mandipropamid 2:1 200:100 X.05 Mandipropamid 6.6:1.sup. 200:30 X.05 Mandipropamid .sup.1:1.6 60:100 X.05 Mandipropamid 2:1 60:30 X.05 Oxathiapiprolin 2:1 200:100 X.05 Oxathiapiprolin 6.6:1.sup. 200:30 X.05 Oxathiapiprolin .sup.1:1.6 60:100 X.05 Oxathiapiprolin 2:1 60:30 X.05 Fludioxonil 2:1 200:100 X.05 Fludioxonil 6.6:1.sup. 200:30 X.05 Fludioxonil .sup.1:1.6 60:100 X.05 Fludioxonil 2:1 60:30 X.05 Cyprodinil 2:1 200:100 X.05 Cyprodinil 6.6:1.sup. 200:30 X.05 Cyprodinil .sup.1:1.6 60:100 X.05 Cyprodinil 2:1 60:30 X.05 Metalaxyl-M 2:1 200:100 X.05 Metalaxyl-M 6.6:1.sup. 200:30 X.05 Metalaxyl-M .sup.1:1.6 60:100 X.05 Metalaxyl-M 2:1 60:30 X.05 N-[5-bromo-2-methyl-6-(1-methyl-2-propoxy- 2:1 200:100 ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidine X.05 N-[5-bromo-2-methyl-6-(1-methyl-2-propoxy- 6.6:1.sup. 200:30 ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidine X.05 N-[5-bromo-2-methyl-6-(1-methyl-2-propoxy- .sup.1:1.6 60:100 ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidine X.05 N-[5-bromo-2-methyl-6-(1-methyl-2-propoxy- 2:1 60:30 ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidine X.05 N-isopropyl-N-[5-methoxy-2-methyl-4-(2,2,2 2:1 200:100 trifluoro-1-hydroxy-1-phenyl-ethyl)phenyl]-N- methyl-formamidine X.05 N-isopropyl-N-[5-methoxy-2-methyl-4-(2,2,2- 6.6:1.sup. 200:30 trifluoro-1-hydroxy-1-phenyl-ethyl)phenyl]-N- methyl-formamidine X.05 N-isopropyl-N-[5-methoxy-2-methyl-4-(2,2,2- .sup.1:1.6 60:100 trifluoro-1-hydroxy-1-phenyl-ethyl)phenyl]-N- methyl-formamidine X.05 N-isopropyl-N-[5-methoxy-2-methyl-4-(2,2,2- 2:1 60:30 trifluoro-1-hydroxy-1-phenyl-ethyl)phenyl]-N- methyl-formamidine X.05 methyl (Z)-3-methoxy-2-[2-methyl-5-[3- 2:1 200:100 (trifluoromethyl)pyrazol-1-yl]phenoxy]prop-2- enoate X.05 methyl (Z)-3-methoxy-2-[2-methyl-5-[3- 6.6:1.sup. 200:30 (trifluoromethyl)pyrazol-1-yl]phenoxy]prop-2- enoate X.05 methyl (Z)-3-methoxy-2-[2-methyl-5-[3- .sup.1:1.6 60:100 (trifluoromethyl)pyrazol-1-yl]phenoxy]prop-2- enoate X.05 methyl (Z)-3-methoxy-2-[2-methyl-5-[3- 2:1 60:30 (trifluoromethyl)pyrazol-1-yl]phenoxy]prop-2- enoate X.05 methyl (Z)-3-methoxy-2-[2-methyl-5-(3- 2:1 200:100 propylpyrazol-1-yl)phenoxy]prop-2-enoate X.05 methyl (Z)-3-methoxy-2-[2-methyl-5-(3- 6.6:1.sup. 200:30 propylpyrazol-1-yl)phenoxy]prop-2-enoate X.05 methyl (Z)-3-methoxy-2-[2-methyl-5-(3- .sup.1:1.6 60:100 propylpyrazol-1-yl)phenoxy]prop-2-enoate X.05 methyl (Z)-3-methoxy-2-[2-methyl-5-(3- 2:1 60:30 propylpyrazol-1-yl)phenoxy]prop-2-enoate X.05 methyl (Z)-2-(5-cyclohexyl-2-methyl-phenoxy)-3- 2:1 200:100 methoxy-prop-2-enoate X.05 methyl (Z)-2-(5-cyclohexyl-2-methyl-phenoxy)-3- 6.6:1.sup. 200:30 methoxy-prop-2-enoate X.05 methyl (Z)-2-(5-cyclohexyl-2-methyl-phenoxy)-3- .sup.1:1.6 60:100 methoxy-prop-2-enoate X.05 methyl (Z)-2-(5-cyclohexyl-2-methyl-phenoxy)-3- 2:1 60:30 methoxy-prop-2-enoate X.05 methyl (Z)-2-(5-cyclopentyl-2-methyl-phenoxy)- 2:1 200:100 3-methoxy-prop-2-enoate X.05 methyl (Z)-2-(5-cyclopentyl-2-methyl-phenoxy)- 6.6:1.sup. 200:30 3-methoxy-prop-2-enoate X.05 methyl (Z)-2-(5-cyclopentyl-2-methyl-phenoxy)- .sup.1:1.6 60:100 3-methoxy-prop-2-enoate X.05 methyl (Z)-2-(5-cyclopentyl-2-methyl-phenoxy)- 2:1 60:30 3-methoxy-prop-2-enoate X.05 methyl (Z)-2-[5-(3-isopropylpyrazol-1-yl)-2- 2:1 200:100 methyl-phenoxy]-3-methoxy-prop-2-enoate X.05 methyl (Z)-2-[5-(3-isopropylpyrazol-1-yl)-2- 6.6:1.sup. 200:30 methyl-phenoxy]-3-methoxy-prop-2-enoate X.05 methyl (Z)-2-[5-(3-isopropylpyrazol-1-yl)-2- .sup.1:1.6 60:100 methyl-phenoxy]-3-methoxy-prop-2-enoate X.05 methyl (Z)-2-[5-(3-isopropylpyrazol-1-yl)-2- 2:1 60:30 methyl-phenoxy]-3-methoxy-prop-2-enoate X.05 methyl (Z)-3-methoxy-2-[2-methyl-5-(4- 2:1 200:100 propyltriazol-2-yl)phenoxy]prop-2-enoate X.05 methyl (Z)-3-methoxy-2-[2-methyl-5-(4- 6.6:1.sup. 200:30 propyltriazol-2-yl)phenoxy]prop-2-enoate X.05 methyl (Z)-3-methoxy-2-[2-methyl-5-(4- .sup.1:1.6 60:100 propyltriazol-2-yl)phenoxy]prop-2-enoate X.05 methyl (Z)-3-methoxy-2-[2-methyl-5-(4- 2:1 60:30 propyltriazol-2-yl)phenoxy]prop-2-enoate X.05 methyl (Z)-3-methoxy-2-[2-methyl-5-[4- 2:1 200:100 (trifluoromethyl)triazol-2-yl]phenoxy]prop-2- enoate X.05 methyl (Z)-3-methoxy-2-[2-methyl-5-[4- 6.6:1.sup. 200:30 (trifluoromethyl)triazol-2-yl]phenoxy]prop-2- enoate X.05 methyl (Z)-3-methoxy-2-[2-methyl-5-[4- .sup.1:1.6 60:100 (trifluoromethyl)triazol-2-yl]phenoxy]prop-2- enoate X.05 methyl (Z)-3-methoxy-2-[2-methyl-5-[4- 2:1 60:30 (trifluoromethyl)triazol-2-yl]phenoxy]prop-2- enoate X.05 TAEGRO 2:1 200:100 X.05 TAEGRO 6.6:1.sup. 200:30 X.05 TAEGRO .sup.1:1.6 60:100 X.05 TAEGRO 2:1 60:30 X.05 Timorex GoldTM 2:1 200:100 X.05 Timorex GoldTM 6.6:1.sup. 200:30 X.05 Timorex GoldTM .sup.1:1.6 60:100 X.05 Timorex GoldTM 2:1 60:30 X.05 N-methoxy-N-[[4-[5-(trifluoromethyl)-1,2,4- 3.3:1.sup. 200:60 oxadiazol-3- yl]phenyl]methyl]cyclopropanecarboxamide X.05 N-methoxy-N-[[4-[5-(trifluoromethyl)-1,2,4- 33.3:1 200:6 oxadiazol-3- yl]phenyl]methyl]cyclopropanecarboxamide X.05 N-methoxy-N-[[4-[5-(trifluoromethyl)-1,2,4- 1:1 60:60 oxadiazol-3- yl]phenyl]methyl]cyclopropanecarboxamide X.05 N-methoxy-N-[[4-[5-(trifluoromethyl)-1,2,4- 10:1 60:6 oxadiazol-3- yl]phenyl]methyl]cyclopropanecarboxamide X.05 N,2-dimethoxy-N-[[4-[5-(trifluoromethyl)-1,2,4- 3.3:1.sup. 200:60 oxadiazol-3-yl]phenyl]methyl]propanamide X.05 N,2-dimethoxy-N-[[4-[5-(trifluoromethyl)-1,2,4- 33.3:1 200:6 oxadiazol-3-yl]phenyl]methyl]propanamide X.05 N,2-dimethoxy-N-[[4-[5-(trifluoromethyl)-1,2,4- 1:1 60:60 oxadiazol-3-yl]phenyl]methyl]propanamide X.05 N.2-dimethoxy-N-[[4-[5-(trifluoromethyl)-1,2,4- 10:1 60:6 oxadiazol-3-yl]phenyl]methyl]propanamide X.05 N-ethyl-2-methyl-N-[[4-[5-(trifluoromethyl)-1,2,4- 3.3:1.sup. 200:60 oxadiazol-3-yl]phenyl]methyl]propanamide X.05 N-ethyl-2-methyl-N-[[4-[5-(trifluoromethyl)-1,2,4- 33.3:1 200:6 oxadiazol-3-yl]phenyl]methyl]propanamide X.05 N-ethyl-2-methyl-N-[[4-[5-(trifluoromethyl)-1,2,4- 1:1 60:60 oxadiazol-3-yl]phenyl]methyl]propanamide X.05 N-ethyl-2-methyl-N-[[4-[5-(trifluoromethyl)-1,2,4- 10:1 60:6 oxadiazol-3-yl]phenyl]methyl]propanamide X.05 1-methoxy-3-methyl-1-[[4-[5-(trifluoromethyl)- 3.3:1.sup. 200:60 1,2,4-oxadiazol-3-yl]phenyl]methyl]urea X.05 1-methoxy-3-methyl-1-[[4-[5-(trifluoromethyl)- 33.3:1 200:6 1,2,4-oxadiazol-3-yl]phenyl]methyl]urea X.05 1-methoxy-3-methyl-1-[[4-[5-(trifluoromethyl)- 1:1 60:60 1,2,4-oxadiazol-3-yl]phenyl]methyl]urea X.05 1-methoxy-3-methyl-1-[[4-[5-(trifluoromethyl)- 10:1 60:6 1,2,4-oxadiazol-3-yl]phenyl]methyl]urea X.05 1,3-dimethoxy-1-[[4-[5-(trifluoromethyl)-1,2,4- 3.3:1.sup. 200:60 oxadiazol-3-yl]phenyl]methyl]urea X.05 1,3-dimethoxy-1-[[4-[5-(trifluoromethyl)-1,2,4- 33.3:1 200:6 oxadiazol-3-yl]phenyl]methyl]urea X.05 1,3-dimethoxy-1-[[4-[5-(trifluoromethyl)-1,2,4- 1:1 60:60 oxadiazol-3-yl]phenyl]methyl]urea X.05 1,3-dimethoxy-1-[[4-[5-(trifluoromethyl)-1,2,4- 10:1 60:6 oxadiazol-3-yl]phenyl]methyl]urea X.05 3-ethyl-1-methoxy-1-[[4-[5-(trifluoromethyl)-1,2,4- 3.3:1.sup. 200:60 oxadiazol-3-yl]phenyl]methyl]urea X.05 3-ethyl-1-methoxy-1-[[4-[5-(trifluoromethyl)-1,2,4- 33.3:1 200:6 oxadiazol-3-yl]phenyl]methyl]urea X.05 3-ethyl-1-methoxy-1-[[4-[5-(trifluoromethyl)-1,2,4- 1:1 60:60 oxadiazol-3-yl]phenyl]methyl]urea X.05 3-ethyl-1-methoxy-1-[[4-[5-(trifluoromethyl)-1,2,4- 10:1 60:6 oxadiazol-3-yl]phenyl]methyl]urea X.05 Ethyl 1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3- 3.3:1.sup. 200:60 yl]phenyl]methyl]pyrazole-4-carboxylate X.05 Ethyl 1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3- 33.3:1 200:6 yl]phenyl]methyl]pyrazole-4-carboxylate X.05 Ethyl 1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3- 1:1 60:60 yl]phenyl]methyl]pyrazole-4-carboxylate X.05 Ethyl 1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3- 10:1 60:6 yl]phenyl]methyl]pyrazole-4-carboxylate

(109) TABLE-US-00048 Component A Ratio Conc. (ppm) (Compound) Component B A:B (A:B) X.07 Azoxystrobin 2:1 200:100 X.07 Azoxystrobin 6.6:1.sup. 200:30 X.07 Azoxystrobin .sup.1:1.6 60:100 X.07 Azoxystrobin 2:1 60:30 X.07 Trifloxystrobin 2:1 200:100 X.07 Trifloxystrobin 6.6:1.sup. 200:30 X.07 Trifloxystrobin .sup.1:1.6 60:100 X.07 Trifloxystrobin 2:1 60:30 X.07 Metyltetraprole 2:1 200:100 X.07 Metyltetraprole 6.6:1.sup. 200:30 X.07 Metyltetraprole .sup.1:1.6 60:100 X.07 Metyltetraprole 2:1 60:30 X.07 Cyproconazole 2:1 200:100 X.07 Cyproconazole 6.6:1.sup. 200:30 X.07 Cyproconazole .sup.1:1.6 60:100 X.07 Cyproconazole 2:1 60:30 X.07 Difenoconazole 2:1 200:100 X.07 Difenoconazole 6.6:1.sup. 200:30 X.07 Difenoconazole .sup.1:1.6 60:100 X.07 Difenoconazole 2:1 60:30 X.07 Hexaconazole 2:1 200:100 X.07 Hexaconazole 6.6:1.sup. 200:30 X.07 Hexaconazole .sup.1:1.6 60:100 X.07 Hexaconazole 2:1 60:30 X.07 Prothioconazole 2:1 200:100 X.07 Prothioconazole 6.6:1.sup. 200:30 X.07 Prothioconazole .sup.1:1.6 60:100 X.07 Prothioconazole 2:1 60:30 X.07 Mefentrifluconazole 2:1 200:100 X.07 Mefentrifluconazole 6.6:1.sup. 200:30 X.07 Mefentrifluconazole .sup.1:1.6 60:100 X.07 Mefentrifluconazole 2:1 60:30 X.07 Fenpropidin 2:1 200:100 X.07 Fenpropidin 6.6:1.sup. 200:30 X.07 Fenpropidin .sup.1:1.6 60:100 X.07 Fenpropidin 2:1 60:30 X.07 Fenpropimorph 2:1 200:100 X.07 Fenpropimorph 6.6:1.sup. 200:30 X.07 Fenpropimorph .sup.1:1.6 60:100 X.07 Fenpropimorph 2:1 60:30 X.07 Fluxapyroxad 2:1 200:100 X.07 Fluxapyroxad 6.6:1.sup. 200:30 X.07 Fluxapyroxad .sup.1:1.6 60:100 X.07 Fluxapyroxad 2:1 60:30 X.07 Fluopyram 2:1 200:100 X.07 Fluopyram 6.6:1.sup. 200:30 X.07 Fluopyram .sup.1:1.6 60:100 X.07 Fluopyram 2:1 60:30 X.07 Benzovindiflupyr 33.3:1 200:6 X.07 Benzovindiflupyr 100:1 200:2 X.07 Benzovindiflupyr 10:1 60:6 X.07 Benzovindiflupyr 30:1 60:2 X.07 Pydiflumetofen 2:1 200:100 X.07 Pydiflumetofen 6.6:1.sup. 200:30 X.07 Pydiflumetofen .sup.1:1.6 60:100 X.07 Pydiflumetofen 2:1 60:30 X.07 Fluindapyr 3.3:1.sup. 200:60 X.07 Fluindapyr 33.3:1 200:6 X.07 Fluindapyr 1:1 60:60 X.07 Fluindapyr 10:1 60:6 X.07 Florylpicoxamid 2:1 200:100 X.07 Florylpicoxamid 6.6:1.sup. 200:30 X.07 Florylpicoxamid .sup.1:1.6 60:100 X.07 Florylpicoxamid 2:1 60:30 X.07 Metarylpicoxamid 3.3:1.sup. 200:60 X.07 Metarylpicoxamid 33.3:1 200:6 X.07 Metarylpicoxamid 1:1 60:60 X.07 Metarylpicoxamid 10:1 60:6 X.07 Chlorothalonil 2:1 200:100 X.07 Chlorothalonil 6.6:1.sup. 200:30 X.07 Chlorothalonil .sup.1:1.6 60:100 X.07 Chlorothalonil 2:1 60:30 X.07 Mancozeb 2:1 200:100 X.07 Mancozeb 6.6:1.sup. 200:30 X.07 Mancozeb .sup.1:1.6 60:100 X.07 Mancozeb 2:1 60:30 X.07 Mandipropamid 6.6:1.sup. 200:30 X.07 Mandipropamid .sup.1:1.6 60:100 X.07 Mandipropamid 2:1 60:30 X.07 Oxathiapiprolin .sup.1:1.6 60:100 X.07 Oxathiapiprolin 2:1 60:30 X.07 Fludioxonil .sup.1:1.6 60:100 X.07 Fludioxonil 2:1 60:30 X.07 Cyprodinil .sup.1:1.6 60:100 X.07 Cyprodinil 2:1 60:30 X.07 Metalaxyl-M .sup.1:1.6 60:100 X.07 Metalaxyl-M 2:1 60:30 X.07 N-[5-bromo-2-methyl-6-(1-methyl-2-propoxy- 2:1 200:100 ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidine X.07 N-[5-bromo-2-methyl-6-(1-methyl-2-propoxy- 6.6:1.sup. 200:30 ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidine X.07 N-[5-bromo-2-methyl-6-(1-methyl-2-propoxy- .sup.1:1.6 60:100 ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidine X.07 N-[5-bromo-2-methyl-6-(1-methyl-2-propoxy- 2:1 60:30 ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidine X.07 N-isopropyl-N-[5-methoxy-2-methyl-4-(2,2,2- 2:1 200:100 trifluoro-1-hydroxy-1-phenyl-ethyl)phenyl]-N- methyl-formamidine X.07 N-isopropyl-N-[5-methoxy-2-methyl-4-(2,2,2- 6.6:1.sup. 200:30 trifluoro-1-hydroxy-1-phenyl-ethyl)phenyl]-N- methyl-formamidine X.07 N-isopropyl-N-[5-methoxy-2-methyl-4-(2,2,2- .sup.1:1.6 60:100 trifluoro-1-hydroxy-1-phenyl-ethyl)phenyl]-N- methyl-formamidine X.07 N-isopropyl-N-[5-methoxy-2-methyl-4-(2,2,2- 2:1 60:30 trifluoro-1-hydroxy-1-phenyl-ethyl)phenyl]-N- methyl-formamidine X.07 methyl (Z)-3-methoxy-2-[2-methyl-5-[3- 2:1 200:100 (trifluoromethyl)pyrazol-1-yl]phenoxy]prop-2- enoate X.07 methyl (Z)-3-methoxy-2-[2-methyl-5-[3- 6.6:1.sup. 200:30 (trifluoromethyl)pyrazol-1-yl]phenoxy]prop-2- enoate X.07 methyl (Z)-3-methoxy-2-[2-methyl-5-[3- .sup.1:1.6 60:100 (trifluoromethyl)pyrazol-1-yl]phenoxy]prop-2- enoate X.07 methyl (Z)-3-methoxy-2-[2-methyl-5-[3- 2:1 60:30 (trifluoromethyl)pyrazol-1-yl]phenoxy]prop-2- enoate X.07 methyl (Z)-3-methoxy-2-[2-methyl-5-(3- 2:1 200:100 propylpyrazol-1-yl)phenoxy]prop-2-enoate X.07 methyl (Z)-3-methoxy-2-[2-methyl-5-(3- 6.6:1.sup. 200:30 propylpyrazol-1-yl)phenoxy]prop-2-enoate X.07 methyl (Z)-3-methoxy-2-[2-methyl-5-(3- .sup.1:1.6 60:100 propylpyrazol-1-yl)phenoxy]prop-2-enoate X.07 methyl (Z)-3-methoxy-2-[2-methyl-5-(3- 2:1 60:30 propylpyrazol-1-yl)phenoxy]prop-2-enoate X.07 methyl (Z)-2-(5-cyclohexyl-2-methyl-phenoxy)-3- 2:1 200:100 methoxy-prop-2-enoate X.07 methyl (Z)-2-(5-cyclohexyl-2-methyl-phenoxy)-3- 6.6:1.sup. 200:30 methoxy-prop-2-enoate X.07 methyl (Z)-2-(5-cyclohexyl-2-methyl-phenoxy)-3- .sup.1:1.6 60:100 methoxy-prop-2-enoate X.07 methyl (Z)-2-(5-cyclohexyl-2-methyl-phenoxy)-3- 2:1 60:30 methoxy-prop-2-enoate X.07 methyl (Z)-2-(5-cyclopentyl-2-methyl-phenoxy)- 2:1 200:100 3-methoxy-prop-2-enoate X.07 methyl (Z)-2-(5-cyclopentyl-2-methyl-phenoxy)- 6.6:1.sup. 200:30 3-methoxy-prop-2-enoate X.07 methyl (Z)-2-(5-cyclopentyl-2-methyl-phenoxy)- .sup.1:1.6 60:100 3-methoxy-prop-2-enoate X.07 methyl (Z)-2-(5-cyclopentyl-2-methyl-phenoxy)- 2:1 60:30 3-methoxy-prop-2-enoate X.07 methyl (Z)-2-[5-(3-isopropylpyrazol-1-yl)-2- 2:1 200:100 methyl-phenoxy]-3-methoxy-prop-2-enoate X.07 methyl (Z)-2-[5-(3-isopropylpyrazol-1-yl)-2- 6.6:1.sup. 200:30 methyl-phenoxy]-3-methoxy-prop-2-enoate X.07 methyl (Z)-2-[5-(3-isopropylpyrazol-1-yl)-2- .sup.1:1.6 60:100 methyl-phenoxy]-3-methoxy-prop-2-enoate X.07 methyl (Z)-2-[5-(3-isopropylpyrazol-1-yl)-2- 2:1 60:30 methyl-phenoxy]-3-methoxy-prop-2-enoate X.07 methyl (Z)-3-methoxy-2-[2-methyl-5-(4- 2:1 200:100 propyltriazol-2-yl)phenoxy]prop-2-enoate X.07 methyl (Z)-3-methoxy-2-[2-methyl-5-(4- 6.6:1.sup. 200:30 propyltriazol-2-yl)phenoxy]prop-2-enoate X.07 methyl (Z)-3-methoxy-2-[2-methyl-5-(4- .sup.1:1.6 60:100 propyltriazol-2-yl)phenoxy]prop-2-enoate X.07 methyl (Z)-3-methoxy-2-[2-methyl-5-(4- 2:1 60:30 propyltriazol-2-yl)phenoxy]prop-2-enoate X.07 methyl (Z)-3-methoxy-2-[2-methyl-5-[4- 2:1 200:100 (trifluoromethyl)triazol-2-yl]phenoxy]prop-2- enoate X.07 methyl (Z)-3-methoxy-2-[2-methyl-5-[4- 6.6:1.sup. 200:30 (trifluoromethyl)triazol-2-yl]phenoxy]prop-2- enoate X.07 methyl (Z)-3-methoxy-2-[2-methyl-5-[4- .sup.1:1.6 60:100 (trifluoromethyl)triazol-2-yl]phenoxy]prop-2- enoate X.07 methyl (Z)-3-methoxy-2-[2-methyl-5-[4- 2:1 60:30 (trifluoromethyl)triazol-2-yl]phenoxy]prop-2- enoate X.07 TAEGRO 2:1 200:100 X.07 TAEGRO 6.6:1.sup. 200:30 X.07 TAEGRO .sup.1:1.6 60:100 X.07 TAEGRO 2:1 60:30 X.07 Timorex GoldTM 2:1 200:100 X.07 Timorex GoldTM .sup.1:1.6 60:100 X.07 Timorex GoldTM 2:1 60:30 X.07 N-methoxy-N-[[4-[5-(trifluoromethyl)-1,2,4- 3.3:1.sup. 200:60 oxadiazol-3- yl]phenyl]methyl]cyclopropanecarboxamide X.07 N-methoxy-N-[[4-[5-(trifluoromethyl)-1,2,4- 33.3:1 200:6 oxadiazol-3- yl]phenyl]methyl]cyclopropanecarboxamide X.07 N-methoxy-N-[[4-[5-(trifluoromethyl)-1,2,4- 1:1 60:60 oxadiazol-3- yl]phenyl]methyl]cyclopropanecarboxamide X.07 N-methoxy-N-[[4-[5-(trifluoromethyl)-1,2,4- 10:1 60:6 oxadiazol-3 yl]phenyl]methyl]cyclopropanecarboxamide X.07 N,2-dimethoxy-N-[[4-[5-(trifluoromethyl)-1,2,4- 3.3:1.sup. 200:60 oxadiazol-3-yl]phenyl]methyl]propanamide X.07 N,2-dimethoxy-N-[[4-[5-(trifluoromethyl)-1,2,4- 33.3:1 200:6 oxadiazol-3-yl]phenyl]methyl]propanamide X.07 N,2-dimethoxy-N-[[4-[5-(trifluoromethyl)-1,2,4- 1:1 60:60 oxadiazol-3-yl]phenyl]methyl]propanamide X.07 N,2-dimethoxy-N-[[4-[5-(trifluoromethyl)-1,2,4- 10:1 60:6 oxadiazol-3-yl]phenyl]methyl]propanamide X.07 N-ethyl-2-methyl-N-[[4-[5-(trifluoromethyl)-1,2,4- 3.3:1.sup. 200:60 oxadiazol-3-yl]phenyl]methyl]propanamide X.07 N-ethyl-2-methyl-N-[[4-[5-(trifluoromethyl)-1,2,4- 33.3:1 200:6 oxadiazol-3-yl]phenyl]methyl]propanamide X.07 N-ethyl-2-methyl-N-[[4-[5-(trifluoromethyl)-1,2,4- 1:1 60:60 oxadiazol-3-yl]phenyl]methyl]propanamide X.07 N-ethyl-2-methyl-N-[[4-[5-(trifluoromethyl)-1,2,4- 10:1 60:6 oxadiazol-3-yl]phenyl]methyl]propanamide X.07 1-methoxy-3-methyl-1-[[4-[5-(trifluoromethyl)- 3.3:1.sup. 200:60 1,2,4-oxadiazol-3-yl]phenyl]methyl]urea X.07 1-methoxy-3-methyl-1-[[4-[5-(trifluoromethyl)- 33.3:1 200:6 1,2,4-oxadiazol-3-yl]phenyl]methyl]urea X.07 1-methoxy-3-methyl-1-[[4-[5-(trifluoromethyl)- 1:1 60:60 1,2,4-oxadiazol-3-yl]phenyl]methyl]urea X.07 1-methoxy-3-methyl-1-[[4-[5-(trifluoromethyl)- 10:1 60:6 1,2,4-oxadiazol-3-yl]phenyl]methyl]urea X.07 1,3-dimethoxy-1-[[4-[5-(trifluoromethyl)-1,2,4- 3.3:1.sup. 200:60 oxadiazol-3-yl]phenyl]methyl]urea X.07 1,3-dimethoxy-1-[[4-[5-(trifluoromethyl)-1,2,4- 33.3:1 200:6 oxadiazol-3-yl]phenyl]methyl]urea X.07 1,3-dimethoxy-1-[[4-[5-(trifluoromethyl)-1,2,4- 1:1 60:60 oxadiazol-3-yl]phenyl]methyl]]urea X.07 1,3-dimethoxy-1-[[4-[5-(trifluoromethyl)-1,2,4- 10:1 60:6 oxadiazol-3-yl]phenyl]methyl]urea X.07 3-ethyl-1-methoxy-1-[[4-[5-(trifluoromethyl)-1,2,4- 3.3:1.sup. 200:60 oxadiazol-3-yl]phenyl]methyl]urea X.07 3-ethyl-1-methoxy-1-[[4-[5-(trifluoromethyl)-1,2,4- 33.3:1 200:6 oxadiazol-3-yl]phenyl]methyl]urea X.07 3-ethyl-1-methoxy-1-[[4-[5-(trifluoromethyl)-1,2,4- 1:1 60:60 oxadiazol-3-yl]phenyl]methyl]urea X.07 3-ethyl-1-methoxy-1-[[4-[5-(trifluoromethyl)-1,2,4- 10:1 60:6 oxadiazol-3-yl]phenyl]methyl]urea X.07 Ethyl 1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3- 3.3:1.sup. 200:60 yl]phenyl]methyl]pyrazole-4-carboxylate X.07 Ethyl 1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3- 33.3:1 200:6 yl]phenyl]methyl]pyrazole-4-carboxylate X.07 Ethyl 1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3- 1:1 60:60 yl]phenyl]methyl]pyrazole-4-carboxylate X.07 Ethyl 1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3- 10:1 60:6 yl]phenyl]methyl]pyrazole-4-carboxylate

(110) TABLE-US-00049 Component A Ratio Conc. (ppm) (Compound) Component B A:B (A:B) X.14 Azoxystrobin 2:1 200:100 X.14 Azoxystrobin 6.6:1.sup. 200:30 X.14 Azoxystrobin .sup.1:1.6 60:100 X.14 Azoxystrobin 2:1 60:30 X.14 Trifloxystrobin 2:1 200:100 X.14 Trifloxystrobin 6.6:1.sup. 200:30 X.14 Trifloxystrobin .sup.1:1.6 60:100 X.14 Trifloxystrobin 2:1 60:30 X.14 Metyltetraprole 2:1 200:100 X.14 Metyltetraprole 6.6:1.sup. 200:30 X.14 Metyltetraprole .sup.1:1.6 60:100 X.14 Metyltetraprole 2:1 60:30 X.14 Cyproconazole 2:1 200:100 X.14 Cyproconazole 6.6:1.sup. 200:30 X.14 Cyproconazole .sup.1:1.6 60:100 X.14 Cyproconazole 2:1 60:30 X.14 Difenoconazole 2:1 200:100 X.14 Difenoconazole 6.6:1.sup. 200:30 X.14 Difenoconazole .sup.1:1.6 60:100 X.14 Difenoconazole 2:1 60:30 X.14 Hexaconazole 2:1 200:100 X.14 Hexaconazole 6.6:1.sup. 200:30 X.14 Hexaconazole .sup.1:1.6 60:100 X.14 Hexaconazole 2:1 60:30 X.14 Prothioconazole 2:1 200:100 X.14 Prothioconazole 6.6:1.sup. 200:30 X.14 Prothioconazole .sup.1:1.6 60:100 X.14 Prothioconazole 2:1 60:30 X.14 Mefentrifluconazole 2:1 200:100 X.14 Mefentrifluconazole 6.6:1.sup. 200:30 X.14 Mefentrifluconazole .sup.1:1.6 60:100 X.14 Mefentrifluconazole 2:1 60:30 X.14 Fenpropidin 2:1 200:100 X.14 Fenpropidin 6.6:1.sup. 200:30 X.14 Fenpropidin .sup.1:1.6 60:100 X.14 Fenpropidin 2:1 60:30 X.14 Fenpropimorph 2:1 200:100 X.14 Fenpropimorph 6.6:1.sup. 200:30 X.14 Fenpropimorph .sup.1:1.6 60:100 X.14 Fenpropimorph 2:1 60:30 X.14 Fluxapyroxad 2:1 200:100 X.14 Fluxapyroxad 6.6:1.sup. 200:30 X.14 Fluxapyroxad .sup.1:1.6 60:100 X.14 Fluxapyroxad 2:1 60:30 X.14 Fluopyram 2:1 200:100 X.14 Fluopyram 6.6:1.sup. 200:30 X.14 Fluopyram .sup.1:1.6 60:100 X.14 Fluopyram 2:1 60:30 X.14 Benzovindiflupyr 33.3:1 200:6 X.14 Benzovindiflupyr 100:1 200:2 X.14 Benzovindiflupyr 10:1 60:6 X.14 Benzovindiflupyr 30:1 60:2 X.14 Pydiflumetofen 2:1 200:100 X.14 Pydiflumetofen 6.6:1.sup. 200:30 X.14 Pydiflumetofen .sup.1:1.6 60:100 X.14 Pydiflumetofen 2:1 60:30 X.14 Fluindapyr 3.3:1.sup. 200:60 X.14 Fluindapyr 33.3:1 200:6 X.14 Fluindapyr 1:1 60:60 X.14 Fluindapyr 10:1 60:6 X.14 Florylpicoxamid 2:1 200:100 X.14 Florylpicoxamid 6.6:1.sup. 200:30 X.14 Florylpicoxamid .sup.1:1.6 60:100 X.14 Florylpicoxamid 2:1 60:30 X.14 Metarylpicoxamid 3.3:1.sup. 200:60 X.14 Metarylpicoxamid 33.3:1 200:6 X.14 Metarylpicoxamid 1:1 60:60 X.14 Metarylpicoxamid 10:1 60:6 X.14 Chlorothalonil 2:1 200:100 X.14 Chlorothalonil 6.6:1.sup. 200:30 X.14 Chlorothalonil .sup.1:1.6 60:100 X.14 Chlorothalonil 2:1 60:30 X.14 Mancozeb 2:1 200:100 X.14 Mancozeb 6.6:1.sup. 200:30 X.14 Mancozeb .sup.1:1.6 60:100 X.14 Mancozeb 2:1 60:30 X.14 Mandipropamid 2:1 200:100 X.14 Mandipropamid 6.6:1.sup. 200:30 X.14 Mandipropamid .sup.1:1.6 60:100 X.14 Mandipropamid 2:1 60:30 X.14 Oxathiapiprolin 2:1 200:100 X.14 Oxathiapiprolin 6.6:1.sup. 200:30 X.14 Oxathiapiprolin .sup.1:1.6 60:100 X.14 Oxathiapiprolin 2:1 60:30 X.14 Fludioxonil 2:1 200:100 X.14 Fludioxonil 6.6:1.sup. 200:30 X.14 Fludioxonil .sup.1:1.6 60:100 X.14 Fludioxonil 2:1 60:30 X.14 Cyprodinil 2:1 200:100 X.14 Cyprodinil 6.6:1.sup. 200:30 X.14 Cyprodinil .sup.1:1.6 60:100 X.14 Cyprodinil 2:1 60:30 X.14 Metalaxyl-M 2:1 200:100 X.14 Metalaxyl-M 6.6:1.sup. 200:30 X.14 Metalaxyl-M .sup.1:1.6 60:100 X.14 Metalaxyl-M 2:1 60:30 X.14 N-[5-bromo-2-methyl-6-(1-methyl-2-propoxy- 2:1 200:100 ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidine X.14 N-[5-bromo-2-methyl-6-(1-methyl-2-propoxy- 6.6:1.sup. 200:30 ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidine X.14 N-[5-bromo-2-methyl-6-(1-methyl-2-propoxy- .sup.1:1.6 60:100 ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidine X.14 N-[5-bromo-2-methyl-6-(1-methyl-2-propoxy- 2:1 60:30 ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidine X.14 N-isopropyl-N-[5-methoxy-2-methyl-4-(2,2,2- 2:1 200:100 trifluoro-1-hydroxy-1-phenyl-ethyl)phenyl]-N- methyl-formamidine X.14 N-isopropyl-N-[5-methoxy-2-methyl-4-(2,2,2- 6.6:1.sup. 200:30 trifluoro-1-hydroxy-1-phenyl-ethyl)phenyl]-N- methyl-formamidine X.14 N-isopropyl-N-[5-methoxy-2-methyl-4-(2,2,2- .sup.1:1.6 60:100 trifluoro-1-hydroxy-1-phenyl-ethyl)phenyl]-N- methyl-formamidine X.14 N-isopropyl-N-[5-methoxy-2-methyl-4-(2,2,2- 2:1 60:30 trifluoro-1-hydroxy-1-phenyl-ethyl)phenyl]-N- methyl-formamidine X.14 methyl (Z)-3-methoxy-2-[2-methyl-5-[3- 2:1 200:100 (trifluoromethyl)pyrazol-1-yl]phenoxy]prop-2- enoate X.14 methyl (Z)-3-methoxy-2-[2-methyl-5-[3- 6.6:1.sup. 200:30 (trifluoromethyl)pyrazol-1-yl]phenoxy]prop-2- enoate X.14 methyl (Z)-3-methoxy-2-[2-methyl-5-[3- .sup.1:1.6 60:100 (trifluoromethyl)pyrazol-1-yl]phenoxy]prop-2- enoate X.14 methyl (Z)-3-methoxy-2-[2-methyl-5-[3- 2:1 60:30 (trifluoromethyl)pyrazol-1-yl]phenoxy]prop-2- enoate X.14 methyl (Z)-3-methoxy-2-[2-methyl-5-(3- 2:1 200:100 propylpyrazol-1-yl)phenoxy]prop-2-enoate X.14 methyl (Z)-3-methoxy-2-[2-methyl-5-(3- 6.6:1.sup. 200:30 propylpyrazol-1-yl)phenoxy]prop-2-enoate X.14 methyl (Z)-3-methoxy-2-[2-methyl-5-(3- .sup.1:1.6 60:100 propylpyrazol-1-yl)phenoxy]prop-2-enoate X.14 methyl (Z)-3-methoxy-2-[2-methyl-5-(3- 2:1 60:30 propylpyrazol-1-yl)phenoxy]prop-2-enoate X.14 methyl (Z)-2-(5-cyclohexyl-2-methyl-phenoxy)-3- 2:1 200:100 methoxy-prop-2-enoate X.14 methyl (Z)-2-(5-cyclohexyl-2-methyl-phenoxy)-3- 6.6:1.sup. 200:30 methoxy-prop-2-enoate X.14 methyl (Z)-2-(5-cyclohexyl-2-methyl-phenoxy)-3- .sup.1:1.6 60:100 methoxy-prop-2-enoate X.14 methyl (Z)-2-(5-cyclohexyl-2-methyl-phenoxy)-3- 2:1 60:30 methoxy-prop-2-enoate X.14 methyl (Z)-2-(5-cyclopentyl-2-methyl-phenoxy)- 2:1 200:100 3-methoxy-prop-2-enoate X.14 methyl (Z)-2-(5-cyclopentyl-2-methyl-phenoxy)- 6.6:1.sup. 200:30 3-methoxy-prop-2-enoate X.14 methyl (Z)-2-(5-cyclopentyl-2-methyl-phenoxy)- .sup.1:1.6 60:100 3-methoxy-prop-2-enoate X.14 methyl (Z)-2-(5-cyclopentyl-2-methyl-phenoxy)- 2:1 60:30 3-methoxy-prop-2-enoate X.14 methyl (Z)-2-[5-(3-isopropylpyrazol-1-yl)-2- 2:1 200:100 methyl-phenoxy]-3-methoxy-prop-2-enoate X.14 methyl (Z)-2-[5-(3-isopropylpyrazol-1-yl)-2- 6.6:1.sup. 200:30 methyl-phenoxy]-3-methoxy-prop-2-enoate X.14 methyl (Z)-2-[5-(3-isopropylpyrazol-1-yl)-2- .sup.1:1.6 60:100 methyl-phenoxy]-3-methoxy-prop-2-enoate X.14 methyl (Z)-2-[5-(3-isopropylpyrazol-1-yl)-2- 2:1 60:30 methyl-phenoxy]-3-methoxy-prop-2-enoate X.14 methyl (Z)-3-methoxy-2-[2-methyl-5-(4- 2:1 200:100 propyltriazol-2-yl)phenoxy]prop-2-enoate X.14 methyl (Z)-3-methoxy-2-[2-methyl-5-(4- 6.6:1.sup. 200:30 propyltriazol-2-yl)phenoxy]prop-2-enoate X.14 methyl (Z)-3-methoxy-2-[2-methyl-5-(4- .sup.1:1.6 60:100 propyltriazol-2-yl)phenoxy]prop-2-enoate X.14 methyl (Z)-3-methoxy-2-[2-methyl-5-(4- 2:1 60:30 propyltriazol-2-yl)phenoxy]prop-2-enoate X.14 methyl (Z)-3-methoxy-2-[2-methyl-5-[4- 2:1 200:100 (trifluoromethyl)triazol-2-yl]phenoxy]prop-2- enoate X.14 methyl (Z)-3-methoxy-2-[2-methyl-5-[4- 6.6:1.sup. 200:30 (trifluoromethyl)triazol-2-yl]phenoxy]prop-2- enoate X.14 methyl (Z)-3-methoxy-2-[2-methyl-5-[4- .sup.1:1.6 60:100 (trifluoromethyl)triazol-2-yl]phenoxy]prop-2- enoate X.14 methyl (Z)-3-methoxy-2-[2-methyl-5-[4- 2:1 60:30 (trifluoromethyl)triazol-2-yl]phenoxy]prop-2- enoate X.14 TAEGRO 2:1 200:100 X.14 TAEGRO 6.6:1.sup. 200:30 X.14 TAEGRO .sup.1:1.6 60:100 X.14 TAEGRO 2:1 60:30 X.14 Timorex GoldTM 2:1 200:100 X.14 Timorex GoldTM 6.6:1.sup. 200:30 X.14 Timorex GoldTM .sup.1:1.6 60:100 X.14 Timorex GoldTM 2:1 60:30 X.14 N-methoxy-N-[[4-[5-(trifluoromethyl)-1,2,4- 3.3:1.sup. 200:60 oxadiazol-3- yl]phenyl]methyl]cyclopropanecarboxamide X.14 N-methoxy-N-[[4-[5-(trifluoromethyl)-1,2,4- 33.3:1 200:6 oxadiazol-3- yl]phenyl]methyl]cyclopropanecarboxamide X.14 N-methoxy-N-[[4-[5-(trifluoromethyl)-1,2,4- 1:1 60:60 oxadiazol-3- yl]phenyl]methyl]cyclopropanecarboxamide X.14 N-methoxy-N-[[4-[5-(trifluoromethyl)-1,2,4- 10:1 60:6 oxadiazol-3- yl]phenyl]methyl]cyclopropanecarboxamide X.14 N,2-dimethoxy-N-[[4-[5-(trifluoromethyl)-1,2,4- 3.3:1.sup. 200:60 oxadiazol-3-yl]phenyl]methyl]propanamide X.14 N,2-dimethoxy-N-[[4-[5-(trifluoromethyl)-1,2,4- 33.3:1 200:6 oxadiazol-3-yl]phenyl]methyl]propanamide X.14 N,2-dimethoxy-N-[[4-[5-(trifluoromethyl)-1,2,4- 1:1 60:60 oxadiazol-3-yl]phenyl]methyl]propanamide X.14 N,2-dimethoxy-N-[[4-[5-(trifluoromethyl)-1,2,4- 10:1 60:6 oxadiazol-3-yl]phenyl]methyl]propanamide X.14 N-ethyl-2-methyl-N-[[4-[5-(trifluoromethyl)-1,2,4- 3.3:1.sup. 200:60 oxadiazol-3-yl]phenyl]methyl]propanamide X.14 N-ethyl-2-methyl-N-[[4-[5-(trifluoromethyl)-1,2,4- 33.3:1 200:6 oxadiazol-3-yl]phenyl]methyl]propanamide X.14 N-ethyl-2-methyl-N-[[4-[5-(trifluoromethyl)-1,2,4- 1:1 60:60 oxadiazol-3-yl]phenyl]methyl]propanamide X.14 N-ethyl-2-methyl-N-[[4-[5-(trifluoromethyl)-1,2,4- 10:1 60:6 oxadiazol-3-yl]phenyl]methyl]propanamide X.14 1-methoxy-3-methyl-1-[[4-[5-(trifluoromethyl)- 3.3:1.sup. 200:60 1,2,4-oxadiazol-3-yl]phenyl]methyl]urea X.14 1-methoxy-3-methyl-1-[[4-[5-(trifluoromethyl)- 33.3:1 200:6 1,2,4-oxadiazol-3-yl]phenyl]methyl]urea X.14 1-methoxy-3-methyl-1-[[4-[5-(trifluoromethyl)- 1:1 60:60 1,2,4-oxadiazol-3-yl]phenyl]methyl]urea X.14 1-methoxy-3-methyl-1-[[4-[5-(trifluoromethyl)- 10:1 60:6 1,2,4-oxadiazol-3-yl]phenyl]methyl]urea X.14 1,3-dimethoxy-1-[[4-[5-(trifluoromethyl)-1,2,4- 3.3:1.sup. 200:60 oxadiazol-3-yl]phenyl]methyl]urea X.14 1,3-dimethoxy-1-[[4-[5-(trifluoromethyl)-1,2,4- 33.3:1 200:6 oxadiazol-3-yl]phenyl]methyl]urea X.14 1,3-dimethoxy-1-[[4-[5-(trifluoromethyl)-1,2,4- 1:1 60:60 oxadiazol-3-yl]phenyl]methyl]urea X.14 1,3-dimethoxy-1-[[4-[5-(trifluoromethyl)-1,2,4- 10:1 60:6 oxadiazol-3-yl]phenyl]methyl]urea X.14 3-ethyl-1-methoxy-1-][4-[5-(trifluoromethyl)-1,2,4- 3.3:1.sup. 200:60 oxadiazol-3-yl]phenyl]methyl]urea X.14 3-ethyl-1-methoxy-1-[[4-[5-(trifluoromethyl)-1,2,4- 33.3:1 200:6 oxadiazol-3-yl]phenyl]methyl]urea X.14 3-ethyl-1-methoxy-1-[[4-[5-(trifluoromethyl)-1,2,4- 1:1 60:60 oxadiazol-3-yl]phenyl]methyl]urea X.14 3-ethyl-1-methoxy-1-[[4-[5-(trifluoromethyl)-1,2,4- 10:1 60:6 oxadiazol-3-yl]phenyl]methyl]urea X.14 Ethyl 1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3- 3.3:1.sup. 200:60 yl]phenyl]methyl]pyrazole-4-carboxylate X.14 Ethyl 1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3- 33.3:1 200:6 yl]phenyl]methyl]pyrazole-4-carboxylate X.14 Ethyl 1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3- 1:1 60:60 yl]phenyl]methyl]pyrazole-4-carboxylate X.14 Ethyl 1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3- 10:1 60:6 yl]phenyl]methyl]pyrazole-4-carboxylate